International SOS 
EMS Protocols
Protocols, Policies & Procedures
2025
EMR / EMT / A-EMT / Paramedic
Policies Adult Medical Adult Trauma Procedures
Pharmaceuticals Peds Medical Peds Trauma Resources



Table of Contents
Preliminary Information
Introduction……………………………………………………………………………………………………………………….………..……….……..……………….. 8
Guidelines……………………………………………………………………………………………………………………………………..…..……….…....………….. 9
Dedication…………………………………………………………………………………………………………………………………..…………….………....………. 10
Policies
Medical Transport Destination…………………………………………………………………………………………………………………..…..….…………..11
Request for Helicopter EMS (HEMS)………………………………………………………………………………………………………………..………....... 12
EMS Physician Response…………………………...………………………………………………………………………………………………………...………..13
Do Not Resuscitate (DNR)…………………………………………………………………………………………………………………………………...………….14
Criteria for Death / Withholding Resuscitation / Termination of Resuscitation……………………………………………………………. 15
Child / Elder Abuse Recognition and Reporting ……………………………………………………………………………………………………………. 16
Abandoned Infant…………………..……………………………………………………………………………………………….………………………...………... 17
Documentation of Patient Care……………………………………………………………………………………………………………………………………...18
Domestic Violence (Spousal and/or Partner Abuse Recognition and Reporting)……………………………………………………..........19
Emergent Interhospital Transfers…………………………………………………………………………………………………………………………………...20
Lights and Siren During Patient Transport……………………………………………………………………………………………………………………... 21
Non-Paramedic Transport of Patients……………………………………………………………………………………………………………………………. 22
Paramedic Intercept Guidelines…………………………………………………………………………………………………………………………………….. 23
Patient Care During Transport………………………………………………………………………………………………………………………………………..24
Medical Provider Bystander on Scene……………………………………………………………………………………………………………………………. 25
Poison Control………………………………………………………………………………………………………………………………………………………………..26
Patients in Police Custody……………………………………………………………………………………………………………………………………………….27
Radio Report Format……………………………………………………………………………………………………………………………………………………… 28
Transfer of Care at Hospital…………………………………………………………………………………………………………………………………………….29
Persons with EMS Care Plans……………………………………………………………………………………………………………………………..…………..30
Adult Medical Protocols
General Approach…………………………………………………………………………………………………………………………………………………………..31
Airway / Breathing
Airway Management………………………………………………………………………………………………………………………….……….………….. 32
Rapid Sequence Airway………………………………………………………………………………………………………………………….…….………….33
Post Advanced Airway Sedation……………………………………………………………………………………………………………………………... 34
COPD / Asthma…………………………………………………………………………………………………………………………………………….…………. 35
CHF / Pulmonary Edema……………………………………………………………………………………………………………………………...…………. 36
Circulation
Cardiac Arrest……………………………………………………………………………………………………………………………………………..………….. 37
ECPR or “ECMO”…………………………………………………………………………………………………………………………………………………….. 39
Post-Resuscitation………………………………………………………………………………………………………...…………………..…………………… 40
Chest Pain / Suspected Acute Coronary Syndrome………………………………………………..………………………………..……………… 41
ST-Elevation Myocardial Infarction (STEMI)………………………………………………………………………………………………..…………...42
Tachycardia With a Pulse………………………………………….…………………………………………………………………..…………….…………..43
Bradycardia With a Pulse…………………………………………………………………………………………………………………………....…………..44
Abdominal Pain / GI Bleeding…………………………………………………………………………………………………………………………...…………...45
Allergic Reaction………………………………………………………………………………………………………………………………………….………………... 46
Behavioral Emergencies…………………………………………………………………………………………………………………………………...…………… 47
Diabetic Emergencies………………………………………………………………………………………………………………….…………………….………….. 48
IV Access……………………………………………………………………………………………………………..………………………………………………........... 49

Table of Contents
Adult Medical Protocols (continued)
Obstetrics and Gynecology
OB General………………………………………………………………………………………………………………………………………...…………….….….50
OB / Vaginal Bleeding……………………………………………………………………………………………………………………………...……...……...51
Labor / Imminent Delivery…………………………………………………………………………………………………………………………...……...….52
Newly Born………………………………………………………………………………………………………………………………………………...……..…... 53
Toxicology
Overdose and Poisoning…………………………………………………………………………………………………………………………………………..54
Overdose and Poisoning Reference………………………………………………………………………………………………………………………….55
Cholinergic / Organophosphate Overdose……….…………………………………………………………………..………………………………….56
Carbon Monoxide Poisoning………………………………………………………………………………………………………………..…………..…….. 57
Pain Management……………………………………………………………………………………………………………………………..………………………….. 58
Refusals
Refusal Protocol……………………………………………………………………………………………………………...……………………………...……...59
Refusal After EMS Treatment Protocol………………………………………………………………………………..…………………………………..60
Seizure………………………………………………………………………………………………………………………………………………………………...……….. 61
Sepsis Screening………………………………………………………………………………..………………………………………………………………………….. 62
Shock/Hypotension (Non-Trauma)………………………………………………………….…………………………………………………………………….. 63
Suspected Stroke…………………………………………………………………………………………………………………………………………………………….64
Syncope or Near-Syncope……………………………………………………………………………………………………………………………………………….65
Adult Trauma Protocols
General Approach…………………………………………………………………………………………………………………………………………..……….……..66
Destination Determination……………………………………...……………………………………………………………………………………….…….…….. 67
Bites and Envenomations……………………………………………..………………………………………………………………………..……………….……..68
Burns…………………………………………………………………………………………………………………………………………………………………..………….69
Traumatic Cardiac Arrest………………………………………………………..………………………………………………………………..…………………….70
Chemical / Electrical Burn…………………………………………………………...………………………………………………………….…………………….. 71
Chest Injury……………………………………………………………………………………...………………………………………………………….……………….. 72
Prolonged Crush Injury…………………………………………………………………………...…………………………………………………………….…..…..73
Near-Drowning / Submersion Injury……………………………………………………………..………………………………………………………..……...74
Environmental – Hyperthermia………………………………………………………………………...……………………………………………….…………..75
Environmental – Hypothermia………………………………………………………………………………...………………………………………….….……..76
Extremity Injury…………………………………………………………………………………………………………...…………………………………….…………. 77
Eye Pain……..……………………………………………………………………………………………………………………...………………………………….….….. 78
Hazmat, General……………………………………………………………………………………………………………………...……………………….…………...79
Head Injury…………………………………………………………………………………………………………………………………...…………………….….……..80
Hemorrhage Control………………………………………………………………………………………………………………………………………….……….…. 81
Lightning Strike………………………………………………………………………………………………………………………………………...………….………..82
Electronic Control Device (a.k.a. TASER)………………………………………………………………………………………………………...……….……..83
Selective Spinal Motion Restriction…………...………………………………………………………………………………………………………….…..…..84
Shock / Hypotension (Trauma)…………………………………………………………………...……………………………………………………….…………85
Special Operations
Public Safety Personnel Rehab……………………………………………………………………………...…………………………………………….…..86

Table of Contents
Peds Medical Protocols
Quick Reference…………………………………………………………..………………………………………………….………………………...….……………... 87
Destination Determination……………………………………………………………………………………………………………………………..…………….. 88
General Approach………………………………………………………………………………………………………………………………………………...………..89
Airway / Breathing
Airway Management…………………………………………………………………………………………………………………………………………..….. 90
Rapid Sequence Airway……………………………………….…………………………………………………………………………………………………. 91
Post Airway Sedation…………………………………………….………………………………………………………………………………………………… 92
Wheezing / Asthma………………………………………………………...……………………………………………………………………………………….93
Circulation
Neonatal Resuscitation………………………………………………………….…………………………………………………………………………………94
Cardiac Arrest, General……………………………………………………………..……………………………………………………………………………. 95
Cardiac Arrest, Reference………………………………………………………………………………………………………………………………………...96
Post Resuscitation Care…………………………………………………………………...……………………………………………………………………...97
Tachycardia With A Pulse…………………………………………………………………….…………………………………………………………………..98
Bradycardia With A Pulse…………………………………………………………………………….…………………………………………………………..99
Allergic Reaction……………………………………………………………………………………………………………………………………………………………. 100
Behavioral Emergencies……………………………………………………………………………………………………………………………………………….. 101
Brief Resolved Unexplained Event (BRUE – formerly “ALTE”)………………………………………………………………………………………... 102
Diabetic Emergencies………………………………………………………………………………………………………...…………………………………………..103
IV Access……………………………………………………………………………………………………………………………………………………………………….. 104
Toxicology
Overdose and Poisoning, General………………………………………………………………………………………...………………………………….105
Overdose and Poisoning, Reference………………………………………………………………………………………………………………………...106
Pain Management…………………………………………………………………………………………………………………………….…………………………….107
Refusal Protocol……………………………………………………………………………………………………………………………………...……………………..108
Seizure………………………………………………………………………………………………………………………………………………………...………………...109
Shock / Hypotension……………………..…………………………………………………………………………………………………………………..…………..110
Sickle Cell Crisis……………………………………………………………………………………………………………………………………………………………… 111
Syncope / Near Syncope……………………………………………………………………………….………………………………………………………………...112
Peds Trauma Protocols
Quick Reference………………………………………………………...…………………………………………………………………………………………………..113
Destination Determination……………………………………………..…………………………………………………………………………………………….. 114
General Approach………………………………………………………………...………………………………………………………………………………………..115
Traumatic Cardiac Arrest…………………………………………………………...…………………………………………………………………………………..116
Bites and Envenomations………………………………………………………………………………………………………………………………………………. 117
Burns……………………………………………………………………………………………………….……………………………………………………………………..118
Chest Injury…………………………………………………………………………………………………...……………………………………………………………….119
Prolonged Crush Injury………………………………………………………………………………………………………………………………………………….. 120
Near-Drowning / Submersion Injury………………………………………………………………………...…………………………………………………….121
Environmental – Hyperthermia……………………………………………………………………………………..………………………………………………. 122
Environmental – Hypothermia…………………………………………………………………………………………..………………………………………….. 123
Extremity Injury……………………………………………………………………………………………………………………….……………………………………..124
Eye Pain………………………………………………………………………………………………………………………………………...……………………………….125
Head Injury……………………………………………………………………………………………………………………………………………………………………. 126
Hemorrhage Control………………………………………………………………………………………………………………………………..……………………. 127
Selective Spinal Motion Restriction…………...…………………………………………………………………………………………...……………………..128

Table of Contents
Procedures
Cardiac Monitoring
12-Lead ECG………………………………………………………………………………………………………………………………………………..…….…….129
Right Sided ECG………………………………………………………………………………………………………………………………………………...…....130
Posterior ECG……………………………………………………………………………………………………………………………………………………….…. 131
Airway
Airway Obstruction………………………………………………………………………………………………………………………………………………....132
Pulse Oximetry…………………………………………………………………………………………………………………………………………………...….. 133
Intubation…………………………………………………………………………………………………………………………………………..………………..... 134
Pediatric Intubation………………………………………………………………………………………………………………………………………….…….. 136
King LTS-D Laryngeal Tube Airway…………………………………………………………………………………………………………….………….....138
i-gel Airway……………………………………………………………………………………………………………………………………………………………...140
Suctioning (Basic)……………………………………………………………………………………………………………………………………………..........142
Suctioning ET Tube…………………………………...……………………………………………………………………………………………………………..143
Tracheostomy Care…………………………………………………………………………………………………………………………………………………. 144
Continuous Positive Airway Pressure (CPAP)…………………………………………………………………………………………………........... 146
Capnography………………………………………………………………………………………………………………………………………………..………….147
Cricothyrotomy………………………………………………………………………………………………………………………………………………..........148
Cricothyrotomy (Open) Surgical…………………………………………………………………………………………………………………..…………..149
Control Cric……………………………………………………………………………………………………………………………………………………………...150
Needle Jet Insufflation………………………………………………………………………………………………………………………………….………….151
Blood Glucose……………………………………………………………………………………………………………………………………………………..………….152
Carbon Monoxide Measurement………………………………………………………………………………………………………………………..…………. 153
Cardiac
Cardioversion………………………………………………………………………………………………………………………………………………..………...154
Cardiopulmonary Resuscitation (CPR)…………………………………………………………………………………………………………...……….. 155
High-Performance CPR……………………………………………………………………………………………………………………………………...……. 156
Defibrillation…………………………………………………………………………………………………………………………………………………...……...157
Double Sequential Defibrillation……………………………………………………………………………………………………………………………...158
External Cardiac Pacing………………………………………………………………………………………………………………………………...………… 159
Mechanical CPR Device (LUCAS)………………………………………………………………………………………………………………………...……160
Mechanical CPR Device (AutoPulse)………………………………………………………………………………………………………………………...162
Chest Decompression………………………………………………………………………………………………………………………………………...…………. 164
BE-FAST Stroke Screen………...……………………………………………………………………………………………………………………………...……….. 165
FAST-ED Stroke Screen…………………………………………………………………………………………………………………………………………………...166
Intranasal………..................................................................................................................................................................... 167
Orogastric Tube Insertion………………………………………………………………………………………………………………………..……………………..168
Restraints……………………………………………………………………………………………………………………………………………………..………………..169
Spinal Immobilization…………………………………………………………………………………………………………………………………………..………...170
Spinal Immobilization of Athletes with Helmets…………………………………………………………………………………………..………………...171
Splinting……………………………………………………………………………………………………………………………………………………………..…………. 172
Pelvic Binder…………………………………………………………………………………………………………………………………………………………………..173
Tourniquet (CAT – Combat Application Tourniquet)………………………………………………………………………………………………………. 174
SOF Tactical Tourniquet – Wide…………………………………………………………………………………………………………………………………….. 175
Venous Access
Accessing Peripherally Inserted Central Catheter (PICC)……………………………………………………………..………………………….. 176
Extremity Venous Access…………………………………………………………………………………………………………………………..……………. 177
Intraosseous Venous Access…………………………………………………………………………………………………………………..………………..178
External Jugular Venous Access…………………………………………………………………………………………………………………..………….. 179
Wound Care / Wound Packing……………………………………………………………………………………………………………………………..……….. 180
Ventricular Assist Device (VAD)………………………………………………………………………………………………………………………………………………. 181
Nitrous Oxide……………………………………………………………………………………………………………………………………………………………………..……182
SALT Triage / Base Hospital..…………………………………………………………………………………………………………………………………………………….183
K9 – Care for Law Enforcement Working Canine……………………………………………………………………………………………………………………...186
Push Dose Epinephrine…………………………………………………………………………………………………………………………………………………………….190

Table of Contents
Pharmaceuticals
Overview………………………………………………………………………………………………………………...……………………………..…………..………….191
Acetaminophen……………………………………………………………..………………………………………………………………………………………….….. 192
Adenosine……………………………………………………………………………………………………………………...……………………………………..…..…..193
Albuterol……………………………………………………………………………………………………………………………...………………………………..……...194
Amiodarone……………………………………………………………………………………………………………………………...……………………………..…….195
Aspirin…………………………………………………………………………………………………………………………………………...………………………….….. 196
Atropine……………………………………………………………………………………………………………………………………………...…………………..…….197
Calcium……………………………………………………………………………………………………………………………………………………….…….…….……..198
Dextrose…………………………………………………………………………………………………………………………………………………………….……..…...199
Diazepam……………………………………………………………………………………………………………………………………………………………….……... 200
Diltiazem……………………………………………………………………………………………………………………………………………………………...…….....201
Diphenhydramine………………………………………………………………………………………………………………………...……………………….…..…..202
DuoDote Kit…………………………………………………………………………………………………………………………………………….………………………203
Epinephrine………………………………………………………………………………………………………………………………………………………………......204
Etomidate………………………………………………………………………………………………………………………………………………………………..……. 205
Famotidine………………………………………………………………………………………………………………………………………………………...….……….206
Fentanyl…………………………………………………………………………………………………………………………………………………………………….….. 207
Glucagon……………………………………………………………………………………………………………………………………………………………………….. 208
Glucose (Oral)………………………………………………………………………………………………..……………………………………………………….…….. 209
Haloperidol………………………………………………………………………………………………………...…………………………………………………….…...210
Hydroxocobalamin…………………………………………………………………………………………………..……………………………………………………. 211
Ibuprofen………………………………………………………………………………………………………………………………………………………………………. 212
Ipratropium…………………………………………………………………………………………………………………………………………………………………... 213
Ketamine………………………………………………………………………………………………………………………………………………………………………. 214
Ketorolac……………………………………………………………………………………………………………………………………..………………………...…….. 215
Lidocaine………………………………………………………………………………………………………………………………………………………………………..216
Lorazepam…………………………………………………………………………………………………………………………………………………………………….. 217
Magnesium…………………………………………………………………………………………………………………...……………………………………………….218
Mark 1 Kit…………………………………………………………………………………………………………………………...………………………………………….219
Methylprednisolone………………………………………………………………………………………………………………...…………………………………….220
Midazolam…………………………………………………………………………………………………………………………………...………………………………..221
Naloxone…………………………………………………………………………………………………………………………………………...…………………………..222
Nitroglycerin.…………………………………………………………………………………………………………………………………………….…………….……..223
Nitrous Oxide………………………………………………………………………………………………………………………………………………..………………. 224
Norepinephrine………………………………………………………………………………………………………………………………………………...……………225
Ondansetron…………………………………………………………………………………………………………………………………………………………...……. 226
Rocuronium……………………………………………………………………………………………………………………………...……………………………….…..227
Sodium Bicarbonate……………………………………………………………………………………………………………………...………………………….…...228
Succinylcholine…………………………………………………………………………………………………………………………………………………………...... 229
Tranexamic Acid (TXA)……………………………………………………………………………………………………………………………..……………………. 230
Quick References 
King Chart…………………………………………………………………………………………………………………………………………………………….…………231
Pressor Reference…………………………………………………………………………………………………………………………………………………………..233
Adult Med Quick Reference……………………………………………………………………………………………………………………………………...……235
Peds Airway…………………………………………………………………………………………………………………………………………………………………… 241
Peds Cardiac Arrest……………………………………………………………………………………………………………………………………………………..… 242
Peds Arrhythmias…………………………………………………………………………………………………………………………………………………………...243
Peds Allergic Reaction………………………………………………………………………………………………………………………………………………….…244
Peds Seizure………………………………………………………………………………………………………………………………………………………………...…245
Approved Abbreviations……………………………………………………………………………………………………………………………………….………..246
Index………………………………………………………………………………………………………………………………………………………………………………….. 250

Authorization:
The following medical protocols are authorized by the International SOS Government Medical Services (GMS) EMS Medical 
Director. Changes to these protocols may only be made with explicit authorization from the Medical Director."
David Angelette
Medical Director
Jonathan Campbell 
Medical Director
Alexander Smith
Director of Clinical Operations
Aaron Duncan
EMS Chief
Introduction:
The EMS protocols contained within this document are intended to ensure standardized treatment for all patients receiving 
care from EMS agencies and providers participating in the International SOS Government Medical Services (GMS) EMS 
Programs. These protocols are exclusively applicable to agencies and providers operating under the authority of the 
International SOS GMS EMS Programs. Any other use must receive prior approval from the International SOS GMS EMS 
Medical Director.
These protocols are the product of extensive review, incorporating evidence-based guidelines, historically validated 
treatments, and best practices from internationally recognized EMS systems. It is our intent that this document serves as a 
valuable resource for education, training, and reference, thereby enabling the International SOS GMS EMS Programs to 
consistently deliver the highest quality of pre-hospital care. While every effort has been made to cover a wide array of 
patient care scenarios, unforeseen circumstances or unique patient care needs may arise. In such cases, EMS providers 
should rely on their education, experience, clinical judgment, and the principles of patient-centered care to deliver optimal 
outcomes. Online Medical Control remains available at all times for consultation and assistance with any situation or 
patient presentation not explicitly addressed within these protocols.
Acknowledgements:
These protocols have undergone rigorous review by the International SOS GMS EMS Medical Director, the Medical Advisory 
Committee, and representatives from various sectors of the medical community. The goal is to provide uniformity and 
consistency in patient treatment across all provider levels. The protocols have been assessed for clinical relevance, 
practicality, and internal consistency. While perfection is challenging to achieve, it is our sincere belief that this document 
represents a comprehensive and robust protocol framework aligned with, if not exceeding, internationally recognized EMS 
standards. International SOS GMS EMS Programs acknowledges and appreciates the contributions and efforts of all 
individuals and groups involved in the creation and review of this document.
“Don’t judge each day by the harvest you reap, but by the seeds that you plant.”
-Robert Louis Stevenson
8

Guidelines for Use of Protocols:
In general, the protocols are divided into Adult and Pediatric sections, with subheadings for Medical and Trauma. For 
pediatric patients, the appropriate pediatric-specific protocol should be used if one exists. If there is no pediatric-specific 
protocol for a condition, use the adult protocol but use weight-based dosing for medications. The adult dose of a 
medication should never be exceeded for a pediatric patient.
There have been significant updates from previous versions of the EMS protocols. While the core purpose—to deliver the 
highest quality, patient-centered care—remains unchanged, this edition represents a substantially revised and updated 
document. A summary of the primary formatting changes is provided below; however, it does not substitute for a thorough 
review of the protocol document itself. Providers should take adequate time to become familiar with the new structure, 
content, and workflow of the updated protocols.
In order to make the flowcharts easier to read, a standardized presentation has been adopted. For circumstances 
where an EMS Provider needs to make a decision, the question appears in a diamond-shaped box with the answers 
coming off in separate, usually opposite directions. For simplicity, every attempt was made to make these “yes/no” 
or dichotomous decisions whenever possible.
When an EMS Provider is referenced to another PROTOCOL within the book, the name of the Protocol appears in a 
rectangular box, with a lime-green shadow.
If there is a bi-directional arrow referencing another PROTOCOL, the intention is that the EMS Provider returns to 
the current Protocol after a critical assessment or treatment is completed in the referenced Protocol. For example, 
a bi-directional arrow referencing the Airway Management, Adult Protocol would imply that after the airway has 
been addressed that the Provider return to the current Protocol for further evaluation and patient management.
When an EMS Provider is referenced to a PROCEDURE within the book, the name of the Procedure appears in a 
rectangular box, with a purple shadow.
When medications are referenced in the Protocol, they are coded to the level of the EMS Provider with a key 
attached to the left side of the medication box. Procedures and medications that are in the scope of EMR providers 
have a CLEAR box attached to the left side, EMTs have a GRAY box with the letter B, Advanced EMTs have a 
YELLOW box with the letter A and Paramedics have a BLUE box with the letter P. Any time Medical Control must be 
contacted for approval or authorization, the key is RED with the letter M. The Legend appears in the top left corner 
of all Protocols for reference. Rather than have multiple boxes attached to each medication, the supposition is that 
all providers credentialed at a level higher than the key are authorized to administer the medication. For example, 
albuterol has a clear box in the key and is authorized for the EMR, EMT, Advanced EMT and Paramedic. 
Under the heading for each Protocol, there are two sections immediately below entitled, “Pertinent Positives and 
Negatives” and “Differential”. These boxes are meant to be a guide to assist with the pertinent historical information as 
well as a reminder of the multiple potential causes for a patient presentation that should be considered by the EMS 
Provider. It is expected that these elements be considered in the patient evaluation and appear in the documentation for 
the call.
Finally, the “Pearls” section at the bottom of the page provides further guidance as well as some tips to keep in mind when 
assessing patients and scenes. It is impossible to condense all of Emergency Medicine into a single page flow chart, but the 
pearls section allows for expanded medical advice, dosages and descriptions of special situations. Please study these 
sections along with the rest of the flowcharts – there is likely something to learn on every page! 
These protocols are the basis of the care we provide. Combined with your experience and education, this document 
should help you provide patient care that rivals the best in the world.
9
A
P
M
B

Dedication:
These protocols are dedicated to you, the EMS Providers of International SOS Government Medical Services. Your 
unwavering dedication, commitment to continuous improvement, and solemn promise to care for the sick and injured are 
what define the exceptional quality and compassion of our EMS community. While missed time with family and friends 
occurs too often and expressions of gratitude come too infrequently, know that your efforts and sacrifices are deeply 
appreciated.
Some people spend their entire lives wondering if they made a difference—you don’t have that problem.
Honoring Our Fallen Responders:
We respectfully honor and remember all EMS, Fire, and Law Enforcement personnel who have fallen in the line of duty. 
Thank you for your dedication, sacrifice, and unwavering commitment to the safety and well-being of your communities.
“Use your skills, your knowledge, your instincts to serve – to go change the world in the way that only you can.”
-Robert F. Smith
10

Purpose:
To provide guidelines for the transport of patients with Time Critical Diagnoses (TCDs) to the most appropriate facility that can provide 
definitive level care. 
Policy:
When feasible, patients AND/OR their healthcare power of attorney should be permitted to make autonomous decisions regarding their 
destination hospital, and given the opportunity to choose. Occasionally, patients may need to be directed away from their preferred institution 
in favor of a specialty resource center, which can provide advanced levels of care not available at every hospital . In those instances, the EMS 
Provider’s decision should be calmly and respectfully communicated to the patient and their family. By keeping a patient-centered focus and 
always working to do what is right for the patient, transport to the most appropriate level of care will hopefully be an obvious decision. At the 
time of publication, the following centers have achieved the appropriate level of credentialing for each of the Time Critical Diagnoses (TCDs) 
and Specialty Resource Center listed:
Any patient who is judged to be too unstable for transfer to definitive care may be transported to the closest Emergency Depa rtment for 
immediate stabilization
ST-Segment Elevation MI:
St. Mary’s – Madison
UW Hospital – Main Campus
VA Hospital
Level I Trauma:
UW Hospital – Main Campus
Level II Trauma:
St. Mary’s – Madison 
Mercy Hospital – Janesville
Burn Center:
Peds and Adult 
UW Hospital – Main Campus
Pediatric Intensive Care Unit:
UW Hospital – Main Campus
OB, Labor and Delivery Receiving:
Fort Memorial Hospital – Ft. Atkinson
Mercy Hospital – Janesville
Meriter Hospital
Monroe Clinic
The Richland Hospital – Richland Center
Neonatal Intensive Care Unit:
Meriter Hospital
St. Mary’s – Madison
UW Hospital – Main Campus
Level I Pediatric Trauma:
< 18 years old
UW Hospital – Main Campus
ED ECMO Center:
UW Hospital – Main Campus
OB, Labor and Delivery Receiving (cont):
Sauk Prairie Hospital
St. Clare Hospital - Baraboo
St. Mary’s – Madison
St. Mary’s – Janesville
Upland Hills Health – Dodgeville
Columbus Hospital
Comprehensive Stroke Center:
UW Hospital – Main Campus
Primary Stroke Center:
Mercy Hospital – Janesville
Meriter Hospital
St. Mary’s – Madison
VA Hospital
Acute Stroke Ready (CT and tPA Only):
Fort Memorial Hospital – Ft. Atkinson
The Richland Hospital – Richland Center
Stoughton Hospital
St. Clare Hospital – Baraboo
St. Mary’s – Sun Prairie
St. Mary’s – Janesville 
Upland Hills Health – Dodgeville
UW – East Madison Hospital
Columbus Hospital
Level III Trauma:
Sauk Prairie Hospital
St. Clare Hospital – Baraboo
St. Mary’s – Janesville
Level IV Trauma:
Meriter Hospital
Monroe Clinic
Stoughton Hospital
St. Mary’s – Sun Prairie
Upland Hills Health – Dodgeville
Columbus Hospital
Edgerton Hospital
Forensic Nurse Examiner
(Also Known As SANE Nurse):
Meriter Hospital
11
Medical Transport Destination
Policies
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Purpose:
To provide general guidelines for the appropriate utilization of Helicopter EMS (HEMS) Response during routine daily operations.
Policy:
EMS Providers are trained and equipped to manage emergency situations. Occasionally, a situation occurs that may benefit from care beyond 
the scope or resources of an EMS provider, such as utilization of HEMS. 
Helicopter EMS activation should be considered in Time Critical Diagnoses (TCDs) when transport via helicopter is anticipated to provide a 
significant time advantage over ground transport in the delivery of the patient to definitive care. Examples of when HEMS may be beneficial to 
consider: 
q Patient has a TCD (e.g. major trauma, STEMI, stroke) and HEMS will meaningfully shorten the time of delivery of the patient to definitive
care. Consideration for situations where scene time may be prolonged (such as extrication) HEMS may offer additional time savings.
q Patient is located in a geographically isolated area, which would make ground transport difficult or delayed.
q Patient is likely to require high-level life support available from HEMS, which isn’t readily available by ground transport.
q Local EMS resources are exceeded (e.g. mass casualty incident with multiple critically ill or injured patients), when activation would not put 
responding HEMS unit at increased risk (e.g. active shooter without neutralized threat). 
Procedure:
q The highest credentialed EMS Provider on scene will determine if HEMS response is appropriate for the patient.
q When considering air transport, the following terminology should be referenced when speaking with HEMS Dispatch:
 “Status Inquiry” or “Inquiry” - contact asking whether HEMS is available to fly or not based on current weather conditions , aircraft 
availability and crew status. An aircraft will NOT be reserved. 
 “Stand-by” - aircraft will be pulled out and prepared for flight with blades turning and ready to lift. If the aircraft has not been
“Requested” or stood down by that point, HEMS will “launch and stage” in the air approximately 5 nautical miles from the scene. 
 “Request” - final decision has been made by the EMS Provider(s) on scene to transport the patient by air, and the helicopter will launch 
(or proceed if already airborne) to the scene or rendezvous point as soon as possible.
q A safe Landing Zone (LZ) must be established per International SOS EMS Protocols prior to HEMS arrival. At night, clearly mark the LZ with 
flares, strobes, vehicle lights, or other suitable ground-based lighting.
q Patients coming from a Hazardous Materials (HazMat) scene need to be fully decontaminated prior to HEMS transport. This includes 
contamination with various fuels as well as ingestions of volatile substances which may cause off -gassing.
q Under NO circumstances should patient transport be delayed to use a helicopter.
Multiple pre-designated helicopter landing zones (LZs) may be available that do not require additional setup by fire or law enforcement personnel. EMS 
providers may use these LZs if appropriate based on weather, patient condition, and safety considerations.
Minimum Medevac Landing Zone Criteria:
Size: At least 100 ft x 100 ft (30 m x 30 m), level, firm surface
Clearance: Free of overhead obstructions (wires, poles, trees)
Marking: Clearly indicated with cones, lights, or reflective markers (avoid flares if possible)
Visibility: Clear of smoke, dust, or other visibility hazards
Security: Restricted from unauthorized personnel and vehicle traffic
12
Request for Helicopter EMS (HEMS)
Policies
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Purpose:
To provide general guidelines for the appropriate utilization of EMS Physician Response during routine daily operations.
Policy:
EMS Providers are trained and equipped to manage emergency situations. Occasionally, a situation occurs that may benefit from care beyond 
the scope or resources of an EMS provider, such as utilization of EMS Physician Response. 
EMS Physicians who are knowledgeable about local EMS and healthcare resources, may be beneficial to support EMS providers in the rare 
situation when advanced skills, authority, or access to hospital resources may be warranted. EMS Physician response DOES NOT replace ALS 
resources. Examples of when EMS Physician Response may be beneficial to consider: 
q Patient requires specialized medical attention in the field that is beyond the scope of the EMS Providers present on scene or available at
the time of the emergency (i.e. field amputation). 
q Mass Casualty Incident with multiple critically ill or injured patients. Physicians can provide on scene medical support or provision of treat/
release and/or alternative destination recommendations. 
q Expanding events with unclear patient involvement or community threats. 
Procedure:
q The highest credentialed EMS Provider on scene will determine if EMS Physician response is appropriate for the patient .
q EMS providers should request dispatch of the closest, most appropriate EMS Physician Response Unit, if available.
13
EMS Physician Response
Policies
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

14
Do Not Resuscitate (DNR)
Purpose:
To clarify Do Not Resuscitate (DNR) guidelines and outline specific exceptions when standard resuscitation may or may not apply.
Policy:
A valid Do Not Resuscitate (DNR) order directs EMS providers not to initiate cardiopulmonary resuscitation if the patient experiences cardiac or respiratory 
arrest. "Resuscitation" includes chest compressions, artificial ventilation, advanced airway management, defibrillation, administration of cardiac 
medications, and related procedures. It does not include procedures to clear airway obstructions, such as abdominal or chest thrusts.
Valid DNR orders are typically indicated by an approved identification bracelet. Commonly accepted bracelets include hospital-style plastic ID 
bands or authorized metal medical-alert bracelets. EMS providers should be familiar with and recognize all identification methods approved by 
local, national, or international authorities.
Patients with valid DNR orders should still receive supportive EMS care per International SOS EMS Protocols, including airway management, 
supplemental oxygen, comfort positioning, splinting, hemorrhage control, pain management, emotional support, and transport to an 
appropriate medical facility for evaluation.
DNR orders shall be followed by EMS Providers, except in the following situations:
q The Do-Not-Resuscitate bracelet appears to have been tampered with or removed
q The emergency medical technician, first responder or member of the emergency health care facility knows that the patient is pregnant
q The Do-Not-Resuscitate order is revoked. Methods for revocation may occur at any time by the following (154.21):
 The patient expresses to an emergency medical technician, first responder or to a person who serves as a member of an emergency 
health care facility’s personnel the desire to be resuscitated. The emergency medical technician, first responder or the member of the 
emergency health care facility shall promptly remove the do-not-resuscitate bracelet.
 The patient defaces, burns, cuts or otherwise destroys the do-not-resuscitate bracelet.
 The patient removed the do-not-resuscitate bracelet or another person, at the patient’s request, removed the do-not-resuscitate 
bracelet.
q The Guardian or Health Care Agent of an incapacitated qualified patient may direct an emergency medical technician , first responder or a 
person who serves as a member of an emergency health care facility's personnel to resuscitate the patient. The emergency medical 
technician, first responder or the member of the emergency health care facility shall promptly remove the do-not-resuscitate bracelet. 
(154.225)
Under Wisconsin Statute 154.23, no physician, emergency medical technician, first responder, health care professional or emergency health 
care facility may be held criminally or civilly liable, or charged with unprofessional conduct, for any of the following:
q Under the directive of a do-not-resuscitate order, withholding or withdrawing, or causing to be withheld or withdrawn, resuscitation from a
patient.
q Failing to act upon the revocation of a do-not-resuscitate order unless the person or facility had actual knowledge of the revocation.
q Failing to comply with a do-not-resuscitate order if the person or facility did not have actual knowledge of the do-not-resuscitate order or if
the person or facility in good faith believed that the order had been revoked.
Policies
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

15
Criteria for Death / Withholding Resuscitation / 
Termination of Resuscitation
Criteria for Death / Withholding Resuscitation:
To provide guidelines for situations when initiation of resuscitative efforts by EMS Personnel is not appropriate . For patients with a valid Do-Not-Resuscitate 
(DNR) order, please refer to the Do Not Resuscitate Policy.
Policy:
Resuscitative efforts should not be undertaken for an adult patient >18 years of age who is pulseless and apneic IF one or more of the following criteria are met:
q Decapitation
q Incineration
q Decomposition of Body Tissue
q Rigor Mortis and/or Dependent Lividity
q Massively Deforming Head or Chest Injury
q Freezing to the point of Rigor Mortis or inability to provide chest compressions
q Traumatic arrest that meets criteria according to Traumatic Arrest Protocol page 70
Do not initiate resuscitative measures for patients meeting the above criteria. Confirmation of asystole with a 4-lead cardiac monitor is acceptable if 
appropriate for the situation. If resuscitative efforts are in progress, consider discontinuation of efforts (EMT-P only), or contact Medical Control for 
consultation. If the patient is believed to have severe hypothermia (core temperature <82oF or <28oC), go to the Environmental, Hypothermia – Adult, Trauma 
Protocol.
If the circumstances are unknown or unclear, or if there is question about the validity of a DNR order, initiate resuscitation while simultaneously contacting 
On-Line Medical Control for further advice. 
Termination of Resuscitation:
To provide guidelines for discontinuation of resuscitative efforts in the out-of-hospital environment, when attempts have not resulted in Return Of 
Spontaneous Circulation (ROSC).
Policy:
The successful resuscitation of an out-of-hospital cardiac arrest requires a very well coordinated team effort, aggressive management of malignant 
dysrhythmias and thoughtful consideration of the reversible causes of cardiac arrest (the proverbial H’s and T’s). Unfortunately, there are a significant number 
of patients that – despite appropriate and aggressive medical management – are not able to achieve ROSC in the field. This policy is evidence driven and based 
on best practice, and it is intended to provide guidance for arrests when it is more prudent to stop resuscitation efforts than to risk provider and public safety 
with a patient transport.
This policy may ONLY be considered by EMT-Paramedics without Medical Control contact if ALL of the criteria below are met:
q The patient is an ADULT (>18 years of age) and the arrest is presumed to be of a primary cardiac origin
q The initial rhythm on patient contact is asystole
q The American Heart Association ACLS algorithm for cardiac arrest has been followed for a minimum of 20 minutes
q The airway has been secured with either an Endotracheal Tube (ETT) OR Blindly Inserted Airway Device (BIAD), and confirmed by digital capnography
q The quantitative End-tidal CO2 (EtCO2) is <20mmHg despite effective compressions and after 20 minutes of ACLS
q The final rhythm is asystole and is again confirmed in at least two leads on a printed strip
If ALL criteria above are NOT met, the ACLS algorithm must be followed for a minimum of 20 minutes and then Medical Control contacted for approval of field 
termination of resuscitation if the patient does not achieve ROSC. 
The EMS Provider always has the discretion to continue resuscitative efforts if provider safety, scene safety, location of arrest or bystander input compels the 
decision.
q All pediatric cardiac arrest cases should be managed according to Pediatric Advanced Life Support (PALS) guidelines and the International SOS EMS 
Pediatric Cardiac Arrest Protocols.
q Notify law enforcement upon determination of patient death. If death occurs in a medical facility under supervision of medical personnel, you may 
notify the patient’s primary physician directly. Once resuscitation efforts are withheld or discontinued, maintain respect for patient dignity and family 
sensitivity. Ensure high situational awareness, as the scene may require investigation; avoid disturbing any potential evidence.
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Policies
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Child/Elder Abuse Recognition and Reporting
Purpose:
To provide guidelines for the EMS Provider who encounters suspected and/or confirmed cases of child or elder abuse while on duty.
Policy:
Child Abuse is the physical and mental injury, sexual abuse, negligent treatment and/or maltreatment of a child under the age of 18 by a person who is 
responsible for the child’s welfare. The recognition of abuse and the proper reporting is a critical step to improving the safety of children and preventing child 
abuse.
An elderly person is typically defined as an individual aged 60 or older. Elder abuse includes physical, emotional, or sexual harm, neglect, or maltreatment 
inflicted by caregivers, family members, or acquaintances. Recognizing signs of abuse and promptly reporting concerns are critical steps toward protecting the 
health and safety of elderly individuals.
Effective management of a case of suspected abuse or neglect is based upon the following:
q Protect the patient from harm
q Suspect that the patient may be a victim of abuse, especially if the illness/injury is not consistent with the reported 
history
q Respect the privacy of the patient and the family
q Collect as much information as possible, and preserve any physical evidence
Any suspicion or evidence of abuse or neglect must be immediately reported to law enforcement or protective services upon arrival at the receiving facility. If 
patient contact does not result in transport, notify authorities prior to clearing the scene. Incidents occurring outside your primary service area should be 
reported to local authorities responsible for that jurisdiction.
There are many subtle signs of abuse that may be missed without a high index of suspicion. ALL patients evaluated by EMS should be screened for these cues. 
Some include:
Psychological cues – excessively passive behavior, fearful behavior, excessive aggression, violent tendencies, excessive or inappropriate crying, substance 
abuse, medical noncompliance or repeat EMS requests for seemingly minor problems.
Physical cues – injuries inconsistent with the reported mechanism, defensive injuries (i.e. forearms), injuries during pregnancy are suggestive of abuse. 
Multiple bruises and injuries in various stages of healing may also suggest repeated violence against the victim.
Signs of neglect – inappropriate level of clothing for weather, poor hygiene, absence of and/or inattentive caregivers, poor living conditions and physical signs 
of malnutrition.
EMS Providers in the State of Wisconsin are required by law to report suspected cases of child abuse and neglect as well as those situations in which they 
have reason to believe that a child / elder has been treated with abuse or neglect or that abuse or neglect will occur.
For Suspected Elder Abuse or Neglect -
q For elder abuse or neglect occurring outside of licensed facilities, contact the appropriate local human services or elder protection agency helpline.
q For elder abuse or neglect cases occurring within licensed nursing homes, contact the appropriate local regulatory authority or division responsible for 
nursing home oversight.
q For elder abuse or neglect cases occurring within licensed assisted living facilities, community-based residential facilities, or adult family homes, contact the 
appropriate local regulatory agency responsible for oversight of these facilities.
q For elder abuse or neglect cases occurring outside your local operational area, contact the appropriate elder care or protective services agency designated 
for that region.
For Suspected Child Abuse or Neglect -
Contact the appropriate local Protective Services agency:
q If caregivers are refusing the evaluation or treatment of a child that you suspect may be the victim of abuse or neglect, do not hesitate to contact Medical 
Control for advice. If necessary, Law Enforcement may be consulted to help settle disagreements on scene, while maintaining the effective management 
principles above.
q If a child has a life- or limb-threatening condition and caregivers refuse evaluation or transport, initiate immediate transport to the closest appropriate 
facility. Simultaneously notify law enforcement and seek immediate guidance from Online Medical Control. If your Medical Director is unavailable, 
contact alternate medical oversight as appropriate.
q When abuse or suspected abuse is reported to Law Enforcement, it is required that name and badge number of the officer receiving the report be captured 
in your documentation.
16
Policies
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Abandoned Infant
Purpose: 
To provide a guideline to EMS personnel that is following WI Statute 48.195. This statute relates to the right a parent has in relinquishing a child that is less than 72 
hours old and has not been abused.
BACKGROUND:
Taking a child into custody
q WI Statute 48.195 allows a parent to anonymously relinquish custody of a child that is 72 hours old or younger to a law enforcement officer, emergency 
medical technician (EMT), or hospital staff member and does not express any intent to return for the child. 
q This can be accomplished by: 
 Bringing the child to any place where these personnel are located or 
 Calling “911” and relinquishing custody on arrival of a law enforcement officer or EMT. 
q Upon receipt of a child, any action necessary to protect the health and safety of the child shall be taken. The child then needs to be delivered to an intake 
worker within 24 hours. 
Anonymity and Confidentiality 
q A parent who relinquishes custody and any person who assists the parent has the right to remain anonymous. 
q This shall not affect the way the recipient performs his or her duties. 
q No person may induce or coerce a parent or person assisting a parent into revealing his or her identity, unless the person has reasonable cause to suspect that 
the child has been the victim of abuse or neglect. 
q No person shall pursue a parent or person assisting a parent unless the person has reasonable cause to suspect that the child has been the victim of abuse or 
neglect. 
q No officer, employee, or agent of this state or of a political subdivision of this state may attempt to locate or ascertain the identity of a parent who relinquishes 
custody of a child. 
q Any information obtained related to the relinquishment of the child shall be kept confidential. Information may be provided to specific agencies or persons as 
listed in Act 2. 
Information for Parents 
q The recipient of the child shall make available to the parent the maternal and child health toll-free telephone number (1-800-722-2295). The parent may refuse 
this number. 
Immunity from Liability 
q The parent or person assisting the parent is: 
 Immune from any civil or criminal liability 
 Has the right to leave at any time 
 The right not to accept any information and 
 Immunity from prosecution. 
q Any law officer, EMT or hospital staff who take a child into custody are immune from any civil or criminal liability for any good faith actions or omission 
occurring solely in connection with the act of receiving custody of the child. This person is not immune for any act or omission occurring in subsequently 
providing care for the child. 
Medical Assistance Eligibility: A child taken into custody is presumed to be eligible for medical assistance.
Procedure: 
q Accept the child. 
q Initiate treatment of any life-threatening conditions.
q Attempt to verify that custody of the child is being relinquished. 
q Provide the parent or person assisting the parent with the maternal and child health toll-free telephone number. This person has the right to refuse acceptance 
of this.
q Do not attempt to induce or coerce an identity from this person unless abuse is suspected. 
q Do no attempt to pursue this person unless abuse is suspected. 
q Provide medical care to child as appropriate. 
q Transport child to the Emergency Department. 
q Document appropriately on a Patient Care Record.
17
Policies
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

18
Policies
Purpose:
To provide guidelines and to set best practice for documentation of patient encounters in the electronic Patient Care Report (ePCR).
Policy:
As EMS Providers and out-of-hospital care becomes increasingly more important to the healthcare community , it has brought a focus on the 
need to have a more robust set of standards for the Patient Care Reports generated. What you document is almost as important as what you 
see and the interventions you make to help your sick and injured patients. To that end, these criteria should help set the standards for 
documentation and maximize your productivity as members of the healthcare delivery team. At a minimum, every ePCR should include:
q A clear history of the present illness with chief complaint, onset time, associated complaints, pertinent positives and negatives, mechanism 
of injury, etc. This should be included in the subjective portion of the PCR. The section should be sufficient to refresh the clinical situation 
after it has faded from memory.
q Consider the P-SOAP-delta format for the narrative. Only approved medical abbreviations may be used – see Appendix.
 P – prearrival information, including delays to scene or factors inhibiting patient access or treatment
 S – subjective information (what the patient tells the EMS Provider)
 O – objective information (VS, physical exam findings, etc.) 
 A – assessment (EMS Provider Impression of patient illness as well as differential diagnosis)
 P – plan of treatment (EMS Provider interventions planned to administer)
 Delta – change in patient condition due to EMS Provider interventions
q An appropriate physical assessment that includes all relevant portions of a head -to-toe physical exam. When appropriate, this information 
should be included in the procedures section of the PCR.
q Vital Signs (VS) play a critical role in patient assessment and evaluations, and must be documented in the ePCR for any patient. At least two 
complete sets of vital signs. A complete set of vitals includes:
 Pulse Rate, Systolic AND Diastolic Blood Pressure, Respiratory Rate, SpO2, Pain and GCS for trauma patients. Temperature, EtCO2, 
Level of Awareness are also encouraged. 
q These vital signs should be repeated and documented after drug administration , prior to patient transfer, and as needed during transport. 
Any abnormal VS should be followed closely, and repeated as indicated by change in patient subjective status or clinical condition . Vital 
signs should be included in the ePCR either via manual entry or a monitor to ePCR integration. Incorrect vitals imported from the monitor 
integration should be updated as needed.
q The CAD to PCR interface embedded within the PCR system should be used to populate all PCR data fields it supplies. When 9-1-1 center 
times are improperly recorded, these may be edited as necessary.
q Medications administered, dosages, route, administration time, treatments delivered and patient response.
q Extremity neurovascular status after splinting affected limb, or all limbs after spinal immobilization. 
q For IV administration, the catheter size, site, number of attempts, type of fluid, and flow rate.
q Requested Medical Control orders and whether approved or denied. 
q Any waste of controlled medications should include the quantity wasted , where wasted, and name of the person who witnessed the waste. 
Hospital personnel should be utilized (if available) to witness. 
q ALL crew members are responsible for, and should review, the content of the ePCR for accuracy.
q After the ePCR is closed, patient care information may not be modified for any reason. Corrections or additions should be in the form of an 
addendum to the ePCR, with note for the reason of the addendum.
q When possible, all ePCRs should be completed and the report closed within 24 hours of the incident.
q Paper copies of the ECG, DNR paperwork, Skilled Nursing Facility documentation and - when applicable - documentation of refusal to 
accept an appropriate assessment, treatment, or hospital destination shall be provided to the receiving hospital.
q If the patient refuses EMS evaluation, an assessment of capacity must be completed AND documented in the ePCR . Detailed 
documentation should be captured regarding the patient’s clinical presentation, reason for refusing (if known) and the refusal process in 
the ePCR narrative. Be sure to capture the names of family members, Law Enforcement personnel or other EMS personnel who are present 
for this conversation and evaluation.
q If patient transported from the scene with red lights and siren, be sure to document the reason for doing so.
Remember – if you didn’t document it, it never happened!
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Documentation of Patient Care & Vital Signs
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Purpose:
To provide guidelines and resources for the EMS Provider who encounters suspected and/or confirmed cases of domestic violence while on 
duty.
Policy:
Domestic Violence is physical, sexual or psychological abuse and/or intimidation which attempts to control another person in a current or 
former family, dating or household relationship. The recognition, appropriate reporting and referral of abuse is an essential step to improving 
patient safety, providing quality care and preventing further abuse.
Effective management of a case of suspected abuse or neglect is based upon the following:
q Protect the patient from harm
q Suspect that the patient may be a victim of abuse, especially if the illness/injury is not consistent with the reported history
q Respect the privacy of the patient and the family
q Collect as much information as possible, and preserve physical evidence
Any findings of abuse or neglect OR suspicion of abuse or neglect must be handled with sensitivity and delicacy by the EMS Pr ovider. 
Provision of emotional support is key, without passing judgment on the victim or alleged perpetrator of domestic violence. Discretion should be 
a high priority, and when possible questions regarding abuse and safety should be done in private . Offering the resources below to the patient 
may feel awkward at the time, but are excellent resources and may be used at any time in the future. Have a low threshold to transport 
patients of suspected or confirmed domestic violence, as they may not have other means of escaping their assailant and accessing resources 
that may be available at the hospital.
There are many subtle signs of abuse that may be missed without a high index of suspicion. Some include:
Psychological cues – excessively passive in nature, fearful behavior, excessive aggression, violent tendencies, excessive or inappropriate crying, 
substance abuse, medical noncompliance or repeat EMS requests for seemingly minor problems.
Physical cues – injuries inconsistent with the reported mechanism, defensive injuries (i.e. forearms), injuries during pregnancy are suggestive of 
abuse. Multiple bruises and injuries in various stages of healing may also suggest repeated violence against the victim.
Signs of neglect – inappropriate level of clothing for weather, poor hygiene, absence of and/or inattentive caregivers, poor living conditions and 
physical signs of malnutrition. 
For Suspected Domestic Violence –
q EMS providers should privately offer victims contact information for local domestic violence intervention services or a 24-hour crisis helpline 
available in the region.
q EMS Providers may also provide the National Hotline (800) 799-SAFE (7233) inside the United States.
q Depending on the situation, transport should be considered regardless of the illness or injury, so that the victim may receive the expert 
consultation and additional services that are available in the Emergency Department . 
19
Domestic Violence (Spousal and/or Partner Abuse) 
Recognition and Reporting
Policies
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

20
Emergency Interhospital Transfers
Policies
Purpose:
To provide guidelines for EMS Provider expectations and medical care of patients during emergent transfer between Hospitals . This Policy does 
not supersede or replace existing EMTALA regulations.
This Policy IS NOT intended to authorize services or care that are not part of an EMS Services ’ operational plan with the State of Wisconsin. 
Rather, it is intended to provide guidance for the rare but foreseeable circumstances when a critically ill or injured patient may ne ed to be 
rapidly moved to a higher level of care, and time is of the essence.
Policy:
IEMS providers should perform emergent interhospital transfers primarily for patients with Time-Critical Diagnoses (TCDs) requiring specialized 
care not immediately available. During Mass Casualty Incidents (MCIs) or when Crisis Standards of Care are activated, EMS Medical Directors or 
their designees should provide real-time guidance. If EMS providers receive requests for emergent interhospital transfers of non-TCD patients, 
consult your EMS supervisor prior to transport.
Emergent Interhospital Transport decisions should be made based on the needs of the patient(s), any expected changes in their clinical condition 
and the familiarity / comfort level of the responding EMS Providers with the clinical situation as well as any medications or devices being used . 
If a patient is unstable, receiving medications, or using medical devices beyond the EMS provider’s scope of practice or familiarity, the sending 
facility must supply an appropriately credentialed provider familiar with the medications and equipment for the entire transfer. Contact your EMS 
Supervisor immediately if difficulties arise with this requirement.
Clear communication and coordination between hospitals and EMS providers are essential prior to initiating an emergent interhospital transfer to 
ensure patient safety and appropriate medical care during transport. Responsibilities for patient care must be clearly established before departing 
the sending facility. If the patient unexpectedly deteriorates during transport, notify the sending facility immediately, but contact the receiving 
facility for additional Medical Control guidance. Follow the International SOS EMS Protocols as appropriate until further direction is received.
Unless extenuating circumstances exist (e.g., Mass Casualty Incident, Crisis Standards of Care), EMS providers performing emergent interhospital 
transfers should deliver patients directly to the receiving facility’s Emergency Department for further care and coordination.
As with any Protocol, contact On-Line Medical Control with any questions or concerns.
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

21
Lights and Sirens During Patient Transport
Policies
Purpose:
To provide guidelines for the appropriate use of red lights and siren when transporting a patient from the scene of an emergency to the 
hospital. This Policy intends to help identify patients for whom safe use of red lights and siren can potentially reduce morbidity and mortality, 
and eliminate the unnecessary use of emergency lights and siren during transport to improve patient comfort, reduce anxiety and enhance 
safety for the patient, the EMS team, and the Dane County community. It is impossible to clearly identify each scenario where a patient could 
benefit from the use of lights and sirens by EMS, so provider discretion must be used to weigh the potential benefit of time saved against the 
ability for prehospital interventions to stabilize patients.
Policy:
q Use of lights and siren during response to the incident location should be dictated by local department policy.
q At the discretion of the ambulance crew, driving with lights and siren may be considered if the following clinical conditions or circumstances
exist:
 Difficulty in sustaining the ABCs (airway, breathing, circulation) including (but not limited to):
q Inability to establish an adequate airway or ventilation.
q Severe respiratory distress or respiratory injury not responsive to available field treatment.
q Inability to correct hemodynamic instability.
q Severe uncontrolled hemorrhage.
q Shock, unresponsive to available treatment.
q Severe trauma resulting in hemodynamic compromise, airway instability, or neurovascular compromise of an extremity that 
cannot be managed or corrected in the field.
q Status epilepticus that is not responsive to prehospital interventions.
q Substantial or rapidly deteriorating level of consciousness.
q Obstetrical emergencies such as prolapsed cord, breech presentation, arrested delivery, or suspected ruptured ectopic pregnancy.
q For any transport where reducing time to definitive care is clinically indicated, consider options other than emergent driving. In these 
cases, an alternative mode of transportation or higher level of care (such as ALS intercept, physician response vehicles, or air-medical)
should be considered if it is available and appropriate.
q For any lights and siren transport, specifically document in the narrative the patient’s condition, case circumstances and the rationale for
choosing emergent transport.
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
~ This Space Intentionally Left Blank ~
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

22
Non-Paramedic Transport of Patients
Policies
Purpose:
To provide guidelines for interactions of EMS Providers while on scene, and to help guide determination of the most appropriate level of service 
to transport patients to the Emergency Department.
This policy is intended to clarify expectations of providers on scene during situations when multiple levels of provider with transport capability 
arrive concurrently. It is NOT intended to be used as justification for refusal of transfer to a Paramedic level of service when a lower level is 
requesting it.
Policy:
For the purposes of this protocol, “Paramedic” refers to an EMS provider credentialed by the International SOS EMS System with no current 
restrictions on their clinical practice.
The provider with the highest credential level on scene will perform a detailed patient assessment, including interview and physical examination, to 
identify the chief complaint and level of distress. If the provider determines the patient is stable and that all care can safely be managed by a lowerlevel EMS provider, patient care and transport responsibilities may be transferred accordingly. All personnel on scene should actively participate in 
patient care, regardless of who ultimately attends the patient during transport.
The determination of who attends should be based on the patient’s immediate treatment needs and any reasonably anticipated treatment needs 
while en route to the hospital. The highest credentialed provider on scene retains the right to make the decision to personally attend to any 
patient transported based on his or her impression of the patient’s clinical conditions, current needs or anticipated needs based on the EMS 
Provider’s evaluation and experience.
The highest credentialed EMS Provider who performs the assessment and determines the appropriate level of care for transport must document 
the findings of their assessment. Additional documentation shall be completed by the transporting provider. As with all documentation, both 
providers are responsible for the content of the report.
Patients who meet the criteria below shall be attended by Paramedics (per their operational plan) in the patient care compartment, unless mass 
casualty incident, natural disaster or previously approved by policy or the On-Line Medical Control. The care of the following patients cannot be 
transferred to a lower level of credentialing:
q Any patient who requires or might reasonably require additional or ongoing medications, procedures AND/OR monitoring beyond the 
scope of practice of the lower credentialed provider. This includes any critically ill or unstable patient as advanced airway management
may be required in any decompensating patient. EMT-Basic and EMT-Advanced providers may be credentialed to perform some but not all
airway management, and medications associated with airway management are limited to the Paramedic scope of practice by the Wisconsin
State Medical Board.
q Any patient for whom ALL EMS providers on scene do not agree can be safely transported without a Paramedic in attendance in t he patient
care compartment. As a general rule, if providers are questioning who should attend the patient, the highest credentialed level of care
should attend.
q Post-ictal patients with high probability of recurrent seizure.
q Patients who have been medicated on the scene cannot be transferred to a provider of a lower credentialing level UNLESS the provided
medication is included in the receiving EMS Provider’s scope.
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

23
Paramedic Intercept Guidelines
Policies
Purpose:
To outline circumstances in which an Advanced Life Support (ALS) Service should be requested for intercept with a non-ALS level Service. 
Policy:
The situations listed below are not all-inclusive, but are intended to serve as examples of when a higher level of care would be appropriate for 
advanced interventions and patient safety. In addition to advanced skills and additional medication options, Paramedics also bring an 
experience with critically ill and injured patients, and can assist with the safe evaluation and destination determination process.
While patient care remains the highest priority for all EMS providers, decisions to request an ALS intercept should consider factors such as time of 
day, traffic conditions, weather, and proximity to appropriate medical care. When feasible, arrangements should be made to rendezvous with ALS 
units en route to minimize delays in providing advanced skills and medications.
Some examples of patients that may benefit from ALS level evaluation and management include but are not limited to ;
q Sepsis
q Cardiopulmonary Arrest
q Altered Mental Status not explained by simple hypoglycemia or opiate overdose
q Severe Respiratory Distress AND/OR Impending Airway Compromise
q Multi-System Trauma
q Unstable or Deteriorating Vital Signs
q Chest Pain with Hemodynamically Compromising Dysrhythmia
q ST-Segment Elevation MI with Hypotension, Altered Mental Status or Impending Cardiac Arrest
q Complex Seizures (First Seizure without History, Seizure After Head Injury, Recurrent Seizure without Return to Baseline)
q Allergic Reaction assessed to be ‘Severe’ or ‘Impending Cardiac Arrest’
q Asthma Exacerbation not improving after Albuterol OR Requiring Multiple Nebs
q Complications of Childbirth
q Mass Casualty Incident
q Any situation in which the EMS provider or Medical Control determines ALS evaluation and management are necessary.
We are all working together to get the right patient to the right level of care at the right time!
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

24
Patient Care During Transport
Policies
Purpose:
To provide general guidelines and to set best practice when caring for patients both on the scene of an emergency as well as in the ambulance 
during transport to the receiving facility.
Policy:
All sick or injured persons requesting transport shall be transported without delay to the most appropriate Emergency Departm ent, with high 
consideration given to patient preference. Exceptions to this policy are as follows:
q An "appropriate local Emergency Department" includes facilities designated by International SOS EMS Protocols within the operational region. 
A patient’s ability to pay or insurance status must not influence destination decisions. If transport requests impact EMS unit availability, 
contact your EMS Supervisor for guidance prior to initiating transport.
q All sick or injured persons requesting transport who do not express a preference or who rely on the knowledge of the EMS Provider should be 
transported to the closest, most appropriate local Emergency Department.
q Patients who are suffering from a Time Critical Diagnosis (TCD) or a condition covered under the Destination Determination Protocols should 
be transported in accordance with the specialty resource required by the treatment flowchart . All other patients should be transported per 
the policy statement above.
q Transport destination decisions should take into consideration the preexisting healthcare relationships that a patient may ha ve. In general, a 
patient should be taken to the hospital at which they typically receive care and/or where their primary care physician has affiliation, unless 
the patient expressly requests otherwise. Providers should discuss risks and benefits of transport to a facility that has not previously cared for 
the patient, and document the discussion clearing in the electronic Patient Care Report (ePCR).
The following situations shall require more than one EMS Provider in the passenger compartment of the transporting vehicle , to provide 
adequate medical care. The additional provider(s) is/are present not only to serve as additional “hands”, but to expand the critical thinking of 
the team and to help optimize patient outcomes. For these circumstances, students with the current training permit may assist with patient 
care, but may NOT count as one of the additional EMS Providers.
q Cardiac Arrest of Medical OR Traumatic etiology
q Post Resuscitation Return of Spontaneous Circulation (ROSC) patients, even if Vital Signs are stable
q Active Airway Management, regardless of modality chosen (Endotracheal Tube, Blindly Inserted Airway Device (BIAD) or Bag-Valve Mask
(BVM)
q Impending Arrest or “Peri-Code” Situation
q Imminent Delvery
q Newly Born Patients (Mother and Newborn count as two patients, and require an attendant for each)
q At the Attending EMS Provider’s Judgement, for cases not covered above
If a second EMS Provider is not available and transport would be delayed, initiation may be started under these two circumstances:
q An Advanced Care Intercept (Ground ALS or HEMS) has been contacted and arrangements made for rendezvous en route
OR
q The case has been reviewed with On-Line Medical Control (OLMC) AND approval granted
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

25
Medical Provider Bystander On Scene
Policies
Purpose:
To define the responsibilities of EMS Providers responding to an emergency scene , to identify the chain of command and to prevent potential 
conflicts regarding patient care that may arise during EMS evaluation and management when a trained medical provider is on sc ene. No other 
healthcare professionals are permitted to provide medical direction under this policy.
This policy is not intended to apply to Service Medical Directors.
Policy:
The medical evaluation and management of patients at an emergency scene is the responsibility of the EMS provider operating under International 
SOS EMS Protocols. On occasion, a physician or medical provider present may wish to assume patient care or direct EMS personnel. To assume 
care, the physician must:
 Provide photo identification verifying his/her current credentialing as a physician (MD/DO) AND a current copy of his/her license to practice 
medicine in the State of Wisconsin AND
 Assume care of the patient AND allow documentation of of his/her assumption of care on the electronic Patient Care Report (ePCR), as 
verified by his/her signature, AND
 Agree to accompany the patient during transport to the receiving hospital AND
 Not appear to be impaired or under the influence of drugs, alcohol or medical conditions AND
 Explicitly express willingness to accept liability for the care provided to the patient under their personal medical license
Contact with Medical Control must be established as soon as possible, and the Medical Control Physician must agree to relinquish responsibility 
for patient care to the Physician On Scene.
Once care has been transferred from the On-Line Medical Control to the Physician On Scene, the EMS Provider may provide care under the 
license and authority of the Physician On Scene. Direction provided by the Physician On Scene assuming care of the patient should be followed 
by the EMS Provider, granted that the interventions are not believed by the EMS Provider to endanger the well -being of the patient. 
Orders from an authorized on-scene physician may be followed, even if they differ from existing protocols, provided they involve only skills or 
medications within the EMS provider’s approved scope of practice and credentialing. Under no circumstances shall EMS providers perform 
procedures or administer medications outside their authorized scope of practice.
Conflict with Physician or Medical Provider On Scene:
If the Physician or Medical Provider On Scene is judged by the EMS Provider on scene to be potentially harmful or dangerous t o the patient, the 
EMS Provider should politely voice their objection, and immediately contact On-Line Medical Control for further assistance. On-Line Medical 
Control should be briefed by the EMS Provider, and the Physician or Medical Provider On Scene allowed to communicate directly with the OnLine Medical Control. When at all possible, these conversations should be held on a recorded line.
If the Physician or Medical Provider Bystander On Scene and On-Line Medical Control are in conflict, it is the responsibility of the EMS Provider to:
q Follow the directions of On-Line Medical Control
q Enlist the aid of Law Enforcement as necessary to regain control of the emergency scene and resume authority of the scene
Documentation:
All interactions with Physicians and Medical Providers On Scene must be thoroughly documented in the electronic Patient Care Report (ePCR), 
including the full name and medical license number, as well as the interventions performed at their direction.
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

26
Poison Control
Policies
Purpose:
To provide guidelines for involving Poison Control with out-of-hospital management of patients with potential or actual poisonings.
Policy:
Patients who have sustained significant poisonings, envenomations, and environmental/biochemical terrorism exposures in the out-of-hospital 
setting require timely and appropriate level of care, including the decisions regarding scene treatment and transport destination. By integrating 
the State Poison Center into the out-of-hospital response plan for HazMat and biochemical terrorism incidents, this policy aims to empower the 
out-of-hospital care provider and enhance the ability to deliver the most appropriate care to the patient possible.
If the patient is assessed by the EMS Provider and no immediate life threat or indication for immediate transport is identifi ed, the EMS Provider 
may conference call with the Poison Center at the Wisconsin State Poison Center at 1 (800) 222-1222.
The Poison Center will help evaluate the exposure and make recommendations regarding the need for on -site treatment and hospital transport 
in a timely manner. If EMS transport to the hospital is determined to be necessary, the Poison Center will contact the receiving hospital and 
provide information regarding the poisoning, including treatment recommendations. EMS may also contact On-Line Medical Control for further 
instructions or for treatment options.
If EMS transport is determined to not be necessary, the contact phone number for the patient will be provided to the Poison Center. The 
Poison Center will make a minimum of one follow-up phone call to determine the status of the patient. Additionally, the EMS Provider must 
contact On-Line Medical Control to review the case and discuss the recommendations of the Poison Center and what is believed to be in the 
best interest of the patient.
As detailed elsewhere in this document, exposures and/or poisonings that are the result of suicide attempts or gestures, or children who sustain 
an exposure and/or poisoning due to child abuse or neglect SHOULD NOT be allowed to refuse transport. These are both vulnerable 
populations who are at an increased risk of death or permanent disability if not cared for appropriately . As always, good Provider judgment and 
patient advocacy will be the cornerstones of making sound, defensible patient treatment decisions.
In any cases of poisoning, whether accidental, intentional or the consequence of a bioterrorism event, the safety of the First Responders should 
be of the highest priority. At a minimum, the following information should be gathered so that the Poison Center can make the best 
recommendations for the current situation:
q Age of the patient
q Substance(s) involved with the exposure (if known)
q Time and Duration of exposure (if known)
q Signs and Symptoms
q Any Treatments provided and the response to the intervention
As with many of the EMS Protocols, a significant amount of information is collected by the EMS Providers on scene and can be extremely 
valuable for downstream providers. Be sure to notice and document HazMat placards in cases of transportation incidents, any MSDS sheets 
available in the industrial / manufacturing setting, or the contents and volumes of products / substances present in the cases of household 
ingestion.
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

27
Patients in Police Custody
Policies
Purpose:
To provide guidelines for the evaluation and management of patients requiring EMS assessment while in the custody of Law Enforcement. As 
with every patient interaction, it is important that the EMS Provider serve as a patient advocate and use their best medical judgment to assist 
Law Enforcement in making safe, appropriate decisions regarding medical aid and disposition decisions.
Policy:
When evaluating a patient in law enforcement custody, EMS providers should treat the patient with the same respect and consideration as any 
other patient. EMS providers are not authorized to provide “Medical Clearance” for detention. Providers must perform an unbiased medical 
assessment and make recommendations based on International SOS EMS Protocols, clinical judgment, and experience.
These patient encounters have a higher than average incidence of scrutiny on review; as such, take steps to ensure that your documentation is 
clear, descriptive and complete. Law Enforcement Agent names and badge numbers are essential in the EMS Provider documentation. 
q If a patient in custody of Law Enforcement is evaluated by EMS and felt to need transport to the Emergency Department and the patient is
refusing transport:
 Evaluate the patient’s capacity to make informed decisions according to International SOS EMS Protocols.
 Advise the Law Enforcement Agent of the decision of the patient, and consider potential risks or hazards to Law Enforcement if the 
patient were to refuse (i.e. lacerations that may pose a biohazard to officers or other detainees).
q If Law Enforcement requests transport, document their request and coordinate safe transport to the closest, most appropriate 
Emergency Department. In these instances, the Law Enforcement Agent must take the patient into Protective Custody and effectively 
making decisions as the healthcare power of attorney for the patient.
q Document that Law Enforcement has taken Protective Custody of the patient.
q In this instance, the Law Enforcement Agent must accompany the patient to the Emergency Department.
 If the patient is evaluated to have capacity and does not pose an undue risk to law enforcement, document a patient refusal according to
International SOS EMS Protocols.
q If a patient in custody of Law Enforcement is evaluated by EMS and felt to need transport to the Emergency Department and the Law
Enforcement Agent is refusing transport:
 Advise law enforcement that transport is medically indicated per International SOS EMS Protocols, and clarify that EMS providers are not 
authorized to provide medical clearance in the field.
 Contact On-Line Medical Control for consultation and assistance as needed.
q If Law Enforcement continues to decline transport for medical evaluation and management, allow the patient to remain in the 
custody of the Law Enforcement Agent, and advise them that EMS may be re-contacted at any time to provide medical assistance as 
needed.
q The Law Enforcement Agent in these situations is taking the patient into Protective Custody and effectively making decisions as the 
healthcare power of attorney for the patient.
q Document that Law Enforcement has taken Protective Custody of the patient.
 Document the Law Enforcement Agency as well as the name and badge number of the responsible officer along with specifics of t he 
discussion in your electronic Patient Care Report (ePCR).
q If a patient in custody of Law Enforcement requires transport to the Emergency Department and is requiring physical restraint by the Law 
Enforcement Agent for behavior modification:
 Advise law enforcement personnel that International SOS EMS Protocols require their presence in the patient compartment of the 
ambulance during transport to the Emergency Department.
q With active restraints in place, it is an issue of patient safety as well as provider safety.
 Refer to the Behavioral Emergencies section of the International SOS EMS Protocols, or contact Online Medical Control for guidance 
regarding medication management to ensure safe and efficient transport.
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

28
Radio Report Format
Purpose:
To provide guidelines for clear communication between EMS Providers and receiving facilities prior to delivery of the patient.
Policy:
For all patients being transported to the hospital by EMS, every effort should be made to contact the receiving facility as early as possible once 
the destination facility has been chosen and transport initiated. 
Procedure:
Begin each transmission with the agency name and unit number, and wait for acknowledgement from the receiving facility.
After the receiving facility acknowledges contact with your unit, give a clear, concise report which includes the following:
q Agency Unit
q ETA
q If applicable; Alerts – Medical, Trauma, STEMI, Stroke, Sepsis (repeat this twice)
q Age
q Chief Complaint / Observations
 Vital Signs – Brief and Concise
 Pertinent Interventions
 Special Resources/Needs – interpreter, respiratory therapy, security, bariatric, cath lab, labor/delivery, etc.
Contacting Medical Control
q Medical Control may be contacted for any additional orders, to consult as needed for patients refusing transport and for any questions 
regarding patient management on scene or en route to the receiving facility. Any orders given should be repeated back for clarification and 
patient safety.
q Make sure your request of Medical Control is clearly communicated, and be prepared to answer follow up questions regarding the protocol 
you are following as well as your assessment of the situation.
Remember: you are the one who has the patient in front of you – your assessment and impression matter!
CATEGORY
Medical ALERT
Trauma ALERT
DEFINITION
High acuity of illness, with unstable VS or requiring 
immediate support from ED staff
Severe mechanism of injury, life or limb threatening injury
SEPSIS ALERT
STEMI ALERT
SEPSIS Screening Positive
STEMI Interpretation of Field ECG (EMS or Monitor)
STROKE ALERT Focal Neurologic Deficit with Last Known Normal <24 Hours
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Policies
~ This Space Intentionally Left Blank ~
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

29
Transfer of Care at Hospital
Policies
Purpose:
To provide guidelines for in-person communication with receiving facilities, and to clarify expectations of EMS Provider documentation.
Policy:
When delivering a patient to the receiving facility, it is imperative that a clear, concise communication happen between the EMS Provider and 
the emergency medical staff assuming care. In order to prevent miscommunication, a full verbal report should be communicated in a face-toface fashion, preferably with the entire medical team assembled at the patient bedside. On the occasion that the complete team is not 
available, verbal report should be given to a receiving caregiver credentialed at the RN level or higher.
All treatments and interventions initiated under the Dane County Protocols may be continued after arrival in the receiving fa cility up until the 
appropriate personnel and equipment are assembled to assume care of the patient. At that time, responsibility for all medical care and 
continued treatment is transferred to the facility, and the Dane County EMS Protocols are no longer authorized for patient management. OnLine Medical Control should not be contacted for additional orders once this handoff has occurred. In the rare circumstance that the EMS 
Provider is requested/invited to participate, direction will be at the authorization and the discretion of the supervising on-scene physician. It is 
important that the involvement, orders received and name of the responsible physician be captured in the electronic Patient Care Report 
(ePCR) as part of the medical care provided by EMS.
Verbal Report
Verbal report at the time of handoff shall include all pertinent known information about the patient, the history of present illness or mechanism 
of injury, treatments administered by EMS Providers as well as the patient’s responses to treatment. In addition, all prehospital ECGs and 
provided paper medical records should be turned over to the treatment team assuming care .
Written Report
Wisconsin DHS Administrative Rule 110.34(7) specifically addresses EMS responsibility for written patient report at the time of handoff at the 
receiving facility. The rule states:
An emergency medical service provider shall, “...submit a written report to the receiving hospital upon delivering a patient, and a complete 
patient care report within 24 hours of patient delivery. A written report may be a complete patient care report or other documentation 
approved by the department and accepted by the receiving hospital.”
The expectation is that there will be written documentation left at the receiving facility, and conveyed either in printed or electronic format
prior to your departure and returning available to service. It is not required that the documentation left at the facility be the completed, 
finalized electronic Patient Care Report (ePCR). HOWEVER, all EMS Providers in Dane County are integral members of the healthcare team, and 
may hold key pieces of information not available to any of the downstream providers and which are at significant risk of being lost, overlooked 
or miscommunicated if not documented in a prompt manner. 
Given the nature of EMS and out-of-hospital care, it should be the goal of every Dane County EMS Service at minimum to have a draft narrative , 
list of the EMS interventions, medications given and vital signs documented prior to leaving the facility and returning to duty.
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

30
Persons with EMS Care Plans
Policies
Purpose:
To establish a uniform approach for the evaluation and management of persons having an established Care Plan , developed by the EMS Service 
and approved by the Medical Director.
Policy:
All sick or injured persons requesting transport shall be transported without delay to an appropriate local Emergency Departm ent of the 
patient’s preference. The only exceptions to this rule are found below:
q Patients who are suffering from a Time Critical Diagnosis (TCD) or whose condition is covered under the Destination Determination 
Protocols shall be transported in accordance with those specialty algorithms to the appropriate receiving facility . The presence of a Care 
Plan DOES NOT supersede the Destination Determination Protocol. 
q Patients known to have been discharged from an Emergency Department within the last 48 hours should generally be transported back to 
the same ED, unless they meet specialty center destination criteria, as outlined in the Destination Determination Protocol.
q Patients who have been identified as frequent users of the EMS System may have a designated Care Plan, which has been developed with 
the patient and/or their healthcare providers, the EMS Service and one or more of the Dane County hospitals. If a patient has a formal Care 
Plan approved by the EMS Service Medical Director, the patient should be evaluated, treated and transported in accordance with the Plan, 
unless the patient meets criteria for transport to a specialty receiving center, as outlined above. Regardless of the existence of a Care Plan, 
all patients should be treated with respect and dignity, and fully evaluated as per the standards set forth in this Protocol Book.
There may be exceptions to this guideline, and if there are questions while evaluating a patient with a Care Plan, do not hesitate to contact the 
Officer In Charge (OIC) or the Medical Director or Medical Director’s designee for clarification.
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Pearls
REQUIRED EXAM: VS, GCS, Nature of Complaint
 12-Lead ECG should be done early for any non-traumatic pain complaint between the ear lobes and the umbilicus (belly button). 
 Include Blood Glucose reading for any patient with complaints of weakness, altered mental status, seizure, loss of consciousness, known history of diabetes OR Cardiac 
Arrest.
 Measure and document SpO2, EtCO2 for ANY patient with complaint of weakness, altered mental status, respiratory distress, respiratory failure or EMS managed airway.
 If hypotensive (Systolic BP<100mmHg) and/or clinical evidence of dehydration, consider IV Access Protocol and Shock (Non-Trauma) Adult Medical Protocol .
 Any patient contact which does not result in an EMS transport must have a completed refusal form. 
 Never hesitate to consult medical control for assistance with patient refusals that can’t meet all required fields, clarification of protocols or for patients that make you 
uncomfortable.
Assessment
Scene Patient
Safety
Stage,
Call for Law Enforcement 
and/or Additional 
Resources
PPE
Hazmat
Unsafe
Insufficient
Safe
Sufficient
Notify Comm Center, 
Activate Hazmat 
Resources
Yes
Presentation OR 
Traumatic 
Mechanism
Go To Appropriate Adult 
Trauma Protocol Yes
Check for Pulse
No
Cardiac Arrest Protocol
p37
Pulseless,
Apneic
A,B,C’s
Support Airway,
Support Oxygenation,
Support Circulation
Airway Management Protocol
p32
Minimize Scene Time,
Notify Receiving Facility of 
Critical Patient Early
Present
Obstructed Airway,
Ventilations Inadequate
Hemorrhage Control Protocol
p81
Exsanguinating
Hemorrhage
Ventilations Adequate,
BP and RR Adequate
Evaluate and Treat Per 
Appropriate Medical Protocol
Notify Receiving Facility,
Contact Medical Control As Necessary
M Contact Medical Control
Doesn’t Fit Protocol,
Exhausted Protocol
All Patients should remain Nothing By 
Mouth (NPO) Unless Specified by 
Treatment Protocol
31
General Approach – Adult, Medical
Pertinent Positives and Negatives
 Age, VS, BP, RR, SpO2
 SAMPLE history
 OPQRST history
 Source of blood loss, if any (GI, vaginal, AAA, ectopic)
 Source of fluid loss, if any (vomiting, diarrhea, fever)
 Pregnancy history
Differential
 Cardiac Dysrhythmia
 Hypoglycemia
 Ectopic Pregnancy
 AAA
 Sepsis
 Occult Trauma
 Adrenal Insufficiency
 Mental Status
 Pale, Cool Skin
 Delayed Cap Refill
 Coffee Ground Emesis
 Tarry Stools
 Allergen Exposure
Medical Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

32
Airway Management - Adult
Pearls
REQUIRED EXAM: VS, GCS, Head, Neck, Blood Glucose
 If BIAD in place and adequately ventilating/oxygenating - Do Not Remove.
 Digital capnography is the standard of care and is to be used with all methods of advanced airway management and endotracheal intubation. If a service uses color change 
capnometry only and an Invasive Airway Device is placed, an intercept with a digital capnography capable service MUST be completed.
 Goal EtCO₂ = 35-45mmHg.
 If Airway Management is adequately maintained with a Bag-Valve Mask and waveform SpO2 >93%, it is acceptable to defer advanced airway placement in favor of basic 
maneuvers and rapid transport to the hospital.
 Always assume that patient reports of dyspnea and shortness of breath are physiologic, not psychogenic.
 Gastric decompression with Oral Gastric Tube should be considered on all patients with advanced airways, if time and situation allow.
 Once secured, every effort should be made to keep the endotracheal tube in the airway; commercially available tube holders and C-collars are good adjuncts.
 For all protocols, an Advanced Airway Attempt is defined as: passing the tip of the laryngoscope blade or Blindly Inserted Airway Device (BIAD) tube past the teeth.
Medical Protocols - Adult
General Approach – Adult, Medical
Notify Receiving Facility,
Contact Medical Control As Necessary
Basic Airway Maneuvers
(Open Airway, Suction, NPA vs. OPA)
BVM with airway adjunct
Consider Advanced Airway
Placement ETT, BIAD
P
Consider Rapid Sequence Airway 
Protocol p33
Evaluate and Treat Per Appropriate 
Adult, Medical Protocol
Anticipate and Prepare for the 
Difficult Airway
LEMON Rule
 Look Externally
 Evaluate with 3:3:2 Rule
 Mallampati Classification
 Obstruction
 Neck Mobility (or lack thereof)
If obstruction suspected, Go to Airway 
Obstruction Procedure p132
Assess Airway 
(obstruction, blood, vomit, FB, etc.) 
A,B,C’s
(RR, effort, adequacy)
Adequate
Inadequate
Each Attempt should include change in approach, 
operator and/or equipment
If endotracheal tube placement is attempted, after 
two (2) unsuccessful attempts move towards 
alternative airway device
P
Consider Surgical Airway p148-150
 If unable to oxygenate/ventilate with any 
other less invasive method 
Consider early if sign of facial trauma/swelling/
distortion or complete obstruction
Post Advanced Airway Sedation 
Protocol p34
Evaluate and Treat Per Appropriate 
Adult, Medical Protocol
Unsuccessful Successful
Unobstructed
Consider Need for ALS Level Service
Post Advanced Airway Sedation Protocol p34 
Evaluate and Treat Per Appropriate Adult, Medical 
Protocol
Consider CPAP Procedure p146
For respiratory distress with intact airway 
protection
Consider Midazolam 2mg IV/IN or 
Ketamine 0.25mg/kg IV/IM/IO (max 25mg)
If needed for CPAP compliance
Obstructed
B
P
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Airway Management – Adult, Medical
Notify Receiving Facility,
Contact Medical Control As Necessary
P Rapid Sequence Airway 
Preparation 
IV, O2, Continuous Cardiac Monitor, SpO2, EtCO2, BP
Check Laryngoscope Bulb, Check video laryngoscope function, ETT Balloon, Stylet, 
Syringes, Optimize Positioning
Prepare Rescue Airway Device
Medications Drawn Up and Labeled
Optimize hemodynamics and consider preparing a push dose Epinephrine (p190)
Preoxygenate
100% O2 x 5 Minutes
8 Vital Capacity Breaths via BVM or NRB
Continue Until Airway Secured
Continue apneic oxygenation via Nasal Cannula throughout procedure 
Pretreatment
Consider Cricoid Pressure (Sellick’s Maneuver)
Coordinate with crew re: order of meds, anticipated course and contingency plans
Paralysis and Induction 
Etomidate 0.3mg/kg IV/IO (max 30mg) OR
Ketamine 2mg/kg IV/IO (max 200mg)
THEN
Succinylcholine 2mg/kg IV/IO (max 200mg) OR
Rocuronium 1.0mg/kg (max 100mg)
Placement with Proof 
Continuous EtCO2 Monitoring
Auscultation, Chest Rise, Fogging in Tube
Secure Device
Post Placement Management 
Indications for Adult Rapid Sequence 
Airway Management
Determining whether RSA is indicated for a patient is 
multifactorial, requires experienced clinical judgement, and a 
robust training/QA support system. These indications to 
consider RSA are meant to serve as guidelines and RSA should 
not be considered if unable to ventilate with BVM unless all 
other options have been exhausted. 
Failure to oxygenate 
Failure to ventilate
Failure of airway protection
Post-Advanced Airway Sedation Adult p34
Each Attempt should include change in approach, operator and/
or equipment
If endotracheal tube placement is attempted, after two (2) 
unsuccessful attempts move towards alternative airway device
33
Rapid Sequence Airway - Adult
Pearls
REQUIRED EXAM: VS, GCS, Head, Neck, Blood Glucose, Lung Exam, Posterior Pharynx
 Resuscitate first, hemodynamically unstable patients are at high risk for cardiac arrest.
 Digital capnography is the standard of care and is to be used with all methods of advanced airway management and endotracheal intubation. If a service uses color change 
capnometry only and an Invasive Airway Device is placed, an intercept with a digital capnography capable service MUST be completed.
 If Airway Management is adequately maintained with a Bag-Valve Mask and waveform SpO2 >93%, it is acceptable to defer advanced airway placement in favor of basic 
maneuvers and rapid transport to the hospital.
 Gastric decompression with Oral Gastric Tube should be considered on all patients with advanced airways, if time and situation allows.
 Once secured, every effort should be made to keep the endotracheal tube in the airway; commercially available tube holders and C-collars are good adjuncts.
 For all protocols, an Advanced Airway Attempt is defined as passing the tip of the laryngoscope blade or Blindly Inserted Airway Device (BIAD) tube past the teeth.
 Recent history of Upper Respiratory Infection, Missing / Loose Teeth or Dentures all will increase complexity of airway management.
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 History of CHF, COPD, Asthma
Differential
 Head Injury
 Electrolyte Abnormality
 COPD Exacerbation
 CHF Exacerbation
 DM, CVA, Seizure, Tox
 Sepsis
 Asthma Exacerbation
 Drug Ingestion / Overdose
 Lung Sounds before AND after
intervention
 Allergen Exposure
 Toxic / Environmental Exposure
Medical Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

P
Fentanyl 1mcg/kg IV/IO (max 100mcg) 
AND / OR
P
Midazolam 0.1mg/kg IV/IO (max 5mg) OR 
Midazolam 0.2 mg/kg IM/IN (max 10mg)
OR
Lorazepam 0.1mg/kg IV/IO/IM (max 2mg)
P
OR
Consider Ketamine 2mg/kg IV/IO (max 200mg) 
P May Repeat Sedation (max 3 doses)
M
Contact Medical Control
Consider Rocuronium 1.0mg/kg 
(max 100mg)
Airway Management – Adult, Medical
Assess and Document
BP, HR, SpO2, Continuous Cardiac Monitoring, EtCO2
Signs of 
Discomfort
Rising BP, Increasing HR, Tearing, Pulling at Lines and Tubes, 
Coughing or Gagging on Invasive Airway Device, 
Clinical Signs of Agitation 
Yes
Improved 
Comfort Yes No
Monitor VS Closely
Notify Receiving Facility,
Contact Medical Control As Necessary
No
A
Consider Ondansetron 0.15mg/kg (max 4mg) 
IV/IO/IM
34
Post Advanced Airway Sedation - Adult
Pearls
REQUIRED EXAM: VS, GCS, Nature of Complaint
 Paralytics block movement of skeletal muscle but do NOT change awareness. Remember that without sedation, patients may be awake but paralyzed.
 Monitor Vital Signs closely when managing airways and sedation. Changes that indicate pain, anxiety as well as tube dislodgment may be subtle (at first)!
 Document Vital Signs before and after administration of every medication to prove effectiveness.
 ANY change in patient condition, reassess from the beginning. Use the mnemonic DOPE (Dislodgment, Obstruction, Pneumothorax, Equipment) to troubleshoot problems 
with the ET Tube.
 Continuous End Tidal CO2 is mandatory for all intubated patients – color change is NOT sufficient proof of ET Tube in the trachea.
Pertinent Positives and Negatives
 Age, VS, BP, RR, SpO2
 SAMPLE history
 OPQRST history
Differential
 Cardiac Dysrhythmia
 Hypoglycemia
 Overdose
 Toxidrome
 Sepsis
 Occult Trauma
 Adrenal Insufficiency
 Mental Status
 Pale, Cool Skin
 Delayed Cap Refill
Medical Protocols - Adult
REMEMBER
It is critical that we do not administer 
paralytics without adequate sedation
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Monitor VS Closely
Notify Receiving Facility,
Contact Medical Control As Necessary
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

P
Nebulized Epinephrine 1mg Neb
(1:1000) in 2 mL NS
OR
Racemic Epinephrine 2.25% 3mL/5mL 
Normal Saline Neb
A IV Access Protocol p49
General Approach Adult, Medical Airway Management Protocol p32
Allergic Reaction Protocol p46
Cardiac Monitor
Wheezing / Lower Airway Respiratory Exam Stridor / Upper Airway
Albuterol 2.5mg/3mL Neb
OR 6 puffs MDI
(max 3 doses)
Consider Albuterol 2.5mg/3mL Neb, 
OR 6 puffs MDI
(max 3 doses) 
P
Consider Methylprednisolone 
125 mg IV/IO
Yes
No
Yes
No
Yes
 12 Lead ECG Procedure p129
Notify Receiving Facility,
Contact Medical Control As Necessary
Improving
Improving
Airway Patent, 
Respirations Adequate, 
Apply O₂ 
Allergic Reaction/
Anaphylaxis
No
No
Yes
35
COPD / Asthma - Adult
Pearls
REQUIRED EXAM: VS, 12 Lead, GCS, RR, Lung Sounds, Accessory muscle use, nasal flaring
 Do not delay inhaled meds to get extended history.
 Supplemental O2 for all cases of hypoxia, tachypnea, subjective air hunger.
 Keep patient in position of comfort if partial obstruction.
 If COPD, monitor mental status.
 Severe Asthma may restrict airway enough to not hear wheezing.
Pertinent Positives/Negatives:
 Age, VS, SpO2, EtCO2
 SAMPLE history
 OPQRST history
 Asthma, COPD, CHF history
 Home meds used prior to call 
 (Nebs, Steroids, Theophylline)
 Wheezing, Rhonchi
 Accessory Muscle Use
 Decreased Ability to Speak
 History of CPAP/Intubation/ICU Admission 
from previous flares
 Smoke Exposure, Inhaled Toxins
Differential
 Simple Pneumothorax
 Tension Pneumothorax
 Pericardial Tamponade
 STEMI, CHF
 Inhaled Toxins (CO, CN, 
etc.)
 Anaphylaxis
 Asthma/COPD
Medical Protocols - Adult
B Ipratropium 0.5mg Neb, max 2 doses
P
Consider Methylprednisolone 125 mg 
IV/IO
Consider Airway Management Protocol p32
B
P
Consider CPAP Procedure 
IF SBP >100 p146
 Consider Midazolam 2mg IV/IN or 
Ketamine 0.25mg/kg IV/IM/IO (max 25mg) 
If needed for CPAP compliance
Albuterol 2.5mg/3mL Neb
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
P
Consider Mag Sulfate 2g IV/IO 
Infuse over 10 minutes
B Ipratropium 0.5mg Neb, max 2 doses
B Consider Epi 0.3-0.5mg IM (1:1,000)
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

B
12-Lead ECG Procedure p129
CHF / Pulmonary Edema - Adult
General Approach – Adult, Medical
36
Pearls
REQUIRED EXAM: VS, GCS, Head, Neck, Blood Glucose
 If CHF / Cardiogenic Shock is from inferior MI (II, III, aVF), consider RIGHT sided ECG
 If ST Elevation in V3, V4 OR Inferior Leads (II, III, aVF), Nitroglycerin may cause severe hypotension requiring IV Fluid boluses
 NTG goal is 20% reduction in SBP or symptom relief. If patient reports no relief with home Nitroglycerin, consider potency of medication (is the medicine expired? Would 
EMS supply be useful?)
 BE CAUTIOUS – Benzodiazepines may worsen respiratory depression, altered mental status, agitation especially if recent EtOH or illicit drug use. This med should be 
considered with EXTREME caution. All efforts should be made to verbally coach compliance PRIOR to BZD use in respiratory distress
Medical Protocols - Adult
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 CHF, CAD, Chest Pain History
 Peripheral Edema
Differential
 Myocardial Infarction
 Pericardial Tamponade
 Pulmonary Embolism
 Congestive Heart Failure
 Toxic Exposure
 COPD Exacerbation
 Acute Renal Failure
 Home meds used prior to call (Digoxin, 
Lasix, Viagra, Cialis)
 Respiratory Distress, Rales
 Orthopnea, JVD
 Pink, Frothy Sputum
General Approach – Adult, Medical
Airway Patent,
Respirations 
Adequate
Airway Management Protocol
p32
Aspirin 324mg PO Chewed or Powdered
IF Awake and Protecting Airway
A
M
Nitroglycerin 0.4mg SL
Repeat every 5 min.
Repeat and Document BP
SBP >100
IV Access Protocol p49
Continuous Cardiac Monitor
No
Access
Successful Access
Go To Appropriate Arrhythmia Protocol
Severity of 
Symptoms
Mild
Normal HR
Normal or Elevated SBP (>100 but <180)
Moderate / Severe
Increased HR
Markedly Elevated SBP (>180)
Cardiogenic Shock
Initial Tachycardia, then later Bradycardia
Initial HTN, then progressing to 
Hypotension
Yes
A
P
Nitroglycerin Paste
(if available)
Nitroglycerin Tab/Spray 0.4mg SL
Repeat every 5 min.
A
P
Nitroglycerin Paste
(if available)
Nitroglycerin Tab/Spray 0.4mg SL
Repeat every 5 min.
P
Norepinephrine infusion IF Available
Start 4-16mcg/min IV/IO
Titrate to SBP >100, MAP>65, or 
signs of improved perfusion
Dysrhythmia STEMI Protocol
p42
STEMI OR
**Acute MI**
Improving No
Yes
SBP <100
Consider CPAP Procedure 
p146
Continuous Cardiac Monitor
No Consider Sepsis Screening Protocol When 
Appropriate p62
P
Nitroglycerin Paste (If Available)
 SBP >100, 1 inch of paste
 SBP >150, 1.5 inches of paste
 SBP >200, 2 inches of paste
Note: For SBP >200, NTG Paste will 
likely not have a significant impact on 
BP; consider SL NTG
P
Consider Midazolam 2mg IV/IN or 
Ketamine 0.25mg/kg IV/IM/IO 
(max 25mg)
If needed for CPAP compliance
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Notify Receiving Facility,
Contact Medical Control As Necessary
Consider Airway Management Protocol
p32
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Cardiac Arrest - Adult
Consider Criteria for Death/Withholding Resuscitation 
Policy p15
Contact Law Enforcement and/or Medical Examiner
If no signs of ROSC and >20min ACLS, 
Consider Termination of Resuscitation Policy p15
37
Medical Protocols - Adult
General Approach – Adult, Medical
Pulseless,
Apneic No Go To Appropriate Adult Medical Protocol
Yes
Shockable
If Signs of ROSC, go to Post-Resus Care p40
Notify Receiving Facility,
Contact Medical Control As Necessary
Start HPCPR Procedure p156
Attach Monitor / Defibrillator
Defibrillate at max joules, Continue HPCPR x 2 minutes
Yes
V-fib / Pulseless VT
Continue HPCPR x 2 minutes
A IV Access Protocol p49
P
No
PEA / Asystole
Defibrillate at max joules, Continue HPCPR x 2 minutes Yes Shockable No Continue HPCPR x 2 minutes
Treat Reversible Causes
A IV Access Protocol p49
Treat Reversible Causes
P
P
P
ROSC
No
Yes No
Epinephrine (1:10,000) 1mg IV/IO
Repeat every 3-5min
Consider Airway Management Protocol p32
Epinephrine (1:10,000) 1mg IV/IO
Repeat every 3-5min
Amiodarone 300mg IV/IO bolus
May Give 2
nd dose 150mg IV/IO bolus
Airway Management Protocol p32
(If not already done)
Epinephrine (1:10,000) 1mg IV/IO
Repeat every 3-5min
Airway Management Protocol p32
(If not already done)
Activating An “ECMO Alert”
(The time to consider ECMO is with the first dose 
of epi). Contact the ECMO Capable Hospital by 
radio early. 
Continue HPCPR and follow ECMO protocol 
p39
P
Sedation during Resuscitation
Ketamine
2mg/kg (Max 200mg) IV/IO
if needed for sedation during resuscitation if 
patient consciousness during CPR is interfering in 
care
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Supplemental O2, BVM with NPA or OPA
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

CONSIDER CORRECTABLE CAUSES OF ARRHYTHMIA:
 Hypoxia – Secure airway and ventilate
 Hypothermia – Active Rewarming
 Hydrogen Ion (acidosis) – secure airway and ventilate
 Toxins: 
Narcotic OD – Naloxone 2mg IV/IO/IN/IM
Cardiac Arrest - Adult
38
CPR Quality
 Push Hard (at least 2 inches) and fast (100-120/min) and allow complete chest recoil
 Minimize interruptions in compressions
 Avoid excessive ventilation
 Rotate compressors every 2 minutes, sooner if fatigued
 If no advanced airway, 30:2 compression: ventilation ratio
 Quantitative waveform capnography
 If EtCO2 <10mmHg, attempt to improve CPR quality
 Consider Mechanical CPR device by 6 minutes of resuscitation; may consider sooner if 
resources allow
 Consider advanced airway placement by 6 mnutes of resuscitation; may consider sooner 
if resources allow
High Performance CPR (HPCPR)
HPCPR is an emphasis on communication, efficient movement 
of resuscitationists, and an increased emphasis on the BASICS 
that improves outcomes
CONSIDER ALS EARLY if not auto dispatched
If at any time Patient has Return of Spontaneous Circulation (ROSC) Go to Post Resuscitation 
Protocol p40
Drug Therapy
Epinephrine IV/IO dose: 1mg every 3-5 minutes 
Consider Max 5 doses epi IF not responding to resuscitation efforts
Amiodarone IV/IO dose: First dose 300mg bolus. Second dose 150mg bolus.
*Ketamine sedation during resuscitation consider 2mg/kg IV/IO
Double Sequential Defibrillation
 Consider for cases of shock refractory V-fib or Pulseless 
V-tach that have not converted after 3 defibrillation 
attempts AND >1 dose of ACLS medication
 There is the potential to cause damage to equipment 
when performing this procedure. Therefore, it is 
recommended to be attempted using an AED and a 
monitor to minimize risk.
 Because of the potential for adverse equipment results, 
it is important that your Service Director and Medical 
Director approve this procedure BEFORE attempting
Advanced Airway
 Endotracheal Intubation or supraglottic airway
 Waveform capnography to confirm and monitor ET tube 
placement
 Once advanced airway in place, give 1 breath every 6 
seconds (10 breaths/min) with continuous chest 
compressions 
Return of Spontaneous Circulation (ROSC)
 Pulse and blood pressure
 Abrupt sustained increase in ETCO2 (typically >40mmHg)
Pearls
RECOMMENDED EXAM: Mental Status, Pulse, Initial and Final Rhythm
 Immediately after defibrillation, resume chest compressions with a different operator compressing. Do not pause for post-shock rhythm analysis. Stop 
compressions only for signs of life (patient movement) or rhythm visible through compressions on monitor or pre-defibrillation rhythm analysis every 2 minutes 
and proceed to appropriate protocol.
 Based on current literature, Ventricular Fibrillation and Pulseless Ventricular Tachycardia patients who are successfully resuscitated should be transport ed to a 
24/7 STEMI capable facility if reasonable to do so.
 In the event a patient suffers cardiac arrest in the presence of EMS, the absolute highest priority is to apply the AED/Defibrillator and deliver a shock 
immediately if indicated.
 Reassess airway frequently and with every patient move. Cycle compressors frequently – compression quality deteriorates before fatigue is perceived.
 Designate a “Code Leader” to coordinate transitions, defibrillation and pharmacological interventions. “Code Leader” ideally should have no procedural tasks. 
 External Compression Devices may be considered if available and will not impede patient care.
 Consider sodium bicarb early in cases of sudden cardiac arrest in Excited Delirium.
 Consider Ketamine if needed for sedation during resuscitation if patient consciousness during CPR is interfering in care.
Medical Protocols - Adult
Refractory/Recurrent Vfib (Shockable Rhythm)
 Consider changing position of pads, reduce impedance, 
double sequential (see below), ECMO, transport
A
 Hypoglycemia – D10W 100ml IV/IO
 Hypovolemia – NS Bolus IV/IO
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
P
Hyperkalemia – Sodium Bicarbonate 50mEq IV/IO AND
 - Calcium Chloride 1g IV/IO
Hypomagnesemia / Torsades – Magnesium 2g IV/IO over 2 min
Tension Pneumothorax – Chest Decompression Procedure
Tamponade, Cardiac
Toxins:
Calcium Channel and B-Blocker OD – Glucagon 2mg IV/IO infusion
Calcium Channel Blocker OD – Calcium Chloride 1g IV/IO infusion
(contraindicated if pt. also on Digoxin/Lanoxin)
Tricyclic Antidepressant OD – Sodium Bicarb 1mEq/kg IV/IO
Thrombosis, Pulmonary
Thrombosis, Coronary
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Cardiac Arrest – Adult, Medical
ECPR Candidate
Consider Application of Mechanical CPR 
Device
Consult with ECMO Capable Hospital Early,
“ECMO Alert”
Continue HPCPR Procedure p156
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Yes
No Go To Appropriate Arrest Protocol
39
Extracorporeal Cardiopulmonary Resuscitation 
(ECPR or “ECMO”) - Adult
Pearls
REQUIRED EXAM: VS, GCS, RR, Lung Sounds, Cardiac Exam, JVD
 Goal is estimated time of arrest to on ECMO Circuit <60 minutes
 It is important to balance High Performance CPR on scene with ECPR potential; Strongly consider candidate patient if not responding to quality CPR. 
 Ideally, decision to move patient should be made and transport from scene should happen in <16 minutes
 Contact ECPR-capable receiving hospital with “ECMO Alert” early; consider contact after 2
nd shock for refractory V-fib, rearrest after ROSC, EMS Discretion, etc.
 ECPR is a highly time-critical intervention; it is important to consider the patient circumstances and whether pt. could be a candidate. Consultation with ECMO center early is 
a priority
 There are many variables that go into the decision to start a patient in ECPR circuit; not every candidate patient will be able to be cannulated on arrival to the ED
Inclusion Criteria for ECPR:
q Age 13 -70 years; weight >40kg
q Arrest is EITHER:
 Witnessed OR
 Initial Shockable Rhythm OR
 Intermittent ROSC
q ECPR can be initiated within ~60 minutes of estimated initial arrest
q Suspect reversible cause of arrest – STEMI, massive PE, cardiac toxin 
overdose, primary arrhythmia, accidental hypothermia, etc. 
q ECPR and full ICU care are consistent with patient wishes (if known by family 
at bedside)
Exclusions to ECPR:
q Estimated BMI >40 due to morbid obesity
 (i.e. >300lbs at 6' tall; >250lbs at 5'6" tall; cannot fit into LUCAS device)
q Cannot safely anticoagulate
 (i.e. Trauma, Aortic Dissection, ICH, Uncontrolled Hemorrhage)
q Cannot perform ADLs at baseline, including (if known or reported by family)
 Resident of Nursing Home, SNF, LTAC
 Not oriented to self and place and/or not conversational
q Advanced comorbidities (if known or reported by family)
 Oxygen-dependent lung disease
 Previously evaluated and deemed not a candidate for LVAD
 ESRD requiring dialysis
 ESLD, including jaundice, ascites, varices and/or transplant list
 Metastatic cancer and/or receiving chemo or radiation
q DNR/DNI (if known or reported by family)
q Attending physician perception of futility, including
 EtCO2 <10mmHg for >20minutes
Medical Protocols - Adult
Medical Control 
Recommends 
ECPR
No
Yes
Return To Appropriate Arrest Protocol
Initiate Transport to ECMO Center
Continue HPCPR Procedure p156
Activating An “ECMO Alert”
q Contact the ECMO Capable Hospital Early 
by radio. “We are on scene with a 
potential ECPR Candidate”
q Over the radio, give a reliable phone 
number for the Medical Control Physician 
to call you back (may require 
communication of HIPAA protected 
patient information)
q Medical Control will call you directly to 
review the case and make a decision 
regarding patient candidacy for ECPR
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Cardiac Arrest – Adult, Medical
Airway Management, Adult Protocol 
(if not already done) p32
Yes
Appropriate Adult Protocol
Consider Post Advanced Airway Sedation, Adult 
Protocol p34
Notify Receiving Facility,
Contact Medical Control As Necessary
Consider Shock / Hypotension (Non-Trauma) 
Protocol p63
40
Post Resuscitation - Adult
Pearls
RECOMMENDED EXAM: Mental Status, Pulse, Initial and Final Rhythm
 The American Heart Association no longer supports routine prehospital hypothermia induction for all out of hospital cardiac a rrests based on the most current literature. 
 Acute myocardial infarction, cardiomyopathy, and primary arrhythmia are the most common causes for cardiac arrest.
 Based on current literature, Ventricular Fibrillation and Pulseless Ventricular Tachycardia patients who are successfully resuscitated should be transported to a 24/7 STEMI 
capable facility if reasonable to do so.
 In observational studies, PaCO2 in a normal range (35 to 45 mmHg) when measured at 37°C is associated with better outcomes than higher or lower PaCO2.
 Antiarrhythmic drugs should be reserved for patients with recurrent or ongoing unstable arrhythmias.
 No data support the routine or prophylactic use of antiarrhythmic drugs after the return of spontaneous circulation following cardiac arrest, even if such medications were 
employed during the resuscitation. 
 Determining and correcting the underlying cause of the arrhythmia (eg, electrolyte disturbance, acute myocardial ischemia, toxin ingestion) is the best intervention.
Perform and Document Complete Neurologic Exam
Optimize Ventilation and Oxygenation
SpO2 >93%
EtCO2 goal 35-45mmHg
Pertinent Positives and Negatives
 Events leading to arrest
 Estimated downtime
 Past Medical History
 Medications
Differential
 Medical or Trauma
 Vfib vs Pulseless Vtach
 Asystole
 Pulseless electrical activity (PEA)
 Existence of terminal illness
 Signs of lividity, rigor mortis
 Code Status (DNR)
Medical Protocols - Adult
Monitor for Hypotension, Dysrhythmias, or Airway 
Compromise
Consider Bradycardia Protocol p44
Consider Tachycardia Protocol p43
P
Consider push dose Epi 5-20mcg p190
If suspected imminent re-arrest 
Every 1-2 minutes for SBP>100, MAP >65,
or signs of improved perfusion
12-Lead ECG Procedure p129
Regardless if completed prior to arrest
A
IV Access Protocol
(if not already done) p49
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Continuous Cardiac Monitor
General Approach – Adult, Medical
No STEMI
A
M
Nitroglycerin 0.4mg SL
Repeat every 5 min.
Repeat Vitals and Document BP 
after each dose 
No Access AND
SBP >100 AND
Continued Symptoms
Notify Receiving Hospital Early,
“STEMI Alert”
STEMI read OR
**Acute MI**
STEMI Protocol
p42
Consider IV Access Protocol
p49
Systolic BP >100
CHF / Pulmonary Edema Protocol
p36
Evidence of CHF / 
Pulmonary Edema
A NS Bolus IV/IO
Consider Shock / Hypotension (NonTrauma) Protocol p63
No
A
P
Nitroglycerin Paste
(if available)
Nitroglycerin 0.4mg SL
Repeat every 5 min.
Yes
No
Yes
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Continued
Ischemic Symptoms
Symptom
Free
12-Lead ECG Procedure p129
Obtain & Transmit within 10 min.
No Access
Consider Pain Management Protocol
p58
41
Pearls
REQUIRED EXAM: VS, GCS, RR, Lung Sounds, Cardiac Exam, JVD
 Avoid Nitroglycerin in any patient who has used Viagra (Sildenafil) or Levitra (Vardenafil) in the last 24 hours or Cialis (Tadalifil) in the last 36 hours
 If no IV Access, ECG MUST be obtained and reviewed by Medical Control prior to administration of Nitroglycerin (even patient supplied)
 If patient takes Aspirin immediately prior to EMS arrival, confirm the medication and expiration date. If uncertain, administer full dose aspirin
 NTG goal is 20% reduction in SBP or symptom relief. If patient reports no relief with home Nitroglycerin, consider potency of medication (is the medicine expired? Would 
EMS supply be useful?)
 Use Nitroglycerin with caution if Inferior, Right Ventricle or Posterior MI is suspected
 Elderly patients, diabetics and women are more likely to have atypical chest pain – SOB, fatigue, weakness, back pain, jaw pain
 Have a low threshold to get a 12-Lead ECG. They are minimally invasive, painless and can evolve with time
 If ST Elevation in V3, V4 or Inferior Leads (II, III, aVF), Nitroglycerin may cause hypotension requiring IV Fluid Boluses
Chest Pain / Suspected Acute Coronary Syndrome -
Adult
ASA 324mg (chewed or powdered)
A
Consider Ondansetron 0.15mg/kg 
(max 4mg) 
IV/IO/ODT
Successful
Access
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE History
 OPQRST History
 CHF, CAD, Chest Pain History
 Home meds prior to EMS Arrival 
(Digoxin, Lasix, ASA, Viagra, Cialis)
 Respiratory Distress
 Orthopnea, JVD
Differential
 Pericardial Tamponade
 Pericarditis
 Asthma / COPD
 Aortic Dissection
 Sympathomimetic Overdose
 Pulmonary Embolism
 Esophageal Spasm
 Gastroesophageal Reflux (GERD)
Medical Protocols - Adult
P
Nitroglycerin Paste (If Available)
 SBP >100, 1 inch of paste
 SBP >150, 1.5 inches of paste
 SBP >200, 2 inches of paste
Note: For SBP >200, NTG Paste will likely 
not have a significant impact on BP; 
consider SL NTG
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Apply Defib Pads
A
42
ST Elevation Myocardial Infarction - Adult
Pearls
REQUIRED EXAM: VS, GCS, RR, Lung Sounds, Cardiac Exam, JVD
 Goal is First Medical Contact (YOU!!) to arrival at the 24/7 PCI capable STEMI facility should be <60 minutes.
 Goal is to limit on-scene time with a STEMI patient to <10 minutes.
 NTG goal is 20% reduction in SBP or symptom relief. If patient reports no relief with home Nitroglycerin, consider potency of medication (is the medicine expired? Would 
EMS supply be useful?).
 If long transport time expected due to geography, traffic, etc. consider activation of Air EMS for delivery directly to cath lab.
 Transmit STEMI or **Acute MI** 12-Leads early and call STEMI receiving hospital with “STEMI Alert” early; inform them of full report to follow.
Medical Protocols - Adult
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE History
 OPQRST History
 CHF, CAD, Chest Pain History
Differential
 Pericardial Tamponade
 Pericarditis
 Asthma / COPD
 Aortic Dissection
 Home meds prior to EMS Arrival 
(Warfarin, Anticoagulation, ASA, 
Viagra, Cialis)
 Respiratory Distress
 Orthopnea, JVD
 Sympathomimetic Overdose
 Pulmonary Embolism
General Approach – Adult, Medical
STEMI Interpretation of 12-Lead 
-OR-
**Acute MI**
ASA 324mg (chewed or powdered) 
if not already done
Notify Receiving Hospital Early,
“STEMI Alert”
Inferior Wall MI
(Elevation in II, III, 
aVF)
CHF / Pulmonary 
Edema 
CHF / Pulmonary Edema Protocol 
p36
Consider Right Sided ECG Procedure 
(If Time Allows) p129
IV Access Protocol p49
Systolic BP <100, 
MAP <65 or signs 
of poor perfusion
Consider Pain Management
Protocol, Adult p58
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Symptom
Free
Yes
No
Yes
Yes
No
No Shock / Hypotension (Non-Trauma) 
Protocol p63
A Consider NS Bolus IV/IO
No Go To Appropriate Medical Protocol
P
Nitroglycerin Paste (If Available)
 SBP >100, 1 inch of paste
 SBP >150, 1.5 inches of paste
 SBP >200, 2 inches of paste
Note: For SBP >200, NTG Paste will 
likely not have a significant impact on 
BP; consider SL NTG
M
A
P
Nitroglycerin Paste
(if available)
If No IV, Nitroglycerin 0.4mg SL
Repeat every 5 min. 
Nitroglycerin 0.4mg SL
Repeat every 5 min.
A
Consider Ondansetron 4mg 
IV/IO/ODT
Yes
Consider Air Transport if Long Transport
Determine if known IV Dye Allergy
(Important for Cardiac Cath team)
Continued
Ischemic 
Symptoms
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Go to appropriate Protocol 
(Ie.sepsis, dehydration, DKA, hypovolemia)
Supportive Care / 
Treat Underlying Causes
43
Tachycardia With A Pulse - Adult
12-Lead ECG Procedure p129
Narrow
(<120ms)
Notify Receiving Facility,
Contact Medical Control As Necessary
A
IV Access Protocol p49
NS Bolus 
Monomorphic
P
Amiodarone 150mg IV/IO
Over 10 minutes
Are P waves 
Present?
No
Supportive Care / 
Treat Underlying Causes
M
A
Consider Chest Pain Protocol
p41
Is the Rhythm 
Regular?
No
QRS Duration?
Yes
Polymorphic P Consider Vagal Maneuvers
Unstable* / 
Imminent Arrest Yes
No
Pearls
REQUIRED EXAM: VS, GCS, RR, Lung Sounds, Cardiac Exam, JVD
 *Unstable – Severe Hypotension, Signs of Shock, AMS Secondary to Arrhythmia.
 Not all cases of tachycardia need to be rate controlled; sepsis, hypovolemia, and acute hemorrhage will do worse if their ability to compensate is taken away
 Adenosine has a very short half life (5sec or less) so it must be infused rapidly in a patent IV site, preferably the AC fossa or more proximal 
General Approach – Adult, Medical
P
Synchronized Cardioversion Procedure 
p154 Repeat as needed
Consider analgesia/sedation 
P
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Consider Vagal Maneuvers if suspected 
SVT and symptomatic
Yes
Diltiazem 0.25mg/kg IV/IO
(Max 20mg)
Consider Adenosine 6mg IV/IO 
Rapid Push, may repeat 12mg IV/IO
P
Fentanyl 1mcg/kg IV/IO (max 100mcg) 
AND / OR
P
Midazolam 0.1mg/kg IV/IO (max 5mg) or 
0.2 mg/kg IM/IN (max 10mg)
OR
Lorazepam 0.1mg/kg IV/IO/IM (max 2mg)
P
Amiodarone 150mg IV/IO
Over 10 minutes
P
Mag Sulfate 2g IV/IO
Infuse over 1-2min
Wide
(>120ms)
Medical Protocols - Adult
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

P
Consider External Cardiac Pacing Procedure 
p159
A
Consider IVF bolus IV/IO, repeat as 
indicated for patient condition
Continuous Cardiac Monitor
Supplemental O2 to maintain SpO2 >93%
44
Bradycardia With A Pulse - Adult
Pearls
REQUIRED EXAM: VS, GCS, RR, Lung Sounds, Cardiac Exam, JVD
 Not all cases of bradycardia need to be treated with medicine or pacing; use good clinical judgement and follow symptoms.
 Continually monitor for signs of decompensation and be prepared to move to external cardiac pacing if the patient condition changes. Place the pads while reaching for the 
meds.
 Atropine is unlikely to work in cases of complete heart block. Atropine is contraindicated in patients with narrow angle glaucoma.
 Elderly patients, diabetics and women are more likely to have atypical chest pain – SOB, fatigue, weakness, back pain, jaw pain.
 Have a low threshold to get a 12-Lead ECG. They are minimally invasive, painless and can evolve with time.
Medical Protocols - Adult
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE History
 OPQRST History
 CHF, CAD, Chest Pain History
 QRS <0.12 sec (<3 small squares)
Differential
 Pericardial Tamponade
 Pericarditis
 Pacemaker Failure
 Hypothermia
 Sinus Bradycardia
 Home meds prior to EMS Arrival 
(Digoxin, Lasix, ASA, Viagra, Cialis)
 Respiratory Distress
 Orthopnea, JVD
 Head Injury
 Spinal Cord Injury
 Sick Sinus Syndrome
 Acute MI
 AV Block (1
o
, 2
o
, 3
o
)
General Approach – Adult, Medical
A IV Access Protocol p49
Notify Receiving Facility,
Contact Medical Control As Necessary
HR <60bpm AND 
Unstable / Imminent 
Arrest
Yes
Yes Symptomatic No Look for and Treat Underlying Causes
Consider Specific Overdose and Poisoning 
Protocol p54
Go To STEMI Treatment Protocol
p42 STEMI
P
Atropine 1.0mg IV/IO
May Repeat every 3-5min; Max 3mg
Improving
P
Epinephrine (1:1,000) 2-10 mcg/min IV/IO
Titrate to SBP>100, MAP>65, 
OR signs of improved perfusion
No
P
Consider push dose Epi 5-20mcg p190
every 1-2 minutes SBP>100, MAP >65, 
or signs of improved perfusion
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
P
External Cardiac Pacing Procedure
p159
Consider analgesia/sedation 
P
Fentanyl 1mcg/kg IV/IO (max 100mcg) 
AND / OR
P
Midazolam 0.1mg/kg IV/IO (max 5mg) or 
0.2 mg/kg IM/IN (max 10mg)
OR
Lorazepam 0.1mg/kg IV/IO/IM (max 2mg)
12-Lead ECG Procedure
p129
Consider SEPSIS Screening p62
No
Yes
Consider Hypotension / Shock (Non-Trauma) 
Protocol p63
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

45
Abdominal Pain / GI Bleeding - Adult
Pearls
REQUIRED EXAM: VS, GCS, Focal Tenderness, Rebound Tenderness, Distal Pulses, Abdominal Masses
 Nothing by mouth (NPO) Status for all patients with abdominal pain
 If pain is above the umbilicus, perform a 12-Lead ECG. Go to Chest Pain Protocol as indicated
 Abdominal pain in women of child bearing age should be treated as an ectopic pregnancy until proven otherwise
 The diagnosis of AAA should be considered in patients >50 years old. Assess the abdomen for a midline pulsatile mass and feel for pulses in feet / legs
 Rebound tenderness is pain that is increased when releasing pressure from palpation
 Appendicitis may present with vague, peri-umbilical pain that slowly migrates to the Right Lower Quadrant (RLQ) over time
 Blood loss from the GI Tract has a very distinct smell; use all of your senses when evaluating your patients. GI Bleed patients have a high risk of serious hemorrhage
 Abdominal Pain and known pregnancy, go to OB Protocol
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Last Meal / Oral Fluids
 Menstrual / Pregnancy History
 Anticoagulant Use
Differential
 AAA +/- Rupture
 Perforated Ulcer
 Appendicitis
 Ectopic Pregnancy +/- Rupture
 Diverticulitis
 Small Bowel Obstruction
 Splenic Enlargement / 
Rupture
 Nausea, Vomiting, Diarrhea
 Constipation
 Hematochezia (Bloody 
Stool)
 Recent Travel
 Recent Antibiotics
Medical Protocols - Adult
General Approach – Adult, Medical
Nausea and/or 
Vomiting
A
IV Access Protocol
p49
Hypotension
(SBP <100), MAP <65 or 
signs of poor perfusion
A
Ondansetron 0.15mg/kg (max 4mg) 
IV/IO/ODT/IM
Yes
No
A
Consider IVF bolus IV/IO, repeat as indicated 
for patient condition
Shock/Hypotension (Non-Trauma) Protocol
p63
Notify Receiving Facility,
Contact Medical Control As Necessary
Consider Chest Pain/Suspected Acute Coronary 
Syndrome Protocol p41
Consider Pain Management Protocol – Adult, 
Medical p58
Yes
Repeat and Document BP
No
Normotensive
(SBP >100)
Yes
No
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Consider ALS if not already done 
Epi 0.3-0.5mg IM (1:1000)
P
Albuterol 2.5mg/3mL Neb 
May repeat Q10min, Max 3
P Methylprednisolone, 125mg IV/IO
General Approach – Adult, Medical
P Epi Infusion 2-10mcg/min IV/IO
Allergic Reaction Anaphylaxis
Flushing, Hives, Itching, Erythema
Normal BP, No Respiratory Involvement
Multi System involvement or 
Hypotension, respiratory distress, AMS
Dyspnea, Wheezing, Chest Tightness, Vomiting or 
Abdominal Pain
Epi 0.3-0.5mg IM (1:1000)
Improving
46
Allergic Reaction - Adult
Pearls
REQUIRED EXAM: VS, GCS, Skin, Cardiovascular, Pulmonary
 Epinephrine Infusion: Mix 1mg (1:1,000) in 250mL NS. If worsening/refractory anaphylaxis, contact Med Control as soon as practical. Start at 2mcg/min, titrate up.
 Famotidine dilution no longer required. Infuse over 2 minutes.
 In general, the shorter the time from allergen contact to start of symptoms, the more severe the reaction.
 Consider the Airway Management Protocol early in patients with Severe Allergic Reaction or subjective throat closing.
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Onset and Location of Symptoms
Differential
 Urticaria (Rash Only)
 Anaphylaxis (Systemic Effect)
 Shock (Vascular Effect)
 Angioedema
 Aspiration / Airway 
Obstruction
 Vasovagal Event
 Asthma / COPD
 CHF
 Lung Sounds before AND after
intervention
 Allergen Exposure
 Toxic / Environmental Exposure
 Subjective throat “tightness” OR “closing”
Medical Protocols - Adult
P
P Famotidine 20mg IV/IO If available
Diphenhydramine 50mg 
IV/IM/IO/PO
Monitor and Reassess
Document Response to Medications
Notify Receiving Facility,
Contact Medical Control As Necessary
No
Improving No
Yes
Consider push dose Epi 5-20mcg p190
If suspected imminent arrest.
Every 1-2 minutes SBP>100, MAP >65, or signs 
of improved perfusion
Consider Airway Management Protocol p32
12-Lead ECG Procedure p129
Consider Hypotension/Shock Protocol p63
Yes
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
A IV Access Protocol p49
A
Consider IVF bolus IV/IO, repeat as indicated 
for patient condition
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

P
A
P
General Approach – Adult, Medical
Pearls
REQUIRED EXAM: VS, GCS, Skin, Cardiovascular, Pulmonary
 Safety First – For Providers, Police and Patients! Never restrain any patients in the prone (face down) position.
 Physical and/or chemical restraints should ONLY be used if patient is deemed a danger to themselves or others and is uncooperative and less invasive measures to 
deescalate have failed or were deemed unsafe to attempt.
 All patients who require chemical restraint MUST be continuously monitored by ALS Personnel.
 Patients who are actively fighting physical restraints are at high risk for Behavioral Emergencies and In-Custody Death; Have a low threshold to activate ALS for chemical 
restraint.
 There are multiple possible causes of behavioral emergencies. Keep a broad differential when evaluating and treating these patients. 
 Transport of patients requiring handcuffs or Law Enforcement (LE) restraint require LE to ride in the ambulance to the hospital – they have the keys!
 *Avoid Haloperidol in patients with known history of MAOI Antidepressant use (Phenelzine, Tranylcypromine) OR history of Parkinson’s Disease.
 If a patient with severe agitation suddenly becomes cooperative/quiet, reassess them quickly! Sudden Cardiac Death is common in this population.
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Provider Safety
Yes
No
Stage,
Call for Law Enforcement and/or Additional 
Resources
Evidence of 
Exposure / 
Toxidrome
No
Consider Overdose and Poisoning Protocol 
p54 Yes
Evidence of 
Head Injury
Head Injury, Adult Trauma Protocol 
p80 Yes Remove Patient from stressful environment, use verbal calming techniques
Consider Restraints Procedure, As Appropriate 
p169
Blood Sugar Diabetic Emergencies Protocol
p48 <70
Uncooperative 
AND Danger To Self 
or Others
No
*Haloperidol 5 mg IM 
AND/OR 
Midazolam 0.1mg/kg IV/IO (max 5mg) OR 
Midazolam 0.2 mg/kg IM/IN (max 10mg) 
OR
Lorazepam 0.1mg/kg IV/IO/IM (Max 2mg)
>70 OR
Unobtainable
Due to Condition
No
M Contact Medical Control Patient
Refusing
Consider Need for ALS Level Service
EARLY
Consider Safety of ALL Responders including 
Law Enforcement
IV Access Protocol
(When Appropriate) p49
47
Behavioral Emergencies - Adult
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Situational Crisis
Differential
 EtOH Intoxication / Withdrawal
 Toxic Ingestion
 Substance Use / Abuse
 Schizophrenia
Medical Protocols - Adult
 Hypoglycemia
 Hypoxia
 Head Injury
 Occult Trauma
 Cerebral Hypoperfusion
 Psychiatric Illness / Medication History
 Medic Alert Bracelet, DM History
 Anxiety, Agitation or Confusion
 Suicidal / Homicidal Thoughts or History
 Evidence of Substance Use / Overdose
Yes
No
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Consider Ketamine 2mg/kg IV/IO 
(max 200mg) -ORKetamine 4mg/kg IM/IN 
(max 400mg)
Reassess. Follow Mental Status, SpO2, 
Respiratory Effort and Rate CLOSELY
Monitor for Laryngospasm
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
B
Consider Glucagon 1mg IM
One time
48
Diabetic Emergencies - Adult
Pearls
REQUIRED EXAM: VS, SpO2, Blood Glucose, Skin, Respiratory Rate and Effort, Neuro Exam
 Do NOT administer oral glucose to patients that can’t swallow or adequately protect their airway.
 Simple Hypoglycemia for these protocols is defined as: hypoglycemia caused by insulin ONLY and not suspected to be due to occult infection or trauma.
 Prolonged hypoglycemia may not respond to Glucagon; be prepared to start an IV and administer IV Dextrose.
 Alcoholics and patients with advanced liver disease may not respond to Glucagon due to poor liver glycogen stores.
 Patients on oral diabetes medications are at a very high risk of recurrent hypoglycemia and should be transported. Contact Medical Control for advice/patient counseling if 
patient is refusing. See Refusal after Hypoglycemia Treatment Protocol for additional information as necessary.
 Always consider intentional insulin overdose, and ask patients / family / friends / witnesses about suicidal ideation or gestures.
Pertinent Positives/Negatives:
 Age, VS, Blood Glucose Reading
 SAMPLE History
 OPQRST History
 Last Meal, History of Skipped Meal
Differential
 Toxic Ingestion
 Head Injury
 Sepsis
 Stroke/TIA
 Seizure
 EtOH Abuse/Withdrawal
 Drug Abuse/Withdrawal
 Diaphoresis
 Siezures
 Abnormal Respiratory Rate
 History of DKA
IV Access Protocol
p49
Medical Protocols - Adult
General Approach – Adult, Medical
Blood Glucose
Hypotension
(SBP <100, MAP 
<65 or signs of 
poor perfusion)
<70 >250
>70 and <250
oral glucose 15g PO 
May repeat x1
OR Appropriate PO intake
Yes
Clinically 
Dehydrated
No
Hypotension / Shock (Non-Trauma) 
Protocol p63
Yes
Go To Appropriate Adult Medical 
Protocol
No
Go To Appropriate Adult Medical 
Protocol
Normal Mental 
Status
Execute and Document Refusal of 
Transport Protocol p60
No
Consider Sepsis Screening Protocol 
p62
Consider Sepsis Screening Protocol 
p62
A
IV Access Protocol
p49
A
Dextrose Dosing:
D10W 125mL IV/IO OR
Titrate to effect
Yes
Repeat BG 
within 10 min <70
No
>70 >70
Taking Oral 
Diabetes Meds Yes
No No
Secondary 
Issue / 
Complaint
Accepts 
Transport
Go To Appropriate Adult Medical 
Protocol
Consider Sepsis Screening Protocol 
p62
Notify Receiving Facility,
Contact Medical Control As Necessary Yes
Notify Receiving Facility,
Contact Medical Control As Necessary
Yes
No Yes
Awake AND 
Protecting Airway
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
A
IF Viable Site Identified 
Extremity Venous Access
Procedure p177
P
General Approach – Adult, Medical
Notify Receiving Facility,
Contact Medical Control As Necessary M Contact Medical Control
First Access For 
Cardiac Arrest Yes
Emergent OR 
Potentially Emergent 
Medical OR Traumatic 
Condition
Consider IN/IM/PO Medications As 
Appropriate for Condition No
No
A
Extremity Venous Access 
Procedure p177
A
External Jugular Venous Access 
Procedure
p179
Yes
Unsuccessful/
Peripherally Exhausted
Success in <3 
Total Attempts
Monitor Access Site for Swelling, Pain, 
Redness, Evidence of Extravasation Yes
A Monitor Infusion of IV Fluids
Life Threatening 
Condition
No
Yes No
Successful Go To Appropriate Medical Protocol
Intraosseous Venous Access 
Procedure p178
49
IV Access - Adult
Pearls
 In the setting of CARDIAC ARREST ONLY, any preexisting dialysis shunt or central line may be used by Paramedics
 For patients who are hemodynamically unstable or in extremis, Medical Control MUST be contacted prior to accessing any preexisting catheters
 Upper Extremity sites are preferred over Lower Extremity sites. Lower Extremity IVs are discouraged in patients with peripheral vascular disease or diabetes
 In post-mastectomy patients and patients with forearm dialysis fistulas, avoid IV attempts, blood draws, injections or blood pressures in the upper extremity on the affected
side
 Saline Locks are acceptable in cases where access may be necessary but the patient is not volume depleted; having an IV does not mandate IV Fluid infusion
 The preferred order of IV Access is: Peripheral IV, External Jugular IV, Intraosseous IV UNLESS medical acuity or situation dictate otherwise.
Medical Protocols - Adult
Intraosseous Venous Access 
Procedure
(Life Threatening Event) p178
A
Consider Second IV Access Site for 
Critical Medical / Trauma Patients
No viable IV site
P
Consider 10-20mg Lidocaine IO. 
Allow Lidocaine to sit in the 
marrow for 30 seconds prior to 
fluid infusion through the line.
Patient is awake 
& aware of pain
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Seizure Protocol p. 61
Seizure Protocol p. 61
Seizure Protocol p. 61
Seizure Protocol p. 61
Consider Shock / Hypotension 
(Non-Trauma) Protocol p63
Notify Receiving Facility,
Contact Medical Control As Necessary
Vaginal Bleeding/ 
Abdominal Pain
Labor / Imminent Delivery Protocol 
p52
Left Lateral Recumbent Position
A
IV Access Protocol
p49
Labor
Known/Suspected 
Pregnancy OR Missed 
Period
No Go To Appropriate Medical Protocol
Seizure Activity
Consider Diabetic Emergencies Protocol
p48
Hypotension/ 
Shock
Blood Sugar
A
Remember you have TWO patients during 
pregnancy; evaluate, treat and protect BOTH
Left Lateral Recumbent Position takes pressure 
off of the Inferior Vena Cava and prevents 
supine hypotension
Preeclampsia and Eclampsia are typically 
encountered in 3
rd trimester, but may be in 
late 2
nd trimester and up to 6 weeks after 
delivery
Pain
Yes No
No 
<70 
Yes
Yes
>70
Bleeding No
50
OB General - Adult
Pearls
REQUIRED EXAM: VS, GCS, Mental Status, Neuro, Abdominal Exam, Cardiovascular
 Magnesium is the priority for pregnant seizures (eclampsia), but if seizing on EMS arrival give IM/IN Midazolam until IV Access achieved.
 Continuous monitoring is required, as magnesium may cause hypotension and decreased respiratory drive.
 Hypertension, Severe headache, vision changes, RUQ pain, diffuse edema may indicate preeclampsia. This may progress to seizures (eclampsia). 
 Any pregnant patient involved in an MVC or other trauma should be evaluated by MD for evaluation and fetal monitoring.
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Pregnancy History (G’s and P’s)
Differential
 Pre-Eclampsia / Eclampsia
 Ectopic Pregnancy 
 Hypertensive Encephalopathy
 Uterine Rupture 
 Pulmonary Embolism
General Approach – Adult, Medical
 Threatened / Impending / 
Missed Spontaneous Abortion
 Head Injury / Cushing’s Reflex 
(Bradycardia + HTN)
 Domestic Abuse
 Headache
 Abdominal Pain +/- Contractions
 Blurred Vision
 Vaginal Bleeding
 Chest Pain, Dyspnea, Hypoxia
Medical Protocols - Adult
P
Consider TXA 1gm IV/IO 
Over 10 minutes
Seizure Protocol
p61
Consider IVF bolus IV/IO, repeat as 
indicated for patient condition
M
If persistent OR recurrent seizure 
consider 
Magnesium Sulfate 2g IV/IO
P
Magnesium Sulfate 4g IV/IO
Over 10 minutes 
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Yes
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
IV Access Protocol 
p49
A
Consider IVF bolus IV/IO, repeat as indicated 
for patient condition, consider permissive 
hypotension in setting of ongoing serious 
hemorrhage
General Approach – Adult, Medical
Notify Receiving Facility,
Contact Medical Control As Necessary
Known/Suspected 
Pregnancy OR Missed 
Period
OB General Protocol
p50 Yes
Improving
Hypotension/ 
Shock
No
Abdominal Pain
Shock / Hypotension (Non-Trauma) Protocol 
p63
Consider Abdominal Pain Protocol 
p45 Yes
Blood Sugar
Consider Labor/Imminent Delivery Protocol p52
If situation appropriate
Cramping,
Urge to Push
Diabetic Emergencies Protocol
p48
No
No
Yes <70
>70
No
Yes
51
OB / Vaginal Bleeding - Adult
Pearls
REQUIRED EXAM: VS, GCS, Mental Status, Neuro, Abdominal Exam, Cardiovascular
 Always suspect pregnancy as a cause of vaginal bleeding in reproductive age women; patient report regarding menstrual history and sexual activity may not be accurate.
 Ectopic pregnancy is a surgical emergency! Patients with vaginal bleeding, unstable vital signs and suspected ectopic pregnancy should be transferred to an OB receiving 
facility for emergent evaluation and management when possible.
 Always have a high suspicion for domestic violence and /or sexual assault when evaluating a female with a reproductive or GU related complaint.
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Pregnancy History (G’s and P’s)
Differential
 Ectopic Pregnancy
 Domestic Violence
 Sexual Assault
 Dysfunctional Uterine Bleeding
 Threatened / Impending / 
Missed Spontaneous Abortion
 Normal Menstrual Period
 Abdominal Pain +/- Contractions
 Blurred Vision
 Estimated Blood Loss (Pads / 
Tampons Per Hour)
 Chest Pain, Dyspnea, Hypoxia
Medical Protocols - Adult
P Consider TXA 1gm IV/IO over 10 min 
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Adult, Medical
Notify Receiving Facility,
Contact Medical Control As Necessary
Inspect Perineum
NO Digital Vaginal 
Exam
Left Lateral Recumbent Position
A
Abnormal Vaginal 
Bleeding/Hypertension
OB General Protocol
p50 Yes
No
IV Access Protocol p49
M Contact Medical Control
Unable To Deliver
Create air passage by supporting presenting part of 
infant
Place 2 fingers alongside the nose and push away from 
the infant’s face
Transport in Knee-Chest or Left Lateral Recumbent 
Position
No Crowning Crowning, >36 Weeks Gestation Crowning, <36 Weeks Gestation
Abnormal Presentation
Severe Vaginal Bleeding
Multiple Gestation
Activate ALS Monitor and Document VS
Reassess Frequently
Crowning, >36 Weeks Gestation
Prolapsed Cord / 
Shoulder Dystocia
Breech / Footling / Abnormal 
Presentation
Hips Elevated, Knees to Chest
Insert Gloved Fingers Into Vagina
Relieve Pressure on Umbilical Cord
Moist Saline Dressing Over Cord
Eval Fetal Heart Rate / Cord Pulsation
Transport knees to chest 
Unless Delivery Imminent
Encourage Mother to Refrain from 
Pushing
Support Presenting Parts, Do NOT Pull
No
Yes
Crowning, Delivery Imminent
Control delivery with gentle support of 
head to prevent injury to Mother/Baby
Check for nuchal cord; if present slip 
over head gently
Gently apply downward pressure to 
deliver anterior shoulder, then upward 
to deliver posterior shoulder
Cord
Once the cord stops pulsating, then double-clamp 
approximately 10-12cm from the infant’s abdomen. 
Cord should be cut between the two clamps.
52
Labor / Imminent Delivery - Adult
Pearls
REQUIRED EXAM: VS, GCS, Mental Status, Neuro, Abdominal Exam, Cardiovascular
 If Delivery is Completed, go to Newly Born Protocol for evaluation and management of the infant p.53
 Remember that you have TWO patients during Pregnancy, Labor and Delivery; be sure to monitor and protect both throughout your management
 After Delivery, massage the uterus through the anterior abdomen and wait for the placenta; NEVER pull on the umbilical cord to expedite the afterbirth
 Record the APGAR Scores for the infant at 1minute and 5minutes after delivery; if either in the Moderately Depressed range, continue to record and document every 5 
minutes while supporting the infant per the Newly Born Protocol
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Pregnancy History (G’s and P’s)
 Estimated Due Date
Differential
 Endometritis
 Normal Active Labor
 Abnormal Presentation
 Prolapsed Cord
 Preterm Labor
 Threatened / Impending / Missed 
Spontaneous Abortion
 Premature Rupture of Membranes
 Placenta Previa / Placenta 
Abruption
 Prenatal Care / High Risk Pregnancy
 Time of Contraction Onset, 
Frequency
 Rupture of Membranes and Time
 Sensation of Fetal Movement
Medical Protocols - Adult
Expedite Transport to Nearest OB 
Receiving Facility
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Labor / Imminent Delivery – Adult, 
Medical
Notify Receiving Facility,
Contact Medical Control As Necessary
Heart Rate <100
Agonal Breathing OR
Apnea
Warm, Dry and Stimulate Infant
Clear Mouth, then Nose As Needed
Term Gestation
Breathing or Crying
Good Muscle Tone
Yes
No
Airway Suctioning
Routine Suctioning of the Newborn is NO LONGER 
Recommended
Clear Amniotic Fluid
Suction ONLY when obstruction is present and/or 
BVM is required
Meconium Present
Non-Vigorous Newborns may undergo suctioning 
under direct laryngoscopy
M
Contact Medical Control
If Any Questions
Provide Warmth, Dry Infant
Wipe Mouth, then Nose As Needed
Pulse Oximetry
Skin-To-Skin Contact With Mother 
If Situation Appropriate
Labored Breathing/ 
Persistent Cyanosis
BVM Assisted Ventilations with 10-15L
X 30 seconds, 60bpm
Pulse Oximetry
Continuous Cardiac Monitor
Yes
No Yes
No
Heart Rate <100
Supplemental O2 via Blow-By
Maintain SpO2 >93%
Pulse Oximetry
Skin-To-Skin Contact With Mother 
If Situation Appropriate
No
BVM Assisted Ventilations with 10-15L
X 30 seconds, 60bpm
Pulse Oximetry
Continuous Cardiac Monitor
Yes
Heart Rate <60 Neonatal Resuscitation Protocol
p94 Yes No
Activity
(Muscle Tone)
Pulse
Grimace
(Reflexes, 
Irritability)
Appearance
(Skin Color)
Respirations
0 Points
Absent
Absent
Flaccid
Blue, Pale
Absent
1 Point
Arms and 
Legs Flexed
<100 bpm
Some 
Flexion of 
Extremities
Body Pink, 
Extremities 
Blue
Slow, 
Irregular
2 Points
Active 
Movement
>100 bpm
Active 
Motion 
(Sneeze, 
Cough, Pull 
Away)
Completely 
Pink
Vigorous Cry
Points 
Totaled
Severely Depressed 0-3
Moderately Depressed 4-6
Excellent Condition 7-10
53
Newly Born - Peds
Pearls
REQUIRED EXAM: VS, GCS, Mental Status, Neuro, Abdominal Exam, Cardiovascular
 Most Newborns requiring resuscitation will respond to supplemental O2, BVMs, airway clearing maneuvers. If not, go to Neonatal Resuscitation Protocol
 Consider birth trauma during evaluation of non-vigorous Newborn; pneumothorax, hypovolemia, hypoglycemia
 Term gestation, strong cry / adequate respirations with good tone will generally need no resuscitation
 Expected Pulse Ox Readings: Birth – 1min = 60-65%, 1-2min = 65-70%, 3-4min = 70-75%, 4-5min = 75-80%, 5-10min = 80-85%, >10min = >90%
 APGAR scores at 1min and 5 min. Appearance, Pulse, Grimace, Activity, Respirations. Each score gets 0, 1 or 2 points (Total 10). If either in the moderately depressed range, 
continue to record and document every 5 minutes.
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Pregnancy History (G’s and P’s)
 Estimated Due Date
Differential
 Maternal Medication Effect
 Hypovolemia
 Pneumothorax
 Hypoglycemia
 Congenital Heart Defect
 Maternal / Newborn Infection / 
Sepsis
 Airway Obstruction – Secretions
 Choanal Atresia (imperforate 
nares)
 Prenatal Care / High Risk 
Pregnancy
 Time of Contraction Onset, 
Frequency
 Rupture of Membranes and Time
 Sensation of Fetal Movement
Medical Protocols - Peds
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

 12 Lead ECG Procedure 
p129
A
IV Access Protocol 
p49
A
Consider IVF bolus IV/IO, repeat as 
indicated for patient condition
Overdose and Poisoning, Adult
Carbon Monoxide/Cyanide Protocol
p57
Assess for specific 
ingestions/exposures
p55
54
Pearls
REQUIRED EXAM: VS, GCS, Mental Status, Skin, Blood Glucose
 Resuscitate first, hemodynamically unstable patients are high risk for cardiac arrest.
 Be suspicious of scenes where multiple people and/or animals appear to be affected. 
 In opioid overdose – poor respiratory efforts is what kills patients, emphasis should be on ventilation support FIRST and naloxone administration second.
 Patients are unreliable historians in overdose situations, particularly in suicide attempts. Trust what they tell you, but verify (pill bottles, circumstances, etc.).
 Critical Scene Information: Time of Ingestion, Number and Type of meds ingested, Seizure or mental status changes; Please consider bringing pill bottles, contents, emesis and 
reliable contact info to the ED; this will be important in patient evaluation and assessment.
 Be careful of off-gassing in cases of inhalation of volatile agents.
 Many intentional overdoses involve multiple substances, some with cardiac toxicity; a 12-Lead ECG should be obtained on all overdoses situation permitting.
 If smoke exposure consider carbon monoxide/Cyanide protocol p63. 
 Consider Cyanide when exposed to any products of combustion, mining incidents or industrial organic chemistry exposure. 
 Poison Control : 1-800-222-1222
Medical Protocols - Adult
General Approach – Adult, Medical
Hazmat Scene Call For Additional Resources, Stage Until 
Safe
Diabetic Emergencies Protocol
p48
Assess Mental 
Status & Airway
Yes
No
Awake,
Protecting Airway
Go To Appropriate Arrhythmia Protocol
Blood Sugar
>70
Arrhythmia /
STEMI
<70
Altered/respiratory 
depression
Airway Management Protocol 
p32
If suspected opioid overdose, 
Naloxone 0.4-2.0mg IN/IV/IO/IM
Consider Defib Pad Placement
Organophosphte/Cholinergic
p56
Consider ALS Early
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Overdose - Adult
41
Beta Blocker Overdose
Clinical Features: 
Cardiovascular – hypotension, bradycardia, AV block
Pulmonary – bronchospasm, wheezing
Metabolic – Hypoglycemia, Hyperkalemia
Neuro – Stupor
Common Beta Blockers -
Metoprolol (Lopressor, Toprol-XL) Propanolol (Inderal LA, InnoPran XL)
Atenolol (Tenormin) Sotalol
Labetalol Carvedilol (Coreg)
-------------------------------------------------------------------------------------
Many beta blocker ingestions do not cause symptoms; exceptions are the 
elderly, poor cardiac/respiratory reserve, and coingestions with other cardiac 
medications
Antipsychotic/Acute Dystonic Reaction 
Clinical Features:
Dystonia refers to sustained muscle contractions, frequently causing twisting, 
repetitive movements or postures, and may affect any part of the body
Common -
Antipsychotics – i.e. Haldol, Prolixin, Thorazine
Antiemetics – i.e. prochlorperazine, metaclopramide
Antidepressants – i.e. buspirone, sumitriptan
Antibiotics – i.e. erythromycin
Anticonvulsants – i.e. carbamazepine, vigabatrin
H2 Receptor Blockers – i.e. ranitadine, cimetidine
Recreational Drugs – i.e. cocaine
---------------------------------------------------------------------------------------
Acute dystonic reactions are extrapyramidal side effects of antipsychotic and 
certain other medications. 90% occur within 5 days of starting a new med
Medical Protocols - Adult
Calcium Channel Blocker Overdose
Clinical Features:
Cardiovasccular – hypotension, bradycardia, shock
Pulmonary – pulmonary edema, rales, crackles
Metabolic – Hyperglycemia (can be a marker of severity)
Neuro – Seizures, myoclonus, dizziness, syncope
GI – Nausea and vomiting
Common Calcium Channel Blockers -
Amlodipine (Norvasc)
Diltiazem (Cardizem, Tiazac)
Nicardipine
Nifedipine (Procardia)
Verapamil (Calan, Verelan)
---------------------------------------------------------------------------------------
Sustained release preparations may have delayed onset of toxic symptoms (up 
to 12 hours)
Overdoses with Calcium Channel Blockers have a high mortality!! Electrical 
conduction abnormalities, vasodilation, myocardial depression are severe
Cocaine or Sympathomimetic Overdose
Clinical Features:
Hypertension, Tachycardia, Agitation, Seizure, Dilated Pupils
Common Sympathomimetics -
Cocaine Pseudoephedrine
Ephedrine Methamphetamine
Phenylephrine Amphetamines
Terbutaline
---------------------------------------------------------------------------------------
Patients on MAOIs for depression may have symptoms of a 
Sympathomimetic Overdose after eating certain foods such as aged 
cheese, beer, mushrooms
Patients with Cocaine or Sympathomimetic Overdose are at high risk of 
Arrhythmias, Myocardial Infarction and Stroke
Sympathomimetics are drugs that mimic the effects of the 
sympathetic nervous system
TCA Overdose
Clinical Features: 
Neuro – AMS, seizures
Cardiovascular – Hypotension, arrhytmias, wide QRS interval
Common Tricyclic Antidepressants:
Amitriptyline
Clomipramine
Doxepin
Imipramine
Nortryptyline
Protriptyline
-------------------------------------------------------------------------------------
Opioid Overdose
Clinical Features:
Cardiovascular – hyptension
Pulmonary – respiratory depression
Neuro – AMS, pin point pupils 
Common Opioid Medications:
Oxycodone (Percocet, Oxycontin, MS Contin)
Hydrocodone(Vicodin, Norco, Vicoprofen)
Morpine
Heroin
Dilaudid
Fentanyl
Codeine (T3)
Methadone
P
Midazolam 0.1mg/kg IV/IO (max 5mg) or 
0.2mg/kg IM/IN (max 10mg) 
OR Lorazepam 0.1mg/kg IV/IO/IM (max 2mg) 
P
If QRS >0.12 
Sodium Bicarb 1mEq/kg IV/IO slow push, 
may repeat every 5 minutes until narrowing of QRS
P
Diphenhydramine 50mg IV/IO/IM/PO
If not improving, consider Midazolam 0.1mg/kg IV/IO (max 5mg) or 
0.2mg/kg IM/IN (max 10mg)
P
Consider Calcium Chloride 1gm IV/IO
Consider Glucagon 2mg IV/IO, if available for hypotension, may 
repeat if available
Manage symptoms of Bradycardia per Protocol p44
P
Consider Glucagon 2mg IV/IO may repeat if available
Manage symptoms of Bradycardia per Protocol p44
Naloxone 0.4-2.0mg IN/IV/IO/IM
55
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

P
*
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Seizure, Adult Medical Protocol
p61
General Approach, Adult Medical
Estimate Symptom 
Severity
Asymptomatic Minor Symptoms
Respiratory Distress + SLUDGEM
Major Symptoms
Altered Mental Status, Seizure, 
Respiratory Distress/Failure
Organophosphate / Pesticide Exposure /
Cholinergic Crisis Patient Management
Consider provider safety, number of patients and early 
notification of receiving facility
Toxicity to the crew may occur from inhalation or topical 
exposure to the offending agent
DuoDote AND/OR Mark-I Kit may be used for civilians IF 
cache released from the State of Wisconsin
Scene Safe
Yes
No
Stage,
Call for Law Enforcement and/or 
Additional Resources
Evidence of 
Exposure / 
Toxidrome
No
Yes
A
Consider IV Access Protocol
p49 A
IV Access Protocol
p49 A
IV Access Protocol
p49
Atropine 2mg IV/IO/IM
Repeat Q5 min until symptoms 
resolve as available
P
Atropine 2mg IV/IO/IM
Repeat Q5 min until symptoms 
resolve as available
DuoDote x 1 dose IM
EMS Provider Use only, if available 
May repeat x1 if symptoms return 
at 10 minutes
*
DuoDote x3 doses IM
EMS Provider only, if available
Yes Seizure No
Consider Hazmat, General – Adult p79
56
Cholinergic / Organophosphate Overdose - Adult
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 *Each DuoDote Kit contains 600mg 2-PAM and 2.1mg of Atropine. The kits in the ambulance are intended for responder use only. If/When the emergency cache has been 
released by the State of Wisconsin, those kits may be used for the general public.
 SLUDGEM – Salivation, Lacrimation, Urination (Incontinence), Defecation (Incontinence), GI Upset, Emesis, Miosis.
 For patients with major symptoms, there is no max dosing for Atropine; continue administering until salivation/secretions improved.
 Follow all Hazmat procedures, strictly adhere to personal protective equipment for exposure prevention and begin decontamination early.
 Patients who have been exposed to organophosphates are highly likely to off-gas; be sure to use all responder PPE and to avoid exposure to clothing or exhalations of victims. 
Helicopter EMS is generally NOT appropriate for these patients.
 A cholinergic crisis is an over-stimulation at a neuromuscular junction due to an excess of acetylcholine (ACh), as of a result of the inactivity or inhibition of the AChE enzyme, 
which normally breaks down acetylcholine.
Begin Triage and Decontamination, 
As Appropriate
Pertinent Positives/Negatives:
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 History of Ingestion or Suspected Ingestion
 Dysrhythmias
 SLUDGEM
 DUMBELLS
Differential
 Head Injury
 Hazmat Exposure
 Electrolyte Imbalance
 DM, CVA, Seizure
 Sepsis
 Time of Ingestion
 Type, Number and Dose of Pills Taken (if 
known)
 Seizures
 Mental Status Change
 Vomiting
Medical Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Administer 100% O2 via NRB
General Approach, Adult Medical
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Provider Safety
Yes
No
Stage,
Call for Law Enforcement and/or 
Additional Resources
CarboxHgb 
No (SpCO) Available
Consider Need for ALS Level Service
EARLY
Consider Safety of ALL Responders 
including Law Enforcement
Consider SCBA if Toxic Inhalation 
Suspected
Remove patient from Suspicious 
Environment, Administer 100% O2
Clincal Suspicion 
of CO Toxicity
Go To Appropriate Medical Treatment 
Protocol No
Asses and 
Docment SpCO Treatment for CO Not Indicated
Go To Appropriate Medical Treatment 
Protocol
Treatment for CO Not Indicated
Measure SpO2 
on Room Air
Yes
>5% <5%
Yes
SpCO <15% 
AND/OR
SpO2 >93%
Consider Screening Home/Work 
Environment for elevated CO
Go To Appropriate Medical Treatment 
Protocol
Symptoms of 
Hypoxia OR 
CO Toxicity
SpCO >15% AND/OR
SpO2<93%
12-Lead ECG Procedure
p129
BE-FAST Procedure
p165
Yes
Assess Blood Sugar Level
>70
No
Go To Appropriate Cardiac Arrhythmia 
or STEMI Protocol p42
Suspected Stroke Protocol
p64 Positive
Arrhythmia /
STEMI
Negative
Sinus Rhythm
Diabetic Emergencies Protocol
p48 <70
57
Carbon Monoxide Poisoning - Adult
Pearls
REQUIRED EXAM: VS, GCS, Mental Status, Neuro, Abdominal Exam, Cardiovascular
 Fetal hemoglobin has a stronger affinity for CO than adult, and will preferentially take the CO from the Mother, giving her a FALSE LOW SpCO level.
 Hospital evaluation should be strongly encouraged for any pregnant or suspected to be pregnant females; all hospitals should have access to Rad-57 device.
 The absence or low levels of SpCO is not a reliable predictor of firefighter/victim exposures to other toxic byproducts of combustion. Consider the Cyanide Poisoning Protocol.
 Multiple patients presenting with vague, influenza-like symptoms simultaneously should raise your suspicion of CO exposure. Ask about home heating methods, generator
use, exposure to combustible fuels.
Pertinent Positives/Negatives:
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Known or suspected CO Exposure
 Source and Duration of Exposure
 Dysrhythmias
Differential
 Acute Myocardial Infarction
 Hypoglycemia
 Diabetic Ketoacidosis
 Subarachnoid Hemorrhage
 Acute Stroke
 Influenza
 Other toxic 
inhalation
 Tension Headache
 Headache, Nausea/Vomiting
 Chest Pain, Arrhythmias
 Respiratory Distress
 Seizures
 Mental Status Change
 Vomiting
Medical Protocols - Adult
High Suspicion of Cyanide
(exposed to any products of combustion, mining 
incidents or industrial organic chemistry)
P
Cyanokit, 70mg/kg IV/IO 
(max 5g)
Infuse over 15 minutes if 
available
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
IV Access Protocol
p49
A
Consider **Ketorolac 15mg IV OR
**Ketorolac 30mg IM
P
Consider Fentanyl 0.5 -1mcg/kg IV/IO/IM 
(max 100mcg)
Max 3 doses
P
Consider Ketamine 0.25mg/kg IV/IO 
(max dose 25mg) 
Max 3 doses
General Approach – Adult 
Medical -OR- Trauma
Assess Pain
0-10 Pain Scale
Moderate / Severe Pain
(5-10)
Place patient on cardiac monitor, continuous 
SpO2 and EtCO2
P
Consider IN Fentanyl 2mcg/kg (max 50mcg 
per naris)
58
Pain Management - Adult
Pertinent Positives and Negatives
 Age, VS, GCS
 SAMPLE History
 OPQRST History
 History of chronic pain
Differential
 Head injury
 Spine Injury
 Compartment Syndrome
 Fracture, Sprain, Strain
 Pneumo/hemo-thorax
 Pericardial effusion
 Aortic Dissection
 Internal organ injury
Pearls
REQUIRED EXAM: Vital Signs, GCS, Neuro Exam, Lung Sounds, Abdominal Exam, Musculoskeletal Exam, Area of Pain
 Provider discretion to be used for patients suffering from chronic pain related issues. However, please note that history of chronic pain does not preclude 
the patient from treatment of acute pain related etiologies. 
 Pain severity (0-10) is a vital sign to be recorded pre- and post-medication delivery and at disposition.
 As with all medical interventions, assess and document change in patient condition pre- and post-treatment.
 Opiate naive patients and the elderly can have a dramatic response to analgesic medications; start low and titrate up as appropriate.
 Allow for position of maximum comfort as situation allows.
 Acetaminophen or Ibuprofen if no contraindications may be considered for analgesic benefit in the setting of fever.
 **Ketorolac is contraindicated in: Pregnancy, anticoagulation or bleeding diatheses, anticipated surgery, NSAID use (including EMS administered 
ibuprofen), GI bleeding, possible intracranial hemorrhage, renal disease. Extreme caution in females of reproductive age (hospitals will not give to 
patients without a negative pregnancy test), elderly patients, and potential renal insufficiency.
 *Oral medications are contraindicated in anyone who may need an emergent surgery or procedure; “if in doubt, don’t give PO”.
Medical Protocols - Adult
B
Consider Acetaminophen PO* 15mg/kg 
(max 1000mg)
B
Consider Ibuprofen PO*
10mg/kg (Max 400mg)
None – Mild Pain
(0-4)
A
Consider NITROUS Procedure
p182
Reassess Pain Worsening
Improved
Document response to meds, VS 
(HR, BP, SpO2, EtCO2)
Continue with Adult Specific Protocol
A
Consider Ondansetron 0.15 mg/kg IV/IO/
ODT/IM (max 4mg)
Notify Receiving Facility,
Contact Medical Control As Necessary
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Adult, Medical
q >18 Years of Age OR
q Court Emancipated Minor OR
q Legally Married Person of Any Age OR
q Unwed Pregnant Female <18 IF and ONLY IF EMS Call 
Related to Pregnancy
q Altered Mental Status OR
q Impaired Decision Making Ability OR
q Hallucinations or Thought Disorder OR
q Incapacitated* OR
q Suicidal or Homicidal Ideation
q Clinically Intoxicated** OR
q EtOH Use AND Prudent EMS Provider Believes 
Treatment IS Needed
q Bronchospasm Resolved after ONE Nebulizer Treatment 
OR
q Insulin Only Induced Hypoglycemia Resolved After ONE 
Treatment
Parent/Legal Guardian of Patient 
Can Be Contacted
Pediatric Refusal Protocol
p108 No
Transport Required Under Implied Consent
OR
Police Protective Custody
No
Yes
q Consult PD To Determine Appropriate Disposition
q Transport by Ambulance or Alternative (Wisconsin State Statute 51.45)
q Police Officer Name and Badge Number REQUIRED in Documentation
Refusal After EMS Treatment Protocol
p60
q Document assessment including physical exam and vitals, at least one (preferentially two >5 minutes apart) full set of vitals (GCS/AVPU, BP, HR, RR, SpO2 and 
evidence of decision making capacity.
q Blood glucose check and documentation for any patient with history of diabetes, EtOH, seizure OR altered mental status
q Assure that the patient/parent/guardian understands the possible consequences of refusal
q Complete documentation of refusal and obtain signatures 
q Contact On-Line Medical Control for refusals that arise after EMS treatment has been initiated
Yes
Yes
No
No
Yes
No
59
Refusal Protocol - Adult
Pertinent Positives and Negatives
 Age, VS, BP, RR, SpO2
 SAMPLE history
 OPQRST history
Differential
 Cardiac Dysrhythmia
 Hypoglycemia
 Overdose
 Toxidrome
 Sepsis
 Occult Trauma
 Adrenal Insufficiency
 Mental Status
 Pale, Cool Skin
 Delayed Cap Refill
Pearls
REQUIRED EXAM: VS, GCS, Nature of Complaint
 *Incapacitated definition: A person who, because of alcohol consumption or withdrawal, is unconscious or whose judgment is impaired such that they are incapable of 
making rational decisions as evidenced by extreme physical debilitation, physical harm or threats of harm to themselves, others or property. Evidence of incapacitation: 
inability to stand on ones own, staggering, falling, wobbling, vomit/urination/defecation on clothing, inability to understand and respond to questions, DTs, unconsciousness, 
walking or sleeping where subject to danger, hostile toward others.
 **Intoxicated definition: A person whose mental or physical functioning is substantially impaired as a result of the use of alcohol.
 If there is ANY question, do not hesitate to involve Law Enforcement to ensure the best decisions are being made on behalf of the patient. 
Medical Protocols - Adult
Yes
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Refusal Protocol – Adult, Medical
Consider Additional Patient Safety Measures
q A Family Member or Caregiver is available to stay with the patient to assist/activate EMS if symptoms return
q Assure that the patient/parent/guardian understands the possible consequences of refusal
q Request the patient to follow up with their physician as soon as possible and/or to contact 9-1-1 if symptoms return
q Document assessment including mental status, physical exam, vitals, and SpO2
q Blood sugar evaluation and documentation for any patient with history of diabetes, 
EtOH OR altered mental status
q Assure that the patient/parent/guardian understands the possible consequences of 
refusal
q Complete documentation of refusal and obtain signatures
ALL ‘Yes’
Reason for EMS 
Activation Bronchospasm, Resolved after Nebulizer Insulin-only Induced Hypoglycemia
q Asymptomatic After One Treatment
q Presentation is Consistent with Mild 
Asthma/COPD Exacerbation
q No pain, no sputum, afebrile, no 
hemoptysis
q Not hypoxic after Treatment (SpO2 
>93%)
q Complete Resolution of Symptoms
q Vital Signs WNL after Treatment
Transport Required
OR
Police Protective Custody
Contact On-Line Medical Control as necessary
q Asymptomatic After Treatment
q Patient is on insulin ONLY (does not 
take ANY oral diabetes medications)
q Presentation consistent with simple 
hypoglycemia
q Vital Signs WNL after Treatment
q No indication of intentional overdose
ALL ‘Yes’ ALL ‘Yes’
ANY ‘No’
ANY ‘No’
Transport Required
OR
Police Protective Custody
Contact On-Line Medical Control as necessary
ANY ‘No’
60
Refusal After EMS Treatment - Adult
Pertinent Positives and Negatives
 Age, VS, BP, RR, SpO2
 SAMPLE history
 OPQRST history
Differential
 Cardiac Dysrhythmia
 Hypoglycemia
 Overdose
 Toxidrome
 Sepsis
 Occult Trauma
 Adrenal Insufficiency
 Mental Status
 Pale, Cool Skin
 Delayed Cap Refill
Pearls
REQUIRED EXAM: VS, GCS, Nature of Complaint
 *Incapacitated definition: A person who, because of alcohol consumption or withdrawal, is unconscious or whose judgment is impaired such that they are incapable of 
making rational decisions as evidenced by extreme physical debilitation, physical harm or threats of harm to themselves, others or property. Evidence of incapacitation: 
inability to stand on ones own, staggering, falling, wobbling, vomit/urination/defecation on clothing, inability to understand and respond to questions, DTs, unconsciousness, 
walking or sleeping where subject to danger, hostile toward others.
 Simple Hypoglycemia for these protocols is defined as: hypoglycemia caused by insulin ONLY and not suspected to be due to occult infection or trauma
 **Intoxicated definition: A person whose mental or physical functioning is substantially impaired as a result of the use of alcohol.
 If there is ANY question, do not hesitate to involve Law Enforcement to ensure the best decisions are being made on behalf of the patient. 
Medical Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Consider Airway Management Protocol p32
P
Midazolam 0.1mg/kg IV/IO (max 5mg) OR
Midazolam 2mg/kg IM/IN (max 10mg)
OR
Lorazepam 0.1 mg/kg (max 2mg) IV/IO/IM
PConsider Airway Management Protocol p32
Midazolam 0.1mg/kg IV/IO (max 5mg) OR 
Midazolam 0.2mg/kg IM/IN(max 10mg) 
OR
Lorazepam 0.1mg/kg IV/IO/IM (Max 2mg)
Consider Airway Management Protocol p32
Consider Airway Management Protocol p32
General Approach – Adult, Medical
Environmental 
Cause or Toxic 
Exposure
Notify Comm Center 
and Hazmat Team
Ensure Responder 
and Public Safety
Hazmat, General Protocol 
p79
Actively Seizing on 
EMS Arrival
Diabetic Emergencies Protocol 
p48
Loosen Constrictive Clothing
Protect Patient from Injury
Consider Airway Management Protocol 
p32
Loosen Constrictive Clothing
Protect Patient from Injury
A
IV Access Protocol
p49
A
IV Access Protocol
p49
Monitor and Reassess
Normal Mental 
Status
Seizure 
Returns
Still Seizing
No
Yes
<70
No Yes
<70
>70 >70
Status 
Epilepticus
Notify Receiving Facility,
Contact Medical Control As Necessary
Yes
No
No Yes
Consider ALS Early
Prolonged Seizures Are BAD for Neurologic 
Outcomes!
Yes
Yes
Blood Glucose Blood Glucose
61
Seizure - Adult
 Pertinent Positives and Negatives
 Age, VS, GCS, SpO2, Blood Sugar
 SAMPLE History
 OPQRST History
 Seizure History, Med Compliance
 Differential
 Hypoxia
 Hypoglycemia
 Electrolyte Imbalance
 Eclampsia
 Stroke
 Hyperthermia
 Drugs, EtOH Abuse
 Drugs, EtOH Withdrawal
 Occult Head Injury
 Tumor
 Liver / Kidney Failure
 Infection / Sepsis
 Bowel or Bladder Incontinence
 Tongue Biting
 Pregnancy History
 Evidence of Trauma
 Number of Seizures and Duration
Pearls
REQUIRED EXAM: Blood Sugar, SpO2, GCS, Neuro Exam
 Midazolam is effective in terminating seizures. Do not delay IM/IN administration to obtain IV access in an actively seizing patient.
 Do not hesitate to treat recurrent, prolonged (>1 minute) seizure activity.
 Status epilepticus is >2 successive seizures without recovery or consciousness in between. These patients require airway management and rapid transport.
 Assess for possibility of occult trauma, substance abuse.
 Active seizure in known or suspected pregnancy >20 weeks, give Magnesium 4gm IV/IO over 10 minutes.
Medical Protocols - Adult
Contact Medical Control for additional meds 
as needed
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Pearls
REQUIRED EXAM: VS, SpO2, Blood Glucose, Neuro Exam, Cincinnati Stroke Scale
 SIRS: The body’s inflammatory response to an insult that results in the activation of the immune response
 Sepsis: SIRS + documented or highly suspected infection 
 Severe Sepsis: Sepsis + sepsis induced organ dysfunction
 Septic Shock: Sepsis-induced hypotension persisting despite adequate fluid resuscitation resulting in tissue hypoperfusion
 Surviving Sepsis Campaign (SSC): An international initiative to reduce mortality in patients with sepsis. Mortality with severe sepsis is 30-50%, and 
increases to 60% when shock is present. There are 750,000 new cases and 210,000 US fatalities are attributed to sepsis annually.
 The importance of early identification of sepsis and prompt appropriate treatment cannot be understated; EMS is the critical first link! 
 Fluid resuscitation, pressors and EARLY antibiotics are the things that save lives in sepsis.
62
Sepsis - Adult
Medical Protocols - Adult
Are Systemic Inflammatory Response Syndrome (SIRS) 
criterial met?
Is the patient’s history / complaint suggestive of an 
infection? (Consider all sources of infection)
 Respiratory 
 UTI
 Abdominal Infection
 Blood Stream Catheter Infection
 Bone or Joint Infection
 Skin or Soft Tissue Infection
 Central Nervous System Infection (i.e. Meningitis)
 Endocarditis
 Recent Surgery
>2 Criteria Met
Yes
 Temperature >38oC (100.4
o
F) OR Chills/Rigors
 Temperature <36oC (96.8
o
F)
 Pulse >90
 Respiratory Rate >20
 EtCO2 <25
 Acute Mental Status Changes from Baseline
 Monitor and reassess patient as indicated
 Notify Receiving Hospital for any changes in 
patient condition
 Consider Pain Mgmt Protocol
<2 Criteria
Met
 Monitor and reassess patient as indicated
 Notify Receiving Hospital for any changes in 
patient condition
No
Continue Treatment per Appropriate Medical 
Protocol
Continue Treatment per Appropriate Medical 
Protocol
Notify Receiving Hospital of “SEPSIS ALERT” as part of radio report
Begin IVF and Consider Shock / Non-Trauma Protocol
Consider ALS intercept - IVF resuscitation and pressors with early 
antibiotics are key to patient survival
General Approach – Adult, Medical
Notify Receiving Facility,
Contact Medical Control As Necessary
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Repeat and Document BP, assess for evidence of 
adequate perfusion
A
Consider IVF bolus IV/IO, repeat as indicated 
for patient condition
CAUTION in CHF/volume overload
P
Norepinephrine infusion IF Available
Start 4-16mcg/min IV/IO
Titrate to SBP >100, MAP >65, or signs of 
improved perfusion
OR
Epinephrine (1:10,000) infusion
Start 2-10mcg/min IV/IO
Etiologies & Considerations
Hypovolemic
(Dehydration, GI Bleed)
Distributive
(Sepsis, Anaphylaxis)
Blood Glucose
Blood Glucose
12 Lead ECG Procedure 
p129
Blood Glucose
Acute Adrenal Insufficiency
State where the body cannot produce 
enough steroids. Primary adrenal disease 
vs. recent discontinuation of steroids 
(Prednisone) after long term use. 
M
63
Hypotension / Shock (Non-Trauma) - Adult
Pertinent Positives and Negatives
 Age, VS, BP, RR, SpO2
 SAMPLE history
 OPQRST history
 Source of blood loss, if any (GI, vaginal, AAA, ectopic)
 Source of fluid loss, if any (vomiting, diarrhea, fever)
 Pregnancy history
Differential
 Cardiac Dysrhythmia
 Hypoglycemia
 Ectopic Pregnancy
 AAA
 Sepsis
 Occult Trauma
 Adrenal Insufficiency
 Mental Status
 Pale, Cool Skin
 Delayed Cap Refill
 Coffee Ground Emesis
 Tarry Stools
 Allergen Exposure
General Approach – Adult, Medical
A
IV Access Protocol 
p49
Diabetic Emergencies
Protocol p48
Go To Appropriate Cardiac Dysrhythmia 
OR STEMI Protocol p42
Consider Airway Management Protocol 
p32
<70 or >250
Abnormal
BOTH Normal
Notify Receiving Facility,
Contact Medical Control As Necessary
Consider Sepsis Screening Protocol 
p62
Methylprednisone 2mg/kg IV/IO 
(max 125mg)
Cardiogenic
(STEMI, CHF*)
Obstructive
(PE, Tamponade)
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Pearls
REQUIRED EXAM: VS, GCS, RR, Lung sounds, JVD
 Shock may present with normal VS and progress insidiously; Tachycardia may be the first and only sign of shock.
 *Patients receiving a fluid bolus should be continuously re-evaluated for signs of fluid overload. This is especially true for patients with suspected obstructive or
cardiogenic etiologies of shock.
 If evidence or suspicion of trauma, move to Hemorrhage Protocol early.
 Document respiratory rate, SpO2 and breath sounds with IV Fluids, and consider Pulmonary Edema Protocol as appropriate.
Medical Protocols - Adult
P
If suspected imminent arrest, 
Consider push dose Epi 5-20mcg p190
every 1-2 minutes SBP>100, MAP >65, or signs 
of improved perfusion
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Keep Scene Time < 10 min.
Blood Glucose
General Approach – Adult, Medical
BE-FAST Stroke Screen Procedure 
p165
Diabetic Emergencies Protocol
p48
Establish Definite Time of Last 
Known Well (actual time)
Call Early “Stroke Alert” to 
Stroke Facility
Monitor and Reassess Symptoms
Consider Shock / Hypotension (NonTrauma) Protocol p63
>1 item(s) positive
<24 hours
SBP <100
SBP >100 
<70 or >250
Notify Receiving Facility,
Contact Medical Control As Necessary
Go To Appropriate Cardiac Dysrhythmia 
OR STEMI Protocol p42 12 Lead ECG Procedure p129
Keep Scene Time < 10 min.
Airway Mangement Protocol
p32
64
FAST-ED Stroke Screen p166
If FAST-ED positive alert of “potential LVO” 
(Large Vessel Occlusion)
Suspected Stroke - Adult
Pearls
REQUIRED EXAM: VS, SpO2, Blood Glucose, Neuro Exam, BE-FAST Stroke Scale
 In Stroke, BE-FAST – Sudden onset of Balance loss or incoordination, Eyes/vision changes, Facial Asymmetry, Arm Strength, Speech difficulty or Terrible 
headache.
 Be very diligent observing for airway compromise in suspected acute stroke (swallowing, vomiting, aspirating).
 Consider Elevate Head of Stretcher 15-30 degrees.
 Hypoglycemia, Infection and Hypoxia can present with Neurologic deficit, especially in the elderly.
 IV Access is important, but establishment of a line should not significantly delay initiation of transport. Time lost is brain lost! 
 Pre-notification to the receiving hospital is critical to ensure timely brain imaging, administration of thrombolytics and thrombectomy procedures.
 When calling in last known well time, identify actual time vs. duration of symptoms.
Pertinent Positive/Negative:
 SAMPLE History
 OPQRST History
 History of CVA, TIA
 Previous Cardiac, Vascular Surgery
 Anticoagulant Use
Differential
 TIA
 Seizure
 Hypoglycemia
 Tumor
 Occult Trauma
 Stroke
-Ischemic (~85%)
-Hemorrhagic (~15%)
 Weakness / Paralysis
 Aphasia / Dysarthria
 Headache
 Vertigo
 Seizure
Medical Protocols - Adult
SpO2 <93%
>93%
>24 hours
A
IV Access Protocol
p49
Monitor and Reassess BP
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Consider causes of presyncope/impending arrest syndrome:
 Acute coranary syndrome (ACS) : look for evidence of ischemia
 Tachydysrhythmias
 Bradydysrythmias and heart bloks
 Wolff-Parkinson-White (WPW): look for short PR, prolonged QRS and a delta wave
 Brugada Syndrome: look for rugada sin with coved ST segment elevation >2mm in >1 V1-V3 followed by a negative T Wave
 Hypertrophic Cardiomyopaathy (HCM): look for evidence of left ventricular hypertrophy with deep narrow “dagger like” Q waves in lateral and inferior leads, may also have 
left atrial enlargement
 Long or short QT-intervals: look for a QTc <300 or >450
 Arrythmogenic Right Ventricular Dysplasia (ARVD): look for epsilon waves +/- T wave inversions in V1-V3
 Miscellanous: PE, right sided heart strain, electrolyte abnormalities, ICH, etc.
General Approach – Adult, Medical
Blood Glucose p152
12 Lead ECG Procedure p129
Diabetic Emergencies
Protocol p48
Go To Appropriate Cardiac 
Dyshrhythmia or STEMI Protocol
<70 or >250
Abnormal
12-Lead Normal,
Blood Glucose >70 and <250
Suspected Stroke Protocol 
p64
Notify Receiving Facility,
Contact Medical Control As Necessary
Positive
Negative
65
Syncope or Near-Syncope
Pearls
REQUIRED EXAM: VS, GCS, Head, Neck, Blood Glucose
• Pay special attention to head and neck exam for bruising or signs of injury.
• Syncope/Altered Mental Status may be the presenting sign of environmental hazards / toxins. Protect yourself and other providers / community if concern. Involve 
Hazmat early.
• Safer to assume hypoglycemia if doubt exists. Recheck blood sugar after dextrose/oral glucose administration and reassess.
• Do not let EtOH fool you! Alcoholics frequently develop hypoglycemia, Alcoholic Ketoacidosis (AKA) and often hide traumatic injuries!
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 History of DM, medic alert bracelet
Differential
 Head Injury
 Electrolyte Abnormality
 Psychiatric Disorder
 Cardiac Dysrhythmia
 DM, CVA, Seizure, Tox
 Sepsis
 Hypothermia
 Hypothyroidism
 Pulmonary
Medical Protocols - Adult
BE-FAST procedure p165
A IV Access Protocol p49
A
Consider IVF bolus IV/IO, repeat as 
indicated for patient condition
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Assessment
Scene
Safety
Stage,
Call for Law 
Enforcement and/or 
Additional 
Resources
PPE
Hazmat
Multiple 
Patients
Unsafe
Insufficient
Safe
Sufficient
Notify Comm 
Center, Activate 
Hazmat Resources
Yes
Notify Comm Center, 
Activate MCI Incident
Consider Base Hospital
Consider Additional 
Resources,
MCI if Necessary
≥5
<5
Primary Survey
Yes
Traumatic Cardiac Arrest 
Protocol p70
Pulseless,
Apneic
A,B,C’s
Support Airway,
Support Oxygenation,
Support Circulation
Minimize Scene Time,
Notify Receiving Facility of 
Trauma Patient Early
Obstructed Airway,
Ventilations Inadequate
Hemorrhage Control 
Protocol p81
Exsanguinating 
Hemorrhage
P
Consider Chest 
Decompression 
Procedure p163
Airway Patent,
Poor Chest Compliance OR
Unstable VS
Ventilations Adequate,
BP and HR Adequate
Selective Spinal Motion 
Restriction Protocol p84
Evaluate and Treat Per 
Appropriate Trauma 
Protocol
66
General Approach – Adult, Trauma
Differential
 Stroke
 STEMI
 Overdose
 Elder Abuse
 Domestic Violence
 Non-Accidental Trauma
Pertinent Positives and Negatives
 Age, VS, GCS
 Time of Injury, Mechanism of Injury
 DCAP-BTLS
 SAMPLE History
 OPQRST History
 Pain / Swelling
 Mental Status
 Hypotension / Shock
Pearls
REQUIRED EXAM: Vital Signs, GCS, Loss of Consciousness, Location of Pain (then targeted per Appropriate Trauma Protocol)
 If presentation is not consistent with traumatic mechanism consider potential medical etiologies.
 Trauma Destination for patients <18 - Pediatric Destination Determination Protocol p113
 Assess for major trauma criteria immediately upon patient contact
-RR <10 or >29; SBP <90; Pulse <50 or >140; GCS <13; SpO2<93%
-Transport to Trauma Center, minimize scene time to goal of <10 minutes
 Disability – assess for neuro deficits including paralysis, weakness, abnormal sensation
 Suspect Tension Pneumothorax when:
-Mechanism consistent with Chest Trauma; Resp Distress; Decreased Breath Sounds; JVD; Low BP; Tachycardia; Tracheal Deviation
-Signs and Symptoms of Tension Pneumothorax may be present with or without positive pressure ventilations
-Needle Decompression should be performed with a 3" 14ga needle at the 2
nd intercostal space, midclavicular line
-If repeat decompression necessary, continue to move laterally along the superior aspect of the 3
rd rib
Trauma Protocols - Adult
No
Yes
Consider Airway Obstruction 
Procedure p132
Airway Management 
Protocol p32
Shock/Hypotension 
(Trauma) Protocol p85
Signs of 
Shock
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Measure Vital Signs and Level of Consciousness 
Glasgow Coma Scale ≤13
Systolic blood pressure (mmHg) <100 mmHG
Respiratory rate <10 or >29 bpm 
 OR need for ventilation support
Assess Anatomy of Injury
Transport to Level 1 or 2
Trauma Center;
Notify via Radio as early as 
possible
<18 transport to Level 1 
Pediatric Trauma Center 
 Penetrating Injury to head, neck, torso, extremities proximal to knee
 Chest wall instability or deformity
 ≥2 proximal long bone fractures
 Crushed, degloved, or mangled extremity
 Amputation proximal to wrist or ankle
 Pelvic fracture
 Open or depressed skull fracture
 Paralysis
Assess Mechanism of injury and evidence of High Energy Impact
 Falls > 20 ft
 High Risk Auto Crash
 Auto vs. Pedestrian/Bicyclist thrown, run over or significant (>20 mph) impact
 Motorcycle crash >20 mph
Step One
Step Two
Step Three
Yes
No
Yes
Yes
No
Transport to closest 
appropriate Leveled Trauma 
Center
No
Assess Special Patient or System Considerations
 Age ≥55 years
 Anticoagulation and bleeding disorders
 Burns
- without other trauma, transport to burn facility
- with traumatic mechanism, transport to trauma center
 End Stage Renal Disease requiring Hemodialysis
 Pregnancy ≥20 weeks
 EMS provider judgment
Consider Trauma Center or 
Specialty Resource Center; 
Contact Medical Control as 
needed
Step Four
Yes
Transport according to Appropriate Trauma Protocol
No
Any Airway Compromise not 
able to be managed by EMS 
should be taken to the CLOSEST 
FACILITY for stabilization 
immediately
67
Destination Determination – Adult, Trauma
Trauma Protocols - Adult
Step Five
https://www.dhs.wisconsin.gov/publications/p0/p00730.pdf
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Adult, Trauma
Offending 
Organism(s) 
Neutralized
Call For Resources,
Stage Until Scene Safe
Active 
Hemorrhage
Hemorrhage Control Protocol 
p81
Allergic Reaction Allergic Reaction Protocol 
p46
Evaluate Pain Consider Pain Management – Adult, 
Protocol p58
Identification of 
Offending Organism
Snakebite
Spider, Bee, Wasp, Hornet Mammalian Bite (including Human)
Immobilize Injury, 
Remove jewelry distal to bite
Immobilize Injury, 
Remove jewelry distal to bite
Mark Edges of Erythema with Marking Pen
Muscle 
Spasms
P
Consider
Midazolam 0.1mg/kg (max 5mg) IV/IO 
OR
Midazolam 2mg IM/IN (max 10mg) 
Immobilize Injury, 
Remove jewelry distal to bite
Yes
No
Yes
No
Yes
No
None or Mild
Moderate OR
Severe
Yes
Contact Dane Co. Animal Control
1-608-255-2345
Wound Care Procedure 
p179 No
Notify Receiving Facility,
Contact Medical Control As Necessary
68
Bites and Envenomations – Adult, Trauma
Differential
 Penetrating Trauma
 Dry Bite (Snake)
 Abscess/Cellulitis
 Non-Accidental Trauma
 Projectile Injury
Pertinent Positives and Negatives
 Age, VS, Pulses distal to wound
 SAMPLE History
 OPQRST History
 Description or photo of offending creature
 Tetanus status
 Immunization History of 
Creature (if known)
 Domestic vs. Wild Animal
 Allergic Reaction
 Hypotension, Shock, Fever
Pearls
REQUIRED EXAM: VS, GCS, Evidence of Intoxication, Affected Extremity Neurovascular Exam
 Cat bites may not initially appear serious, but can progress rapidly to severe infection
 Human bites have higher rates of infection than animal bites and necessitate evaluation in the Emergency Department for antib iotics
 It is not necessary to bring the offending insects, animals or reptiles to the ED for identification; this may result in added danger to others
 Bites on the hands and lacerations over knuckles should be assumed to be “Fight Bites” until proven otherwise, and need evaluation
 Brown recluse spider bites are usually painless at the time of bite. Pain and tissue necrosis develops over hours to days
 Immunocompromised patients have higher risk of infection – Think: Diabetes, Chemotherapy, Organ Transplant
Trauma Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Pearls
REQUIRED EXAM: VS, GCS, Lung Sounds, HEENT, Posterior Pharynx
 Burns to face and eyes, remove contact lenses prior to irrigation.
 Chemical burns require removal of contaminated clothing, brush away dry powder before irrigation. Flush with copious warm water on scene and continue irrigation en 
route. Be sure to brush excess away and remove contaminated clothing BEFORE beginning irrigation. Early intubation is strongly recommended if suspicion of inhalation 
injury. Suspicion is high in patients involved in an enclosed space fire, who have facial burns or show signs of airway involvement; carbonaceous sputum, facial burns or 
edema, hoarseness, singed nasal hairs, agitation, hypoxia or cyanosis.
 Indications of possible Cyanide Poisoning - Exposure to fumes from burning Nitrile (polyurethane, vinyl) Seizures, coma, cardiac arrest, headache, vertigo and/or cherry red 
skin color from increased venous O2 concentration.
General Approach – Adult, Trauma
Estimate TBSA 
Burned / Severity
Minor Burn Serious Burn Critical Burn
<5% TBSA, 1
st
– 2
nd Degree Burn
No inhalation Injury,
Normal BP, SpO2
Remove Rings, Bracelets and Constricting 
Items
Remove or Cool Heat Source (if not 
already done)
Apply Dry Clean Sheet or Non-Adherent 
Dressing;
Consider Plastic Cling Wrap Application
5-15% TBSA, 2
nd
– 3
rd Degree Burn
Suspected Inhalation Injury,
Hypotension, Altered Mental Status
>15% TBSA, 2
nd
– 3
rd Degree Burn
Burn with Trauma
Burn with Airway Compromise
Consider Pain Management – Adult
p58
Consider Airway Management – Adult 
p32
Transport to Designated Burn Center
Burn to Hands, 
Feet, Face or 
Perineum
No Yes
Consider Need for Airway 
Management EARLY, if concern 
request ALS
69
Burns – Adult, Trauma
Differential
 Blast Injury
 Radiation Injury
 Electrical Injury
 Cyanokit Need?
 Cellulitis
 Dermatitis
 Drug Reaction (Stevens-Johnson 
Syndrome)
Pertinent Positives and Negatives
 Age, VS
 SAMPLE History
 OPQRST History
 Mechanism of Burn (heat, gas, chemical)
 Time of Injury
 Singed Facial Hair
 Wheezing, Hoarseness
 Subjective Throat Swelling
 Loss of Consciousness
Trauma Protocols - Adult
Remove Rings, Bracelets and Constricting 
Items
Remove or Cool Heat Source (if not 
already done)
Apply Dry Clean Sheet or Non-Adherent 
Dressing;
Consider Plastic Cling Wrap Application
Transport to Facility of Choice
Consider CN Exposure for Enclosed 
Space Fire with Synthetic Materials
Notify Receiving Facility,
Contact Medical Control As Necessary
Notify Receiving Facility,
Contact Medical Control As Necessary
A
IV Access Protocol 
p49 A
A
IV Access Protocol 
p49
LR Preferred over NS, If available
500mL IV/IO
Given over 1 hour
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Begin Transport
Perform interventions concurrently. 
Provide early notification to hospital
P
Bilateral Chest Decompression Procedure 
p163
Airway Management 
*consider BIAD for isolated penetrating trauma to thorax and/or 
abdomen
A IV Access Protocol p49
P
Consider TXA 1gm IV/IO 
Over 10 minutes
Hemorrhage Control, consider pelvic 
binder, tourniquets, wound care
P
Bilateral Chest Decompression 
Procedure p163
Airway Management 
General Approach – Adult, Trauma
Injuries Incompatible With Life?
(Incineration, Decapitation, Hemicorpectomy) or 
Obvious Signs of Death
Apply Continuous Cardiac Monitor
Do not attempt resuscitation. 
Contact LE/ME
Criteria for Death/Withholding 
Resuscitation Policy p15
Did Cardiac Arrest occur prior to EMS arrival?
Yes
Yes
Yes
Begin Resuscitation
Begin HPCPR Procedure p155
ROSC?
Yes
No
EMS Discretion based on scene or situation 
to inititate resuscitation. Recommend 
OLMC consulation as soon as possible
No
70
Traumatic Cardiac Arrest – Adult, Trauma
Pearls
REQUIRED EXAM: Pupillary Light Reflex, Palpation of Pulses, Heart and Lung Auscultation
 Special consideration for patients – hanging, suspected hypothermia, drowning, or lightning strikes follow medical cardiac arrest protocol and consider 
early OLMC consultation.
 Injuries incompatible with life include; decapitation, incineration, massively deforming head or chest injury, or obvious signs of death (p15)
 Consider using medical cardiac arrest protocols if uncertainty exists regarding etiology of arrest
 Use of a long spine board will make chest compressions more effective; however, if spinal immobilization interferes with CPR use reasonable effort to limit 
patient and spine movement
 Be aware that these may be crime scenes: do your best to avoid disturbing forensic evidence
 If provider safety becomes a concern, transport of deceased patients to the hospital is acceptable
 Pregnancy EDC can be estimated by palpating the gravid uterus; above the level of the umbilicus is generally >22 weeks
Trauma Protocols - Adult
Potential Medical cause of arrest? 
(including hanging, suspected hypothermia, drowning, 
or lightning strikes)
No
Go To Cardiac Arrest Adult Protocol 
p37
No
ACLS meds and CPR are less effective in 
traumatic arrests and priority should be on 
treating reversible causes
Asystole or PEA <40?
Do not attempt resuscitation. 
Contact LE/ME
Criteria for Death/Withholding 
Resuscitation Policy p15
Contact OLMC for field 
termination orders 
A IV Access Protocol p49
P
Consider TXA 1gm IV/IO 
Over 10 minutes
Isolated Penetrating Blunt or 
Multisystem injuries
Rapid transport to nearest I/II 
trauma center
Follow Post-ROSC protocol and 
contact OLMC as needed
Yes
Isolated Penetrating Injuries to the Thorax/Abdomen
Does the patient meet all three criteria?
 1. EMS Witnessed Arrest
 2. Isolated penetrating injury to the thorax/abdomen
 3. Transport time to Level I/II less than 15 min. 
No
Yes
No
Continue Resuscitation During Transport. 
Follow Post-ROSC protocol if pulses are restored. 
Contact OLMC as needed
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Adult, Trauma
Estimate TBSA 
Burned / Severity
Minor Burn Serious Burn Critical Burn
<5% TBSA, 1
st
– 2
nd Degree Burn
No inhalation Injury
Normal BP, SpO2
5-15% TBSA, 2
nd
– 3
rd Degree Burn
Suspected Inhalation Injury
Hypotension, Altered Mental Status
Preferred Transfer to Burn Center
>15% TBSA, 2
nd
– 3
rd Degree Burn
Burn with Trauma
Burn with Airway Compromise
Preferred Transfer to Burn Center
Consider need for Airway 
Management EARLY
Chemical / Electrical Burn Patient Management
Consider provider safety, number of patients and early 
notification of receiving facility
Hazmat / Downed 
Power Lines Scene
No
Eye Involvement
Irrigate Involved Eye(s) with 2L NS or 
Sterile Water x 15 minutes
Repeat as needed
Yes
Flush Burned Areas with Normal Saline 
x 15 minutes
Repeat as needed
No
Consider Pain Management, Adult
p58
Consider Burn, Trauma Protocol 
p69
Consider Responder and Citizen Safety, 
Follow Downed Power Lines Safety
Hazmat, General Protocol 
p79
Notify Receiving Facility,
Contact Medical Control As Necessary
Yes
Continuous Cardiac Monitor for ALL 
Electrical Burns
Consider Cardiac Dysrhythmia Protocol, As 
Appropriate
71
Chemical / Electrical Burn – Adult, Trauma
Differential
 Thermal Injury
 Chemical Burn
 Electrical Injury
 Blast Injury
 Abrasion
 Contusion
 Laceration
 Compartment Syndrome
Pertinent Positives and Negatives
 Type of exposure (heat, gas, chemical)
 Central and Peripheral Pulses
 Nausea, Vomiting, Diarrhea
 Chemical Name (if known)
 Time of Exposure (duration)
 Mechanism of secondary injury 
(blunt vs. penetrating)
 Voltage of Electrical Current (if 
known)
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Provider Safety is paramount! Ensure Chemical Source is not a hazard to responders and Electrical Sources are not contacting patient prior to assessment. 
Don’t allow yourself or your crew to become victims.
 Safety First! Assure a Chemical source of burn is NOT a hazard to responders. Assure an Electrical source of burn is OFF or no longer contacting pt.
 High Voltage Electrical Burns (>600 volts) require spinal immobilization, continuous cardiac monitor and IV access regardless of external appearance of 
injury
 Chemical burns require removal of contaminated clothing, brush away dry powder before irrigation. Flush with copious warm water on scene and 
continue irrigation en route. Be sure to brush excess away and remove contaminated clothing BEFORE beginning irrigation 
 Superficial appearance of Electrical Burns does NOT indicate severity of underlying tissue damage
 Attempt to locate contact points in Electrical Burns, generally contact point with source and where patient is grounded. Do not refer to them as entry or 
exit wounds. Surface appearance may belie the damage below
 Electrical Burns cause ventricular and atrial irritability and dysrhythmias; anticipate cardiac problems and treat accordingly
Trauma Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Adult, Trauma
Selective Spinal Motion Restriction 
Protocol p84
A
IV Access Protocol 
p49
Notify Receiving Facility,
Contact Medical Control As Necessary
Mechanism
Assess Breath Sounds, SpO2
Blunt Penetrating
Apply Occlusive 
Dressing and Assist 
Ventilations
Consider Pain Management, 
Protocol p58
Stabilize Foreign Body if 
applicable, Assess Breath 
Sounds, SpO2
Open OR Sucking
Chest Wound
Support 
Ventilations, 
Monitor VS, watch 
for JVD, tracheal 
deviation
Assist Ventilations as Needed
Decreased Unilateral
Breath Sounds
Clear and Equal
Bilaterally
Support 
Ventilations, 
Monitor VS, watch 
for JVD, tracheal 
deviation
Assist Ventilations as Needed
Decreased Unilateral
Breath Sounds
Clear and Equal
Bilaterally
Signs of Tension 
Pneumothorax
Yes
Consider Airway Management 
Protocol p32
No
Consider Airway Management 
Protocol p32
Continuous Cardiac Monitor
Continuous Cardiac Monitor
P
Chest Decompression 
Procedure p163
72
Chest Injury – Adult, Trauma
Differential
 Simple Pneumothorax
 Tension Pneumothorax
 Pericardial Tamponade
 Aortic Root Disruption
 Bronchial Tree Injury
 Tracheal Disruption
 Great Vessel Laceration
 Cardiac Contusion
 Cardiac Laceration
Pertinent Positives and Negatives
 Type of injury
 Mechanism (blunt vs. penetrating)
 Respiratory Effort, Adequacy
 Abnormal Breath Sounds (unilateral vs. bilateral)
 SAMPLE History
 OPQRST History
 Evidence of Intoxication
 Evidence of Multi-System 
Trauma
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Consider tension pneumothorax in any patient with penetrating chest trauma, OR blunt chest trauma with decreased unilateral breath sounds, 
hypotension, tachycardia, hypoxia, tracheal deviation (late) or JVD (late)
 Aortic root injuries, bronchial disruption and tracheal disruptions are common with major deceleration injuries (i.e. MVC)
 Cardiac contusions are common with blunt chest trauma, and may present with ectopy, PVCs or even STEMI appearance on cardiac monitor
 Pericardial Tamponade is a surgical emergency and needs rapid transport. Look for muffled heart tones, hypotension, tachycardia
Trauma Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Immediately Prior to Extrication
Albuterol 2.5mg/3mL Neb
Repeat as needed to run 
continuously
Prolonged Crush Injury – Adult, Trauma
Pertinent Positives and Negatives
 Age, VS, GCS
 SAMPLE History
 OPQRST History
 Crushed under heavy load ≥30 min
Differential
 Compartment Syndrome
 Entrapment without Crush
 Fracture, Sprain, Strain
 Building collapse, trench 
collapse, industrial accident, 
heavy equipment pinning
P
Sodium Bicarbonate 50mEq IV/IO
AND*
Calcium Chloride 1g IV/IO over 3 min
General Approach – Adult, Trauma
A IV Access Protocol p49
A
Consider IVF Bolus IV/IO, Repeat as 
indicated for patient condition
Selective Spinal Motion Restriction 
Protocol p84
Continuous Cardiac Monitor 12-Lead ECG Procedure p129
(when possible)
Yes
Consider Pain Management, Adult
p58 P
Sodium Bicarbonate 50mEq IV/IO
AND*
Calcium Chloride 1g IV/IO over 3 min
Go To Appropriate Cardiac Arrest Protocol
Monitor and Reassess for Fluid Overload
Yes
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Management of Crush Injury Patient
Crush Injury should be suspected in prolonged 
pinnings >1 hour, AND proximal to the knee or 
elbow.
This protocol is NOT intended for hands or feet 
trapped in machinery or farm equipment
Shock / Hypotension (Trauma) Protocol 
p85
Hemodynamically 
Unstable
At risk of crush syndrome 
hyperkalemia/rhabdo
No
No
73
Pearls
REQUIRED EXAM: Vital Signs, GCS, Lung Sounds, Neuro Exam, Musculoskeletal Exam
 Structural Collapse, Crush Scenes are often full of hazards, provider safety is the most important consideration
 Patients may become hypothermic, even in warm environments
-Hypothermia can lead to coagulopathy, which will increase bleeding times and have worse outcomes for the patient
 Crush injuries can result in hyperkalemia from shift of Potassium out of injured cells. Cardiac monitoring is required and 12-lead ECG preferred whenever 
possible (as dicated by the situation)
 Monitor extremities for signs of compartment syndrome after crush injury; Pain, Pallor, Paresthesias, Paralysis, Pulselessness and Poikilothermia (inability 
to regulate core body temperature)
 *Utilize different IV lines or flush between bicarb and calcium to prevent precipitation in the line
Trauma Protocols - Adult
Shock / Hypotension (Trauma) Protocol 
p85
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Continuous Cardiac Monitor
A
Awake but Altered
General Approach – Adult, Trauma
Selective Spinal Motion Restriction 
Protocol p84
Mental Status
Awake and Alert Unresponsive
Pulse
Go To Appropriate Adult MEDICAL Cardiac 
Arrest Protocol
Remove Wet Clothing
Dry and Warm Patient
Monitor and Reassess
Encourage Transport and Evaluation even 
if asymptomatic
Consider Airway Management Protocol 
p32
Consider IV Access Protocol 
p49
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Continuous Cardiac Monitor
A
IV Access Protocol 
p49
Yes
No
Remove Wet Clothing
Dry and Warm Patient
Monitor and Reassess
74
Near Drowning / Submersion Injury – Adult, Trauma
Pertinent Positives and Negatives
 Submersion in water regardless of depth
 SAMPLE History
 OPQRST History
 Temperature of water
 Mental Status Changes
Differential
 Spinal Trauma
 Pre-Existing Medical Condition
 Hypothermia
 Aspiration
 The Bends
 Pressure Injury 
o Barotrauma
o Decompression Sickness
 Post-Immersion Syndrome
 Degree of Water 
Contamination
 Vomiting
 Coughing, Wheezing, Rales, 
Rhonchi, Stridor
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Have a HIGH index of suspicion for possible spinal injuries. Any diving injury or submersion with unclear details should be fully immobilized.
 Hypothermia is often associated with near-drowning and submersion injuries. Consider the Hypothermia Protocol as appropriate.
 All patients with Near-Drowning / Submersion Injury should be transported for evaluation due to delayed presentation of respiratory failure.
 With diving injuries (decompression / barotrauma) consider availability of a hyperbaric chamber; contact Medical Control early.
 Near-drowning patients who are awake and cooperative but with respiratory distress may benefit from CPAP / Positive Pressure Ventilation.
Trauma Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Consider Shock / Hypotension (Trauma) 
p85
Requires 
Transport
General Approach – Adult, Trauma
Remove Patient from Hot Environment
(if applicable)
Estimate 
Severity of 
Symptoms
Heat Cramps Heat Exhaustion Heat Stroke
Painful Spasms of Extremities and/or 
Abdominal Muscles
Normal Mental Status
Normal Vital Signs
Dizziness, Lightheadedness, Headache, 
Irritability, Nausea
Normal or Mildly Depressed Mental Status
Mild Tachycardia (<150)
Normal or Mildly Elevated Temp
Tolerating Oral 
Fluids
Oral Fluids
Sponge with Cool Water and Fan
Keep Patient Supine
Apply 100% Oxygen
Sponge with Cool Water and Fan
Marked Alteration in Level of Consciousness
May Be Sweating OR Hot, Dry, Red Skin
Extremely High Temp, >104oF
Reassess and Document Mental 
Status, VS and ability to take PO A
IV Access Protocol 
p49
Semi-Reclining Position with Head Elevated
Apply 100% Oxygen
Rapid Cooling with Cold Packs, Sponge with 
Cool Water and Fan
A
IV Access Protocol 
p49
Consider Shock / Hypotension 
(Trauma) p85
A
Ondansetron 0.15mg/kg IV/IO
(max 4mg)
Notify Receiving Facility,
Contact Medical Control As Necessary
Yes No
Normal
Yes
Execute and Document Patient 
Refusal Protocol p59 No
Any Abnormal
A
Consider
Ondansetron 0.15 mg/kg (max 
4mg) IV/IO/ODT
P
If Evidence of Sympathomimetic OD
Consider Overdose, Sympathomimetic Protocol
p65
75
Environmental, Hyperthermia – Adult, Trauma
Differential
 Alcohol Withdrawal (DTs)
 Hyperthyroidism (Thyroid Storm)
 Dehydration
 Cocaine or Sympathomimetic OD
 Sepsis
 CNS Lesion or Head Injury
 Abuse or Neglect (Elderly or 
disabled)
 Medication (Serotonin 
Syndrome, Malignant 
Hyperthermia)
Pertinent Positives and Negatives
 Age, VS, Mental Status
 SAMPLE History
 OPQRST History
 Time and length of exposure to hot environment
 Hot, dry or sweaty skin
 Seizures
 Nausea
 Hypotension, Shock, 
Fever
Pearls
REQUIRED EXAM: VS, GCS, Skin, HEENT, Neuro, Evidence of Intoxication, Mental Status
 Extremes of age are more prone to heat emergencies due to inability to easily self-extricate from hot environments
 Patients on Tricyclic Antidepressants, Anticholinergics, Diuretics (i.e. Lasix) are more susceptible to heat emergencies due to medication effects
 Cocaine, amphetamines and salicylates all may elevate body temperature or interfere with the ability to auto-regulate
 Sweating generally disappears as body temperature rises above 104oF
 If Heat Cramps resolved without IV Access or Medications, patients may refuse transport, IF tolerating oral fluids and VS normal
Trauma Protocols - Adult
If Shivering, Consider 
Midazolam 0.1 mg/kg IV/IO
(max 5mg)
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

External Rewarming Measures
12-Lead ECG Procedure 
p129
Environmental, Hypothermia – Adult, Trauma
General Approach – Adult, Trauma
Remove Patient from Cold Environment
(if applicable)
Remove Wet Clothing
Dry and Warm the Patient
Blood Glucose Procedure 
p151
Diabetic Emergencies Protocol 
p48
Estimate 
Severity of 
Symptoms
Mild Hypothermia
90-95oF (32-35oC)
Moderate Hypothermia
82-90oF (28-32oC)
Severe Hypothermia
<82oF (<28oC)
Localized Cold Injury Only
(Frostbite)
Sympathetic Nervous System Excitation –
Shivering, Hypertension, Tachycardia, 
Tachypnea
Awake But May Be Confused
Shivering more violent, ataxia and 
incoordination apparent.
Stumbling pace and Moderate Confusion
Appears pale as surface vessels constrict to 
retain heat.
Heart rate, blood pressure and respiratory rate 
decrease.
Disoriented, confused and combative
Paradoxically may discard clothing
No
<70
Consider Pain Management – Adult 
p58
Manage Wounds Per Burn Protocol p80
Do NOT Rub Skin To Warm
PREVENT Refreezing
A
A
IV Access Protocol 
p49
NS Warmed Fluids
500mL IV/IO over 30 min
Yes
A
IV Access Protocol 
p49
A
Consider Airway Management Protocol 
p32
>70
Notify Receiving Facility,
Contact Medical Control As Necessary
Pertinent Positives and Negatives
 Age, VS, Mental Status
 SAMPLE History
 OPQRST History
 Time and length of exposure to cold environment
Differential
 Alcohol Intoxication
 Hypothyroidism (Myxedema Coma)
 Dehydration
 Sepsis
 CNS Lesion or Head Injury
 Abuse or Neglect (Elderly or 
disabled)
 Medication (beta blocker 
overdose, opiate overdose)
 Cold or clammy skin
 Confusion
 Arrhythmias, J-waves on 
ECG
 Hypotension, Shock
76
Pearls
REQUIRED EXAM: VS, GCS, Skin, HEENT, Neuro, Evidence of Intoxication, Mental Status
 Hypoglycemia is found in many hypothermic patients, because hypothermia may be a result of hypoglycemia
 Severe hypothermia may cause myocardial irritability and rough handling can theoretically cause V-fib. Please handle carefully.
-Do not withhold intubation or CPR for this concern, but only the most experienced provider available should gently attempt intubation
 Below 86oF (30oC), antiarrhythmics may not be effective. If given, they should be given at reduced intervals. Do NOT attempt to pace below 86oF. If 
antiarrhythmics necessary for severely hypothermic patient, Contact Medical Control
 Extremes of age, malnutrition, EtOH and drug abuse and outdoor hobbies / employment all predispose to hypothermia
Trauma Protocols - Adult
Consider IVF Bolus IV/IO 
(Warmed if available) , 
Repeat as indicated for patient condition
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Adult, Trauma
Selective Spinal Motion Restriction 
Protocol p84
Mechanism Soft Tissue Swelling,
Bony Deformity
Wound 
Severity / 
Hemorrhage 
Control
Laceration, Abrasion,
Penetrating Injury
Direct Pressure
Tourniquet Procedure
p173
Bleeding 
Controlled
Pad and Splint Extremity in 
Place
Consider Pain Management 
Protocol p58
(if time allows)
Gentle In-Line Traction
(Avoid Excessive Force)
Mild-Moderate,
Simple Wound
Severe-Exsanguinating,
Complex Wound
No
Yes
Reassess and Document CMS
After Splinting
Pulses Present Pulses Absent
A
 IV Access Protocol 
p49
Consider Shock / Hypotension 
(Trauma) p85
Notify Receiving Facility,
Contact Medical Control As Necessary
A
IV Access Protocol 
p49
Palpate Pulses
Evaluate Distal CMS
Consider Pain Management 
Protocol p58
Consider Hemorrhage Control 
Protocol p81
Consider Pain Management 
Protocol p58
77
Extremity Injury – Adult, Trauma
Differential
 Vascular Disruption
 Amputation
 Fracture, Dislocation
 Sprain, Strain
 Abrasion
 Contusion
 Laceration
 Compartment Syndrome
Pertinent Positives and Negatives
 Type of injury
 Mechanism (blunt vs. penetrating)
 Central and Peripheral Pulses
 Neuro Function Distal to Injury
 SAMPLE History
 OPQRST History
 Evidence of Intoxication
 Evidence of Multi-System 
Trauma
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Immobilization of bony injuries should include the joint above and below. Joint injuries require immobilization of bone above and below
 Palpate and document Circulation, Movement and Sensation both before and after splint application
 Tourniquets should remain in place once hemorrhage control is adequate. The tourniquet is tight enough when the bleeding stops!
 If active hemorrhage and bony/soft tissue deformity, priority should be put on hemorrhage control first, then splinting – remember A,B,C’s
 If amputated extremities available, seal in a plastic bag and place in cool water and bring to the hospital with the patient
Trauma Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Adult, Trauma
Nature of 
Complaint Pain / Vision Loss
Assess Visual Acuity
Assess Pupils
Unrecognized 
Chemical Agent
Shield and Protect Both 
Eyes
Injury
Go To Appropriate Trauma Protocol Isolated to Eye(s)
Irrigate with > 1L NS or Sterile Water
Assess Visual Acuity
Globe Rupture
Non-Traumatic Traumatic
Stroke Protocol 
p64
Focal
Deficit
No
Yes
Normal
Cover and Protect Both Eyes
Yes
No
Chemical Blunt / Trauma
A
A
IV Access Protocol 
p49
Ondansetron 0.15mg/kg IV/IO/ODT
(max 4mg)
Consider Pain Management, Adult 
p58
Shield and Protect 
Both Eyes
Notify Receiving Facility,
Contact Medical Control As Necessary
Yes
No
Neuro Exam
Mechanism
78
Eye Pain – Adult, Trauma
Differential
 Globe Rupture
 Acute Closed Angle Glaucoma
 Stroke
 Retinal Artery Occlusion
 Chemical Burn
 Retinal Venous Thrombus
Pertinent Positives and Negatives
 Age, VS, Visual Acuity
 SAMPLE History
 OPQRST History
 Time of Injury
 Involved Chemical MSDS
 Contact/Corrective Lens Use
 “Shooting” or “Streaking” Lights
 Rust Ring
 “Lowering Shade” in Vision
Pearls
REQUIRED EXAM: VS, GCS, Visual Acuity, Neuro Exam, Extraocular Movements
 Stabilize any penetrating objects. DO NOT remove any embedded / impaled objects
 If Long Spine Board not indicated, transport with head of stretcher elevated to 60 degrees to help reduce intraocular pressure
 Remove contact lenses when possible
 Always cover both eyes to prevent further injury
 Orbital fractures increase concern for globe or optic nerve injury; follow visual acuity and extraocular movements for changes
 Normal visual acuity can be present, even with severe injury
Trauma Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Scene Assessment
Contact Poison 
Control Center
1-800-222-1222
Toxic Exposure 
Or 
Overdose
Overdose and Poisoning 
Protocol p54 OD
Hazmat Exposure
Step 1 – Site Control
 Respond to suspected Hazmat release from 
uphill and upwind
 Utilize binoculars for scene size-up
 Wear all appropriate PPE
 Control the scene by preventing entry into the 
area
Step 2 – Identification of Products
 As soon as safely possible, ID product(s) 
involved
 If moderately or extremely hazardous, notify 
HIT
 Utilize ERG for ID of placards, containers or 
product(s)
Step 3 – Hazard and Risk Assessment
 Utilize the ERG to make risk assessment
Step 4 – Personal Protective Equipment
 Use the ERG to determine PPE requirement
 Structural Firefighting Protective Clothing (SFPC) 
is not recommended for many Hazardous 
Materials
Step 5 – Information and Resource Coordination
 Communicate with additional units as 
appropriate
 Update HIT Leader on their arrival
Step 6 – Control Measures
 Confine and Contain product release as 
appropriate
 Consider additional resources as needed
Step 7 – Decontamination
 Consider appropriate decon after Hazmat 
incident
 Confer with HIT Leader as necessary
Step 8 – Termination Activities
 Before leaving the scene document all actions 
and equipment used
 Document possible parties names, addresses 
and phone numbers
 Turn the scene over to responsible party
Consider Burns – Adult, 
Trauma Protocol p69
Do NOT Use Water To Flush:
Elemental metals (sodium, 
potassium, lithium)
Phenols
Inhalational 
Injury
If available, dilute these burns 
with (in order of effectiveness)
 Polyethylene Glycol
 Glycerol
 Vegetable Oil
Albuterol 2.5mg/3mL Neb
Chlorine Gas OR
Chloramine Gas P
2.5mL Bicarb in 5mL NS, Neb
Inhaled Sodium Bicarb to neutralize 
the HCl formed in the lungs
Toxic
Exposure
Yes
Notify Receiving Facility,
Contact Medical Control As Necessary
Additional Helpful Numbers
Chemtrec: 1-800-424-9300
Chemtell: 1-888-255-3924
Infotract: 1-800-535-5053
3E: 1-800-451-8346
Yes No
No
79
Hazmat, General – Adult, Trauma
Differential
 Alcohol Intoxication
 Hyperthyroidism
 Drug Abuse, Intoxication
 Sepsis
 CNS Lesion or Head Injury
 Abuse or Neglect (Elderly or 
disabled)
 Medication (beta blocker 
overdose, opiate overdose)
Pertinent Positives and Negatives
 Age, VS, Mental Status
 SAMPLE History
 OPQRST History
 Time and length of exposure to toxic environment
 MSDS Sheet Info
 Mode of Release
 Number of Victims
Pearls
REQUIRED EXAM: VS, GCS, Skin, HEENT, Neuro, Evidence of Intoxication, Mental Status
 The most important factor in Hazmat response is provider safety – you can’t help anyone else if you’re a victim as well
 In any Hazmat situation, consider that the exposure may not be accidental; consider intentional releases, secondary devices and terrorism
 Always park upwind and uphill of any potential exposures, and be conscious of any symptoms you may begin to develop
 Communication is key; contact the appropriate Hazmat authority early and notify the Hazmat leader as well as the Comm Center of findings
 In a large-scale event, have the Comm Center activate Dane County Mass Casualty Plan and notify the Base Hospital to get prepared
 Inhaled bicarb is controversial but seems to help. Aslan S, Kandis H, Akgun M, Cakir Z, Inandi T, Görgüner M. The effect of nebulized NaHCO3 treatment on 
"RADS" due to chlorine gas inhalation. Inhal Toxicol. 2006 Oct. 18(11):895-900.
Trauma Protocols - Adult
B Ipratropium 0.5mg Neb
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Maintain SpO2 >93%
Goal EtCO2 35-45mmHg
General Approach – Adult, Trauma
Selective Spinal Motion Restriction 
Protocol p84
A
IV Access Protocol
p49
Blood Glucose Diabetic Emergencies Protocol 
p48
Seizure
Document 
GCS
Consider Airway Management Protocol 
p32
Pain Pain Management, Adult 
p58
>70
<70
No
>8
Yes
Elevate Head of Stretcher 15-30 degrees while 
maintaining Spinal Precautions
<5/10 Monitor and Reassess
Frequent Airway and GCS Evaluations
Notify Receiving Facility,
Contact Medical Control As Necessary
>5/10 OR
Severe
Document Response to Meds,
Repeat GCS, SpO2, EtCO2
Airway Management Protocol 
p32
If evidence of herniation, 
Goal EtCO2 is 30-35mmHg
<8
Nasal Airways are CONTRAINDICATED 
in patients with significant 
Maxillofacial trauma – the cribriform 
plate may be broken and result in the 
NPA going into the patient’s brain
80
Head Injury – Adult, Trauma
Differential
 Skull fracture
 Epidural hematoma
 Concussion, Contusion,
Laceration, Hematoma
 Non-Accidental Trauma
 Spinal Cord Injury
 Subdural Hematoma
 Subarachnoid Hemorrhage
Pertinent Positives and Negatives
 Type of injury
 Mechanism (blunt vs. penetrating)
 Loss Of Consciousness
 Vomiting, Altered Mental Status
 SAMPLE History
 OPQRST History
 Evidence of Intoxication
 Evidence of Multi-System 
Trauma
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 If GCS <13 consider Air transport or Rapid Transport
 Airway interventions can be detrimental to patients with head injury by raising intracranial pressure, worsening hypoxia (and secondary brain injury)
and increasing risk of aspiration. Whenever possible these patients should be managed in the least invasive manner to safely maintain O2 saturation 
>90% (ie. NRB, BVM with 100% O2)
 Acute herniation should be suspected when the following signs are present: acute unilateral dilated and non-reactive pupil, abrupt deterioration in mental 
status, abrupt onset of motor posturing, abrupt increase in blood pressure, abrupt decrease in heart rate.
 Only in suspected acute herniation – increase ventilatory rate (rate 20/minute) and target EtCO2 30-35mmHg
 Increased intracranial pressure (ICP) may cause hypertension and bradycardia (Cushings response)
 Hypotension usually indicates injury or shock unrelated to the head injury and should be treated aggressively
 Most important vital sign to monitor and document is level of consciousness (GCS)
 Concussions are periods of confusion or loss of consciousness (LOC) associated with trauma which may have resolved by the time EMS arrives. Any
confusion or mental status abnormality which does not return to normal within 15 minutes or any documented loss of consciousness should be
transported to an Emergency Department. Any questions or clarifications, contact Medical Control.
Trauma Protocols - Adult
M
Consider TXA 2 gm of TXA via slow 
IV or IO push over 1 min. NOT later 
than 3 hours after injury
Seizure Protocol 
p61
M
Consider TXA 2 gm of TXA via slow 
IV or IO push over 1 min. NOT later 
than 3 hours after injury
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Adult, Trauma
Notify Receiving Facility,
Contact Medical Control As Necessary
Wound 
Severity / 
Hemorrhage 
Control
Direct Pressure
Tourniquet Procedure 
p173
Mild-Moderate,
Simple Wound
Severe-Exsanguinating,
Complex Wound
No
Yes
A
Consider IV Access Protocol 
p49
Consider Pain Management, Adult 
p58
Extremity
Reassess BP
Yes
Hemostatic Dressing for Severe 
Hemorrhage, if available
No
Bleeding 
Controlled
SBP >100
Pain
Moderate 
OR
Severe
None OR
Mild
Consider Shock / Hypotension (Trauma)
p85 SBP <100
Consider Wound Packing 
Procedure, As Appropriate
p179
P
Consider TXA 2 gm of TXA via slow 
IV or IO push over 1 min.
81
Hemorrhage Control – Adult, Trauma
Differential
 Vascular Disruption
 Amputation
 Fracture, Dislocation
 Sprain, Strain
 Abrasion
 Contusion
 Laceration
 Compartment Syndrome
Pertinent Positives and Negatives
 Type of injury
 Mechanism (blunt vs. penetrating)
 Central and Peripheral Pulses
 Neuro Function Distal to Injury
 Time of Injury
 Deformity
 Diminished pulse / capillary 
refill
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Hypotension in trauma needs blood products early, so minimize scene time. Goal for scene time in major trauma cases should be <10 min.
 Multiple casualty incident or obvious life threatening hemorrhage, consider Tourniquet Procedure and/or Hemostatic Dressing FIRST.
 Hemostatic Dressings are appropriate for hemorrhage that can’t be controlled with a tourniquet, such as junctional wounds in the groin or axilla.
 Remember - hemostatic agents are contraindicated in wounds that violate the thoracic or abdominal cavity; if unsure, use sterile roll gauze. 
 Signs/Symptoms of Shock include: altered mental status, pallor, hypotension (SBP <100), cap refill >3 sec, faint/absent peripheral pulses.
Trauma Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Airway Management – Adult Protocol 
p32
Blood Glucose, SpO2, 12-Lead ECG, Full 
Spinal Immobilization Procedures
Cardiac Arrest – Adult Protocol
p37
General Approach – Adult, Trauma
Estimate Symptom 
Severity
Cardiorespiratory Arrest Altered Level of Consciousness Inadequate Respirations
Lightning Strike Patient Management
Typically, victims of lightning strikes who do not suffer 
cardiac or respiratory arrest survive; typical triage protocols 
do not apply under these circumstances, and resuscitation 
should be provided to those who are PNB first.
ECG evidence of direct myocardial damage from lightning 
strike includes ST segment elevation, T-wave inversion and 
prolongation of the QT interval.
Most injuries occur outdoors, but contact with plumbing, 
phone lines, etc. that are struck can injure people indoors. 
Scene Safe
Yes
Notify Receiving Facility,
Contact Medical Control As 
Necessary
No
Stage,
Call for Law Enforcement and/or 
Additional Resources
Normal Mental 
Status
No
Go to Appropriate Medical Protocol Yes
A A A
Seizure, Adult Medical Protocol
p61 Yes Seizure No
Full Spinal Immobilization Procedure 
p169
IV Access Protocol
p49
IV Access Protocol 
p49
Cardiac Arrhythmia – Adult Protocol, 
As Appropriate
IV Access Protocol
p49
Full Spinal Immobilization Procedure 
p169
82
Lightning Strike – Adult, Trauma
 Spine Fracture
 Rhabdomyolysis
 Cardiac Dysrhythmia
 Hypoglycemia
Differential
 Thermal Injury
 Electrical Injury
 Blast Injury
 Acute Myocardial Infarction
Pertinent Positives and Negatives
 Type of Strike (Direct, Splash, Contact)
 Central and Peripheral Pulses
 Nausea, Vomiting, Diarrhea
 Amnesia, Confusion, Neuro Deficits
 Duration of Unresponsiveness 
(if applicable)
 Time of Strike
 Wounds to Hands, Feet or Areas 
of Contact
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 National lightning safety guidelines state that risk continues for 30 minutes after the last lightning is seen or thunder heard.
 Lightning not striking twice is a myth; if there is continued risk to EMS providers, remove the patient to a safe place before treatment.
 Full spinal immobilization should be performed in any patient with altered level of consciousness, as spinal injuries are common from the concussive force
of the strike and/or involuntary muscle spasms.
 There are reports of patients surviving prolonged periods of arrest after lightning strike. Treatment for cardiopulmonary arrest is per ACLS protocols, but
decision to terminate resuscitation should be made in coordination with Medical Control.
Trauma Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Adult, Trauma
Location of 
Electrodes
ANY Electrodes Present In The 
Eye, Face, Neck, Groin, Spinal Column 
or Axilla
Superficial Soft Tissues EXCLUDING 
Eye, Face, Neck, Groin, Spinal Column 
or Axilla
Removed by Law Enforcement prior to 
EMS Evaluation
The Thomas A. Swift Electric Rifle (TASER)
The TASER fires two small dart-like electrodes, 
which stay connected to the main unit by 
conductive wire as they are propelled by small 
compressed nitrogen charges
Scene Safe
Yes
Refer to Police Custody Policy, As 
Appropriate p27
Notify Receiving Facility,
Contact Medical Control As 
Necessary
No
Stage,
Call for Law Enforcement AND/OR
Additional Resources
Evidence of 
Exposure / 
Toxidrome
Begin Triage and Decontamination, 
As Appropriate Yes
Go To Appropriate Cardiac 
Dysrhythmia, Adult Medical Protocol No Yes
DO NOT REMOVE ELECTRODES
Stabilize in Place and Transport
Place one hand flat on the patient 
around the probe and stabilize the skin 
surrounding the puncture site. Place 
your other hand/pliers firmly around 
the base of the probe
In one fluid motion pull the probe 
straight out from the puncture site
Repeat procedure with second probe
Examine Site for Bleeding, Expanding 
Hematoma or Distal Neuro Deficit
Arrhythmia on 
Monitor
Examine Site for Bleeding, Expanding 
Hematoma or Distal Neuro Deficit
Examine Site for Bleeding, Expanding 
Hematoma or Distal Neuro Deficit
Consider Behavioral Emergencies –
Adult, Medical Protocol p52
83
Electronic Control Device (a.k.a. TASER) –
Adult, Trauma
Differential
 Illicit Drug Intoxication
 Drug/EtOH Withdrawal
 Primary Psychosis
 Hypoglycemia
 Hypoxia
 Head Injury
 Occult Trauma
 Cerebral Hypoperfusion
 Toxic Ingestion
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE History
 OPQRST History
 Situational Crisis
 Pyschiatric Illness / Medication History
 Medic Alert Bracelet, DM History
 Anxiety, Agitation or Confusion
 Suicidal / Homicidal Thoughts or History
 Evidence of Substance Use / Overdose
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Safety first – for Providers, Police and Patients. Never restrain any patients in the prone (face down) position.
 Document the site of electrode penetration as well as whether the barb was completely intact or broken on removal.
 Patients who require repeated deployments of the Electronic Control Device are at a significantly higher risk of cardiac dysrhythmias as well as in-custody 
death. Have a high index of suspicion and a low threshold to treat per the Behavioral Emergencies Protocol .
 Patients who are actively restrained by Law Enforcement require an officer be present in the ambulance patient compartment during transport. It is a 
patient safety issue as well as a medicolegal liability for the EMS Provider.
Trauma Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Clean up, take out gray boxes
Simplify collar and bboard
General Approach – Adult, Trauma
Spinal Motion Restriction not indicated
Assess Mechanism of 
Injury (MOI)
Spinal Motion Restriction not indicated
ALL ‘No’
ALL ‘No’
Isolated Penetrating Blunt Trauma
(With OR Without Penetrating Trauma)
q Altered level of consciousness OR 
q (GCS < 15) OR
q Clinical Intoxication* OR
q Midline Neck Pain OR
q Midline Tenderness to Palpation of CSpine OR
q Paraspinal Muscle Tenderness to 
Palpation OR
q Neurologic Deficits OR
q Abnormal Sensation OR
q ANY Anatomic Deformity OR
q Distracting Injury** OR
q Inability to Communicate OR
q Significant Mechanism of Injury OR
q Neurologic Deficits OR
q Abnormal Sensation OR
q Altered Level of Consciousness OR
q (GCS <15) OR
q Clinical Intoxication*
ANY
‘Yes’
ANY
‘Yes’
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Maintain Manual C-Spine Stabilization Until 
Evaluation and/or Immobilization Complete
Apply Rigid Cervical Collar as per Standard
q Midline Thoracic or Lumbar Pain OR
q Tenderness to Palpation of Spine OR
q Neurologic Deficits OR
q Abnormal Sensation OR
q Anatomic Deformity of Spine OR
q Inability to Communicate OR
q Distracting Injury**
Full Spinal Motion Restriction Indicated
ANY ‘Yes’
ALL
‘No’
ALL
‘No’
Evaluate and Treat per Appropriate Adult 
Trauma Protocol
84
Selective Spinal Motion Restriction – Adult, Trauma
Pearls
REQUIRED EXAM: Motor Function both upper and lower extremities, Sensation of upper and lower extremities, subjective abnormal sensation, Tenderness to palpation of bony 
prominences OR paraspinal muscles
 *Clinical Intoxication – A transient condition resulting in disturbances in level of consciousness, cognition, perception, affect or behavior, or other psychophysiological 
functions and responses. Common examples include; ataxia, emotional instability, flight of ideas, tangential thought or motor incoordination.
 **Distracting Injury – Examples include, but are not limited to; long bone fracture, dislocations, large lacerations, deforming injuries, burns OR any condition preventing 
patient cooperation with history.
 ALL shallow water near drownings, diving injuries and high-voltage electrical injuries (lightning, ≥1000V AC or ≥1500V DC) MUST be fully immobilized
 If immobilization indicated but refused; advise the patient of risk of death, permanent disability or long term impairment. Clearly document the refusal and the conversation 
(re: risk); Apply a cervical collar, if allowed and transport in neutral alignment.
 Long spine boards have risks and benefits for patients. Spinal immobilization should always be applied when any doubt exists about the possibility of spinal trauma.
 It is always safer and better patient care to assume that a Cervical Spine injury has occurred and provide protection, and should be the standard of care in trauma patient 
management
 Long spine boards can be very useful for extricating patients, transferring locations, and providing a firm surface for chest compressions.
 Very thoughtful consideration should go into any decision to NOT use the rigid cervical collar OR long spine board.
Trauma Protocols - Adult
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
IV Access Protocol
p49
A
Consider IVF Bolus IV/IO, Repeat as 
indicated for patient condition, consider 
permissive hypotension in setting of 
ongoing serious hemorrhage
P
Consider TXA 2 gm of TXA via slow 
IV or IO push over 1 min.
General Approach – Adult, Trauma
Consider Hemorrhage Control, 
Adult Trauma p81
Notify Receiving Facility,
Contact Medical Control As Necessary
85
Hypotension / Shock (Trauma) – Adult, Trauma
Differential
 Vascular Disruption
 Amputation
 Fracture, Dislocation
 Sprain, Strain
 Abrasion
 Contusion
 Laceration
 Compartment Syndrome
Pertinent Positives and Negatives
 Type of injury
 Mechanism (blunt vs. penetrating)
 Central and Peripheral Pulses
 Neuro Function Distal to Injury
 Time of Injury
 Deformity
 Diminished pulse / capillary 
refill
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Hypotension in trauma needs blood products early, so minimize scene time. Goal for scene time in major trauma cases should be <10 min.
 Remember the Triad of Death in Trauma – Hypotension, Hypothermia and Coagulopathy; IVF are important during resuscitation, but it is important to 
remember how fluids impact these three elements.
 Multiple casualty incident or obvious life threatening hemorrhage, consider Tourniquet Procedure and/or Hemostatic Dressing FIRST.
 Hemostatic Dressings are appropriate for hemorrhage that can’t be controlled with a tourniquet, such as abdominal and pelvic wounds.
 Signs/Symptoms of Shock include: altered mental status, pallor, hypotension (SBP <100), cap refill >3 sec, faint/absent peripheral pulses.
Trauma Protocols - Adult
P
Consider Norepinephrine 4-16 mcg/min 
IV/IO Titrate to SBP >100, MAP >65, or 
signs of improved perfusion
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
P
Consider push dose Epi 5-20mcg every 1-
2 minutes SBP>100, MAP >65, or signs of 
improved perfusion
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Adult, Medical
q Log Member into Rehab Sector
q Assist in removal of all PPE
q Hydrate orally
q Begin temperature controls based on member
temperature and environment
q Rest for at least 10 minutes
q Reassess Vital Signs at 10 minutes
Evaluate and Treat per Appropriate Adult 
Medical Protocol
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Criteria for Entering Rehab
q Use of a 2
nd 30-minute OR 45-
minute self-contained breathing
apparatus (SCBA) cylinder OR
q A single 60-minute SCBA cylinder
OR
q 40 minutes of intense work without
SCBA
Infection Control
Members with direct involvement 
with patient care or exposure to 
bodily fluids must be 
decontaminated fully prior to entry 
into the Rehab Sector and accessing 
rehab supplies. 
q Consider Transport to Medical 
Facility
q Hydrate orally
q Begin temperature controls
based on member temperature
and environment
q Rest for at least 10 minutes
q Reassess Vital Signs at 10 minutes
Baseline 
Assessment
q Chest Pain OR
q Shortness of Breath not Improving with O2 OR
q Irregular HR and/or HR >160 OR
q STEMI OR
q Syncope, Disorientation OR Confusion OR
q Member Requesting Transport For Any Reason
ALL ‘No’
ANY ‘Yes’
Notify Incident Command, Begin ePCR 
and Initiate Transport to Hospital
Go To Appropriate Adult Medical 
Protocol
q Temp >100.5
o
F OR
q Systolic BP >160 OR
q Diastolic BP >100 OR
q Pulse >100 OR
q RR <12 or >20 OR
q SpO2 <93% OR
ALL ‘No’
ANY ‘Yes’
Release Member From Rehab Division
q Consider Transport to Medical 
Facility
q Continue temperature controls
q Orally hydrate, consider IV Fluids
q Rest for 10 minutes
q Reassess Vital Signs every 5 minutes
Abnormal VS
(as Previous)
ALL ‘No’
ANY ‘Yes’
Abnormal VS
(as Previous)
ANY ‘Yes’
ALL ‘No’
Notify Receiving Facility,
Contact Medical Control As 
Necessary
86
Public Safety Personnel Rehab – Special Operations
Pearls
REQUIRED EXAM: Mental Status, Skin Condition, Temperature, Heart Rate, Respiratory Rate, Blood Pressure, SpO2, SpCO
 This Protocol was named “Public Safety Rehab”, and should be applied to any situation during which Firefighters, Law Enforcement Officers, Emergency Medical Services or 
ANY Emergency Response Personnel are exerting themselves for > 40 minutes.
o This INCLUDES training operations, special events and non-emergency operations lasting longer than 40 minutes.
 Per NFPA 1584 Requirements, the Rehab Site should be set up in a location that provides shelter for the members, is far enough away from the active scene that the turnout 
gear, SCBA and protective equipment may be safety doffed, and provide protection from the environmental conditions.
o Ideally, members should be shielded from view of the active scene, to reduce anxiety and to prevent members from trying to exit rehab inappropriately.
 The purpose of this Protocol is to protect the physical and mental condition of members operating at the scene of an emergency or a training exercise and to prevent
decompensation of the individual. By keeping the individuals safe, it improves the safety and integrity of the team as well as the operation.
 At a minimum, turnout coat and nomex hood should be removed and turnout pants pushed down to the knees while seated in Rehab.
Trauma Protocols - Adult
Consider Cyanide
(If exposed to any products of combustion, 
mining incidents or industrial organic 
chemistry without proper functioning gear)
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Quick Reference – Peds (<12 y/o)
Lbs. Kgs. Lbs. Kgs.
Wisconsin EMSC Recommended Weight Conversion
(2.2lbs = 1kg -OR- 1lb = 0.45kg)
Lbs. Kgs.
5 lbs 2 kgs 20 lbs 9 kgs 35 lbs 16 kgs
6 3 21 10 36 16
7 3 22 10 37 17
8 4 23 10 38 17
9 4 24 11 39 18
10 lbs 5 kgs 25 lbs 11 kgs 40 lbs 18 kgs
11 5 26 12 41 19
12 5 27 12 42 19
13 6 28 13 43 20
14 6 29 13 44 20
15 lbs 7 kgs 30 lbs 14 kgs 45 lbs 20 kgs
16 7 31 14 46 21
17 8 32 15 47 21
18 8 33 15 48 22
19 9 34 15
www.chawisconsin.org
49 22
50 lbs 23 kgs
Normal Vital Signs In Children
Heart Rate (Beats Per Minute)
Respiratory Rate 
(Breaths Per Minute)
Age Systolic Blood Pressure
Newborn
Infant (1-12mos)
Toddler (1-2yrs)
Preschool (3-5yrs)
School Age (6-12yrs)
Adolescent (13-17yrs)
Awake Rate Sleeping Rate
100-180 80-160
100-170 75-160
80-150 60-90
70-130 60-90
65-120 60-90
55-90 50-90
30-60
30-60
24-40
20-34
15-30
12-20
60-90
87-105
85-102
89-108
94-120
107-132
Modified Glasgow Coma Scale for Infants and Children
Child Score
Eye Opening
Infant
Spontaneous
To Speech
To Pain
None
Spontaneous
To Speech
To Pain
None
4
3
2
1
Best Verbal 
Response
Coos and Babbles
Irritable, Cries
Cries in Response to Pain
Moans in Response to Pain
None
Oriented, Appropriate
Confused
Inappropriate Words
Incomprehensible Sounds
None
5
4
3
2
1
Best Motor 
Response
Obeys Commands
Localizes Painful Stimulus
Withdraws in Response to Pain
Flexion in Response to Pain
Extension in Response to Pain
None
Moves Spontaneously and Purposely
Withdraws in Reponse to Touch
Withdraws in Response to Pain
Abnormal Flexion Posture to Pain
Abnormal Extension Posture to Pain
None
6
5
4
3
2
1
Equipment
Resuscitation Bag
Oxygen Mask
(NRB)
Oral Airway
(mm)
Laryngoscope Blade 
(Size)
Endotracheal Tube
(mm)
King Airway
LMA
Suction Catheter
(French)
BP Cuff
IV Catheter (ga)
IO (ga)
GRAY
3-5kg
Size 0 (Clear)
NA
Neonatal #5/
Infant
PINK
Small Infant
6-7kg
Infant/Child
Pediatric
50
1 Straight
3.5 Uncuffed
3.0 Cuffed
Size 1 (White)
#1
8
Infant/Child
22-24
18/15
RED
Infant
6-9kg
Infant/Child
Pediatric
50
1 Straight
3.5 Uncuffed
3.0 Cuffed
Size 1 (White)
#1
8
Infant/Child
22-24
18/15
PURPLE
Toddler
10-11kg
Child
Pediatric
60
1 Straight
4.0 Uncuffed
3.5 Cuffed
Size 1 (White)
#1.5
10
Child
20-24
15
YELLOW
Small Child
12-14kg
Child
Pediatric
60
2 Straight
4.5 Uncuffed
4.0 Cuffed
Size 2 (Green)
#2
10
Child
18-22
15
WHITE
Child
15-18kg
Child
Pediatric
60
2 Straight
5.0 Uncuffed
4.5 Cuffed
Size 2 (Green)
#2.5
10
Child
18-22
15
BLUE
Child
19-23kg
Child
Pediatric
70
2 Straight
OR Curved
5.5 Uncuffed
5.0 Cuffed
Size 2.5 
(Orange)
#3
10
Child
18-20
15
ORANGE
Large Child
24-29kg
Child
Pediatric
80
2 Straight
OR Curved
6.0 Cuffed
Size 3 
(Yellow)
#3.5
10
Child
18-20
15
GREEN
Adult
30-36kg
Adult
Pediatric/
Adult
80
3 Straight
OR Curved
6.5 Cuffed
Size 3
(Yellow)
#4
10-12
Small Adult
16-20
15
87
Medical Protocols - Pediatric
NG Tube (French) 5-8 5-8 8-10 10 10 12-14 14-18 16-18
Weight (kg)
2-3
4-10
10-14
14-18
20-42
>50
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Destination Determination
Measure Vital Signs and Level of Consciousness 
Glasgow Coma Scale ≤13
Systolic blood pressure (mmHg) <70 + (age in years x 2)mmHG
Respiratory rate <10 or Inadequate Effort 
 OR need for ventilation support
Assess Severity of Illness Transport to Pediatric ICU Capable Facility;
Notify via Radio as early as possible
 Prolonged Seizure OR Status Epilepticus 
 Cardiac Arrest OR Respiratory Arrest
 Severe Respiratory Distress (Cyanosis OR SpO2 <90%)
 Massive Gastrointestinal Bleeding
 Life Threatening Dysrhythmias
 Compromised Airway not relieved by EMS
 Signs or Symptoms of Sepsis or Shock
Assess for Potential Time-Sensitive Problems
 Altered Mental Status NOT Explained by Simple Hypoglycemia
 Significant Allergic Reaction
 Impending Cardiac OR Respiratory Collapse
 Multiple Medications Administered During Transport (Including Albuterol)
Step One
Step Two
Step Three
Yes
No
Yes
No
Transport to closest appropriate Pediatric 
ICU Capable Facility 
No
Assess Special Patient or System Considerations
 Age <1 year
 Anticoagulation AND/OR history of bleeding disorder(s)
 Significant Toxic Ingestion / Poisoning / Overdose History (Proven OR 
Suspected) with deteriorating vital signs OR not responding to therapy
 Burns
- without other trauma, transport to Burn Facility
- with traumatic mechanism, transport to Trauma Center
 End Stage Renal Disease requiring Hemodialysis
 Medically complex patients requesting transport to non-PICU Facility
 EMS provider judgment
Contact Medical Control; Consider Pediatric 
ICU Capable Facility OR Specialty Resource 
Center
Step Four
Transport according to Appropriate Medical Protocol
Appearance
Tone
Interactiveness
Consolability
Look/Gaze
Speech/Cry
Work of Breathing
Abnormal Breath Sounds
Retractions
Nasal Flaring
Circulation to the Skin
Pallor
Mottling
Cyanosis
Any Airway Compromise not 
able to be managed by EMS 
should be taken to the CLOSEST 
FACILITY for stabilization 
immediately
88
Medical Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Yes
Yes
No
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Peds, Medical
Assessment
Scene Patient
Safety
Stage,
Call for Law 
Enforcement and/or 
Additional Resources
PPE
Hazmat
Unsafe
Insufficient
Safe
Sufficient
Notify Comm Center, 
Activate Hazmat 
Resources
Yes
Presentation OR 
Traumatic 
Mechanism
Yes
No
Pulseless,
Apneic
A,B,C’s
Support Airway,
Support Oxygenation,
Support Circulation
Peds Airway Management Protocol 
p90
Present
Obstructed Airway,
Ventilations Inadequate
Peds Hemorrhage Control Protocol 
p127
Exsanguinating
Hemorrhage
Ventilations Adequate,
BP and RR Adequate
Evaluate and Treat Per 
Appropriate Peds Medical 
Protocol
Notify Receiving Facility,
Contact Medical Control As Necessary
M Contact Medical Control
Doesn’t Fit Protocol,
Exhausted Protocol
Pulse
Go To Appropriate Peds Trauma 
Protocol
Peds Cardiac Arrest Protocol p95
Keep scene time to a minimum and notify receiving 
facility early of critical patient
All Patients should remain Nothing By Mouth (NPO) 
Unless Specified by Treatment Protocol
89
Pearls
REQUIRED EXAM: VS, GCS, Nature of Complaint
 Continuous Cardiac Monitor should be applied early for any non-traumatic pain complaint between the ear lobes and the umbilicus (belly button). Consider 12-Lead if 
concerning findings on Cardiac Monitor.
 Include Blood Glucose reading for any patient with weakness, altered mental status, seizure, loss of consciousness or known history of diabetes.
 Measure and document SpO2, EtCO2 for ANY patient with complaint of weakness, altered mental status, respiratory distress, respiratory failure or EMS managed airway.
 If hypotensive (Systolic BP<Reference Page Value) and/or clinical evidence of dehydration, consider Peds IV Access Protocol and Shock (Non-Trauma) Peds Medical Protocol.
 Any patient contact which does not result in an EMS transport must have an appropriately executed and completed refusal form. 
 Never hesitate to consult Medical Control for assistance with patient refusals that can’t meet all required fields, clarification of protocols or for patients that make you 
uncomfortable.
Pertinent Positives and Negatives
 Age, VS, BP, RR, SpO2
 SAMPLE history
 OPQRST history
 Source of blood loss, if any (GI, vaginal, AAA, ectopic)
 Source of fluid loss, if any (vomiting, diarrhea, fever)
 Pregnancy history
Differential
 Cardiac Dysrhythmia
 Hypoglycemia
 Ectopic Pregnancy
 AAA
Medical Protocols - Pediatric
 Mental Status
 Pale, Cool Skin
 Delayed Cap Refill
 Coffee Ground Emesis
 Tarry Stools
 Allergen Exposure
 Sepsis
 Occult Trauma
 Adrenal Insufficiency
Appearance
Tone
Interactiveness
Consolability
Look/Gaze
Speech/Cry
Work of Breathing
Abnormal Breath Sounds
Retractions
Nasal Flaring
Circulation to the Skin
Pallor
Mottling
Cyanosis
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Each Attempt should include change in approach, 
operator and/or equipment
If endotracheal tube placement is attempted, after 
two (2) unsuccessful attempts move towards 
alternative airway device
P
Surgical Airway p148
 Consider if unable to oxygenate/ventilate with 
any other less invasive method 
Consider early if sign of facial trauma/swelling/
distortion or complete obstruction
Post Advanced Airway Sedation 
Protocol p92
Post Advanced Airway Sedation 
Protocol p92 
BVM with airway adjunct
Consider Advanced Airway
Placement ETT, BIAD
Airway Management - Peds
Pearls
REQUIRED EXAM: VS, GCS, Head, Neck, Blood Glucose
 If BIAD in place and adequately ventilating/oxygenating - Do Not Remove.
 Digital capnography is the standard of care and is to be used with all methods of advanced airway management and endotracheal intubation. If a service uses color change 
capnometry only and an Invasive Airway Device is placed, an intercept with a digital capnography capable service MUST be completed.
 Goal EtCO₂ = 35-45mmHg.
 If Airway Management is adequately maintained with a Bag-Valve Mask and waveform SpO2 >93%, it is acceptable to defer advanced airway placement in favor of basic 
maneuvers and rapid transport to the hospital.
 Always assume that patient reports of dyspnea and shortness of breath are physiologic, not psychogenic.
 Gastric decompression with Oral Gastric Tube should be considered on all patients with advanced airways, if time and situation allow.
 Once secured, every effort should be made to keep the endotracheal tube in the airway; commercially available tube holders and C-collars are good adjuncts.
 For all protocols, an Advanced Airway Attempt is defined as: passing the tip of the laryngoscope blade or Blindly Inserted Airway Device (BIAD) tube past the teeth.
Medical Protocols - Peds
General Approach – Peds, Medical
Notify Receiving Facility,
Contact Medical Control As Necessary
Basic Airway Maneuvers
(Open Airway, Suction, NPA vs. OPA)
P
Consider Rapid Sequence 
Airway Protocol p91
Evaluate and Treat Per Appropriate 
Peds, Medical Protocol
Anticipate and Prepare for the Difficult Airway
LEMON Rule
 Look Externally
 Evaluate with 3:3:2 Rule
 Mallampati Classification
 Obstruction
 Neck Mobility (or lack thereof)
If obstruction suspected, Go to Airway 
Obstruction Procedure p132
Assess Airway (obstruction, 
blood, vomit, FB, etc.) 
A,B,C’s
(RR, effort, adequacy)
Adequate
Inadequate
Evaluate and Treat Per Appropriate 
Peds, Medical Protocol
Unsuccessful Successful
Unobstructed
Consider Need for ALS Level Service
Evaluate and Treat Per Appropriate Peds, Medical 
Protocol
Obstructed
Goal is to support oxygenation and ventilation 
with the least invasive method possible with 
progression to advanced airways ONLY if less 
invasive methods have failed.
90
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Rapid Sequence Airway - Peds
Notify Receiving Facility,
Contact Medical Control As Necessary
P Consider Pediatric Intubation Procedure p136
Preparation 
IV, O2, Continuous Cardiac Monitor, SpO2, EtCO2, BP
Check Laryngoscope bulb, Check Video Laryngoscope Function, ETT Balloon, Stylet, 
Syringes, Positioning
Prepare Rescue Airway Device
Medications Drawn Up and Labeled
Ensure backup airway, alternative techniques and second provider prepared
Optimize hemodynamics and consider preparing a push dose Epinephrine (p190)
Preoxygenate 
100% O2 x 5 Minutes
8 Vital Capacity Breaths via BVM or NRB
Continue Until Airway Secured
Continue apneic oxygenation via Nasal Cannula (if available)
Pretreatment 
Atropine 0.02mg/kg for patients at risk of severe bradycardia (max 0.5mg)
(<1 y/o OR already brady)
Paralysis and Induction
Etomidate 0.3mg/kg IV/IO (max 30mg) OR 
Ketamine 2mg/kg IV/IO, max 200mg
THEN
Succinylcholine 2mg/kg IV/IO (max 200mg) OR
Rocuronium 1.0mg/kg (max 100mg)
Placement with Proof 
Continuous EtCO2, Auscultation, Chest Rise, Fogging in Tube
Secure Device
Capture Video Documentation of tube placement and attach to EMR
Print capnography strip and document depth
Post Placement Management 
Airway Management – Peds, Medical
Post-Advanced Airway Sedation, Peds p92
91
Pearls
REQUIRED EXAM: VS, GCS, Head, Neck, Blood Glucose, Lung Exam, Posterior Pharynx
 Digital capnography is the standard of care and is to be used with all methods of advanced airway management and endotracheal intubation. If a service uses color change 
capnometry only and an Invasive Airway Device is placed, an intercept with a digital capnography capable service MUST be completed.
 If Airway Management is adequately maintained with a Bag-Valve Mask or supraglottic airway and waveform SpO2 >93%, it is acceptable to defer advanced airway 
placement in favor of basic maneuvers and rapid transport to the hospital; Endotracheal Tube placement is a complicated skill that is not without potential consequence.
 Gastric decompression with Oral Gastric Tube should be considered on all patients with advanced airways, if time and situation allows.
 Once secured, every effort should be made to keep the endotracheal tube in the airway; commercially available tube holders and C-collars are good adjuncts.
 For all protocols, an Advanced Airway Attempt is defined as: passing the tip of the laryngoscope blade or Blindly Inserted Airway Device (BIAD) tube past the teeth.
Medical Protocols - Pediatric
Goal is to support oxygenation and ventilation with the 
least invasive method possible with progression to 
advanced airways ONLY if less invasive methods have 
failed.
Indications for Rapid Sequence 
Airway Management
Determining whether RSA is indicated for a patient is 
multifactorial, requires experienced clinical judgement, and a 
robust training/QA support system. These indications to 
consider RSA are meant to serve as guidelines and RSA should 
not be considered if unable to ventilate with BVM unless all 
other options have been exhausted. 
 Failure to oxygenate 
 Failure to ventilate
 Failure of airway protection
Each Attempt should include change in approach, operator and/
or equipment
If endotracheal tube placement is attempted, after two (2) 
unsuccessful attempts move towards alternative airway device
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

P
Fentanyl 1mcg/kg IV/IO (max 100mcg) 
AND / OR
P
Midazolam 0.1mg/kg IV/IO (max 5mg) or Midazolam 0.2 
mg/kg IM/IN (max 10mg)
OR
Lorazepam 0.1mg/kg IV/IO/IM (max 2mg)
P
OR
Consider Ketamine 2mg/kg IV/IO (max 200mg) 
P May Repeat Sedation (max 3 doses)
A
Post Airway Sedation - Peds
Notify Receiving Facility,
Contact Medical Control As Necessary M
Invasive Airway – Peds, Medical
Assess and Document
BP, HR, SpO2, Continuous Cardiac Monitoring, EtCO2
Signs of 
Discomfort
Rising BP, Increasing HR, Tearing Pulling at Lines and Tubes, 
Coughing or Gagging on Invasive Airway Device, 
Clinical Signs of Agitation 
Yes
Improved 
Comfort Yes No
Monitor VS Closely
Notify Receiving Facility,
Contact Medical Control As Necessary
No
Pearls
REQUIRED EXAM: VS, GCS, Nature of Complaint
 Paralytics block movement of skeletal muscle but do NOT change awareness. Remember that without sedation, patients may be awake but paralyzed.
 Monitor Vital Signs closely when managing airways and sedation. Changes that indicate pain, anxiety as well as tube dislodgment may be subtle (at first)!!
 Document Vital Signs before and after administration of every medication to prove effectiveness.
 ANY change in patient condition, reassess from the beginning. Use the mnemonic DOPE (Dislodgment, Obstruction, Pneumothorax, Equipment) to troubleshoot problems 
with the ET Tube.
 Ketamine may be considered for sedation AFTER standard regimen exhausted AND if Ketamine NOT used as induction agent for intubation.
 Continuous End Tidal CO2 is mandatory for all intubated patients – color change is not sufficient proof of ET Tube in the trachea.
92
Medical Protocols - Pediatric
REMEMBER
It is critical that we do not 
administer paralytics 
without adequate 
sedation
Consider Ondansetron 0.15mg/kg (max 4mg)
IV/IO/IM
Contact Medical Control
Consider Rocuronium 1.0mg/kg (max 
100mg)
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Consider Peds Airway Management Protocol 
p90
B
B
Albuterol 2.5mg/3mL Neb or 6 puffs 
MDI (Max 3 doses)
B Ipratropium 0.5mg Neb Max 2 doses
P
Wheezing / Asthma - Peds
General Approach – Peds, Medical
Airway Patent, 
Respirations Adequate, SpO2 >93%
Peds Airway Management Protocol
p90
Allergic Reaction/Anaphylaxis Peds Allergic Reaction Protocol
p100
Cardiac Monitor
Wheezing / Lower Airway Respiratory Exam Stridor / Upper Airway
Nebulized Epinephrine 1mg Neb
(1:1000) in 2 mL NS
OR
Racemic Epinephrine 2.25% 3mL/5mL 
Normal Saline Neb
P
No
Yes
Yes
No
No
Consider Mag Sulfate 50mg/kg IV/IO 
(max 2gm)
Infuse over 10 minutes
No
Yes Notify Receiving Facility,
Contact Medical Control As Necessary
93
Pearls
REQUIRED EXAM: VS, 12 Lead, GCS, RR, Lung Sounds, Accessory muscle use, nasal flaring
 Do not delay inhaled meds to get an extended history. Assessments and interviews may be carried out simultaneously with breathing treatments.
 Supplemental O2 should be administered for all cases of hypoxia, tachypnea, and subjective air hunger.
 Magnesium Sulfate is contraindicated if there is a history of renal failure.
 Keep patient in position of comfort if partial obstruction.
 EpiPen Jr. is 0.15mg and is indicated for patients <60lbs. The adult EpiPen is 0.30mg and is indicated for patients >60lbs.
 Severe Asthma attacks may have such severe obstruction that they do NOT wheeze. Cases of “Silent Chest” need aggressive management with inhaled and IV medications. 
This is an ominous sign of impending respiratory failure.
 * Albuterol max 3 doses total, Ipratropium max 2 doses total. If pt. requires repeat dosing of either medication, contact Med Control AND/OR Activate ALS.
Pertinent Positives/Negatives:
 Age, VS, SpO2, EtCO2
 SAMPLE history
 OPQRST history
 Asthma, COPD, CHF history
 Home meds used prior to call 
 (Nebs, Steroids, Theophylline)
Differential
 Simple Pneumothorax
 Tension Pneumothorax
 Pericardial Tamponade
 STEMI, CHF
Medical Protocols - Pediatric
 Wheezing, Rhonchi
 Accessory Muscle Use
 Decreased Ability to Speak
 History of CPAP/Intubation/ICU Admission 
from previous flares
 Smoke Exposure, Inhaled Toxins
 Inhaled Toxins (CO, CN, etc.)
 Anaphylaxis
 Asthma/COPD
A
Consider Peds IV Access Protocol
p104
P
Consider 
Methylprednisolone 2mg/kg IV/IO
(max 125mg)
Albuterol 2.5mg/3mL Neb or 6 puffs 
MDI (Max 3 doses)
Albuterol 2.5mg/3mL Neb or 6 puffs 
MDI (Max 3 doses)
Ipratropium 0.5mg Neb Max 2 doses
Consider Epi 0.01mg/kg IM (1:1000)
(max 0.3mg)
P
Consider 
Methylprednisolone 2mg/kg IV/IO
(max 125mg)
Improving Improving
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Yes
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Pulse Oximetry and Continuous Cardiac 
Monitor
Blood Glucose Procedure p152
A
If Blood Sugar <40
Dextrose D10W, 5mL/kg IV/IO
Chest Compressions at 120/minute
Newly Born Resuscitation - Peds
Newly Born – Adult, Medical
Notify Receiving Facility,
Contact Medical Control As Necessary
Warm, Dry and Stimulate Infant
Clear Mouth, then Nose As Needed
Supplemental O2 via Blow-By
Maintain SpO2 >94%
Pulse Oximetry
Continuous Cardiac Monitor
Skin-To-Skin Contact With Mother 
If Situation Appropriate
HR >100
BVM Assisted Ventilations with Room Air
At 60 breaths/min X 30 seconds
Pulse Oximetry, Check Glucose
Continuous Cardiac Monitor
HR>60 BUT <100
HR <60
BVM Assisted Ventilations with 10-15L O₂ 
BVM at 3:1 Compressions:Breaths
Activate ALS
Chest Compressions at 120/minute,
BVM at 3:1 Compressions:Breaths
A
P
IO Procedure
p178
Epi (1:10,000) 0.1-0.3mL/kg IV/IO 
(max 1mg)
Repeat every 5 minutes
<60
Heart Rate
Heart Rate
Heart Rate BVM Assisted Ventilations with 10-15L
At 60 breaths/min X 30 seconds >60
<60 Heart Rate
>100
Notify Receiving Facility,
Contact Medical Control As Necessary
>60 BUT <100
>100
A Normal Saline Bolus <100
94
Pertinent Positives and Negatives
 Time of Delivery, Estimated Weight 
or Broselow
 Events Surrounding Arrest
 Estimated Time of Arrest
 Past Medical History (if known)
 Medications
 Concern for Foreign Body Aspiration
 Body Temperature
 History of Congenital Heart Defect
Differential
 Hypoxemia, Hypovolemia, Hypotension, Acidosis
 Toxins, Tension Pneumo, Pericardial Tamponade
 Hypoglycemia, Trauma
 Respiratory Failure
-Foreign Body, Infectious, Epiglottitis
Pearls
REQUIRED EXAM: VS, GCS, Skin, Cardivascular, Pulmonary
 Call early for ALS Intercept on neonates who are critically ill, and involve Medical Control so arrangements can be made at the receiving facility.
 Transport rapidly to an OB Receiving Facility.
 Consider hypoglycemia as etiology of neonatal arrest/peri-arrest situation. If not able to evaluate blood sugar, treat presumptively x 1.
 The increased concentration of fetal hemoglobin (HbF) and its increased affinity for oxygen is a factor to consider in establishing target SpO2 values in the neonate. HbF will
shift the oxygen dissociation curve to the left due to its high affinity for oxygen, which may result in high oxygen saturation (eg, 85 percent) at PaO2 levels below 40 mmHg.
 Per AHA Naloxone is not recommended in initial resuscitation of newborns.
Medical Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Start HPCPR Procedure p 156
Attach Monitor / Defibrillator
Cardiac Arrest, General - Peds
M
95
Medical Protocols - Pediatric
Ventilate at 8-10 breaths per minute with 
continuous compressions 15:2 Ratio Compressions : Ventilations
Advanced
Airway
No 
Advanced
Airway
General Approach – Peds, Medical
Pulseless,
Apneic No Go To Appropriate Peds Medical Protocol
Yes
Shockable
If Signs of ROSC, go to Post-Resus Care p97 If no signs of ROSC and >20min PALS, 
Consider Termination of Resuscitation
Notify Receiving Facility,
Contact Medical Control As Necessary
Supplemental O2, BVM with NPA or OPA
Defibrillate, Continue HPCPR x 2 minutes p156
Yes
V-fib / Pulseless VT
Continue HPCPR x 2 minutes p156
A Peds IV Access Protocol p104
P
No
PEA / Asystole
Defibrillate, Continue HPCPR x 2 minutes p156 Yes Shockable No Continue HPCPR x 2 minutes p156
Treat Reversible Causes
A Peds IV Access Protocol p104
Treat Reversible Causes
P
P
P
ROSC
No
Yes No
Epinephrine 0.01mg/kg (0.1mL/kg of 1:10,000)
(max single dose 1mg)
IV/IO every 3-5 min
Consider Peds Airway Management Protocol p90
Epinephrine 0.01mg/kg (0.1mL/kg of 1:10,000)
(max single dose 1mg)
IV/IO every 3-5 min
Amiodarone 5mg/kg IV/IO
May repeat x 2 OR
Lidocaine 1mg/kg IV/IO (max 3mg)
Peds Airway Management Protocol p90
(If not already done)
Epinephrine 0.01mg/kg (0.1mL/kg of 1:10,000)
(max single dose 1mg)
IV/IO every 3-5 min
Peds Airway Management Protocol p90
(If not already done)
Activating An “ECMO Alert”
Contact the ECMO Capable 
Hospital Early by radio. 
Continue HPCPR and follow 
ECMO protocol page 42
P
Sedation during Resuscitation
Ketamine 2mg/kg (Max 200mg) IV/IO
If needed for sedation during resuscitation 
If patient conscious during CPR and interfering in 
care
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

CONSIDER CORRECTABLE CAUSES:
 Hypoxia – Secure airway and ventilate
 Hypothermia – Active Rewarming
 Hydrogen Ion (acidosis) – secure airway and ventilate
 Toxins: 
Narcotic OD – Naloxone 2mg IV/IO/IN/IM
A
 Hypoglycemia – 0.5 – 1mg/kg (5-10mL/kg of D10W
 Hypovolemia – NS Bolus IV/IO
Cardiac Arrest, General - Peds
CPR Quality
 Push hard (>1/3 of anterior-posterior 
diameter of chest) and fast (at least 100/min) 
and allow for complete chest recoil
 Minimize interruptions in compressions
o Count out loud or use metronome
 Avoid excessive ventilations
o One breath every 6 seconds
 Rotate compressors every 2 minutes
 If no advanced airway, 15:2 
compressions:ventilations ratio.
 If advanced airway, give 10 breaths per 
minute with continuous chest compression**
Shock Energy for Defibrillation
 First Shock 2 J/kg
 Second Shock 4 J/kg
 Subsequent Shocks >4 J/kg
Maximum 10 J/kg or adult dose
Advanced Airway
 If no advanced airway is in place, ventilate with 1 breath every 3-5 seconds (12-
20 breaths per minute)*
 When bag-mask ventilation is unsuccessful... the LMA is acceptable when used 
by experienced providers to provide a patent airway and support ventilation.
 Waveform capnography to confirm and monitor airway placement
 Once advanced airway in place, give 1 breath every 6 seconds (10 breaths per 
minute)**
Return of Spontaneous Circulation (ROSC)
 Glucose, Pulse and Blood Pressure check and documentation
 Spontaneous arterial pressure waves in the intra-arterial monitoring
Reversible Causes
 Hypovolemia
 Hypoxia
 Hydrogen Ion (acidosis)
 Hypoglycemia
 Hypo- / Hyperkalemia
 Hypothermia
 Tension Pneumothorax
 Tamponade, Cardiac
 Toxins
 Thrombosis, Pulmonary
 Thrombosis, Coronary
 Trauma 
96
Pearls
RECOMMENDED EXAM: Mental Status
 IO is the preferred access for all Pediatric Cardiac Arrest patients.
 In order to successfully resuscitate a Pediatric patient, a cause of arrest must be identified and corrected.
 Airway is the most important intervention. This should be addressed immediately. Survival is often dependent on successful airway management.
 Airway management with BVM is often sufficient in the Pediatric patient. 
 If evidence of tension pneumothorax - unilateral decreased or absent breath sounds, tracheal deviation, JVD, tachycardia, hypotension – consider needle thoracostomy. 
Chest decompression may be attempted at the 2
nd intercostal space, mid clavicular line.
 For Neonatal Resuscitation, refer to Neonatal Resuscitation, p. 109.
 *https://eccguidelines.heart.org/wp-content/themes/eccstaging/dompdf-master/pdffiles/part-11-pediatric-basic-life-support-and-cardiopulmonary-resuscitation-quality.pdf.
 * *https://eccguidelines.heart.org/wp-content/uploads/2015/10/PALS-Cardiac-Arrest-Algorithm.png.
 Consider Ketamine if needed for sedation during resuscitation if patient consciousness during CPR is interfering in care.
Pertinent Positives and Negatives
 Age (if known), Estimated Weight or Broselow
 Events Surrounding Arrest
 Estimated Time of Arrest
 Past Medical History (if known)
Differential
 Hypoxemia, Hypovolemia, Hypotension, Acidosis
 Toxins, Tension Pneumo, Pericardial Tamponade
 Hypoglycemia, Trauma
 Respiratory Failure
-Foreign Body, Infectious, Epiglottitis
 Medications
 Concern for Foreign Body 
Aspiration
 Body Temperature
 History of Congenital Heart 
Defect
Medical Protocols - Pediatric
Refractory/Recurrent Vfib (Shockable Rhythm)
Consider changing position of pads, reduce impedance, double sequential (see below), ECMO 
(>13 years of age), transport
P
Amiodarone IV/IO Dose
5mg/kg bolus in VF/pulseless V-Tach, max 300mg May repeat up to 2 times if 
refractory VF/Pulseless VT
Atropine IM/IV/IO Dose 0.02 mg/kg IM/IV/IO, minimum dose 0.1mg; max 1m
Epinephrine IV/IO Dose: 0.01mg/kg (0.1mL/kg of 1:10,000 concentration), 
max 1mg. Repeat every 3-5 minutes.
Lidocaine IV/IO Dose 1mg/kg, max 3mg/kg
Hyperkalemia – Sodium Bicarbonate 1mEq/kg, max 50m IV/IO AND
 - Calcium Chloride 100mg/kg, max 1gm IV/IO
Tension Pneumothorax – Chest Decompression Procedure
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Airway Management, Peds Protocol 
(if not already done) p90
Optimize Ventilation and Oxygenation
SpO2 >93%
EtCO2 goal 35-45mmHg
Post Resuscitation Care - Peds
97
Pertinent Positives and Negatives
 Age (if known), Estimated Weight or Broselow
 Events Surrounding Arrest
 Estimated Time of Arrest
 Past Medical History (if known)
Differential
 Hypoxemia, Hypovolemia, Hypotension, Acidosis
 Toxins, Tension Pneumo, Pericardial Tamponade
 Hypoglycemia, Trauma
 Respiratory Failure
-Foreign Body, Infectious, Epiglottitis
 Medications
 Concern for Foreign Body 
Aspiration
 Body Temperature
 History of Congenital Heart 
Defect
Pearls
RECOMMENDED EXAM: Mental Status
 *if <40kg use saline bag procedure
 Monitor and treat for agitation and seizures.
 Monitor and treat hypoglycemia.
 If evidence of tension pneumothorax - unilateral decreased or absent breath sounds, tracheal deviation, JVD, tachycardia, hypotension – consider needle thoracostomy. 
Chest decompression may be attempted at the 2
nd intercostal space, mid clavicular line.
 Hyperventilation is a significant cause of hypotension / recurrent cardiac arrest in post resuscitation phase; avoid at all costs.
Medical Protocols - Pediatric
Cardiac Arrest – Peds, Medical
Yes
Appropriate Peds Protocol
Consider Post Advanced Airway 
Sedation, Peds Protocol p92
Notify Receiving Facility,
Contact Medical Control As Necessary
12-Lead ECG Procedure p129
Regardless if completed prior to arrest
Consider Peds Shock / Hypotension 
(Non-Trauma) Protocol p110
A
Peds IV Access Protocol
(if not already done) p104
Perform and Document Complete Neurologic Exam
Monitor for Hypotension, Dysrhythmias, or Airway 
Compromise
Consider Peds Bradycardia Protocol p99
Consider Peds Tachycardia Protocol p98
P
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
If suspected imminent arrest, 
Consider push dose Epi 1mcg/kg 
(max 20mcg) p190*
every 1-2 minutes SBP>100, MAP >65, 
or signs of improved perfusion
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

P
P
Adenosine 0.1mg/kg IV/IO (max 6mg) 
Rapid push; May repeat once at
Adenosine 0.2mg/kg IV/IO, (max 12mg) 
A
Tachycardia With A Pulse - Peds
98
Pearls
RECOMMENDED EXAM: Mental Status
 Probable Sinus tachycardia – P-waves present before every QRS, constant P-R interval. Infants usually <220/min, Children usually <180/min.
 Probable SVT – history vague, nonspecific with abrupt rate change, P-waves absent / abnormal, HR not variable. Infants usually >220/min, Children >180/min.
 Don’t delay treatment to get 12-lead ECG if patient is unstable.
 Alternative vagal maneuvers include carotid massage, hold breath in young children, bag valve mask ventilation, cold water or ice to face for 10-15 sec, bring knees to chest 
and hold, hold infant upside down
Medical Protocols - Pediatric
12-Lead ECG Procedure p129
IF situation allows
Wide
(>90ms)
Narrow
(<90ms)
Notify Receiving Facility,
Contact Medical Control As Necessary
Are P waves 
Present?
Yes
No
Consider Vagal Maneuvers if suspected 
SVT and symptomatic
(infant SVT rate usually >220, 
children SVT rate usually >180)
Consider Peds Airway Mgmt Protocol p90
Supportive Care / Treat Underlying Causes –
Go to appropriate Protocol 
(i.e. - sepsis, dehydration, DKA, hypovolemia)
No
Yes
Vagal Maneuvers 
Yes
No
General Approach – Peds, Medical
A Consider IV Access Protocol p104
Unstable*
Yes
No
Monomorphic
No
Infants <220 
Child <180
Yes
No
No change
M Consider Amiodarone 5mg/kg IV/IO (max 300mg) 
over 20-60 minutes
Supportive Care / Treat Underlying Causes –
Go to appropriate Protocol 
(i.e. - sepsis, dehydration, DKA, hypovolemia)
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
P
Synchronized Cardioversion p154 
0.5-1 J/kg may repeat once at 2 J/kg
Consider analgesia/sedation 
P
Fentanyl 1mcg/kg IV/IO (max 100mcg) 
AND / OR
P
Midazolam 0.1mg/kg IV/IO (max 5mg) or 
Midazolam 0.2 mg/kg IM/IN (max 10mg)
OR
Lorazepam 0.1mg/kg IV/IO/IM (max 
2mg)
P
Synchronized Cardioversion p154 
0.5-1 J/kg may repeat once at 2 J/kg
Consider analgesia/sedation 
P
Fentanyl 1mcg/kg IV/IO (max 100mcg) 
AND / OR
P
Midazolam 0.1mg/kg IV/IO (max 5mg) or 
Midazolam 0.2 mg/kg IM/IN (max 10mg)
OR
Lorazepam 0.1mg/kg IV/IO/IM 
(max 2mg)
P
Synchronized Cardioversion p154
0.5-1 J/kg may repeat once at 2 J/kg
Consider analgesia/sedation 
P
Fentanyl 1mcg/kg IV/IO (max 100mcg) 
AND / OR
P
Midazolam 0.1mg/kg IV/IO (max 5mg) or 
Midazolam 0.2 mg/kg IM/IN (max 10mg)
OR
Lorazepam 0.1mg/kg IV/IO/IM 
(max 2mg)
Unstable* /
Imminent 
Arrest
Regular 
Rhythm?
QRS Duration?
No change or become unstable
P
Adenosine 0.1mg/kg IV/IO, (max 6mg) rapid push
May repeat once at
Adenosine 0.2mg/kg IV/IO, (max 12mg) rapid push
OR
Yes
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

P
P
Epinephrine 1:10,000 0.01mg/kg IV/IO 
(max 1mg) 
Repeat every 3-5 minutes
P
IF Bradycardia due to Vagal Tone
Atropine, 0.02mg/kg IV/IO
(min dose 0.1mg, max 1mg)
may repeat ONCE
Consider Sedation Before Initiation of Pacing
Identify and Treat Underlying Cause
Patent Airway, Adequate Ventilations, 
SpO2 >93%
A Peds IV Access Protocol p104
Bradycardia With A Pulse - Peds
Peds Airway Management Protocol 
p90 No
12-Lead ECG Procedure
If Situation Allows p129
Cardiopulmonary 
Compromise
Support A-B-C’s, Give O2
Monitor Closely for Change No
Start Pediatric CPR p155
(C-A-B) if Heart Rate <60
Bradycardia 
Persists No
P Consider External Cardiac Pacing Procedure p158
Yes
At least 100 compressions per minute
15:2 Compressions:Breaths w/o airway
8-10 Breaths/min with advanced airway
Peds Cardiac Arrest Protocol p95
IF loss of pulses at any time
99
Pertinent Positives and Negatives
 Age (if known), Estimated Weight or Broselow
 Events Surrounding Rhythm Change
 Estimated Time of Events
 Past Medical History (if known)
Differential
 Hypoxemia, Hypovolemia, Hypotension, Acidosis
 Toxins, Tension Pneumo, Pericardial Tamponade
 Hypoglycemia, Sepsis
 Increased Intracranial Pressure (trauma, shunt, NAT)
Pearls
RECOMMENDED EXAM: Mental Status
 Cardiopulmonary Compromise defined as hypotension, altered mental status, signs of inadequate perfusion.
 Maintain patent airway throughout evaluation and treatment; assist breathing as necessary.
 Don’t delay treatment to get 12-lead ECG if patient is unstable.
Medical Protocols - Pediatric
Transport to PICU Capable Facility
Contact Medical Control As Necessary
P
Fentanyl 0.5-1mcg/kg IV/IO (max 100mcg) 
AND / OR
Midazolam 0.1mg IV/IO (max 5mg) OR 
Midazolam 0.2mg/kg IM/IN (max 10mg)
OR
Lorazepam 0.1mg/kg IV/IO/IM (max 2mg)
General Approach – Pediatric, Medical
Peds Cardiac Arrest Protocol p95
IF loss of pulses at any time
Yes
Transport to PICU Capable Facility
Contact Medical Control As Necessary
Improving
Yes
No
Transport to PICU Capable Facility
Contact Medical Control As Necessary
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Allergic Reaction - Peds
100
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Onset and Location of Symptoms
Differential
 Urticaria (Rash Only)
 Anaphylaxis (Systemic Effect)
 Shock (Vascular Effect)
 Angioedema
 Aspiration / Airway
Obstruction
 Vasovagal Event
 Asthma / COPD
 CHF
 Lung Sounds before AND after
intervention
 Allergen Exposure
 Toxic / Environmental Exposure
 Subjective throat “tightness” OR “closing”
Pearls
REQUIRED EXAM: VS, GCS, Skin, Cardivascular, Pulmonary
 Epinephrine Infusion: Mix 1mg (1:1,000) in 250mL NS. If worsening or refractory anaphylaxis, contact Med Control first. Start at 2mcg/min, titrate up.
 *if <40kg use saline bag procedure
 Famotidine dilution no longer required. Infuse over 2 minutes.
 In general, the shorter the time from allergen contact to start of symptoms, the more severe the reaction.
 Consider the Airway Management Protocol early in patients with Severe Allergic Reaction or subjective throat closing.
 Imminent Cardiac Arrest should be considered in patients with severe bradycardia, unresponsiveness, no palpable radial or brachial pulse.
 If parents have administered diphenhydramine (Benadryl) prior to EMS arrival, confirm medication given as well as dose.
Medical Protocols - Pediatric
Consider ALS if not already done 
Epi 0.15mg <30kg or-0.3mg >30kg IM (1:1000)
P
Albuterol 2.5mg/3mL Neb 
May repeat Q10min, Max 3
P
Methylprednisolone, 2mg/kg IV/IO
(max 125mg)
General Approach – Peds, Medical
P Epi Infusion 2-10mcg/min IV/IO
Allergic Reaction Anaphylaxis
Flushing, Hives, Itching, Erythema
Normal BP, No Respiratory Involvement
Multi System involvement or 
Hypotension, respiratory distress, AMS
Dyspnea, Wheezing, Chest Tightness, Vomiting or 
Abdominal Pain
Epi 0.15mg <30kg or-0.3mg >30kg IM (1:1000)
Improving
P
P
Famotidine 0.5mg/kg IV/IO 
If available (max 20mg)
Diphenhydramine 1mg/kg
IV/IM/IO/PO (max 50mg)
Monitor and Reassess
Document Response to Medications
Notify Receiving Facility,
Contact Medical Control As Necessary
No
Improving No
Yes
If suspected imminent arrest, 
Consider push dose Epi 1mcg/kg (max 20mcg) 
p190*
every 1-2 minutes SBP>100, MAP >65, or signs 
of improved perfusion
Consider Airway Management Protocol p90
12-Lead ECG Procedure p129
Consider Peds Shock/Hypotension (Non-Trauma) 
Protocol p110
Yes
A IV Access Protocol p104
A
Consider IVF bolus IV/IO, repeat as indicated 
for patient condition
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

P
A
M
General Approach – Peds, Medical
Pearls
REQUIRED EXAM: VS, GCS, Skin, Cardiovascular, Pulmonary
 Safety First – For Providers, Police and Patients! Never restrain any patients in the prone (face down) position.
 Physical and/or chemical restraints should ONLY be used if patient is deemed a danger to themselves or others and is uncooperative and less invasive measures to
deescalate have failed or were deemed unsafe to attempt.
 All patients who require chemical restraint MUST be continuously monitored by ALS Personnel.
 Patients who are actively fighting physical restraints are at high risk for Behavioral Emergencies and In-Custody Death; Have a low threshold to activate ALS for chemical
restraint.
 There are multiple possible causes of behavioral emergencies. Keep a broad differential when evaluating and treating these patients.
 Transport of patients requiring handcuffs or Law Enforcement (LE) restraint require LE to ride in the ambulance to the hospital – they have the keys!
 *Avoid Haloperidol in patients with known history of MAOI Antidepressant use (Phenelzine, Tranylcypromine) OR history of Parkinson’s Disease.
 If a patient with severe agitation suddenly becomes cooperative/quiet, reassess them quickly! Sudden Cardiac Death is common in this population.
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Provider Safety
Yes
No
Stage,
Call for Law Enforcement and/or Additional 
Resources
Evidence of 
Exposure / 
Toxidrome
No
Consider Overdose and Poisoning Protocol 
p54 Yes
Evidence of 
Head Injury
Head Injury, Peds Trauma Protocol 
p126 Yes Remove Patient from stressful environment, Use verbal calming techniques
Consider Restraints Procedure, As Appropriate 
p169
Blood Sugar Peds Diabetic Emergencies Protocol
p103 <70
Uncooperative 
AND Danger To Self 
or Others
No
Midazolam 0.1mg/kg IV/IO (max 5mg) OR 
Midazolam 0.2 mg/kg IM/IN (max 10mg) 
OR
Lorazepam 0.1mg/kg IV/IO/IM (Max 2mg)
>70 OR
Unobtainable
Due to Condition
No
M Contact Medical Control Patient
Refusing
Consider Need for ALS Level Service
EARLY
Consider Safety of ALL Responders including 
Law Enforcement
IV Access Protocol
(When Appropriate) p104
101
Behavioral Emergencies - Peds
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Situational Crisis
Differential
 EtOH Intoxication / Withdrawal
 Toxic Ingestion
 Substance Use / Abuse
 Schizophrenia
Medical Protocols - Pediatric
 Hypoglycemia
 Hypoxia
 Head Injury
 Occult Trauma
 Cerebral Hypoperfusion
 Psychiatric Illness / Medication History
 Medic Alert Bracelet, DM History
 Anxiety, Agitation or Confusion
 Suicidal / Homicidal Thoughts or History
 Evidence of Substance Use / Overdose
Yes
No
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Consider
Ketamine 2mg/kg IV/IO (max 200mg) or 
Ketamine 4mg/kg IM/IN (max 400mg)
Reassess. Follow Mental Status, SpO2, 
Respiratory Effort and Rate CLOSELY
Monitor for Laryngospasm
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Differential
 Hypoglycemia
 Hyponatremia
 Seizure
 Congenital Heart Defect
Pearls
REQUIRED EXAM: VS, GCS, Skin, Cardivascular, Pulmonary
 A Brief Resolved Unexplained Episode (BRUE) occurs in children <1 year of age and may be referred to as an “Apparent Life Threatening Episode (ALTE)” or “Near-miss SIDS”;
it is an episode that is frightening to the observer/caregiver and involves some combination of the following: Apnea, Color Change, Marked Change In Muscle Tone, and 
Choking or Gagging.
 The incidence of BRUE was found to be 7.5% in one studied out-of-hospital infant population
The overwhelming majority of BRUE patients (83%) appeared to be in no apparent distress by EMS assessment
Nearly half of the patients assessed by EMS to be in no apparent distress (48%) were later found to have significant illness upon ED evaluation
 This is why the history of a BRUE must always result in transport to an emergency department regardless of the infant’s appearance at the time of EMS assessment
 If the parent or guardian is refusing EMS transport, OLMC must be contacted prior to executing a refusal. Be supportive of parents as they may feel embarrassed for calling 
when the child now appears well.
 Always have a high index of suspicion for Non-Accidental Trauma (NAT). It affects all ethnicities, socioeconomic statuses and family types.
Brief Resolved Unresponsive Episode (BRUE) - Peds
General Approach – Peds, Medical
(<12 months of Age)
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Skin 
Choking OR 
Gagging
Muscle Tone
Blood Glucose
Continuous Cardiac Monitor
Diabetic Emergencies, Peds 
Protocol p103
Outside of Age
appropriate
Go To Appropriate Cardiac 
Dyshrhythmia, Peds Protocol Abnormal
Consider Airway Management, 
Peds Protocol p90 Cyanotic Consider Allergic Reaction, Peds Protocol p100 Hives, Rash
Normal
Normal
Consider Airway Management, 
Peds Protocol p90 Yes
No
Consider Seizure, Peds Protocol 
p109
Increased, 
Shaking, 
rhythmic movements
OR gaze
Signs or 
Symptoms of 
Illness
Go To Appropriate Medical, Peds 
Protocol Yes
Normal
Go To Appropriate TRAUMA, Peds 
Protocol
Suspect Non-Accidental
Trauma
No
No Parents Refusing Yes M Contact Medical Control
102
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 Events Leading up to 9-1-1
 Non-Accidental Trauma
 Inborn Error of Metabolism
 Periodic Apnea
 Reflux
 Pregnancy History
 Complications During Pregnancy/Delivery
 Mother’s GBS Status at Delivery
 Color, Tone and Appearance During Event
Medical Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
A
B
Diabetic Emergencies - Peds
General Approach – Peds, Medical
Mental Status Age-Defined 
Hypotension
Age appropriate
Hypoglycemia
Age appropriate
Hyperglycemia
oral glucose 15g PO 
One time or appropriate PO 
intake
Glucagon IM 
0.5mg if <25kgs; 1mg if >25kgs
One Time
A
Awake
Protecting Airway
Altered AND/OR
Compromised Gag
Consider Peds IV Access 
Protocol p104
Yes
Clinically 
Dehydrated
No
Go To Appropriate Peds Medical 
Protocol
No
Go To Appropriate Peds Medical 
Protocol
A
Peds IV Access Protocol 
p104
Normal Mental 
Status
Age Appropriate 
Hyperglycemia
No
Yes
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Full Assessment
Evaluate for Secondary 
Complaint
Go To Appropriate Peds Medical 
Protocol
Issue
Discovered
None
Parent/Guardian
Declines Accepts M Contact Medical Control
Age appropriate
Hypoglycemia
Recommend 
Transport
Blood Glucose
Age Appropriate Normal 
Repeat Blood 
Glucose within 10 
minutes
Consider Normal Saline Bolus
Yes
103
Pertinent Positives/Negatives:
 Age, VS, Blood Glucose Reading
 SAMPLE History
 OPQRST History
 Last Meal, History of Skipped Meal
 Diaphoresis
 Siezures
 Abnormal Respiratory Rate
 History of DKA
Differential
 Toxic Ingestion
 Head Injury
 Sepsis
 Stroke/TIA
 Seizure
 EtOH Abuse/Withdrawal
 Drug Abuse/Withdrawal
Pearls
REQUIRED EXAM: VS, SpO2, Blood Glucose, Skin, Respiratory Rate and Effort, Neuro Exam
 Do NOT administer oral glucose to patients that can’t swallow or adequately protect their airway.
 Do NOT give Bicarb to patients with hyperglycemia suspected to be in DKA – This has been proven to result in WORSE outcomes for the patients.
 Prolonged hypoglycemia may not respond to Glucagon; be prepared to start an IV and administer IV Dextrose.
 Infants and patients with congenital liver diseases may not respond to Glucagon due to poor liver glycogen stores.
 Patients on oral diabetes medications are at a very high risk of recurrent hypoglycemia and should be transported. Contact Medical Control for advice/patient counseling if 
patient is refusing. See Refusal after Hypoglycemia Treatment Protocol for additional information as necessary.
 Always consider intentional insulin overdose, and ask patients / family / friends / witnesses about suicidal ideation, comments or gestures.
Medical Protocols - Pediatric
Consider Shock / Hypotension 
(Non Trauma) Protocol p109
Dextrose Dosing:
D10W 125mL IV/IO OR
Titrate to effect
Pediatric Hypoglycemic ranges
0-23 hours: <40
 24 hours-30 days: <50
31 days-5 years: <60
>6 YO <70
Go To Appropriate Peds Medical 
Protocol
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

IV Access - Peds
General Approach – Peds, Medical
Notify Receiving Facility,
Contact Medical Control As 
Necessary
M Contact Medical Control
First Access For 
Cardiac Arrest A
Go To Intraosseous Venous Access 
Procedure p178
Emergent OR 
Potentially Emergent 
Medical OR Traumatic 
Condition
Consider IN/IM/PO Medications As 
Appropriate for Condition No
No
A
Go To Extremity Venous Access 
Procedure p177
A
Go To Intraosseous Venous Access 
Procedure p178
(Life Threatening Event)
Yes
Unsuccessful/
Peripherally Exhausted
Success in <3 
Total Attempts
Monitor Access Site for Swelling, 
Pain, Redness, Evidence of 
Extravasation
Yes
A Monitor Infusion of IV Fluids
Life Threatening 
Condition
No
Yes No
Go To Appropriate Peds Medical 
Protocol A Successful Consider Second IV Access Site for Critical Medical / Trauma Patients
Yes
104
Pearls
 In the setting of CARDIAC ARREST ONLY, any preexisting dialysis shunt or central line may be used by EMS for fluid and medication administration.
 For patients who are hemodynamically unstable or in extremis, Medical Control MUST be contacted prior to accessing any preexisting catheters.
 Upper extremity sites are preferred over Lower Extremity sites. Lower Extremity Ivs are discouraged in patients with peripheral vascular disease or diabetes.
 In patients with hemodialysis catheters, avoid IV attempts, blood draws, injections or blood pressures in the extremity on the affected side.
 Saline Locks are acceptable in cases where access may be necessary but the patient is not volume depleted; having an IV does not mandate IV Fluid infusion.
 The preferred order of IV Access is: Peripheral IV, Intraosseous IV, IN/IM access UNLESS medical acuity or situation dictate otherwise.
 Remember: Proximal Humerus IO is contraindicated in patients <18 years old.
Medical Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Consider Peds Airway Management 
Protocol p90
12 Lead ECG Procedure
p129
A
Peds IV Access Protocol
p104
A
Consider IVF bolus IV/IO, repeat as 
indicated for patient condition
Overdose and Poisoning, General - Peds
105
Pearls
REQUIRED EXAM: VS, GCS, Mental Status, Skin, Blood Glucose
 Patients are unreliable historians in overdose situations, particularly in suicide attempts. Trust what they tell you, but verify (pill bottles, circumstances, etc.)
 Critical Scene Information: Time of Ingestion, Number and Type of meds ingested, Seizure or mental status changes; Please consider bringing pill bottles, contents, emesis and
reliable contact info to the ED; this will be important in patient evaluation and assessment
 Be careful of off-gassing in cases of inhalation of volatile agents
 Many intentional overdoses involve multiple substances, some with cardiac toxicity; a 12-Lead ECG should be obtained on all overdoses situation permitting
 Contact Poison Control for all non-opiate overdoses: 1-800-222-1222
 SLUDGEM – Salivation, Lacrimation, Urination, Defecation, GI Upset, Emesis, Miosis 
 DUMBBELLS – Diarrhea, Urination, Miosis/Muscle Weakness, Bronchorrhea, Bradycardia, Emesis, Lacrimation, Lethargy, Salivation/Sweating
Medical Protocols - Pediatric
Carbon Monoxide/Cyanide 
Assess for specific 
ingestions/exposures
p105
General Approach – Adult, Medical
Hazmat Scene Call For Additional Resources, Stage Until 
Safe
Peds Diabetic Emergencies Protocol 
p103
Assess Mental 
Status & Airway
Yes
No
Awake,
Protecting Airway
Blood Sugar
Age Appropriate Normal/
Hyperglycemia
Arrhythmia /
STEMI
Age 
Appropriate
Hypoglycemia
Altered/respiratory 
depression
If suspected opioid overdose, 
Naloxone 0.4-2.0mg IN/IV/IO/IM
Consider Defib Pad Placement
Organophosphte/Cholinergic
Consider ALS Early
Go To Appropriate Arrhythmia Protocol
Organophosphate OD Protocol, ADULT 
p56
Cyanide OR Carbon Monoxide Poisoning 
Protocol, ADULT p57
Notify Receiving Facility,
Contact Medical Control As Necessary
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Overdose and Poisoning, Reference - Peds
106
Medical Protocols - Pediatric
Beta Blocker Overdose
Clinical Features: 
Cardiovascular – hypotension, bradycardia, AV block
Pulmonary – bronchospasm, wheezing
Metabolic – Hypoglycemia, Hyperkalemia
Neuro – Stupor
Common Beta Blockers -
Metoprolol (Lopressor, Toprol-XL) Propanolol (Inderal LA, InnoPran XL)
Atenolol (Tenormin) Sotalol
Labetalol Carvedilol (Coreg)
-------------------------------------------------------------------------------------
Many beta blocker ingestions do not cause symptoms; exceptions are the 
elderly, poor cardiac/respiratory reserve, and coingestions with other cardiac 
medications
Calcium Channel Blocker Overdose
Clinical Features:
Cardiovasccular – hypotension, bradycardia, shock
Pulmonary – pulmonary edema, rales, crackles
Metabolic – Hyperglycemia (can be a marker of severity)
Neuro – Seizures, myoclonus, dizziness, syncope
GI – Nausea and vomiting
Common Calcium Channel Blockers -
Amlodipine (Norvasc)
Diltiazem (Cardizem, Tiazac)
Nicardipine
Nifedipine (Procardia)
Verapamil (Calan, Verelan)
---------------------------------------------------------------------------------------
Sustained release preparations may have delayed onset of toxic symptoms (up 
to 12 hours)
Overdoses with Calcium Channel Blockers have a high mortality!! Electrical 
conduction abnormalities, vasodilation, myocardial depression are severe
Cocaine or Sympathomimetic Overdose
Clinical Features:
Hypertension, Tachycardia, Agitation, Seizure, Dilated Pupils
Common Sympathomimetics -
Cocaine Pseudoephedrine
Ephedrine Methamphetamine
Phenylephrine Amphetamines
Terbutaline
---------------------------------------------------------------------------------------
Patients on MAOIs for depression may have symptoms of a Sympathomimetic 
Overdose after eating certain foods such as aged cheese, beer, mushrooms
Patients with Cocaine or Sympathomimetic Overdose are at high risk of 
Arrhythmias, Myocardial Infarction and Stroke
Sympathomimetics are drugs that mimic the effects of the sympathetic 
nervous system
TCA Overdose
Clinical Features: 
Neuro – AMS, seizures
Cardiovascular – Hypotension, arrhytmias, wide QRS interval
Common Tricyclic Antidepressants:
Amitriptyline
Clomipramine
Doxepin
Imipramine
Nortryptyline
Protriptyline
Opioid Overdose
Clinical Features:
Cardiovascular – hyptension
Pulmonary – respiratory depression
Neuro – AMS, pin point pupils 
Common Opioid Medications:
Oxycodone (Percocet, Oxycontin, MS Contin)
Hydrocodone (Vicodin, Norco, Vicoprofen)
Morpine
Heroin
Dilaudid
Fentanyl
Codeine (T3)
Methadone
P
P
If QRS >0.12ms, Sodium Bicarb 1mEq/kg IV/IO slow push
May repeat every 5 minutes until narrowing of QRS
P
Consider Calcium Chloride 20mg/kg IV/IO (max 1gm)
Consider Glucagon 2mg IV/IO, if available for hypotension, 
may repeat if available
Manage symptoms of Bradycardia per Protocol p99
P
Consider Glucagon 2mg IV/IO may repat if available
Manage symptoms of Bradycardia per Protocol p99
Naloxone 0.4-2.0mg IN/IV/IO/IM
Antipsychotic/Acute Dystonic Reaction 
Clinical Features:
Dystonia refers to sustained muscle contractions, frequently causing twisting, 
repetitive movements or postures, and may affect any part of the body
Common -
Antipsychotics – i.e. Haldol, Prolixin, Thorazine
Antiemetics – i.e. prochlorperazine, metaclopramide
Antidepressants – i.e. buspirone, sumitriptan
Antibiotics – i.e. erythromycin
Anticonvulsants – i.e. carbamazepine, vigabatrin
H2 Receptor Blockers – i.e. ranitadine, cimetidine
Recreational Drugs – i.e. cocaine
---------------------------------------------------------------------------------------
Acute dystonic reactions are extrapyramidal side effects of antipsychotic and 
certain other medications. 90% occur within 5 days of starting a new med
P
Diphenhydramine 1mg/kg IV/IO/IM/PO (max 50mg)
If not improving, consider
Midazolam 0.1mg/kg IV/IO (max 5mg) -ORMidazolam 0.2mg/kg IM/IN (max 10mg)
Midazolam 0.1mg/kg IV/IO (max 5mg) -ORMidazolam 0.2mg/kg IM/IN (max 10mg) -ORLorazepam 0.1mg/kg IV/IO/IM (max 2mg) 
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
Peds IV Access Protocol
p104
A
Consider **Ketorolac 0.5mg/kg IV (max 15mg) 
OR 
**Ketorolac 1.0mg/kg IM (max 30mg)
P
Consider Fentanyl 0.5 -1mcg/kg IV/IO/IM 
(max 100mcg)
May repeat every 15 minutes (max 3 doses)
Pain Management - Peds
107
Differential
 Head injury
 Spine Injury
 Compartment Syndrome
 Fracture, Sprain, Strain
 Pneumo/hemo-thorax
 Pericardial effusion
 Aortic Dissection
 Internal organ injury
Pertinent Positives and Negatives
 Age, VS, GCS
 SAMPLE History
 OPQRST History
 History of chronic pain
Pearls
REQUIRED EXAM: Vital Signs, GCS, Neuro Exam, Lung Sounds, Abdominal Exam, Musculoskeletal Exam, Area of Pain
 Provider Discretion to be used for patients suffering from chronic pain related issues. Please note that history of chronic pain does not preclude the patient
from treatment of acute pain related etiologies. 
 Pain severity (0-10) is a vital sign to be recorded pre- and post-medication delivery and at disposition.
 As with all medical interventions, assess and document change in patient condition pre- and post-treatment.
 Opiate naive patients can have a much more dramatic response to medications than expected; start low and titrate up as appropriate.
 Allow for position of maximum comfort as situation allows.
 Acetaminophen and/or Ibuprofen if not contraindicated may be considered for analgesic benefit in fever.
 **Ketorolac is contraindicated in: <2 years old, pregnancy, anticoagulation or bleeding diatheses, anticipated surgery, NSAID use (including EMS
administered ibuprofen), GI bleeding, possible intracranial hemorrhage, known renal disease. Extreme caution in females of reproductive age and
potential renal insufficiency.
 *Oral medications are contraindicated in anyone who may need an emergent surgery or procedure; “if in doubt, don’t give PO”.
Medical Protocols - Pediatric
General Approach – Peds Medical OR 
Trauma
Assess Pain
0-10 Pain Scale
Moderate / Severe Pain
(5-10)
Place patient on cardiac monitor, continuous SpO2 
and EtCO2
P
Consider IN Fentanyl 2mcg/kg (max 50mcg per 
naris)
B
Consider Acetaminophen PO* 15mg/kg (max 
1000mg)
B
Consider Ibuprofen PO*
10mg/kg, Max 400mg
None – Mild Pain
(0-4)
P
Consider Ketamine 0.25mg/kg IV/IO 
(max 25mg) 
May repeat every 15 minutes (max 3 doses)
A
Consider NITROUS Procedure
p182
Worsening
Improved
Document response to meds, VS 
(HR, BP, SpO2, EtCO2)
Continue with Peds Specific Protocol
A
Consider Ondansetron 0.15 mg/kg IV/IO/ODT/
IM (max 4mg)
Notify Receiving Facility,
Contact Medical Control As Necessary
Reassess Pain
0-10 Pain Scale
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Refusal Protocol - Peds
General Approach – Peds, Medical
q Document assessment including mental status, physical exam, full set of vital (including BP, HR, RR, Pulse Ox – preferably at least two sets to help 
identify trends or abnormalities), blood glucose and SpO2
q Assure that the patient/parent/guardian understands the possible consequences of refusal
q Complete documentation of refusal and obtain signatures
Parent or Legal Guardian is Present
Parent/Guardian Condition:
q Altered mental status
q Impaired decision making ability
q Hallucinations or thought disorder
q Incapacitated or intoxicated
q Expresses Suicidal or Homicidal Ideation
q Vital Sign or Physical Exam abnormalities
q Reasonable concern that the parent/guardian decision poses a 
threat to the minor
q Advanced Life Support measures initiated and parent/guardian 
refusing
Yes
No
No
Transport Required Under Implied Consent
OR
Police Protective Custody
Transport Required Under Implied Consent
OR
Police Protective Custody
Contact On-Line Medical Control as necessary
Transport Required Under Implied Consent
OR
Police Protective Custody
Contact On-Line Medical Control as necessary
No
Yes
Yes
108
Pertinent Positives and Negatives
 Age, VS, BP, RR, SpO2
 SAMPLE history
 OPQRST history
 Mental Status
 Pale, Cool Skin
 Delayed Cap Refill
Differential
 Cardiac Dysrhythmia
 Hypoglycemia
 Overdose
 Toxidrome
 Sepsis
 Occult Trauma
 Adrenal Insufficiency
Pearls
REQUIRED EXAM: VS, GCS, Nature of Complaint
 *Incapacitated definition: A person who, because of alcohol or drug consumption or withdrawal, is unconscious or whose judgment is impaired such that they are incapable 
of making rational decisions as evidenced by extreme physical debilitation, physical harm or threats of harm to themselves, others or property. 
o Evidence of incapacitation include but are not limited to: inability to stand on one’s own, staggering, falling, wobbling, vomit/urination/defecation on clothing, inability 
to understand and respond to questions, DTs, unconsciousness, walking or sleeping where subject to danger, hostile toward others.
 **Intoxicated definition: A person whose mental or physical functioning is substantially impaired as a result of the use of alcohol or drug consumption or withdrawal.
 If there is ANY question, do not hesitate to involve Law Enforcement to ensure the best decisions are being made on behalf of the patient. 
 Infants and Neonates are higher risk refusals due to difficulty with assessments and may appear well, consider OLMC and low threshold for transporting. 
Medical Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

M
Loosen Constrictive Clothing
Protect Patient from Injury
A
P
Midazolam 0.1mg/kg IV/IO (max 5mg) OR 
Midazolam 0.2mg/kg IM/IN (max 10mg)
Loosen Constrictive Clothing
Protect Patient from Injury
A
Peds IV Access Protocol
p104
Peds IV Access Protocol
p104
Seizure - Peds
General Approach – Peds, Medical
Environmental 
Cause or Toxic 
Exposure
Notify Comm Center and Hazmat Team
Ensure Responder and Public Safety
Go To Hazmat, General Protocol
p79 No
Yes
Consider ALS Early
Prolonged Seizures Are BAD for Neurologic Outcomes!
Subtle Indications of Peds Seizure:
Persistent Gaze Deviation, Jaw Clenching, Rhythmic 
Mouth Movements, Focal Stiffening or Rhythmic 
Twitching of Extremity
Steady HR Despite Moving or Crying
109
Pertinent Positives and Negatives
 Age, VS, GCS, SpO2, Blood Sugar
 SAMPLE History
 OPQRST History
 Seizure History, Med Compliance
Differential
 Hypoxia
 Hypoglycemia
 Electrolyte Imbalance
 Eclampsia
 Drugs, EtOH Abuse
 Drugs, EtOH Withdrawal
 Occult Head Injury
 Non-Accidental Trauma
 Syncope
 Bowel or Bladder Incontinence
 Tongue Biting
 Recent Fever History
 Evidence of Head Trauma
 Number of Seizures and Duration
Pearls
REQUIRED EXAM: Blood Sugar, SpO2, GCS, Neuro Exam
 Consider antipyretic treatment in setting of suspected Febrile seizure and patient has returned to baseline mental status.
 Midazolam is effective in terminating seizures. Do not delay IM/IN administration to obtain IV access in an actively seizing patient.
 Do not hesitate to treat recurrent, prolonged (>1 minute) seizure activity. Have a low threshold to give IN Midazolam rather than spend time on IV Access.
 Status epilepticus is a seizure lasting greater than 5 minutes OR >2 successive seizures without recovery of consciousness in between. These patients require airway 
management and rapid transport to the most appropriate Pediatric ICU Capable facility.
 Assess for possibility of occult trauma, substance abuse.
 Active seizure in known or suspected pregnancy >20 weeks, give Magnesium 4gm IV/IO over 2-3 minutes.
 Some children may be on a Ketogenic Diet Goal of Blood Sugar <50 to manage seizures, consider contacting Medical Control.
Medical Protocols - Pediatric
Peds Diabetic Emergencies Protocol 
p103
Consider Peds Airway Management 
Protocol p90
Monitor and Reassess
Recurrent or 
Unbroken Seizure P
Lorazepam 0.1 mg/kg IV/IO/IM (max 2mg)
OR
Midazolam 0.1mg/kg IV/IO (max 5mg) OR
Midazolam 0.2mg/kg IM/IN (max 10mg)
Age Appropriate 
High
No Yes
Age Appropriate 
Low
Normal for Age Normal for Age
Notify Receiving Facility,
Contact Medical Control As Necessary No
Yes
Yes
No
Blood Glucose Blood Glucose
Contact Medical Control for Additional 
Meds As Necessary
Actively Seizing on 
EMS Arrival
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Recurrent or 
Unbroken Seizure
Recurrent or 
Unbroken Seizure Yes
Monitor and Reassess
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

P
Epinephrine 0.1-0.5mcg/kg/min IV/IO
Titrate to Age Defined Minimum BP
-ORP
M
Contact Medical Control for Additional 
Meds As Necessary
A
Consider IVF bolus IV/IO, repeat as 
indicated for patient condition
Blood Glucose
12 Lead ECG Procedure p129
Hypotension / Shock - Peds
General Approach – Peds, Medical
A Peds IV Access Protocol p104
Peds Diabetic Emergencies
Protocol p103
Go To Appropriate Peds Cardiac 
Dyshrhythmia Protocol
Consider Peds Airway Management 
Protocol p90
History, Exam, Circumstances
Suggest Etiology of Shock?
Peds Hemorrhage Control, Trauma 
Protocol p127
Hypovolemic
(Dehydration, Hemorrhage)
Distributive
(Sepsis)
Cardiogenic
(CHF, Congenital Heart Defect)
Obstructive
(PE, Tamponade)
Repeat and Document BP
Outside Age
Appropriate
Arrhythmia/
STEMI
Trauma
Medical
Notify Receiving Facility,
Contact Medical Control As Necessary
Yes
SBP <70 + (2xage)
Improved
110
Pertinent Positives and Negatives
 Age, VS, BP, RR, SpO2
 SAMPLE history
 OPQRST history
 Source of blood loss, if any (GI, vaginal, AAA, ectopic)
 Source of fluid loss, if any (vomiting, diarrhea, fever)
 Pregnancy history
Differential
 Cardiac Dysrhythmia
 Hypoglycemia
 Ectopic Pregnancy
 AAA
 Sepsis
 Occult Trauma
 Adrenal Insufficiency
 Mental Status
 Pale, Cool Skin
 Delayed Cap Refill
 Coffee Ground Emesis
 Tarry Stools
 Allergen Exposure
Pearls
REQUIRED EXAM: VS, GCS, RR, Lung sounds, JVD
 Shock may present with initially normal VS and progress insidiously; follow frequent blood pressures, particularly if the patient “looks sicker than Vital Signs”
 *if <40kg use saline bag procedure
 Tachycardia may be the first and only sign of shock in the pediatric population; remember – Peds patients compensate to a point, then crash quickly
 If evidence or suspicion of trauma (accidental OR non-accidental), move to Hypotension/Shock (Trauma) Protocol early
 Hypotension is a LATE finding in pediatric patients, and is an ominous sign that they are losing their ability to compensate
Medical Protocols - Pediatric
Acute Adrenal Insufficiency
State where the body cannot produce enough 
steroids. Primary adrenal disease vs. recent 
discontinuation of steroids (Prednisone) after 
long term use. 
M
Methylprednisone 2mg/kg IV/IO 
(max 125mg)
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
No If suspected imminent arrest, 
Consider push dose Epi 1mcg/kg 
(max 20mcg) p190*
every 1-2 minutes SBP>100, MAP >65, or 
signs of improved perfusion
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Sickle Cell Crisis - Peds
Supplemental O2 at 2LPM NC
Titrate Up As Appropriate
Warm Blanket if available
111
Differential
 Dehydration
 Sepsis
 Pneumonia
 Fracture, Sprain, Strain
 Vaso-Occlusive Crisis
 Acute Chest Syndrome
 Splenic Sequestration
 Acute Stroke
Pertinent Positives and Negatives
 Age, VS, GCS
 SAMPLE History
 OPQRST History
 History of chronic pain
 History of Sickle Cell Anemia
 Signs of Infection
 Hypoxia
 Dehydration
 Painful Joint(s)
Pearls
REQUIRED EXAM: Vital Signs, GCS, Neuro Exam, Lung Sounds, Abdominal Exam, Musculoskeletal Exam, Area of Pain
 Provider Discretion to be used for patients suffering from chronic pain related issues. Please note that history of chronic pain does not preclude the patient
from treatment of acute pain related etiologies. 
 Pain severity (0-10) is a vital sign to be recorded pre- and post-medication delivery and at disposition.
 Sickle Cell Anemia is a chronic hemolytic anemia occurring almost exclusively in African Americans; pain crises result from the occlusion of blood vessels by 
masses of misshapen blood cells during times of crisis.
 Sickle Pain Crises occur typically in the joints and back. Liver, Pulmonary and CNS involvement can present with RUQ pain, hypoxia or stroke.
 Patients with sickle cell disease have a high incidence of life-threatening conditions at a very young age.
 Remember: sickle cell patients live with pain every day, and frequently use distraction techniques to cope. Just because a sickle cell patient does not show
classic signs of acute pain or are using a distraction device (like phones) does not mean they are not in pain.
Medical Protocols - Pediatric
A
Peds IV Access Protocol
p104
A
Consider **Ketorolac 0.5mg/kg IV (max 15mg) 
OR 
**Ketorolac 1.0mg/kg IM (max 30mg)
P
Consider Fentanyl 0.5 -1mcg/kg IV/IO/IM 
(max 100mcg)
May repeat every 15 minutes (max 3 doses)
General Approach – Peds Medical
Assess Pain
0-10 Pain Scale
Moderate / Severe Pain
(5-10)
Place patient on cardiac monitor, continuous SpO2 
and EtCO2
P
Consider Fentanyl 2mcg/kg IN
(max 50mcg per naris)
A
Consider Acetaminophen PO* 15mg/kg (max 
1000mg)
A
Consider Ibuprofen PO*
10mg/kg, Max 400mg
None – Mild Pain
(0-4)
P
Consider Ketamine 0.25mg/kg IV/IO 
(max 25mg) 
May repeat every 15 minutes (max 3 doses)
Worsening
Improved
Document response to meds, VS 
(HR, BP, SpO2, EtCO2)
A
Consider Ondansetron 0.15 mg/kg IV/IO/ODT/
IM (max 4mg)
Notify Receiving Facility,
Contact Medical Control As Necessary
Reassess Pain
0-10 Pain Scale
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Syncope / Near- Syncope - Peds
112
Pertinent Positives and Negatives
 Age, VS, SpO2, EtCO2, RR
 SAMPLE history
 OPQRST history
 History of DM, medic alert bracelet
Differential
 Head Injury
 Electrolyte Abnormality
 Psychiatric Disorder
 Cardiac Dysrhythmia
 DM, CVA, Seizure, Tox
 Sepsis
 Hypothermia
 Hypothyroidism
 Pulmonary
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
General Approach – Adult, Medical
Blood Glucose p152
12 Lead ECG Procedure p129
Peds Diabetic Emergencies
Protocol p103
Go To Appropriate Cardiac 
Dyshrhythmia or STEMI Protocol
<70 or >250
Abnormal
12-Lead Normal,
Blood Glucose >70 and <250
Suspected Stroke Protocol, ADULT 
p64
Notify Receiving Facility,
Contact Medical Control As Necessary
Positive
Negative
Pearls
REQUIRED EXAM: VS, GCS, Head, Neck, Blood Glucose
• Pay special attention to head and neck exam for bruising or signs of injury.
• Syncope/Altered Mental Status may be the presenting sign of environmental hazards / toxins. Protect yourself and other providers / community if concern. Involve 
Hazmat early.
• Safer to assume hypoglycemia if doubt exists. Recheck blood sugar after dextrose/oral glucose administration and reassess.
• Do not let EtOH fool you! Alcoholics frequently develop hypoglycemia, Alcoholic Ketoacidosis (AKA) and often hide traumatic injuries!
BE-FAST procedure p165
A Peds IV Access Protocol p104
A
Consider IVF bolus IV/IO, repeat as 
indicated for patient condition
Consider causes of presyncope/impending arrest syndrome:
 Acute coranary syndrome (ACS) : look for evidence of ischemia
 Tachydysrhythmias
 Bradydysrythmias and heart bloks
 Wolff-Parkinson-White (WPW): look for short PR, prolonged QRS and a delta wave
 Brugada Syndrome: look for rugada sin with coved ST segment elevation >2mm in >1 V1-V3 followed by a negative T Wave
 Hypertrophic Cardiomyopaathy (HCM): look for evidence of left ventricular hypertrophy with deep narrow “dagger like” Q waves in lateral and inferior leads, may also have 
left atrial enlargement
 Long or short QT-intervals: look for a QTc <300 or >450
 Arrythmogenic Right Ventricular Dysplasia (ARVD): look for epsilon waves +/- T wave inversions in V1-V3
 Miscellanous: PE, right sided heart strain, electrolyte abnormalities, ICH, etc.
Medical Protocols -Peds
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Quick Reference Page – Peds (<18 y/o)
Trauma Protocols - Pediatric
113
Lbs. Kgs. Lbs. Kgs.
Wisconsin EMSC Recommended Weight Conversion
(2.2lbs = 1kg -OR- 1lb = 0.45kg)
Lbs. Kgs.
5 lbs 2 kgs 20 lbs 9 kgs 35 lbs 16 kgs
6 3 21 10 36 16
7 3 22 10 37 17
8 4 23 10 38 17
9 4 24 11 39 18
10 lbs 5 kgs 25 lbs 11 kgs 40 lbs 18 kgs
11 5 26 12 41 19
12 5 27 12 42 19
13 6 28 13 43 20
14 6 29 13 44 20
15 lbs 7 kgs 30 lbs 14 kgs 45 lbs 20 kgs
16 7 31 14 46 21
17 8 32 15 47 21
18 8 33 15 48 22
19 9 34 15
www.chawisconsin.org
49 22
50 lbs 23 kgs
Normal Vital Signs In Children
Heart Rate (Beats Per Minute)
Respiratory Rate 
(Breaths Per Minute)
Age Systolic Blood Pressure
Newborn
Infant (1-12mos)
Toddler (1-2yrs)
Preschool (3-5yrs)
School Age (6-12yrs)
Adolescent (13-17yrs)
Awake Rate Sleeping Rate
100-180 80-160
100-170 75-160
80-150 60-90
70-130 60-90
65-120 60-90
55-90 50-90
30-60
30-60
24-40
20-34
15-30
12-20
60-90
87-105
85-102
89-108
94-120
107-132
Modified Glasgow Coma Scale for Infants and Children
Child Score
Eye Opening
Infant
Spontaneous
To Speech
To Pain
None
Spontaneous
To Speech
To Pain
None
4
3
2
1
Best Verbal 
Response
Coos and Babbles
Irritable, Cries
Cries in Response to Pain
Moans in Response to Pain
None
Oriented, Appropriate
Confused
Inappropriate Words
Incomprehensible Sounds
None
5
4
3
2
1
Best Motor 
Response
Obeys Commands
Localizes Painful Stimulus
Withdraws in Response to Pain
Flexion in Response to Pain
Extension in Response to Pain
None
Moves Spontaneously and Purposely
Withdraws in Reponse to Touch
Withdraws in Response to Pain
Abnormal Flexion Posture to Pain
Abnormal Extension Posture to Pain
None
6
5
4
3
2
1
Equipment
Resuscitation Bag
Oxygen Mask
(NRB)
Oral Airway
(mm)
Laryngoscope Blade 
(Size)
Endotracheal Tube
(mm)
King Airway
LMA
Suction Catheter
(French)
BP Cuff
IV Catheter (ga)
IO (ga)
GRAY
3-5kg
Size 0 (Clear)
NA
Neonatal #5/
Infant
PINK
Small Infant
6-7kg
Infant/Child
Pediatric
50
1 Straight
3.5 Uncuffed
3.0 Cuffed
Size 1 (White)
#1
8
Infant/Child
22-24
18/15
RED
Infant
6-9kg
Infant/Child
Pediatric
50
1 Straight
3.5 Uncuffed
3.0 Cuffed
Size 1 (White)
#1
8
Infant/Child
22-24
18/15
PURPLE
Toddler
10-11kg
Child
Pediatric
60
1 Straight
4.0 Uncuffed
3.5 Cuffed
Size 1 (White)
#1.5
10
Child
20-24
15
YELLOW
Small Child
12-14kg
Child
Pediatric
60
2 Straight
4.5 Uncuffed
4.0 Cuffed
Size 2 (Green)
#2
10
Child
18-22
15
WHITE
Child
15-18kg
Child
Pediatric
60
2 Straight
5.0 Uncuffed
4.5 Cuffed
Size 2 (Green)
#2.5
10
Child
18-22
15
BLUE
Child
19-23kg
Child
Pediatric
70
2 Straight
OR Curved
5.5 Uncuffed
5.0 Cuffed
Size 2.5 
(Orange)
#3
10
Child
18-20
15
ORANGE
Large Child
24-29kg
Child
Pediatric
80
2 Straight
OR Curved
6.0 Cuffed
Size 3 
(Yellow)
#3.5
10
Child
18-20
15
GREEN
Adult
30-36kg
Adult
Pediatric/
Adult
80
3 Straight
OR Curved
6.5 Cuffed
Size 3
(Yellow)
#4
10-12
Small Adult
16-20
15
NG Tube (French) 5-8 5-8 8-10 10 10 12-14 14-18 16-18
Weight (kg)
2-3
4-10
10-14
14-18
20-42
>50
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Measure Vital Signs and Level of Consciousness 
Glasgow Coma Scale ≤13
Systolic blood pressure (mmHg) <70 + (age in years x 2)mmHG
Respiratory rate <10bpm or >upper normal (p113) 
 OR need for ventilation support
Assess Anatomy of Injury
Transport to Level 1 Pediatric Trauma 
Center;
Notify via Radio as early as possible
 Penetrating Injury to head, neck, torso, extremities proximal to knee
 Chest wall instability or deformity
 ≥2 proximal long bone fractures
 Crushed, degloved, or mangled extremity
 Amputation proximal to wrist or ankle
 Pelvic fracture
 Open or depressed skull fracture
 Paralysis
Assess Mechanism of injury and evidence of High Energy Impact
 Falls > 10 ft or twice the height of the child
 High Risk Auto Crash
 Auto vs. Pedestrian/Bicyclist thrown, run over or significant (>20 mph) 
impact
 Motorcycle crash >20 mph
Step One
Step Two
Step Three
ANY ‘Yes’
ALL
‘No’
Transport to closest appropriate PICUCapable, Leveled Trauma Center
ALL
‘No’
Assess Special Patient or System Considerations
 Age <1 year
 Anticoagulation AND/OR history of bleeding disorder(s)
 Burns
- without other trauma, transport to Burn Facility
- with traumatic mechanism, transport to trauma center
 End Stage Renal Disease requiring Hemodialysis
 Pregnancy ≥20 weeks
 EMS provider judgment
Contact Medical Control; Consider 
Pediatric Trauma Center or Specialty 
Resource Center
Step Four
Transport according to Appropriate Trauma Protocol
Appearance
Tone
Interactiveness
Consolability
Look/Gaze
Speech/Cry
Work of Breathing
Abnormal Breath Sounds
Retractions
Nasal Flaring
Circulation to the Skin
Pallor
Mottling
Cyanosis
Any Airway Compromise not 
able to be managed by EMS 
should be taken to the CLOSEST 
FACILITY for stabilization 
immediately
114
Destination Determination – Peds (<18 y/o)
Trauma Protocols - Pediatric
https://www.dhs.wisconsin.gov/publications/p0/p00730.pdf
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
ANY ‘Yes’
ANY ‘Yes’
ANY ‘Yes’
ALL
‘No’
ALL
‘No’
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

115
General Approach – Peds, Trauma
Differential
 Stroke
 STEMI
 Overdose
 Child Abuse / Non-Accidental Trauma
 Domestic Violence
 Non-Accidental Trauma
Pertinent Positives and Negatives
 Age, VS, GCS
 Time of Injury, Mechanism of Injury
 DCAP-BTLS
 SAMPLE History
 OPQRST History
 Pain / Swelling
 Mental Status
 Hypotension / Shock
Pearls
REQUIRED EXAM: Vital Signs, GCS, Loss of Consciousness, Location of Pain (then targeted per Appropriate Trauma Protocol)
 Assess for major trauma criteria immediately upon patient contact
-RR <10 or >upper normal (p.112 ); SBP <70 + (age in years x 2)mmHG; Pulse <50 or >upper normal (p.112 ); GCS <13; SpO2<93%
-Transport to Trauma Center, minimize scene time to goal of <10 minutes
 Disability – assess for neuro deficits including paralysis, weakness, abnormal sensation
 Suspect Tension Pneumothorax when:
-Mechanism consistent with Chest Trauma; Resp Distress; Decreased Breath Sounds; JVD; Low BP; Tachycardia; Tracheal Deviation
-Signs and Symptoms of Tension Pneumothorax may be present with or without positive pressure ventilations
-Needle Decompression should be performed with an 18-20ga needle at the 2
nd intercostal space, midclavicular line
-If repeat decompression necessary, continue to move laterally along the superior aspect of the 3
rd rib
Trauma Protocols - Pediatric
Assessment
Safety
Stage,
Call for Law 
Enforcement and/or 
Additional 
Resources
PPE
Hazmat
Multiple 
Patients
Unsafe
Insufficient
Safe
Sufficient
Notify Comm 
Center, Activate 
Hazmat Resources
Yes
Notify Comm Center, 
Activate MCI Incident
Consider Base Hospital
Consider Additional 
Resources,
MCI if Necessary
≥5
<5
Primary Survey Peds Traumatic Cardiac 
Arrest Protocol p116
Pulseless,
Apneic
A,B,C’s
Support Airway,
Support Oxygenation,
Support Circulation
Minimize Scene Time,
Notify Receiving Facility of 
Trauma Patient Early
P
Consider Chest 
Decompression 
Procedure p164
Airway Patent,
Poor Chest Compliance OR
Unstable VS
Ventilations Adequate,
BP and HR Adequate
Peds Selective Spinal 
Motion Restriction Protocol 
p128
Evaluate and Treat Per 
Appropriate Trauma 
Protocol
No
Scene
Yes
Consider Airway Obstruction 
Procedure p132
Peds Airway Management 
Protocol p90
Hemorrhage Control 
Protocol p127
Exsanguinating 
Hemorrhage
Shock/Hypotension Peds 
Protocol p110
Signs of 
Shock
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
Obstructed Airway,
Ventilations 
Inadequate
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
General Approach – Peds, Trauma
Injuries Incompatible With Life?
(Incineration, Decapitation, 
Hemicorpectomy)
Continuous Cardiac Monitor
Peds Airway Management Protocol 
p90
Full Spinal Motion Restriction with C-collar 
and Long Spine Board
MANDATORY
Rigor Mortis, Dependent Lividity or 
Decomposition of Body Tissue?
No
Yes
No
Begin Resuscitation
Continue CPR Procedure p155 
Throughout Transport to 
Closest Leveled Trauma Center
(Preference to Level 1 Pediatric Trauma 
Center, if possible)
Return of 
Pulse Go To Appropriate Trauma Protocol No
Notify Receiving Facility,
Contact Medical Control As Necessary M
Notify Receiving Facility,
Contact Medical Control
Yes P
Consider Chest Decompression Procedure 
p164
116
Traumatic Cardiac Arrest – Peds, Trauma
Differential
 Hypovolemic Shock
-External Hemorrhage
-Internal Hemorrhage
-Unstable Pelvic Fracture
 Tension Pneumothorax
 Medical Condition Causing 
Trauma (i.e. Cardiac Arrest)
Pearls
REQUIRED EXAM: Pupillary Light Reflex, Palpation of Pulses, Heart and Lung Auscultation
 This protocol is compliant with the Joint Position Statement of the ACS, ACEP, NAEMSP and AAP and can be referenced here:
http://www.annemergmed.com/article/S0196-0644(14)00074-2/fulltext#sec6
 Injuries incompatible with life include; decapitation, incineration, massively deforming head or chest injury, dependent lividity, rigor mortis
 As with all trauma patients, DO NOT delay transport
 Consider using medical cardiac arrest protocols if uncertainty exists regarding etiology of arrest
 Use of a long spine board will make chest compressions more effective; however, if spinal immobilization interferes with CPR use reasonable effort to limit
patient and spine movement
 Be aware that these may be crime scenes: do your best to avoid disturbing forensic evidence
 If provider safety becomes a concern, transport of deceased patients to the hospital is acceptable
Pertinent Positives and Negatives
 Age, if known
 Mechanism of Injury
 Events leading up to arrest
Trauma Protocols - Pediatric
M Contact Medical Control
Yes
Consider IVF bolus IV/IO, repeat as 
indicated for patient condition
P
Consider TXA 1gm IV/IO 
Over 10 minutes
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Peds, Trauma
Offending 
Organism(s) 
Neutralized
Call For Resources,
Stage Until Scene Safe
Active 
Hemorrhage
Peds Hemorrhage Control 
Protocol p127
Allergic Reaction Peds Allergic Reaction 
Protocol p100
Evaluate Pain Consider Peds Pain Management 
Protocol p107
Identification of 
Offending Organism
Snakebite
Spider, Bee, Wasp, Hornet Mammalian Bite (including Human)
Immobilize Injury, 
Remove jewelry distal to bite
Immobilize Injury, 
Remove jewelry distal to bite
Mark Edges of Erythema with Marking Pen
Muscle 
Spasms
A
P
Peds IV Access Protocol p104
Midazolam 0.1mg/kg IV/IO (max 5mg) 
OR
Midazolam 0.2mg/kg IM/IN (max 10mg)
Immobilize Injury, 
Remove jewelry distal to bite
Yes
No
Yes
No
Yes
No
None or Mild
>5/10 OR
Severe
Contact local Animal Control or 
appropriate animal welfare 
authorities for assistance.
Wound Care Procedure p180
No
Notify Receiving Facility,
Contact Medical Control As Necessary
117
Bites and Envenomations – Peds, Trauma
Differential
 Penetrating Trauma
 Dry Bite (Snake)
 Abscess/Cellulitis
 Non-Accidental Trauma
Pertinent Positives and Negatives
 Age, VS, Pulses distal to wound
 SAMPLE History
 OPQRST History
 Description or photo of offending creature
 Tetanus status
 Immunization History of
Creature (if known)
 Domestic vs. Wild Animal
 Allergic Reaction
 Hypotension, Shock, Fever
Pearls
REQUIRED EXAM: VS, GCS, Evidence of Intoxication, Affected Extremity Neurovascular Exam
 Cat bites may not initially appear serious, but can progress rapidly to severe infection
 Human bites have higher rates of infection than animal bites and need to be evaluated in the Emergency Department for antibiotics
 Bites on the hands and lacerations over knuckles should be assumed to be “Fight Bites” until proven otherwise, and need evaluation
 It is not necessary to bring the offending insects, animals or reptiles to the ED for identification; this may result in added danger to others
 Brown recluse spider bites are usually painless at the time of bite. Pain and tissue necrosis develops over hours to days
 Immunocompromised patients have higher risk of infection – Think: Diabetes, Chemotherapy, Organ Transplant
Trauma Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Remove Rings, Bracelets and Constricting 
Items
Remove or Cool Heat Source (if not 
already done)
Apply Dry Clean Sheet or Non-Adherent 
Dressing;
Consider Plastic Cling Wrap Application
Remove Rings, Bracelets and Constricting 
Items
Remove or Cool Heat Source (if not 
already done)
Apply Dry Clean Sheet or Non-Adherent 
Dressing;
Consider Plastic Cling Wrap Application
Area Age 0 Age 1 Age 5
Age 
10
Age 
15
A=½ of Head 9 ½ 8 ½ 6 ½ 5 ½ 4 ½
B=½ of Thigh 2 ¾ 3 ¼ 4 4 ¼ 4 ½
C=½ of Leg 2 ½ 2 ½ 2 ¾ 3 3 ¼
118
Burns – Peds, Trauma
Differential
 Blast Injury
 Radiation Injury
 Electrical Injury
 Cyanokit Need?
 Cellulitis
 Dermatitis
 Drug Reaction (Stevens-Johnson
Syndrome)
Pertinent Positives and Negatives
 Age, VS
 SAMPLE History
 OPQRST History
 Mechanism of Burn (heat, gas, chemical)
 Time of Injury
 Singed Facial Hair
 Wheezing, Hoarseness
 Subjective Throat Swelling
 Loss of Consciousness
Pearls
REQUIRED EXAM: VS, GCS, Lung Sounds, HEENT, Posterior Pharynx
 Safety First! Assure a Chemical source of burn is NOT a hazard to responders. Assure an Electrical source of burn is OFF or no longer contacting pt. Never overlook the 
possibility that a burn injury may be the result of child abuse / non-accidental trauma.
 High Voltage Electrical Burns (>600 volts) require spinal immobilization, continuous cardiac monitor and IV access regardless of external appearance of injury
 Chemical burns require removal of contaminated clothing, brush away dry powder before irrigation. Flush with copious warm water on scene and continue irrigation en 
route. Be sure to brush excess away and remove contaminated clothing BEFORE beginning irrigation Burns to face and eyes, remove contact lenses prior to irrigation
 Early intubation is strongly recommended if suspicion of inhalation injury. Suspicion is high in patients involved in an enclosed space fire, who have facial burns or show signs
of airway involvement; carbonaceous sputum, facial burns or edema, hoarseness, singed nasal hairs, agitation, hypoxia or cyanosis
 Indications of possible Cyanide Poisoning - Exposure to fumes from burning Nitrile (polyurethane, vinyl) Seizures, coma, cardiac arrest, headache, vertigo and/or cherry red 
skin color from increased venous O2 concentration
Trauma Protocols - Pediatric
General Approach – Peds, Trauma
Estimate TBSA 
Burned / Severity
Minor Burn Serious Burn Critical Burn
<5% TBSA, 1
st
– 2
nd Degree Burn
No inhalation Injury,
Normal BP, SpO2
A
Consider Peds IV Access Protocol 
p104
5-15% TBSA, 2
nd
– 3
rd Degree Burn
Suspected Inhalation Injury,
Hypotension, Altered Mental Status
>15% TBSA, 2
nd
– 3
rd Degree Burn
Burn with Trauma
Burn with Airway Compromise
Consider Peds Airway Management 
Protocol p90
A
A
Peds IV Access Protocol 
p104
LR Preferred over NS, If available
If <5 y/o, 125mL IV/IO
If >5 and <14 y/o, 250mL IV/IO
If >14 y/o, 500mL IV/IO
Fluids given over 1 hour
Transport to Designated Burn Center
Burn to Hands, 
Feet, Face or 
Perineum
No Yes
Consider Need for Airway 
Management EARLY
Transport to Facility of Choice
Consider CN Exposure for Enclosed 
Space Fire with Synthetic Materials
Consider Peds Pain Management p107 Consider Peds Pain Management p107 Consider Peds Pain Management p107
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Peds, Trauma
Peds Selectvie Spinal Restriction Protocol 
p128
A
Peds IV Access Protocol 
p104
Notify Receiving Facility,
Contact Medical Control As Necessary
Mechanism
Assess Breath Sounds, SpO2
Blunt Penetrating
Apply Occlusive 
Dressing and Assist 
Ventilations
Consider Pain Management, 
Peds Protocol p107
Stabilize Foreign Object
Assess Breath Sounds, SpO2
P
Chest Decompression Procedure 
p164
Open OR Sucking
Chest Wound
Support 
Ventilations, 
Monitor VS, watch 
for JVD, tracheal 
deviation
Assist Ventilations as Needed
Decreased Unilateral
Breath Sounds
Clear and Equal
Bilaterally
Support Ventilations, 
Monitor VS, watch for 
JVD, tracheal deviation
Assist Ventilations as Needed
Decreased Unilateral
Breath Sounds
Clear and Equal
Bilaterally
Signs of Tension 
Pneumothorax
Yes
Consider Peds Airway 
Management Protocol p90
Continuous Cardiac Monitor
No
Consider Peds Airway 
Management Protocol p90
119
Chest Injury – Peds, Trauma
Pertinent Positives and Negatives
 Type of injury
 Mechanism (blunt vs. penetrating)
 Respiratory Effort, Adequacy
 Abnormal Breath Sounds (unilateral vs. bilateral)
Differential
 Simple Pneumothorax
 Tension Pneumothorax
 Pericardial Tamponade
 Aortic Root Disruption
 Bronchial Tree Injury
 Tracheal Disruption
 Great Vessel Laceration
 Cardiac Contusion
 Cardiac Laceration
 SAMPLE History
 OPQRST History
 Evidence of Intoxication
 Evidence of Multi-System 
Trauma
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Consider tension pneumothorax in any patient with penetrating chest trauma, OR blunt chest trauma with decreased unilateral breath sounds, 
hypotension, tachycardia, hypoxia, tracheal deviation (late) or JVD (late)
 Aortic root injuries, bronchial disruption and tracheal disruptions are common with major deceleration injuries (i.e. MVC)
 Cardiac contusions are common with blunt chest trauma, and may present with ectopy, PVCs or even STEMI appearance on cardiac monitor
 Pericardial Tamponade is a surgical emergency and needs rapid transport. Look for muffled heart tones, hypotension, tachycardia
Trauma Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
A
P
Sodium Bicarbonate 1mEq/kg IV/IO
AND*
Calcium Chloride 20mg/kg IV/IO over 3 min, 
max 1g
General Approach – Peds, Trauma
Peds IV Access Protocol p104
Continuous Cardiac Monitor 12-Lead ECG Procedure p129
(when possible)
Go To Appropriate Peds Cardiac Arrest Protocol
Yes
Management of Crush Injury Patient
Crush Injury should be suspected in prolonged 
pinnings >1 hour, AND proximal to the knee or 
elbow.
This protocol is NOT intended for hands or feet 
trapped in machinery or farm equipment
Hemodynamically 
Unstable
No
120
Prolonged Crush Injury – Peds, Trauma
Differential
 Compartment Syndrome
 Entrapment without Crush
 Fracture, Sprain, Strain
 Pelvic Fracture
 Hypothermia
Pertinent Positives and Negatives
 Age, VS, GCS
 SAMPLE History
 OPQRST History
 Crushed under heavy load ≥30 min
 Building collapse, trench collapse,
industrial accident, heavy equipment
pinning
Pearls
REQUIRED EXAM: Vital Signs, GCS, Lung Sounds, Neuro Exam, Musculoskeletal Exam
 Structural Collapse, Crush Scenes are often full of hazards, provider safety is the most important consideration
 Patients may become hypothermic, even in warm environments
-Hypothermia can lead to coagulopathy, which will increase bleeding times and have worse outcomes for the patient
 Crush injuries can result in hyperkalemia from shift of Potassium out of injured cells. Cardiac monitoring is required and 12-lead ECG preferred whenever 
possible (as dicated by the situation)
 Monitor extremities for signs of compartment syndrome after crush injury; Pain, Pallor, Paresthesias, Paralysis, Pulselessness and Poikilothermia (inability
to regulate core body temperature)
 * Sodium Bicarb Infusion: 1mEq/kg added to 1L NS, administered 20mL/kg IV just prior to extrication
 **Utilize different IV lines or flush between bicarb and calcium to prevent precipitation in the line
Trauma Protocols - Pediatric
Yes
Consider Peds Pain Management
Protocol p107
Immediately Prior to Extrication
P
Sodium Bicarbonate 1mEq IV/IO
AND*
Calcium Chloride 20mg IV/IO over 3 min
Monitor and Reassess for Fluid Overload Notify Receiving Facility,
Contact Medical Control As Necessary
Albuterol 2.5mg/3mL Neb
Repeat as needed to run continuously
Peds Shock / Hypotension
Protocol p110
At risk of crush syndromey 
hyperkalemia/rhabdo
No
Consider IVF bolus IV/IO, 
repeat as indicated for 
patient condition
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Awake but Altered
General Approach – Peds, Trauma
Peds Selective Spinal Motion Restriction 
Protocol p128
Mental Status
Awake and Alert Unresponsive
Pulse
Go To Appropriate Peds MEDICAL Cardiac 
Arrest Protocol
Remove Wet Clothing
Dry and Warm Patient
Monitor and Reassess
Encourage Transport and Evaluation even 
if asymptomatic
Consider Peds Airway Management 
Protocol p90
Continuous Cardiac Monitor
A
Consider Peds IV Access Protocol 
p104
Notify Receiving Facility,
Contact Medical Control As 
Necessary
Continuous Cardiac Monitor
A
Peds IV Access Protocol 
p104
Yes
No
Remove Wet Clothing
Dry and Warm Patient
Monitor and Reassess
121
Near-Drowning / Submersion Injury – Peds, Trauma
Differential
 Spinal Trauma
 Pre-Existing Medical Condition
 Hypothermia
 Aspiration
 The Bends
 Pressure Injury 
Barotrauma
Decompression Sickness
 Post-Immersion Syndrome
Pertinent Positives and Negatives
 Submersion in water regardless of depth
 SAMPLE History
 OPQRST History
 Temperature of water
 Mental Status Changes
 Degree of Water
Contamination
 Vomiting
 Coughing, Wheezing, Rales,
Rhonchi, Stridor
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Have a HIGH index of suspicion for possible spinal injuries. Any diving injury or submersion with unclear details should be fully immobilized
 Hypothermia is often associated with near-drowning and submersion injuries. Consider the Hypothermia Protocol as appropriate
 All patients with Near-Drowning / Submersion Injury should be transported for evaluation due to delayed presentation of respiratory failure
 With diving injuries (decompression / barotrauma) consider availability of a hyperbaric chamber; contact Medical Control early.
 Near-drowning patients who are awake and cooperative but with respiratory distress may benefit from CPAP / Positive Pressure Ventilation
Trauma Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
Consider IVF bolus IV/IO
(cooled if available)
repeat as indicated for patient 
condition
A Peds IV Access Protocol p104
A
Consider IVF bolus IV/IO, 
(cooled if available)
repeat as indicated for patient condition
Requires 
Transport
General Approach – Peds, Trauma
Remove Patient from Hot Environment
(if applicable)
Estimate 
Severity of 
Symptoms
Heat Cramps Heat Exhaustion Heat Stroke
Painful Spasms of Extremities and/or 
Abdominal Muscles
Normal Mental Status
Normal Vital Signs
Dizziness, Lightheadedness, Headache, 
Irritability, Nausea
Normal or Mildly Depressed Mental Status
Mild Tachycardia (age defined)
Normal or Mildly Elevated Temp
Tolerating Oral 
Fluids
Oral Fluids
Sponge with Cool Water and Fan
Keep Patient Supine
Apply 100% Oxygen
Sponge with Cool Water and Fan
Marked Alteration in Level of Consciousness
May Be Sweating OR Hot, Dry, Red Skin
Extremely High Temp, >105oF
Reassess and Document Mental 
Status, VS and ability to take PO
Semi-Reclining Position with Head Elevated
Apply 100% Oxygen
Rapid Cooling with Cold Packs, Sponge with 
Cool Water and Fan
A
Ondansetron 0.15mg/kg IV/IO
(max 4mg)
P
If shivering, consider Midazolam 0.1mg/
kg IV/IO
(max 5mg)
Notify Receiving Facility,
Contact Medical Control As Necessary
Yes No
Normal
Yes Execute and Document Peds 
Patient Refusal Protocol p108 No
Abnormal
If Evidence of Sympathomimetic OD
Consider Peds Overdose, Sympathomimetic 
Protocol p105
122
Environmental, Hyperthermia – Peds, Trauma
Differential
 Alcohol Withdrawal (DTs)
 Hyperthyroidism (Thyroid Storm)
 Dehydration
 Cocaine or Sympathomimetic OD
 Sepsis
 CNS Lesion or Head Injury
 Abuse or Neglect (Elderly or 
disabled)
 Medication (Serotonin 
Syndrome, Malignant
Hyperthermia)
Pertinent Positives and Negatives
 Age, VS, Mental Status
 SAMPLE History
 OPQRST History
 Time and length of exposure to hot environment
 Hot, dry or sweaty skin
 Seizures
 Nausea
 Hypotension, Shock,
Fever
Pearls
REQUIRED EXAM: VS, GCS, Skin, HEENT, Neuro, Evidence of Intoxication, Mental Status
 Extremes of Age are more prone to heat emergencies due to inability to easily self-extricate from hot environments
 Patients on Tricyclic Antidepressants, Anticholinergics, Diuretics (i.e. Lasix) are more susceptible to heat emergencies due to medication effects
 Cocaine, amphetamines and salicylates all may elevate body temperature or interfere with the ability to auto-regulate
 Sweating generally disappears as body temperature rises above 104oF
 If Heat Cramps resolved without IV Access or Medications, patients may refuse transport, IF tolerating oral fluids and VS normal
Trauma Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
A
Consider Ondansetron 0.15mg/kg 
IV/IO
(max 4mg)
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Manage Wounds Per Peds Burn 
Protocol p118
Do NOT Rub Skin To Rewarm
PREVENT Refreezing 
A
Peds IV Access Protocol 
p104
A
Consider IVF bolus IV/IO, 
(warm if available)
repeat as indicated for 
patient condition
A
Peds IV Access Protocol 
p104
A
External Rewarming Measures
General Approach – Peds, Trauma
Remove Patient from Cold Environment
(if applicable)
Remove Wet Clothing
Dry and Warm the Patient
Blood Glucose Procedure p152 Go To Peds Diabetic Emergencies 
Protocol p103
Estimate 
Severity of 
Symptoms
Mild Hypothermia
<93oF (<34oC)
Moderate Hypothermia
86-93oF (30-34oC)
Severe Hypothermia
<86oF (<30oC)
Localized Cold Injury
(Frostbite)
Sympathetic Nervous System Excitation –
Shivering, Hypertension, Tachycardia, 
Tachypnea
Awake But May Be Confused
Shivering more violent, ataxia and 
incoordination apparent.
Stumbling pace and Moderate Confusion
Appears pale as surface vessels constrict to 
retain heat.
Heart rate, blood pressure and respiratory rate 
decrease.
Disoriented, confused and combative
Paradoxically may discard clothing
No
Consider Peds Pain Management 
Protocol p107
Consider Peds Airway Management Protocol 
p90
12-Lead ECG Procedure 
p129
Yes
123
Environmental, Hypothermia – Peds, Trauma
Differential
 Alcohol Intoxication
 Hypothyroidism (Myxedema Coma)
 Dehydration
 Sepsis
 CNS Lesion or Head Injury
 Abuse or Neglect (Elderly or 
disabled)
 Medication (beta blocker
overdose, opiate overdose)
Pertinent Positives and Negatives
 Age, VS, Mental Status
 SAMPLE History
 OPQRST History
 Time and length of exposure to cold environment
 Cold or clammy skin
 Confusion
 Arrhythmias, J-waves on
ECG
 Hypotension, Shock
Pearls
REQUIRED EXAM: VS, GCS, Skin, HEENT, Neuro, Evidence of Intoxication, Mental Status
 Consider ECMO early if patient arrests
 Hypoglycemia is found in many hypothermic patients, because hypothermia may be a result of hypoglycemia
 Severe hypothermia may cause myocardial irritability and rough handling can theoretically cause V-fib. Please handle carefully.
-Do not withhold advanced airway or CPR for this concern, but only the most experienced provider available should gently attempt advanced airway
 Below 86oF (30oC), antiarrhythmics may not be effective. If given, they should be given at reduced intervals. Do NOT attempt to pace below 86oF. If
antiarrhythmics necessary for severely hypothermic patient, Contact Medical Control
 Extremes of age, malnutrition, EtOH and drug abuse and outdoor hobbies / employment all predispose to hypothermia
Trauma Protocols - Pediatric
Consider IVF bolus IV/IO,
(warm if available)
repeat as indicated for patient condition
Notify Receiving Facility,
Contact Medical Control As Necessary
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Peds, Trauma
Peds Selective Spinal Motion Restriction 
Protocol p128
Mechanism Soft Tissue Swelling,
Bony Deformity
Wound 
Severity / 
Hemorrhage 
Control
Laceration, Abrasion,
Penetrating Injury
Direct Pressure
Tourniquet Procedure 
p174
Bleeding 
Controlled
Pad and Splint Extremity in 
Place
Consider Peds Pain 
Management Protocol p107
(if time allows)
Gentle In-Line Traction
(Avoid Excessive Force)
Mild-Moderate,
Simple Wound
Severe-Exsanguinating,
Complex Wound
No
Yes
Consider Peds Pain Management 
Protocol p107
Reassess and Document CMS
After Splinting
Pulses Present
A
Peds IV Access Protocol
p104
Consider Peds Hemorrhage Control 
Trauma Protocol p127
Notify Receiving Facility,
Contact Medical Control As Necessary
A
Peds IV Access Protocol 
p104
Palpate Pulses
Evaluate Distal CMS
Consider Peds Pain Management 
Protocol p107
Pulses Absent
124
Extremity Injury – Peds, Trauma
Differential
 Vascular Disruption
 Amputation
 Fracture, Dislocation
 Sprain, Strain
 Abrasion
 Contusion
 Laceration
 Compartment Syndrome
Pertinent Positives and Negatives
 Type of injury
 Mechanism (blunt vs. penetrating)
 Central and Peripheral Pulses
 Neuro Function Distal to Injury
 SAMPLE History
 OPQRST History
 Evidence of Intoxication
 Evidence of Multi-System 
Trauma
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Immobilization of bony injuries should include the joint above and below. Joint injuries require immobilization of bone above and below
 Palpate and document Circulation, Movement and Sensation both before and after splint application
 Tourniquets should remain in place once hemorrhage control is adequate. The tourniquet is tight enough when the bleeding stops!
 If active hemorrhage and bony/soft tissue deformity, priority should be put on hemorrhage control first, then splinting – remember A,B,C’s
 If amputated extremities available, seal in a plastic bag and place in cool water and bring to the hospital with the patient
Trauma Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
Peds IV Access Protocol 
p104
General Approach – Peds, Trauma
Nature of 
Complaint Pain / Vision Loss
Assess Visual Acuity
Assess Pupils
Complete Neuro Exam
Unrecognized 
Chemical Agent
Shield and Protect Both 
Eyes
Injury
Isolated to Eye(s)
Go To Appropriate Peds Trauma 
Protocol
Irrigate with 1L NS or Sterile Water
Assess Visual Acuity
Globe Rupture
Non-Traumatic Traumatic
Go To Suspected Stroke Protocol, 
ADULT p64
Focal
Deficit
No
Yes
Normal
Cover and Protect Both Eyes
Yes
No
Chemical Blunt / Trauma
A
Ondansetron 0.15mg/kg IV/IO/
ODT (max 4mg)
Consider Peds Pain Management 
Protocol p107
Shield and Protect 
Both Eyes
Notify Receiving Facility,
Contact Medical Control As Necessary
Yes
No
Mechanism
125
Eye Pain – Peds, Trauma
Differential
 Globe Rupture
 Acute Closed Angle Glaucoma
 Stroke
 Retinal Artery Occlusion
 Chemical Burn
 Retinal Venous Thrombus
Pertinent Positives and Negatives
 Age, VS, Visual Acuity
 SAMPLE History
 OPQRST History
 Time of Injury
 Involved Chemical MSDS
 Contact / Corrective Lens Use
 “Shooting” or “Streaking” Lights
 Rust Ring
 “Lowering Shade” in Vision
Pearls
REQUIRED EXAM: VS, GCS, Visual Acuity, Neuro Exam, Extraocular Movements
 Stabilize any penetrating objects. DO NOT remove any embedded / impaled objects
 If Long Spine Board not indicated, transport with head of stretcher elevated to 60 degrees to help reduce intraocular pressure
 Remove contact lenses when possible
 Always cover both eyes to prevent further injury
 Orbital fractures increase concern for globe or optic nerve injury; follow visual acuity and extraocular movements for changes
 Normal visual acuity can be present, even with severe injury
Trauma Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Maintain SpO2 >93%
Goal EtCO2 35-45mmHg
General Approach – Peds, Trauma
Peds Selective Spinal Motion 
Restriction Protocol p128
A
Peds IV Access Protocol 
p104
Blood Glucose Peds Diabetic Emergencies Protocol 
p103
Altered 
Mentation
Peds Seizure Protocol 
p109
Document 
GCS
Consider Peds Airway Management Protocol 
p90
Pain Peds Pain Management 
Protocol p107
Within Appropriate Range
Lower than
Appropriate
>8
Elevate Head of Stretcher 15-30 degrees while 
maintaining Spinal Precautions
>6/10 Monitor and Reassess
Frequent Airway and GCS Evaluations
Notify Receiving Facility,
Contact Medical Control As 
Necessary
<6/10
Document Response to Meds,
Repeat GCS, SpO2, EtCO2
Peds Airway Management Protocol 
p90
If evidence of herniation, 
Goal EtCO2 is 30-35mmHg
<8
M
Increase Respiratory Rate 
<1 year of age, 35bpm
>1 year of age, 25bpm
Nasal Airways are CONTRAINDICATED 
in patients with significant 
Maxillofacial trauma – the cribriform 
plate may be broken and result in an 
NPA going into the patient’s brain
P Agitation
Consider 
Midazolam 0.1mg/kg IV/IO
(max 5mg) or 0.2mg/kg IN/IM (max 
10mg) or Lorazapam 0.1mg/kg IV/IO/IM 
(max 2mg)
Severe Head Injury Cases Should Be 
Transported to The Peds Trauma 
Center, Unless Patient Condition 
Dictates
126
Head Injury – Peds, Trauma
Differential
 Skull fracture
 Epidural hematoma
 Concussion, Contusion,
Laceration, Hematoma
 Non-Accidental Trauma
 Spinal Cord Injury
 Subdural Hematoma
 Subarachnoid Hemorrhage
Pertinent Positives and Negatives
 Type of injury
 Mechanism (blunt vs. penetrating)
 Loss Of Consciousness
 Vomiting, Altered Mental Status
 SAMPLE History
 OPQRST History
 Evidence of Intoxication
 Evidence of Multi-System 
Trauma
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 If GCS <13 consider Air transport or Rapid Transport to Leveled Trauma Facility
 Airway interventions can be detrimental to patients with head injury by raising intracranial pressure, worsening hypoxia (causing secondary brain
injury) and increasing risk of aspiration. Whenever possible these patients should be managed in the least invasive manner to safely maintain O2 
saturation >90% (ie. NRB, BVM with 100% O2, etc.)
 Acute herniation should be suspected when the following signs are present: acute unilateral dilated and non-reactive pupil, abrupt deterioration in mental 
status, abrupt onset of motor posturing, abrupt increase in blood pressure, abrupt decrease in heart rate.
 Only in suspected acute herniation – increase ventilatory rate with target EtCO2 30-35mmHg
 Increased intracranial pressure (ICP) may cause hypertension and bradycardia (Cushings response)
 Hypotension usually indicates injury or shock unrelated to the head injury and should be treated aggressively
 Most important vital sign to monitor and document is level of consciousness (GCS)
 Concussions are periods of confusion or loss of consciousness (LOC) associated with trauma which may have resolved by the time EMS arrives. Any
confusion or mental status abnormality should be transported to an Emergency Department. Any questions or clarifications, contact Medical Control.
Trauma Protocols - Pediatric
M
Consider TXA 15mg/kg IV/IO (max 1gm) 
over 10min
M
Consider TXA 15mg/kg IV/IO (max 1gm) 
over 10min
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

A
Peds IV Access Protocol 
p104
A
General Approach – Peds, Trauma
Notify Receiving Facility,
Contact Medical Control As Necessary
Wound 
Severity / 
Hemorrhage 
Control
No
Direct Pressure
Tourniquet Procedure 
p174
Mild-Moderate,
Simple Wound
Severe-Exsanguinating,
Complex Wound
No
Yes
A
Consider Peds IV Access Protocol 
p104
Consider Peds Pain Management
Protocol p107
Extremity
Age Defined 
Hypotension
Yes
Hemostatic Dressing for Severe 
Hemorrhage, if available
No
Bleeding 
Controlled
No
Pain
Moderate 
OR
Severe
None OR
Mild
Consider Wound Packing Procedure, As 
Appropriate p180
127
Hemorrhage Control – Peds, Trauma
Differential
 Vascular Disruption
 Amputation
 Fracture, Dislocation
 Sprain, Strain
 Abrasion
 Contusion
 Laceration
 Compartment Syndrome
Pertinent Positives and Negatives
 Type of injury
 Mechanism (blunt vs. penetrating)
 Central and Peripheral Pulses
 Neuro Function Distal to Injury
 Time of Injury
 Deformity
 Diminished pulse / capillary 
refill
Pearls
REQUIRED EXAM: Mental Status, HEENT, Heart, Lungs, Abdomen, Extremity, Back, Neuro
 Hypotension in trauma needs blood products early, so minimize scene time. Goal for scene time in major trauma cases should be <10 min
 Multiple casualty incident or obvious life threatening hemorrhage, consider Tourniquet Procedure and/or Hemostatic Dressing FIRST
 Hemostatic Dressings are appropriate for hemorrhage that can’t be controlled with a tourniquet, such as junctional wounds in the groin or axilla.
 Remember - hemostatic agents are contraindicated in wounds that violate the thoracic or abdominal cavity; if unsure, use sterile roll gauze. 
 Signs/Symptoms of Shock include: altered mental status, pallor, cap refill >3 sec, faint/absent peripheral pulses, hypotension (age defined)
Trauma Protocols - Pediatric
P
Consider TXA 15mg/kg IV/IO (max 1gm)
Over 10min
Consider IVF bolus IV/IO, 
repeat as indicated for 
patient condition, consider permissive 
hypotension in setting of ongoing 
serious hemorrhage
Yes
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

General Approach – Peds, Trauma
Full Spinal Motion Restriction 
with Appropriately Sized
Cervical Collar and Long 
Spine Board
Spinal motion restriction 
not indicated
Evaluate and Treat per Appropriate Peds 
Trauma Protocol
Assess Mechanism 
of Injury (MOI)
Spinal motion restriction 
not indicated
ALL ‘No’
ALL ‘No’
Isolated Penetrating Blunt Trauma
(With OR Without Penetrating Trauma)
q Altered level of consciousness OR 
q (GCS < 15) OR
q Clinical Intoxication* OR
q Midline Neck Pain OR
q Midline Tenderness to Palpation of CSpine OR
q Paraspinal Muscle Tenderness to 
Palpation OR
q Torticollis OR
q Neurologic Deficits OR
q Abnormal Sensation OR
q ANY Anatomic Deformity of Spine OR
q Tenderness to Palpation over Spine OR
q Distracting Injury** OR
q Inability to Communicate OR
q Significant Mechanism of Injury
q Neurologic Deficits OR
q Abnormal Sensation OR
q Altered Level of Consciousness (GCS <15) 
OR
q Clinical Intoxication OR
q Inability to Communicate
ANY
‘Yes’
ANY
‘Yes’
Notify Receiving Facility,
Contact Medical Control As Necessary
Maintain Manual C-Spine Stabilization 
Until Evaluation and/or Immobilization 
Complete
128
Selective Spinal Motion Restriction -
Peds, Trauma
Pearls
REQUIRED EXAM: Motor Function both upper and lower extremities, Sensation of upper and lower extremities, subjective abnormal sensation, Tenderness to palpation of bony 
prominences OR paraspinal muscles
 *Clinical Intoxication – A transient condition resulting in disturbances in level of consciousness, cognition, perception, affect or behavior, or other 
psychophysiological functions and responses. Common examples include; ataxia, emotional instability, flight of ideas, tangential thought or motor 
incoordination. 
 **Distracting Injury – Examples include, but are not limited to: long bone fracture, dislocations, large lacerations, deforming injuries, burns OR any 
condition preventing patient cooperation with history.
 Torticollis, also known as wryneck, is a twisting of the neck that causes the head to rotate and tilt at an odd angle.
 It is always safer and better patient care to assume that a Spinal Cord injury has occurred and provide protection, and should be the standard of care in 
trauma patient management
 Rigid cervical collars and long spine boards have risks and benefits for patients. Spinal immobilization should always be applied when any doubt exists 
about the possibility of spinal trauma.
 EXTREMELY thoughtful consideration and careful physical exam should be part of any decision to apply or not apply the spinal immobilization, and must be
well documented.
Trauma Protocols - Pediatric
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

ECG, 12-Lead - Procedures
Procedure:
q 1. Prepare ECG monitor and connect patient cable to electrodes
q 2. Expose chest and prep as necessary. Modesty of the patient should be respected.
q 3. Apply chest leads and extremity leads using the following landmarks: (Distal to shoulder and distal to hip joint for most accurate ECG)
 RA: Right Arm
 LA: Left Arm
 RL: Right Leg
 LL: Left Leg
 V1: 4
th intercostal space at right sternal border
 V2: 4
th intercostal space at left sternal border
 V3: Directly between V2 and V4
 V4: 5
th intercostal space at midclavicular line
 V5: Level with V4 at left anterior axillary line
 V6: Level with V5 at left midaxillary line
q 4. Instruct patient to remain still, minimize artifact as able (examples include stopping motion of ambulance and instructing
patient to remain still)
q 5. Press the brand specific button to acquire the 12-Lead ECG (complete age and gender questions correctly)
q 6. Provide 12 Lead to hospital staff, transmit when appropriate
q 7. Document the procedure, time, and results on/with the PCR
129
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

ECG, Right-Sided - Procedures
To detect right ventricular STEMI associated with occlusion of the Right Coronary Artery, obtain a Right Sided ECG.
Indications of a Right Ventricle Wall infarct may include:
q ST elevation in the inferior leads, II, III and aVF
 ST elevation that is greatest in lead III is especially significant
q ST elevation in V1 (the only precordial lead that faces the RV on standard 12-lead ECG)
q Right Bundle Branch Block, 2
nd and 3rd Degree AV Blocks, ST elevation in V2 50% greater than the ST depression in aVF
Procedure:
q 1. Prepare ECG monitor and connect patient cable to electrodes
q 2. Expose chest and prep as necessary. Modesty of the patient should be respected.
q 3. Apply chest leads and extremity leads using the following landmarks: (Distal to shoulder and distal to hip joint for most accurate ECG)
 V1R: 4
th intercostal space, left sternal border
 V2R: 4
th intercostal space, right sternal border
 V3R: halfway between V2R and V4R, on a diagonal line
 V4R: 5
th intercostal space, right midclavicular line, same horizontal line as V5R and V6R
 V5R: right anterior axillary line, same horizontal line as V4R and V6R
 V6R: right mid-axillary line, same horizontal line as V4R and V5R
q 4. Instruct patient to remain still, minimize artifact as able (examples include stopping motion of ambulance and instructing patient to
remain still)
q 5. Press the brand specific button to acquire the 12-Lead ECG (complete age and gender questions correctly)
q 6. Provide Right Sided ECG to hospital staff, transmit when appropriate
q 7. Document the procedure, time, and results in the electronic Patient Care Report (ePCR)
130
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

To detect posterior STEMI associated with occlusion of the circumflex artery or dominant right coronary artery , obain a posterior ECG. 
Indications of a posterior wall infarction may include:
q Changes in V1-V3 on the standard 12-lead ECG predominantly, which include
 Horizontal ST depression
 A tall, upright T-wave
 A tall, wide R-wave
 R/S wave ratio greater than one
q Inferior or lateral wall MI (especially if accompanied by ST depression or prominent R waves in leads V1-V3)
Procedure:
q 1. Prepare ECG monitor and connect patient cable to electrodes
q 2. Expose chest and prep as necessary. Modesty of the patient should be respected.
q 3. Place three additional ECG electrodes. TIP: start at V9 (the last electrode) and work forward
 V9: Left spinal border, same horizontal line as V4-6
 V8: midscapular line, same horizontal line as V7 and V9
 V7: posterior axillary line, same horizontal line as V4-6
q 4. Place ECG lead cables as follows (using standard 12-Lead)
 Lead cable V6 connects to electrode V9
 Lead cable V5 connects to electrode V8
 Lead cable V4 connects to electrode V7
 Lead cables V1-V3 are connected the same way as when obtaining a standard 12-lead ECG
q 5. Instruct patient to remain still, minimize artifact as able (examples include stopping motion of ambulance and instructing patient to
remain still)
q 6. Press the brand specific button to acquire the 12-Lead ECG (complete age and gender questions correctly)
q 7. Provide Posterior Sided ECG to hospital staff, transmit when appropriate
q 8. Document the procedure, time, and results in the electronic Patient Care Report (ePCR)
131
ECG, Posterior - Procedures
Procedures
B EMT
A A-EMT
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Procedure:
Foreign Body Airway Obstruction – 1 Year Old Or Less, Conscious
q If coughing, wheezing and exchanging air, do not interfere with the victims efforts to expel the foreign body.
q If unable to cry or speak, weak or absent cough or no air exchange
 1. Support the victim in the head down position with your non-dominant hand and forearm.
 2. Perform 5 back slaps with the heel of your dominant hand between the should blades
 3. Perform 5 chest thrusts with two fingers in the center of the chest
 4. Repeat the steps above until the object is expelled or the victim becomes unresponsive
Foreign Body Airway Obstruction – Greater Than 1 Year Old, Conscious
q If coughing, wheezing and exchanging air, do not interfere with the patient’s efforts to expel the foreign body.
q If unable to speak, weak or absent cough OR no air exchange, perform abdominal thrusts (Heimlich Maneuver).
Foreign Body Airway Obstruction – All Ages, Unconscious
q 1. If patient was responsive and then became unresponsive
 lower the victim to the ground and begin CPR, starting with compressions (do not check for a pulse)
 Every time you open the airway to give breaths, open the mouth wide and look for the object
 If you see an object that can easily be removed, remove it with your finger
 If you do not see an object, continue CPR
q 2. If a foreign body is visualized but cannot be removed with finger, attempt to remove it under direct visualization using the 
Laryngoscope blade and Magill forceps
 Assemble Laryngoscope and check bulb on blade
 Hold Laryngoscope in left hand,
 Place patient in sniffing position
 Using tongue-jaw lift or cross-finger technique to open mouth
 Insert laryngoscope blade into right corner of mouth and move to midline, sweeping tongue out of way
 Elevate mandible to visualize obstruction without using teeth or gums as a fulcrum
 Grasp Magill forceps in right hand and remove obstruction under direct visualization
q 3. Provide suction as needed
q 4. Resume appropriate CPR and airway management
Paramedic:
q If the obstruction is not visualized or cannot be retrieved, attempt endotracheal intubation with appropriate size ET tube or 0.5 smaller if
>12 years old
q If ETT cannot pass and patient is >12 years old perform cricothyrotomy with pertrach.
q If patient is >1year old but <12 years old perform needle jet insufflation
132
Airway Obstruction - Procedures
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
TRANSPORT RAPIDLY TO THE CLOSEST FACILITY!
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Procedure:
q 1. Apply probe to patient finger or toe, as recommended by the device manufacturer.
q 2. Allow machine to register oxygen saturation level
q 3. Record time and initial saturation percent on room air if possible on/with the PCR
q 4. Verify pulse rate on machine or with actual manual pulse check of the patient
q 5. Monitor critical patients continuously until arrival at the hospital. If recording a one-time reading, monitor patients for a few
minutes as oxygen saturation can vary
q 6. Document percent of oxygen saturation every time vital signs are recorded and in response to therapy to correct hypoxemia
q 7. In general, normal saturation is 97-99%. Below 93% suspect a respiratory compromise
q 8. Use the pulse oximetry as an added tool for patient evaluation. Treat the patient, not the data provided by the device
q 9. The pulse oximeter reading should never be used to withhold oxygen from a patient in respiratory distress or when it is the standard of
care to apply oxygen despite good pulse oximetry readings, such as chest pain
q 10. Factors which may reduce the reliability of the pulse oximetry reading include :
 Poor peripheral circulation (blood volume, hypotension, hypothermia)
 Excessive pulse oximeter sensor motion
 Fingernail polish (may be removed with acetone pad)
 Carbon monoxide bound to hemoglobin
 Irregular heart rhythms (atrial fibrillation, SVT, etc.)
 Jaundice
 Placement of Blood Pressure cuff on same extremity as pulse ox probe
Pulse Oximetry - Procedures
~ This Space Intentionally Left Blank ~
133
B EMT
A A-EMT
P Paramedic 
EMR
Procedures
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

134
Adult Endotracheal Intubation - Procedures
When Considering Intubating Any Patient, Prepare Materials EARLY:
q Laryngoscope handle with appropriate size blade
q Proper Size Endotracheal Tube (ETT) PLUS Backup ETT 0.5-1.0mm smaller and BIAD
q Water-soluble lubrication gel, (lubricate distal end of tube at cuff)
q 10cc syringe (larger syringe if low pressure cuff)
q Stylet, (insert into ET tube and do no let stylet extend beyond tip of ET tube) – if not already incorporated into ETT
q Tape or ETT securing device
q Proper size oral pharyngeal airway
q BVM
q Oxygen Source
q Suction Device
q Stethoscope
q Continuous Digital Waveform Capnography
q Oxygen saturation monitor
q Medications to maintain and support hemodynamic stability (fluids, infusions, push-dose epinephrine, etc.)
Procedure:
q 1. Maintain cervical alignment and immobilization, as necessary
q 2. Attach proper blade to laryngoscope handle and check light
q 3. Check endotracheal tube cuff, lubricate distal end of the tube
q 4. Confirm patient attached to cardiac monitor and oxygen saturation monitor
q 5. Ready ETCO2 detection device
q 6. Specify personnel to:
 Maintain cervical alignment and immobilization during procedure
 Watch cardiac and oxygen saturation monitors
q 7. Preoxygenate patient with 100% Oxygen (BVM or NRB) before intubation attempt to achieve O2 saturation >93% or 8 vital capacity
breaths. 
q 8. Remove all foreign objects, such as dentures, Oropharyngeal Airways (OPA), etc., and suction the patients airway if needed. 
 May leave an esophageal ETT if prior unsuccessful attempt to use as landmark for second attempt
q 9. Insert the blade into the right side of the patient’s mouth sweeping the tongue to the left side
q 10. Visualize the vocal cords while avoiding any pressure on the teeth
q 11. Insert the endotracheal tube until the cuff passes the vocal cords. 
 Insert far enough so that balloon port tubing is even with the lips
 Typical depth = tube size (ID) x3 (example would be tube depth of 24 for a 8.0mm tube)
q 12. Remove the laryngoscope blade
q 13. Inflate the endotracheal cuff with the syringe with 5-10cc of air (low pressure cuff may require larger volume) and remove the 
syringe from inflation valve
q 14. Ventilate with BVM and confirm tube placement:
 Observe immediate (within 6 breaths) EtCO2 waveform and number with capnography
 Watch for chest rise AND
 Auscultate abdomen, listening for air movement in the stomach to ensure tube is not esophageal
 Auscultate bilateral breath sounds to confirm tube placement
q 15. Observe oxygen saturation
Note: Regardless of apparent presence of lung sounds, tube misting, chest rise, AND/OR lack of gastric sounds:
if EtCO2 does NOT indicate proper tube location (alveolar waveform), ETT must be removed.
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

135
Adult Endotracheal Intubation - Procedures
Procedure (continued):
q 16. If unilateral right sided breath sounds are heard, consider:
 Right mainstem intubation
 Deflate the cuff and withdraw tube 1-2cm
 Reinflate cuff and repeat auscultation procedure as above for breath sounds
q 17. If bowel sounds heard with bagging or EtCO2 device does not indicate proper ETT placement, deflate cuff, remove tube and
ventilate with BVM for two minutes
 IF AND ONLY IF intubation attempted for medical reason AND unsuccessful on first attempt, may return to Step 7 of Procedure and
repeat
q 18. If intubation attempt unsuccessful, refer to the next step in the Airway Management, Adult protocol.
IF successful intubation confirmed by Steps 13-15 above:
q 19. Secure tube using an endotracheal securing device
q 20. Document depth of tube
q 21. Reassess and document lung sounds, Vital Signs and patient clinical status
q 22. Insert Oropharyngeal Airway (OPA), or use commercially available bite block with ET Tube holder (if available)
q 23. Ensure Cervical Spine is immobilized to prevent accidental dislodgement of ETT during procedures or patient movement
q 24. Continue ventilations at a rate of 8-10 breaths per minute; adjust rate to maintain SpO2 >93% and EtCO2 35-45mmHg, and as
appropriate for patient condition
q 25. Document EtCO2 waveform and reading continuously at time of EACH patient movement, including waveform and reading at
time of transfer of care at the Emergency Department.
Video Assisted Laryngoscopy (VAL)
q Video Assisted Laryngoscopy (VAL) shall be performed in accordance with documented manufacturer recommendations.
q Follow Intubation procedure with the addition of VAL technology .
q It is essential that every operator of a VAL be competent in Direct Laryngoscopy (DL) in preparation for unsuccessful VAL operation or
equipment malfunction.
Procedures
~ This Space Intentionally Left Blank ~
P Paramedic 
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Peds Endotracheal Intubation - Procedures
136
When Considering Intubating ANY Patient, Prepare Materials EARLY:
q Video Laryngoscope on and functioning; Direct Laryngoscope handle with appropriate size blade and bulb function verified
q Proper Size Endotracheal Tube (ETT) PLUS Backup ETT 0.5-1.0mm smaller and BIAD
q Water-soluble lubrication gel, (lubricate distal end of tube at cuff)
q 10mL syringe (larger syringe if low pressure cuff)
q Appropriate size bougie, (insert into ET tube and do no let bougie extend beyond tip of ET tube)
 10fr bougie for use with ETT sizes 4.0 – 6.0
 15fr bougie for use with ETT sizes 6.0 – 8.0 
q Tape or ETT securing device
q Proper size oropharyngeal airway
q BVM
q Oxygen Source
q Suction Device
q Stethoscope
q Continuous Digital Waveform Capnography
q Oxygen saturation monitor
q Medications to maintain and support hemodynamic stability (fluids, infusions, push-dose epinephrine, etc.)
Procedure:
q 1. Maintain cervical alignment and immobilization, as necessary
q 3. Check endotracheal tube cuff, lubricate distal end of the tube
q 4. Confirm patient attached to cardiac monitor and oxygen saturation monitor
q 5. Ready EtCO2 detection device
q 6. Specify personnel to:
 Apply cricoid pressure
 Maintain cervical alignment and immobilization during procedure
 Watch cardiac and oxygen saturation monitors
q 7. Preoxygenate patient with 100% Oxygen (BVM or NRB) before intubation attempt to achieve O2 saturation >93% for 5 minutes or 8 
vital capacity breaths. Have assistant apply cricoid pressure (Sellick’s Maneuver) during entire procedure.
q 8. Remove all foreign objects, such as dentures, Oropharyngeal Airways (OPA), etc., and suction the patients airway if needed. 
 May leave an esophageal ETT if prior unsuccessful attempt to use as landmark for second attempt
q 9. Insert the video laryngoscope midline into the patient’s mouth
q 10. Visualize the vocal cords while avoiding any pressure on the teeth
 Ensure that the video laryngoscope is recording the intubation procedure
 Bougie use is mandatory for video laryngoscopy
q 11. Insert the endotracheal tube until the cuff is visualized passing the vocal cords. 
 Insert far enough so that balloon port tubing is even with the lips
 Typical depth = tube size (ID) x3 (example would be tube depth of 24 for a 8.0mm tube)
q 12. Remove the laryngoscope blade
q 13. Inflate the endotracheal cuff with the syringe with 5-10cc of air (low pressure cuff may require larger volume) and remove the syringe 
from inflation valve
q 14. Ventilate with BVM and confirm tube placement:
 Observe immediate (within 6 breaths) EtCO2 waveform and number with capnography
 Watch for chest rise AND
 Auscultate abdomen, listening for air movement in the stomach to ensure tube is not esophageal
 Auscultate bilateral breath sounds to confirm tube placement
 Note: Regardless of apparent presence of lung sounds, tube misting, chest rise, AND/OR lack of gastric sounds:
 if EtCO2 does NOT indicate proper tube location (alveolar waveform), ETT must be removed.
q 15. Observe oxygen saturation
q 16. Verify ETT cuff pressure using manometer
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Peds Endotracheal Intubation - Procedures
Procedure (continued):
q 16. If unilateral right sided breath sounds are heard, consider:
 Right mainstem intubation
 Deflate the cuff and withdraw tube 0.5-1cm
 Reinflate cuff and repeat auscultation procedure as above for breath sounds
q 17. If bowel sounds heard with bagging or EtCO2 device does not indicate proper ETT placement, deflate cuff, remove tube and ventilate with 
BVM for two minutes
 IF AND ONLY IF intubation attempted for medical reason AND unsuccessful on first attempt, may return to Step 7 of Procedure and repeat
q 18. If intubation attempt unsuccessful, refer to the next step in the Airway Management, Peds protocol.
IF successful intubation confirmed by Steps 13-15 above:
q 19. Secure tube using an endotracheal securing device
q 20. Document depth of tube
q 21. Reassess and document lung sounds, Vital Signs and patient clinical status
q 22. Insert Oropharyngeal Airway (OPA), or use commercially available bite block with ET Tube holder (if available)
q 23. Ensure Cervical Spine is immobilized to prevent accidental dislodgement of ETT during procedures or patient movement
q 24. Continue ventilations at a rate of 8-10 breaths per minute; adjust rate to maintain SpO2 >93% and EtCO2 35-45mmHg, and as appropriate for 
patient condition
q 25. Document EtCO2 waveform and reading continuously at time of EACH patient movement, including waveform and reading at time of transfer
of care at the Emergency Department.
137
Procedures
~ This Space Intentionally Left Blank ~
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

King LT-D and King LTS-D Laryngeal Tube Airway -
Procedures
138
Prepare All Procedure Specific Materials:
q Correctly sized Laryngeal Tube Airway (LTA) – see chart below
q Bag Valve Mask
q Oxygen Reservoir
q Suction Device
q Bite Block AND/OR endotracheal tube holder (if available)
q Appropriately sized syringes for inflating cuff
q End Tidal CO2 and Oxygen Saturation Monitoring Devices
Procedure:
q 1. Pre-oxygenate patient with 100% Oxygen via Bag Valve Mask or spontaneous ventilation to achieve O2 saturation of >93% if possible
q 2. Check the integrity of the cuff inflation system and pilot balloon
q 3. Fully deflate the cuff with the syringe
q 4. Lubricate the posterior distal tip of the device with a water soluble lubricant
q 5. Place patient in neutral sniffing position (if no Cervical Spine/Spinal Injury suspected)
 For patient with suspected Cervical Spine injury, perform two-person insertion technique
 One person maintains manual in-line cervical spine stabilization while the other person proceeds with procedure
q 6. Pull mandible down to open mouth
q 7. Insert uninflated device into oral cavity with midline or a lateral technique
q 8. Advance the tip behind the base of the tongue while rotating tube back to midline so that the blue orientation line faces the chin of the 
patient.
q 9. Without exerting excessive force, advance tube until base of the colored connector is aligned with teeth or gums
q 10. Inflate the King with the appropriate volume:
 If inflated King Airway insertion is difficult, perform jaw thrust, pulling the tongue forward. Alternately, a laryngoscope may be used to 
lift the jaw/mandible to facilitate insertion.
q 11. Attach the BVM to the King.
q 12. While bagging the patient, gently withdraw the tube until ventilation becomes easy and free flowing (large tidal volume with 
minimal airway pressure).
q 13. Adjust cuff inflation if necessary to obtain a seal of the airway at the peak ventilatory pressure employed.
q 14. Obtain End-tidal CO2, auscultate breath sounds bilaterally, look for chest excursion, and check oxygen saturation
 If digital capnography is not available, arrange for intercept with capable service MUST be completed.
q 15. Secure in the midline to help maintain a good seal over the larynx .
q 16. Place bite block, oral airway or endotracheal tube holder (if available) between teeth to prevent biting tube
q 17. Place orogastric tube and attach to low continuous suction as directed in the applicable procedure to assist in gastric 
decompression
q 18. Ensure C-spine is still immobilized
q 19. If repeated attempts are made, oxygenate with 100% O2 for 2 minutes between attempts
q 20. **Follow manufacturers suggested guidelines at all times**
q 21. Document EtCO2 waveform and reading continuously at time of EACH patient movement, including waveform and reading at time of 
transfer of care at the Emergency Department.
Airway Size Connector Color
Patient 
Weight OD/ID (mm)
Cuff Volume 
(ml)
Gastric Tube 
(Fr.)
0 Transparent <5kg NA 10ml 10
1 White 5-12kg NA 20ml 10
2 Green 12-25kg NA 25-35 16
2.5 Orange 41-51 inches NA 30-40 16
3 Yellow 4-5 feet 18/10mm 45-60 Up to 18
4 Red 5-6 feet 18/10 60-80 Up to 18
5 Purple >6 feet 18/10 70-90 Up to 18
Note: regardless of the apparent presence of lung sounds, tube misting and chest rise, or lack of gastric sounds, if ETCO2 does NOT indicate 
proper tube location (alveolar waveform), Advanced Airway must be removed.
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

139
Procedures
2. Advance the tip of the tube behind the base of the 
tongue (see figure 1). Then rotate the tube back to the 
midline so that the blue orientation line faces the chin of 
the patient (see figure 2).
4. Attach BVM to King LT. While bagging the Patient,
gently withdraw the tube until ventilation becomes easy 
and free flowing (large tidal volume with minimal airway 
pressure). Adjust cuff inflation to maintain seal at the 
peak ventilatory pressure employed.
King LT Airway – The correctly placed King LT airway lies with the tip resting in 
the upper esophagus. The distal cuff inflates in the esophagus, isolating the 
larygopharynx from the esophagus. The proximal cuff inflates at the base of the 
tongue. It isolates larygopharynx from the oropharynx and the nasopharynx.
1. Place Patient in neutral (sniffing position if no cervical 
spine injury suspected) and pull down on the mandible to
open the mouth. Insert the King LT into the oral cavity
from either a midline or lateral approach.
3. Without exerting force, advance tube until base of connector is
aligned with the teeth or gums. Then inflate cuff with appropriate
volume.
King LTD and King LTS-D Laryngeal Tube Airway -
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

i-gel Airway - Procedures
Prepare All Procedure Specific Materials:
q Correctly sized i-gel Airway Device – see chart below
q Bag Valve Mask
q Oxygen Reservoir
q Suction Device
q Appropriate endotracheal tube holder (if available)
q End Tidal CO2 and Oxygen Saturation Monitoring Devices
Procedure:
q 1. Pre-oxygenate patient with 100% Oxygen via Bag Valve Mask or spontaneous ventilation to achieve O2 saturation of >93% if possible
q 2. Lubricate the posterior distal tip of the device with a thin layer of water soluble lubricant
q 3. Place patient in neutral sniffing position (if no Cervical Spine/Spinal Injury suspected)
 For patient with suspected Cervical Spine injury, perform two-person insertion technique
 One person maintains manual in-line cervical spine stabilization while the other person proceeds with procedure
q 4. Pull mandible down to open mouth
q 5. Insert device into oral cavity with midline or a lateral technique
q 6. Advance the tip behind the base of the tongue with the i-gel cuff outlet facing toward the chin of the patient
 NOTE: If necessary, the upper airway should be suctioned prior to attempted insertion
q 7. Without exerting excessive force, advance tube downwards and backwards along the hard palate with a continuous but gentle push
until definitive resistance is felt.
 WARNING: Do not apply excessive force on the device during insertion.
8. The incisors should be resting on the device integrated bite block.
q 9. Attach the BVM to the i-gel.
q 10. Obtain End-Tidal CO2, auscultate breath sounds bilaterally, look for chest excursion, and check oxygen saturation
 If digital capnography is not available, arrange for intercept with capable service MUST be completed.
q 11. Secure in the midline to help maintain a good seal over the larynx .
q 12. Place orogastric tube in side port and advance to appropriate position. Attach to low continuous suction as directed in the applicable
procedure to assist in gastric decompression
q 13. Ensure C-spine is still immobilized
q 14. If repeated attempts are made, oxygenate with 100% O2 for 2 minutes between attempts
q 15. **Follow manufacturers suggested guidelines at all times**
q 16. Document EtCO2 waveform and reading continuously at time of EACH patient movement, including waveform and reading at time of
transfer of care at the Emergency Department.
Note: regardless of the apparent presence of lung sounds, tube misting and chest rise, or lack of gastric sounds, if ETCO2 does NOT indicate 
proper tube location (alveolar waveform), Advanced Airway must be removed.
140
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

i-gel Airway - Procedures
141
http://www.intersurgical.com/info/igel
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Suctioning (Basic) - Procedures
Procedure:
q 1. Ensure suction device is in proper working order with suction tip in place.
q 2. Set mechanical suction device to appropriate setting (Adult: 120-150mmHg OR Pediatric: 80-100mmHg).
q 3. Preoxygenate the patient.
q 4. Explain the procedure to the patient, if they are coherent.
q 5. Examine the oropharynx and remove any potential foreign bodies or material that may occlude the airway if dislodged by the su ction
device.
q 6. If applicable, remove ventilation devices (i.e. BVM, OPA) from the mouth and upper airway.
q 7. Insert into mouth without finger hole covered
q 8. Once inserted, cover the finger hole with a gloved finger to remove any secretions, blood, or other substances. The alert patient may
assist with this procedure. Continue to cover the finger hole while removing.
q 9. Max suction time:
 Adult - 15 seconds
 Pediatric - 10 seconds
 Infant - 5 seconds
q 10. Reattach ventilation device (i.e. BVM) and resume ventilations or patient assistance, as applicable.
q 11. Record the time and result of the suctioning procedure in the electronic Patient Care Report (ePCR).
Procedure: 
Permanent Tracheostomy (upper airway structures surgically removed and trachea surgically attached to skin stoma)
q Suction of visible structures in opening in neck (upper airway is surgically absent and aspiration not possible)
q Ventilate as necessary through stoma
q Consider ALS Intercept for intubation if any concerns about airway, ventilation or patient stability
Temporary Tracheostomy (a metal or plastic tube is placed through the anterior neck and is held in place with ties around the neck)
q Suction visible entrance to inner trach tube only
q Ventilate as necessary by attaching bag-valve directly to tube (an adapter from an ET tube may be needed to make the connection
q If ventilating through stoma with uncuffed tube, block the upper airway
q Consider ALS Intercept for intubation if any concerns about airway, ventilation or patient stability
Notes:
Suctioning removes air as well as secretions. Be sure to over-ventilate for 20-30 seconds after suctioning
“Fresh” Tracheostomies (<3 months) are very fragile and have a high potential for creating a false tract if manipulated without trach tube in place – this should 
be avoided unless all other airway options have been exhausted and the patient is in extremis
Stoma Care (Basic) - Procedures
142
Procedures
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
EMR
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Suctioning Endotracheal Tube - Procedures
Procedure:
q 1. Ensure suction device is in proper working order with suction tip in place.
q 2. Preoxygenate the patient.
q 3. Attach suction catheter to suction device, keeping sterile plastic covering over catheter.
q 4. For all devices, use the suprasternal notch as the end of the airway. Measure the depth desired for the catheter (judgement must be
used regarding the depth of suctioning with Endotracheal, Cricothyrotomy and Tracheostomy tubes).
q 5. If applicable, remove ventilation devices (i.e. BVM, OPA) from the airway.
q 6. With the thumb port of the catheter uncovered, insert the catheter through the airway device.
q 7. Once the desired depth (measured in #4 above) has been reached, use a gloved finger to occlude the thumb port and remove the 
suction catheter slowly.
q 8. A small volume (<10mL) of normal saline may be used to lavage secretions as needed, with supplemental oxygen and/or ventilations x
5 tidal volumes between lavages.
q 9. Reattach ventilation device (i.e. BVM) and ventilate or assist the patient as needed.
q 10. Record the time and result of the suctioning procedure in the electronic Patient Care Report (ePCR).
143
Procedures
~ This Space Intentionally Left Blank ~
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Tracheostomy Care - Procedures
Purpose:
q To maintain a patent airway and adequate oxygenation of the patient with a temporary or permanent tracheostomy.
Clinical Indications: 
q Patient with temporary or permanent tracheostomies obstructed by secretions.
q Patient unable to replace own tracheostomy tube.
Procedure: 
Permanent Tracheostomy (upper airway structures surgically removed and trachea surgically attached to skin stoma)
q Suction through opening in neck (upper airway is surgically absent and aspiration not possible)
q If secretions are very thick, instill 2.5-5mL NS to liquefy secretions
q Ventilate as necessary through stoma
q Consider intubation
q Insert ET tube through stoma until cuff is past opening
q Inflate cuff with 6-8mL of air
q Auscultate bilaterally over axilla and stomach to confirm placement
q Connect end-tidal CO2 monitoring as standard
q Secure ET tube
q ET tube may only be shortened to where the balloon inflation line separates from the tube
Temporary Tracheostomy (a metal or plastic tube is placed through the anterior neck and is held in place with ties around the neck)
q Suction through inner trach tube
q If secretions are very thick, instill 2.5-5mL NS to liquefy secretions
q If outer tube has been displaced or is blocked, remove and replace it with patient’s spare tube or an ET tube
q Ventilate as necessary by attaching bag-valve directly to tube (an adapter from an ET tube may be needed to make the connection
q If ventilating through stoma with uncuffed tube, block the upper airway
q Consider intubation
IF ABLE To Intubate Through Stoma
q Remove tracheostomy tube
q Insert ET tube through stoma until cuff is past skin opening
q Inflate cuff with 6-8mL of air
q IF uncuffed ET tube was used, upper airway must be blocked when ventilating
q Auscultate bilaterally over the axilla and stomach to confirm placement
q Connect End-tidal CO2 monitoring as standard
q Secure ET tube
q ET tube may only be shortened to where the balloon inflation line separates from the tube
IF NOT ABLE To Intubate Through Stoma
q Intubate through upper airway
q Pass cuff of tube BELOW stoma opening in anterior neck (partner or assistant to visually verify externally)
q Inflate cuff with 6-8mL of air
q Ventilate, blocking opening in anterior neck
q Auscultate bilateally over axilla and stomach to confirm placement
q Connect End-tidal CO2 monitoring as standard
q Secure ET tube
q No shortening of ET tube permitted
Notes:
q Suctioning removes air as well as secretions. Be sure to over-ventilate for 20-30 seconds after suctioning
q “Fresh” Tracheostomies (<3 months) are very fragile and have a high potential for creating a false tract if manipulated without trach tube in place – this
should be avoided unless all other airway options have been exhausted and the patient is in extremis
144
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Tracheostomy Care - Procedures
145
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Continuous Positive Airway Pressure (CPAP) -
Procedures
Prepare All Procedure Specific Materials:
q Medical Director approved Continuous Positive Airway Pressure (CPAP) Device as per manufacturer written procedure.
Procedure:
q 1. Attach cardiac monitor, End-tidal CO2 (EtCO2) and continuous pulse oximetry (SpO2).
q 2. Assemble device according to manufacturer procedure. Attach supplemental Oxygen per manufacturer procedure.
q 3. Verbally instruct patient and coach breathing with the device.
 Patient must be able to follow commands and interact with EMS Provider to use this tool effectively.
q 4. Instruct patient to slowly breathe in through the nose and exhale through the mouth .
 Inhalation to exhalation ratio should be roughly 4:1.
q 5. Set positive end-expiratory pressure (PEEP) to 5cmH₂O.
q 6. Secure mask in place with head strap.
q 7. Reassess patient and titrate PEEP to desired effect, per protocol.
q 8. Record and monitor vital signs, EtCO2, and SpO2 frequently.
 Changes in patient condition, patient complaint or clinical picture should all result in repeat of full VS and documentation.
q 9. In the event of worsening respiratory status after initiation of CPAP:
 Evaluate patient compliance and offer reassurance, verbal coaching if appropriate.
 Remove CPAP mask and stop treatment if patient unable to tolerate CPAP OR if clinically deteriorating.
 Institute BLS and ALS care per appropriate protocol.
 Document adverse reactions, and reasons why CPAP was discontinued in electronic Patient Care Report (ePCR).
Consider CPAP protocol if:
q Tachypnea, nasal flaring, subcostal/intercostal retractions, tracheal tugging
q Suspected bronchospasm on clinical exam
q Rales suggesting pulmonary edema and patient with history of congestive heart failure (CHF) or renal insufficiency
q Respiratory rate >25 per minute
q Oxygen saturation <93% on high flow Oxygen
Contraindications
q Respiratory Arrest
q Agonal Respirations
q Unconsciousness or obtundation
q Shock associated with cardiac insufficiency
q Persistent nausea and vomiting
q Facial anomalies or trauma
q Inability to cooperate with the procedure
q Current tracheostomy
~ This Space Intentionally Left Blank ~
146
Procedures
B EMT
A A-EMT
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Capnography - Procedures
Nasal End-tidal CO2 (EtCO2)
Procedure:
q 1. Attach capnography tubing to device
q 2. Attach tubing to patient (may supplement with NRB mask if needed)
q 3. Record readings initially and throughout treatment as with other vital signs
q 4. Document the procedure and results on/with the electronic Patient Care Report (ePCR)
Advanced Airway End-tidal CO2 (EtCO2)
Procedure:
q 1. Attach capnography sensor to Advanced Airway.
q 2. Note CO2 level and waveform. 
q 3. Record readings on scene, en route to the hospital and upon patient delivery to receiving facility.
q 4. Any loss of EtCO2 detection of waveform indicates an airway problem – recheck tube placement and remove if appropriate
q 5. End-tidal CO2 goal is 40mmHg
 Above 45mmHg, increase ventilation rate
 Below 35mmHg, slow down ventilation rate
q 6. Document the procedure and results on/with the Patient Care Report (PCR)
http://kidocs.org/wp-content/uploads/2013/11/HYPOVENTILATION.png
http://kidocs.org/wp-content/uploads/2013/11/OESOPHAGEAL-INTUBATION.png
http://kidocs.org/wp-content/uploads/2013/11/ONSTRUCTION.png
147
Procedures
B EMT
A A-EMT
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Cricothyrotomy - Procedures
 When all airway interventions have failed and the patient needs a secure airway immediately, consider performing cricothyrotomy. The 
percutaneous approach is preferred to the open.
 If the patient is not able to be ventilated via BVM, ETT or BIAD and the Paramedic feels a surgical airway is necessary, Medical Control
should be contacted first. If time and situation do not allow it, this Procedure may be completed prior to authorization by Medical Control.
Prepare All Procedure Specific Materials:
q 14 gauge or larger IV catheter
q Needle
q 10 mL syringe
q Adapter from a 3.0mm ETT
q Saline
q Alcohol pad
q 4x4 gauze pad
q Tape
q Suction
Procedure:
q 1. Position patient supine in the sniffing position with slight extension of the neck – identify landmarks of the cricothyroid membrane by
palpation utilizing anatomical landmarks (below the thyroid cartilage and above the cricoid cartilage). 
q 2. Cleanse anterior neck
q 3. Fill a 10mL syringe with 5mL of 0.9% Normal Saline
q 4. Remove dilator from the package and sheath and advance into the tracheostomy tube
q 5. Insert the splitting needle perpendicular to the skin and cricothyroid membrane while gently holding negative pressure and as pirating
with the syringe. Upon entering the trachea there will be a loss of resistance and free flow of air with bubbles flowing easily into the 
syringe.
q 6. Drop the angle of the needle > 45 degrees and aim the tip of the needle toward carina (toward the feet) and complete insertion of
needle, while continuing to aspirateto ensure the needle remains in the trachea.
q 7. While stabilizing the needle in place, disconnect the needle form the syringe and advance guidewire (attached to the dilator) into the
hub of the splitting needle until resistance is met.
q 8. Squeeze wings of needle together. The needle should split in half and allow the guidewire/dilator to be advanced. 
q 9. When the dilator meets resistance at the skin, remove the needle by pulling in opposite directions, while securing the guidewire in the
trachea and the dilator at the skin.
q 10. Place thumb on dilator knob while first and second fingers are curved under flange of trachea tube . With gentle, continuous
pressure, advance the dilator and tracheostomy tube into position until flange is secure against the skin.
q 11. Remove dilator and inflate cuff until device is secure in the airway (max 5mL). 
q 12. Attach EtCO2 and BVM. 
q 13. Secure tube in place using the provided twill tape behind the neck of the patient.
q 14. Confirm placement with gentle ventilation via BVM, continuous digital waveform capnography, and physical exam. Be sure air
movement is fluid with bilateral symmetric chest rise and that no visible neck or soft-tissue distortion is noted
q 15. If tracheal placement is unclear, remove device and transport immediately to the closest Emergency Department.
q 16. Consider Sedation Protocol as appropriate.
q 17. If not previously done, immediately contact receiving facility and Medical Control
148
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Cricothyrotomy (Open) Surgical - Procedures
Clinical Indication: 
q Failed airway management when standard airway procedures cannot be performed or have failed in an adult patient that requires airway
management.
q Upper airway obstruction (eg. facial or neck trauma occluding airway patency, foreign body unable to be removed, angioedema) and
inability to adequately oxygenate and ventilate using less invasive methods.
q If Possible Contact Medical Control Before Proceeding. If not possible, notify receiving hospital as soon as possible. 
Prepare All Procedure Specific Materials:
q Scalpel
q Antiseptic swab
q 6.0 mm endotracheal tube
q 10cmL syringe
q Tracheal hook (if available)
q Bougie device 
q Continuous Digital Waveform Capnography
Procedure: 
q 1. Have suction and supplies available and ready. 
q 2. Position patient supine in the sniffing position with slight extension of the neck – identify landmarks of the cricothyroid membrane by
palpation utilizing anatomical landmarks (below the thyroid cartilage and above the cricoid cartilage). 
q 3. Prep the area with an antiseptic swab. 
q 4. Using the non-dominant hand, spread the overlying skin taut with the thumb and fingers, and slightly depress the skin over the
cricothyroid membrane with the index finger to mark the site of cricothyrotomy. Do not release the non-dominant hand from the neck 
until the procedure is complete. Once the anatomy is found and defined, avoid movement of the anatomy to promote proper 
cricothyrotomy airway placement.
q 5. Using a sterile scalpel, make a vertical incision in the mid-line of the neck extending from just above the lower edge of the thyroid
cartilage to the middle of the cricoid cartilage. Make the depth of this incision sufficient to extend through the skin and fatty tissue 
underneath.
q 6. Using the same scalpel, make a short horizontal incision in the middle of the cricothyroid membrane into the trachea.
 If a tracheal hook is available: prior to removing scalpel from incision, use a tracheal hook to pull anterior and inferior on the thyroid
cartilage (lower edge of horizontal incision). Exercise caution when manipulating the tracheal hook into the incision – the tip of most 
tracheal hooks is particularly sharp-edged.
 If tracheal hook is not available: a bougie device should be used as introducer into the tracheal opening prior to passing the ET tube. 
q 7. Pass a 6.0mm Endotracheal Tube through the horizontal incision in the cricothyroid membrane , angling the tube inferior and
posterior along the tracheal anatomy.
q 8. Inflate the endotracheal cuff with 5-10mL of air and verify airway placement with EtCO2 (continuous digital capnography
monitoring) and physical exam (chest rise, breath sounds). 
q 9. Confirm placement with gentle ventilation via BVM, continuous digital waveform capnography, and physical exam. Be sure 
air movement is fluid with bilateral symmetric chest rise and that no visible neck or soft-tissue distortion is noted
q 10. If tracheal placement is unclear, remove device and transport immediately to the closest Emergency Department.
q 11. Consider Sedation Protocol as appropriate.
q 12. If not previously done, immediately contact receiving facility and Medical Control
q 13. Continually monitor for respiratory changes during transport, especially after any patient movement/transfers. 
q 14. Monitor for complications (ie hemorrhage, expanding neck hematoma, dislodgement).
q 15. Document procedure. 
Contraindications:
q Ability to oxygenate and ventilate using less invasive 
methods.
q Pediatric Patients
q Suspected fractured larynx and/or cricoid cartilage
q Suspected tracheal transection
q Inability to find anatomical landmarks
149
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Control-Cric - Procedures
 When all airway interventions have failed and the patient needs a secure airway immediately, consider performing cricothyrotomy. The 
percutaneous approach is preferred to the open.
 If the patient is not able to be ventilated via BVM, ETT or BIAD and the Paramedic feels a surgical airway is necessary, Medical Control
should be contacted first. If time and situation do not allow it, this Procedure may be completed prior to authorization by Medical Control.
Prepare All Procedure Specific Materials:
q Control-Cric Kit
q Alcohol pad
q 4x4 gauze pad
q Tape
q Suction
Procedure:
q 1. Position patient supine in the sniffing position with slight extension of the neck – identify landmarks of the cricothyroid membrane by
palpation utilizing anatomical landmarks (below the thyroid cartilage and above the cricoid cartilage). 
q 2. Cleanse anterior neck
q 3. If Right-Handed, operator should be positioned on the right side of the patient; if Left-Handed, operator should be positioned
on the left. Operator should stabilize the larynx with the thumb and middle finger of non-dominant hand. Identify the 
cricothyroid membrane, typically 4 finger breadths below the mandible and 3 finger breadths above the sternal notch.
q 4. Use the Cric-Knife to incise the skin. A vertical incision should be made initially to allow positive identification of the
cricothyroid membrane. Once the cricothyroid membrane has been identified, rotate the knife horizontally and make a single, 
perpendicular “plunge” incision through the membrane.
q 5. Once the horizontal incision is made, maintain downward pressure on the knife; do NOT remove knife from the tracheal opening. Slide
the attached tracheal hook through the newly formed stoma until it “pops” through the cricothyroid membrane and stops against the 
posterior wall of the trachea. With your non-dominant hand, grab the handle of the tracheal hook and pull back on the thyroid 
cartilage to hold stable placement.
q 6. While maintaining traction with the trach hook, insert the Cric-Key through the incision. Confirmation of proper placement can be
made by moving the Cric-Key along the anterior wall of the trachea and feeling the tracheal rings with the device . Once correct 
placement is obtained, insert the Cric-Key tube down to level of the flange. Flange should rest on the patient’s anterior neck.
q 7. Rotate the Cric-Key towards patient shoulder and retract to remove from airway .
q 8. Firmly stabilize the Cric-Key tube and remove the Cric-Key introducer with slow, steady pull. Inflate the cuff until resistance is met. 
q 9. Ventilate with BVM and 100% O2.
q 10. Confirm placement with gentle ventilation via BVM, continuous digital waveform capnography, and physical exam. Be sure air
movement is fluid with bilateral symmetric chest rise and that no visible neck or soft-tissue distortion is noted.
q 11. Secure tube with supplied tube holder. 
q 12. Observe for subcutaneous air, which may indicate tracheal injury or extra-tracheal tube position. 
q 13. If tracheal placement is unclear, remove device and transport immediately to the closest Emergency Department.
q 14. Consider Sedation Protocol as appropriate.
q 15. If not previously done, immediately contact receiving facility and Medical Control
Procedures
150
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Needle Jet Insufflation - Procedures
 When all airway interventions have failed and the patient needs oxygenation immediately, consider performing needle jet insufflation. 
 If the patient is not able to be ventilated via BVM, ETT or BIAD and the Paramedic feels needle jet insufflation is necessary, Medical Control
should be contacted first. If time and situation do not allow it, this Procedure may be completed prior to authorization by Medical Control.
Clinical Indications:
Life threatening upper airway obstruction where all other BLS and ALS maneuvers and techniques have failed .
Procedure:
q 1. Use personal protective equipment, including gloves, gown and mask as indicated.
q 2. Locate the cricothyroid membrane and prep the area with antiseptic wipe
q 3. Extend the neck to bring the cricothyroid membrane anterior and as close to the skin as possible
q 4. Insert the #10 gauge angiocath through the membrane at 90° to the skin until loss of resistance
 Use a 3mL syringe and apply negative pressure to confirm free aspiration of air and needle presence in the trachea
 Consider using a second angiocath through the same insertion site if first needle becomes occluded during procedure
q 5. Drop the angle of the needle to approximately 60° with the tip aimed toward the patient’s feet 
 Continue negative pressure on the syringe to confirm continued placement in the trachea
q 6. Attach the 7.0 Endotracheal Tube BVM adapter to the end of the syringe
q 7. Ventilate at a ratio of 1:5 inhalation:exhalation
q 8. If the airway resistance continues to increase, disconnect the BVM to allow for exhalation
 Consider addition of second angiocath for use as an exhalation port
q 9. If subcutaneous emphysema develops, stop insufflation and remove angiocath
 Repeat steps 2-7 as above
q 10. Notify the receiving facility of Failed Airway Protocol use and need for Needle Jet Insufflation.
q 11. Document the procedure and patient response to care in the electronic Patient Care Report (ePCR).
151
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Blood Glucose Analysis - Procedures
Prepare All Procedure Specific Materials:
q Glucometer
q Test Strip
q Lancet
q 2x2 gauze pad
q Alcohol prep pad
q Bandage
Procedure:
q 1. Select appropriate site.
q 2. Blood samples for performing glucose analysis may be obtained simultaneously with intravenous access when possible .
q 3. Cleanse site appropriately with alcohol prep.
q 4. Puncture skin with lancet.
q 5. Dispose of sharps in proper container.
q 6. Wipe first drop of blood with 2x2 gauze.
q 7. Place correct amount of blood on reagent strip or site on glucometer per the manufacturers instructions.
q 8. Apply direct pressure and cover site with bandage as needed.
q 9. If result does not fit patient clinical picture:
 Consider presumptive management per Diabetic Emergencies Protocol while reassessing .
 Consider equipment error, may redraw sample and repeat analysis.
q 10. Record the time and result of the blood glucose analysis in the electronic Patient Care Report (ePCR).
~ This Space Intentionally Left Blank ~
152
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Carbon Monoxide Measurement - Procedures
Procedure:
q 1. Apply probe to patient’s digit(s) as recommended by the manufacturer. If near strobe lights, cover the finger to avoid
interference and/or move away from the lights if possible. Where the manufacturer provides a light shield it should be used.
q 2. Allow machine to register percent circulating carboxyhemoglobin values
q 3. Verify pulse rate on machine with palpated pulse of the patient
q 4. Record levels in electronic Patient Care Report (ePCR) or on the scene rehabilitation form
 If CO <5%, assess for other possible illness or injury
 If CO >5% to <15% and symptomatic from Carbon Monoxide – treat per Carbon Monoxide Exposure Protocol
 If CO >15% - treat per Carbon Monoxide Exposure Protocol
Signs and symptoms of Carbon Monoxide (CO) poisoning – altered mental status, dizziness, headache, nausea/vomiting, chest pain, 
respiratory distress, neurological impairments, vision problems, reddened eyes, tachycardia, tachypnea, arrhythmias, seizures and/or coma.
q 5. Monitor critical patients continuously with continuous pulse oximetry (SpO2) and SpCO until arrival at the hospital.
q 6. Document percent of carboxyhemoglobin values every time vital signs are recorded during therapy for exposed patients.
q 7. Use the SpO2 feature of the device as an added tool for patient evaluation. Treat the patient, not the data provided by the 
device. Utilize the relevant protocol for guidance.
q 8. The SpO2 reading should never be used to withhold oxygen from a patient with respiratory distress or complaining of shortness of
breath.
q 9. Factors which may reduce the reliability of the reading include:
 Poor peripheral circulation (hypovolemia, hypotension, hypothermia).
 Excessive external lighting, particularly strobe/flashing lights
 Excessive sensor motion.
 Fingernail polish (should be removed with acetone pad).
 Irregular heart rhythms (atrial fibrillation, SVT, etc.).
 Jaundice.
 Placement of BP cuff on same extremity as SpO2 probe.
CO poisoning can look a lot like influenza, particularly in the winter months. Have a high index of suspicion when seeing multiple patients 
from the same environment with flu-like illnesses and consider Carbon Monoxide.
153
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Synchronized Cardioversion - Procedures
Procedure:
q 1. Ensure the patient is attached properly to a cardiac monitor/defibrillator capable of synchronized cardioversion.
q 2. Have all equipment prepared for unsynchronized cardioversion/defibrillation, if the patient fails synchronized cardioversion and/or the
clinical condition worsens.
q 3. Firmly apply defib pads to patients chest – assure it is clean, dry, with minimal chest hair.
q 4. Consider the use of Sedation Protocol, as appropriate.
q 5. Set energy selection to the appropriate setting, per Protocol.
q 6. Set monitor/defibrillator to synchronized cardioversion mode, per manufacturer’s instructions.
q 7. Make certain all personnel are clear of the patient.
q 8. PRESS and HOLD the “Shock” button to deploy the charge and cardiovert. Stay clear of the patient until you are certain the energy has
been delivered. 
 NOTE: It may take the monitor/defibrillator several cardiac cycles to “synchronize”, so there may be a delay between activating the
cardioversion and the actual delivery of energy.
q 9. Note patient response – immediately refer to Appropriate Cardiac Dysrhythmia Protocol.
 Document patient response to intervention, VS and clinical condition as situation permits.
q 10. Repeat per protocol until maximum setting or until efforts successful.
q 11. Note procedure, response, and times in electronic Patient Care Report (ePCR).
~ This Space Intentionally Left Blank ~
154
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Cardiopulmonary Resuscitation - Procedures
Procedure:
q 1. Check for responsiveness and feel for a pulse
 Carotid pulse for adults and older children, brachial or femoral pulse for infant
q 2. If compressions are ongoing on EMS arrival, evaluate rate and depth while attaching the Cardiac Monitor OR AED
 If compressions adequate, charge the monitor for rhythm analysis and shock evaluation immediately if appropriate OR begin AED
analysis
 If no compressions OR felt to be inadequate, initiate high quality chest compressions at >100 compressions per minute for two
minutes.
q 3. Open the patient’s airway
 Head-tilt, chin-lift technique if no head or neck trauma suspected
 Jaw-thrust if head or neck trauma suspected or unknown
q 4. For arrests without advanced airway, perform compressions:breaths as age appropriate
 Once advanced airway established, transition to >100 compressions per minute uninterrupted with 8-10 breaths per minute.
q 5. At first rhythm analysis:
 If shock advised by AED or interpreted as V-fib / Pulseless V-tach, defibrillate and notify dispatch of first defibrillation time.
 If no shock advised by AED or interpreted to be non-shockable, discard shock and continue.
q 6. At 2 minutes if no response to resuscitation, consider advanced airway placement (BIAD or ETT) if situation and clinical
presentation appropriate.
 If good chest rise and air exchange achieved, it is acceptable to continue BVM with an airway adjunct (NPA or OPA)
q 7. Begin charging the monitor to prepare for defibrillation approximately 20 seconds before the 2 minute mark
q 8. At every 2 minute mark (200 chest compressions)
 Rotate compressors (as allowed by personnel on scene)
 Perform a rhythm and pulse check.
q If V-fib / Pulseless V-tach, deliver shock as per Appropriate Cardiac Arrest Protocol
 Medications delivered after shock as per Appropriate Cardiac Arrest Protocol
q If no shockable rhythm, safely dump pending charge to prevent negligent discharge and/or responder injury.
 Medications delivered after decision as per Appropriate Cardiac Arrest Protocol
q 9. Resume compressions at 100 per minute, ventilations at 8-10 breaths per minute (as age appropriate if no advanced airway).
 Minimize interruptions in chest compressions as much as possible.
q 10. Repeat steps 7-9 until change in patient condition or decision made to terminate resuscitation after 20 minutes (4 rounds of
ACLS medications)
q 11. Contact Medical Control as needed for orders or with any questions.
Age Location Depth Rate
Neonate
Lower 1/3 of the sternum, 
between nipples, 2 thumbs 
technique
(1/3 of the anterior-posterior 
chest dimension)
90 compressions and 30 
breaths per minute 
1 or 2 Rescuers - 3:1
Infant (<1 year excluding 
newborns)
Over sternum, between 
nipples (inter-mammary 
line), 2-3 fingers
1.5 inches (1/3 the anteriorposterior chest dimension)At least 100-120 per minute 
1 Rescuer - 30:2 
2 Rescuers - 15:2
Child (1 year to puberty)
Over sternum, between 
nipples (inter-mammary 
line), heel of one hand
2 inches (1/3 the anteriorposterior chest dimension)At least 100-120 per minute 
1 Rescuer 30:2 
2 Rescuers 15:2
Adult (puberty through 
adulthood)
Over sternum, just above the 
xyphoid process, hands with 
interlocked fingers
At least 2 inches (1/3 the 
anterior-posterior chest 
dimension)
At least 100-120 per minute 
1 or 2 Rescuers - 30:2 155
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

High Performance CPR - Procedures
High Performance CPR is a basis for increasing communication and efficiency during resuscitation of a cardiac arrest. It is based on four guiding principles taken from proven 
tactics developed by The Resuscitation Academy in Seattle, WA:
q 1. “BLS owns CPR” - focusing on fundamentals, predetermined roles, coordinated movement and minimized interruptions WILL improve outcomes
q 2. “It isn’t complicated, but it isn’t easy.” Standardizing care across EMS systems takes time but ultimately improves efficiency and patient outcomes.
q 3. “Measure, improve, measure, improve...” - tracking our survival rates and making incremental improvements WILL have enormous effects
q 4. “Everyone in V-Fib survives” - If we can get to patients who are in shockable rhythms – OR use HPCPR to get them back to shockable – plan on getting ROSC!
2 Person Resuscitation Crew
#1 – Compressor (Patient Right)
q Checks Pulse - <10 seconds
q Immediately starts CPR (100-120 / minute)
q 30:2 Compressions:Ventilations
q Don’t pause compressions until #2 (Airway) ready
#2 – AED / Airway (Patient Left)
q Applies pads without interrupting compressions
q Operates AED / Monitor (if manual, charge at 1min45sec)
q Manages Airway – OPA with BVM
 (Advanced Airway placed at 6minutes or as resources 
allow) 1
q Alternates with Compressor every 2 minutes
2
3+ Person Resuscitation Crew
#1 – Compressor (Patient Right)
q Checks Pulse - <10 seconds
q Immediately starts CPR (100-120 / minute)
q Alternates every 2 minutes
#2 – AED (Patient Left)
q Applies pads without interrupting compressions
q Operates AED / Monitor (if manual, charge at 1min45sec)
#3 – Airway (Patient Head)
q Alternates with Compressor every 2 minutes
q Manages Airway – OPA with BVM
 (Advanced Airway placed at 6minutes or as resources 
allow)
#4 – Team Leader (Patient Foot)
q Oversight of Care
q Monitors time
q Liaison with Family, Obtains patient history
#5 – Access / ALS 1 (Patient Left Shoulder)
q Obtain IV / IO Access 
q Initiate ACLS meds
q Transition to manual defib when reasonable
#6 – Airway / ALS 2 (Patient Right Shoulder)
q Manages Advanced Airway, if not already done
q Manages Monitor and ALS interventions as needed
Additional Providers
q Rotate with Compressors
q Assist with Family and obtaining patient history
2
Procedures
BLS owns CPR – depth 2-2.4 inches, rate 100-120 compressions minute, rock palms to allow chest recoil, rotate in <5 sec, hover hands during shock delivery
Eliminate ALL unneccessary interruptions in compressions – coordination and communication among expert resuscitationists, count down the last 15sec
Controlled ventilations – 1 second breath delivery, 350-500mL (just enough for chest rise); with advanced airway, 1 breath every 10sec (6x/min) with same volume
AED / Monitor integration – begin charges BEFORE rhythm / pulse check to defibrillate ASAP, hover hands to keep compression delays to a minimum
Metronome always on for cardiac arrests, set to 110bpm
At 6 minutes or as soon as practical, apply mechanical CPR device; monitor for migration of device, particularly before/after patient movement
3 4
5 (ALS)
6(ALS) 1
156
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Defibrillation - Procedures
Automated
Procedure:
q 1. If multiple rescuers available, one rescuer should provide uninterrupted chest compressions while the AED is being prepared for use
q 2. Remove any medication patches on the chest and wipe off any residue
q 3. Apply defibrillator pads per manufacturer recommendations. Use alternate placement when implanted devices (pacemakers, AICDs)
occupy preferred pad positions (front/back or shifted slightly to not rest on the implanted device).
q 4. If necessary, connect defibrillator leads, per manufacturer recommendations
q 5. Activate AED for analysis of rhythm
q 6. Stop chest compressions and clear the patient for rhythm analysis. Keep interruption in chest compressions as brief as possible
q 7. Assertively state “CLEAR” and visualize that no one, including yourself, is in contact with the patient prior to defibrillation. 
q 8. Defibrillate if appropriate by depressing the “shock” button. Biphasic defibrillators will determine the correct joules
accordingly
q 9. Continue to follow protocol
q 10. Record the time and result of the analysis in the electronic Patient Care Report (ePCR).
Manual
Procedure:
q 1. If multiple rescuers available, one rescuer should provide uninterrupted chest compressions while the Monitor is being prepared for
use
q 2. Remove any medication patches on the chest and wipe off any residue
q 3. Apply defibrillator pads per manufacturer recommendations. Use alternate placement when implanted devices (pacemakers, AICDs)
occupy preferred pad positions (front/back or shifted slightly to not rest on the implanted device). Refer to pictures for pediatric 
placement.
q 4. If necessary, connect defibrillator leads, per manufacturer recommendations
q 5. Charge the defibrillator per protocol. Continue chest compressions while the defibrillator is charging
q 6. Pause chest compressions and determine if shockable after reviewing rhythm for max of 5 seconds. 
q 7. Assertively state “CLEAR” and visualize that no one, including yourself, is in contact with the patient prior to defibrillation.
q 8. Defibrillate if appropriate by depressing the “shock” button. 
q 9. If non-shockable discard the shock, per manufacturer recommendations
q 10. Continue to follow protocol
q 11. Record the time and result of the analysis in the patient care report (PCR).
157
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
B EMT
A A-EMT
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Double Sequential Defibrillation - Procedures
Clinical Indications: 
q Patients with refractory or recurrent ventricular fibrillation (V-fib) or pulseless ventricular tachycardia (V-tach) or shockable rhythm per AED
analysis that has not responded to >3 standard defibrillation attempts.
Procedure: 
q 1. Ensure all necessary cardiac arrest interventions have been applied up to this point.
 Uninterrupted and effective CPR.
 Defibrillation at maximum output for at least three rounds of shocks (including first responder AED shocks, if applicable).
 Administration of Amiodarone 300mg.
 Consideration of other possible causes of cardiac arrest.
q 2. Upon decision to attempt Double Sequential Defibrillation, the first set of pads should be removed from the patient
q 3. Apply the manual defibrillator in the parasternal / axillary positions as shown in the figure below (blue pads)
 The first rhythm check after moving the pads should be completed as a single shock, as previous
q 4. Apply an AED in the anterior / posterior positions as shown in the figure below (red pads)
 Assure that the two sets of pads do not contact one another
q 3. Select maximum energy setting for both devices. Charge devices in advance of the anticipated break in CPR and ensure chest 
compressions continue while both devices are being charged.
q 4. At next rhythm analysis, if patient remains in ventricular fibrillation (V-fib) or pulseless ventricular tachycardia (V-tach) OR shock
advised by AED:
 Clear patient.
 Deliver double sequential defibrillation by having two operators depressing both “Shock” buttons simultaneously.
q 5. Once criteria are met for dual sequential defibrillation, all subsequent shocks delivered shall be using this method.
NOTE:
q There is the potential to cause damage to equipment when performing this procedure . Therefore, it is recommended that attempts be
made to perform Double Sequential Defibrillation using an AED in combination with a monitor to reduce risk .
q The case reports of equipment failure have not indicated the mechanism of damage; the steps above are an attempt to improve patient
outcome while mitigating risk, but have not been proven to change outcomes. 
q Because of the potential for adverse equipment results, it is important that your Service Director and Medical Director approve this
procedure BEFORE attempting.
q Devices used for Double Sequential Defibrillation should be removed from service until a full evaluation and function check can be
completed to ensure safety of subsequent patients.
158
Parasternal / Axillary Pad Positions 
(Blue Pads)
Anterior / Posterior Pad Positions 
(Red Pads)
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

External Cardiac Pacing - Procedures
Procedure:
q 1. Attach standard cardiac monitor.
q 2. Apply defibrillation/pacing pads per manufacturer recommendations.
 One pad to left mid chest next to sternum, one pad to left mid posterior back next to spine.
q 3. Place monitor into pacing mode, as specified by manufacturer.
q 4. Adjust heart rate to 70bpm for an adult, 100bpm for pediatric patients.
q 5. Note pacer spikes on EKG screen.
q 6. Slowly increase output until capture of electrical rhythm is noted on the monitor.
q 7. If unable to capture while at maximum current output, stop pacing immediately.
q 8. If capture observed on monitor, check for corresponding pulse and assess vital signs.
q 9. Mechanical capture occurs when paced electrical spikes on the monitor correspond with palpable pulse .
q 10. Consider Sedation Protocol as appropriate.
q 11. Document the dysrhythmia and the response to external pacing with ECG strips in the electronic Patient Care Report (ePCR).
~ This Space Intentionally Left Blank ~
159
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Mechanical CPR Device (LUCAS) - Procedures
Clinical Indications:
 May be used in patients 12 years of age or greater requiring chest compressions related to cardiac arrest.
Contraindications:
 Patients <12 years
 Patients suffering traumatic cardiac arrest or patients with obvious signs of traumatic injury
 Patients who do not fit within the device:
Too large and with whom you cannot press the pressure pad down 2 inches
Too small and with whom you cannot pull the pressure pad down to touch the sternum
Procedure:
q All therapies related to the management of cardiopulmonary arrest should be continued as currently defined .
q Initiate resuscitative measures following protocol – DO NOT DELAY MANUAL CPR FOR THE DEVICE. CONTINUE MANUAL CPR UNTIL THE 
DEVICE CAN BE PLACED
q Detailed instructions for LUCAS device follow:
q 1. While resuscitative measures are initiated, the LUCAS device should be removed from its carrying device and placed on the patient in
the following manner
q 2. The Backplate should be centered on the nipple line and the top of the backplate should be located just below the patients armpits
q 3. In cases which the patient is already on the stretcher, place the backplate underneath the thorax. This can be accomplished by logrolling the patient or raising the torso (placement should occur during a scheduled discontinuation of compressions [ie. After five 
cycles of 30:2 or two minutes of uninterrupted compressions])
q 4. Position the compressor
q 5. Turn the LUCAS Device on (the device will perform a 3 second self test)
q 6. Remove the LUCAS device from its carrying case using the handles provided on each side
q 7. With the index finger of each hand, pull the trigger to ensure the device is set to engage the backplate. Once this is complete you may
removed your index finger from the trigger loop
q 8. Approach the patient from the side opposite the person performing manual chest compressions
q 9. Attach the claw hook to the backplate on the side of the patient opposite that where compressions are being provided .
q 10. Place the LUCAS device across the patient, between the staff members’ arms who is performing manual CPR
q 11. At this point the staff member performing manual CPOR stops and assists attaching the claw hook to the backplate on their sid e
q 12. Pull up once to make sure that the parts are securely attached
160
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Mechanical CPR Device (LUCAS) - Procedures
Procedure Continued:
q 13. Adjust the height of the compression arm
q 14. Use the two fingers (V pattern) to make sure that the lower edge of the Suction Cup is immediately above the end of the sternum. 
If necessary, move the device by pulling the support legs to adjust the position
q 15. Press the Adjust Mode Button on the control pad labeled #1 (this will allow you to easily adjust the height of the compression arm)
q 16. To adjust the start position of the compression arm, manually push down the SUCTION CUP with two fingers onto the chest (without
compressing the patient’s chest)
q 17. Once the position of the compression arm is satisfactory, push the green PAUSE button labeled #2 (This will lock the arm in this
positon), then remove your fingers from the SUCTION CUP
q 18. If the position is incorrect, press the ADJUST MODE BUTTON and repeat the steps
q 19. Start Compressions
q 20. If the patient in not intubated and you will be providing compression to ventilation ratio of 30:2 push ACTIVE (30:2) button to
start
q 21. If the patient is intubated and you will be providing continuous compressions push ACTIVE (continuous) button
q 22. Place the neck roll behind the patient’s head and attach the straps to the LUCAS device (this will prevent the LUCAS from migrating
toward the patient's feet
q 23. Place the patients arms in the straps provided
-Defibrillation can and should be performed with the LUCAS device in place and in operation
-One may apply the defibrillation electrodes either before or after the LUCAS device has been put in position
-The pads and wires should not be underneath the suction cup
-If the electrodes are already in an incorrect position when the LUCAS is placed, you must apply new electrodes
-If the rhythm strip cannot be assessed during compressions, one may stop the compressions for analysis by pushing the PAUSE BUTTON (The 
duration of interruption of compressions should be kept as short as possible and should not be > 10 seconds. There is no need to interrupt
chest compressions other than to analyze the rhythm).
-Once the rhythm is determined to require defibrillation, the appropriate ACTIVE BUTTON should be pushed to resume compressions while the 
defibrillator is charging and then the defibrillator should be discharged .
161
Procedures
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Clinical Indications:
 May be used in patients 12 years of age or greater requiring chest compressions related to cardiac arrest.
Contraindications:
 Patients <12 years
 Patients suffering traumatic cardiac arrest or patients with obvious signs of traumatic injury
 Patients who do not fit within the device:
>300lbs or too small to get adequate tightening of the band; in both, compressions delivered will be ineffective
System Components:
 AutoPulse platform – Patient Surface
 LifeBand
 AutoPulse Battery and Battery Charger
Procedure:
q All therapies related to the management of cardiopulmonary arrest should be continued as currently defined .
q Initiate resuscitative measures following protocol – DO NOT DELAY MANUAL CPR FOR THE DEVICE. CONTINUE MANUAL CPR UNTIL THE 
DEVICE CAN BE PLACED
q Detailed instructions for AutoPulse device follow:
q 1. Power up the device using the ON/OFF button located on the top edge of the device
q 2. Make sure no user advisory, fault or system error messages display
q 3. Open the Velcro LifeBand Chest Compression Assembly (CCA)
q 4. At first practical 2 minute interval and coordinated with rotation of compressors, sit patient up by pulling the patient’s arms
forward (use C-collar and manual stabilization if concern for C-spine injury)
 Make a single cut down the back of any clothing at this time, in order to facilitate removal and placement of device
Mechanical CPR Device (AutoPulse) - Procedures
162
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Procedure (continued):
q 5. Slide the AutoPulse device behind the patient and lower the patient down onto the device , centering the supine patient with the
armpits just above the YELLOW line
q 6. Locate mating slot of band 2 and place on top of band 1 already on chest. Press the bands together to engage and secure the Velcro
fastener. Make sure the bands are not twisted
 If bands cannot be closed, use manual chest compressions instead
q 7. Press and release the START/CONTINUE button once. The AutoPulse automatically adjusts the band to the patient’s chest and
determined the appropriate compression
 Do not touch the patient or the LifeBand CCA while the AutoPulse is analyzing the patient’s size
q 8. Verify the patient is properly aligned and that the LifeBand CCA has taken up any slack in the bands
q 9, Press the START/CONTINUE button a second time to start compression cycles and the AutoPulse will begin chest compression cycles
q 10. Set the mode to either the pre-set compression-to-ventilations or continuous compressions option
q 11. Continue to monitor the placement of the patient on the AutoPulse after moving the patient or during transport to ensure prop er 
alignment. Using Zoll approved restraints to secure the patient to the platform is recommended.
q NOTE: Do not stop the device for more than 10 seconds after at least 2 minutes of compressions per American Heart Association’s (AHA)
CPR guidelines. Intravenous cannulation, endotracheal intubation, or any other procedure should either be attempted during chest
compressions or during the 10 second pause. Approved alternatives to those procedures, such as intraosseous infusion and a BLS airway
(example: King Tube) should be considered. Cardiac defibrillation should be attempted during a 10 second pause.
163
Procedures
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
EMR
Mechanical CPR Device (AutoPulse) - Procedures
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Chest Decompression - Procedures
164
Prepare All Procedure Specific Materials:
q 14 gauge 2–2.5 inch over the needle catheter
q Tape
q Sterile Gauze Pads
q Antiseptic swabs
q Occlusive dressing
Procedure:
q 1. Locate landmarks for needle decompression
 Site A - 2nd intercostal space in the mid-clavicular line on the same side as the pneumothorax
 Site B – 4th intercostal space in the mid-axillary line on the same side as the pneumothorax (Adult ONLY)
 (This is a relatively NEW location for Prehospital Providers and requires familiarity with the anatomy, practice and appropriate 
credentialing)
 BE AWARE of and avoid underlying anatomical structures in the chest (lung, heart, vasculature) as well as abdominal organs that 
move significantly with respiration (spleen, liver, intestine, vasculature).
q 2. Prepare the site with an antiseptic swab
q 3. Firmly introduce catheter immediately above superior edge of rib at selected site
 Remember: the neurovascular bundle (nerve, artery and vein) run under the inferior edge of the ribs)
q 4. Insert the needle perpendicular to the skin with downward pressure until there is a loss of resistance and a return of air .
q 5. Advance the needle another 1/8", to ensure the catheter is inside the thoracic cavity.
 Hold the catheter in place with one hand while removing the needle and disposing of sharps in container .
q 6. Secure the catheter taking care not to allow it to kink
 If time and situation allow, use an occlusive dressing to cover the catheter and tape on 3 sides to create a one-way valve.
q 7. Reassess lung sounds, pulses, tracheal deviation and patient clinical condition
q 8. Dress area with occlusive dressing then cover with sterile gauze pad
q 9. Reassess breath sounds and respiratory status
q 10. Document Procedure, patient response, VS and change in clinical condition in the electronic Patient Care Report 
Procedures
https://rebelem.com/what-is-the-best-anatomic-location-for-needle-thoracostomy/
A – 2
nd Intercostal Space, 
Midclavicular Line
B – 4
th Intercostal Space, MidAxillary Line
C – 4
th Intercostal Space, 
Anterior Axillary Line
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

BE-FAST Stroke Scale - Procedures
Procedure:
q 1. Assess and treat suspected stroke patients as per protocol
q 2. The BE-FAST Stroke Screen should be completed for all suspected stroke patients
q 3. Establish the “time last normal” for the patient. This will be the presumed time of onset.
q 4. Perform the screen through physical exam:
 Screen the patient for sudden loss of Balance or coordination
 Ask the patient about sudden onset of blurred vision, double vision or loss of vision in one or both Eyes
 Look for Facial droop by asking the patient to smile
 Have patient, while sitting upright or standing, extend both arms parallel to floor, close eyes, and turn their palms upward. Assess for
unilateral drift of an Arm.
 Evaluate the patient’s Speech by having the person say, “you can’t teach an old dog new tricks”, or some other simple, familiar saying. 
Assess for the person to slur the words, get some words wrong, or inability to speak.
 Confirm the Time of symptom onset; if possible, bring along witnesses or family to help corroborate information during assessment at 
the hospital
q 5. If one of these exam components is “yes”, then the stroke screen is positive
q 6. Evaluate Blood Glucose level
q 7. If the “time last normal” is <24 hours, blood glucose is between 60 and 400, and at least one of the physical exam elements is
positive, follow the Suspected Stroke Protocol, 
 Alert the receiving hospital by calling a “Stroke Alert” as early as possible.
q 8. All sections of the BE-FAST screen must be completed.
q 9. The complete screening should be documented in the electronic Patient Care Report (ePCR).
165
Procedures
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

FAST-ED Stroke Screen - Procedures
Procedure:
q 1. Assess and treat suspected stroke patients as per protocol (p64)
q 2. Establish the “time last normal” for the patient. This will be the presumed time of onset.
q 3. The FAST-ED Stroke Screen may be considered for all stroke patients with suspected Large Vessel Occlusion (LVO)
 Patients who are likely to have a LVO may benefit from transport to a Comprehensive Stroke Center
q 4. Perform the screen through physical exam:
 Look for facial palsy by asking the patient to smile
 Have patient, while sitting upright or standing, extend both arms parallel to floor, close eyes, and turn their palms upward. Assess for
unilateral weakness or drift of an arm.
 Have the person say, “you can’t teach an old dog new tricks”, or some other simple, familiar saying. Assess for the person to slur the 
words, get some words wrong, or inability to speak.
 Ask the patient to look in all four cardinal directions (up, down, left, right). Assess for the ability of the pupil to cross midline
 Assess the patient’s ability to interpret stimulus from both sides of the body.
q 5. Add up the patient score from the table (below). A score of 4 or greater has a 60-85% prediction of a large vessel occlusion
q 6. Evaluate Blood Glucose level
q 7. If the “time last normal” is <12 hours, blood glucose is between 60 and 400, and the patient has a score of 4 or greater, consider the 
clinical presentation of the patient
 Patients with unstable VS or emergent airway needs should go to the closest appropriate facility
 Patients who are clinically stable and suspected LVO, consider transport directly to a Comprehensive Stroke Center. 
 Alert the receiving hospital with Stroke Alert and FAST-ED score as early as possible.
q 8. The complete screening should be documented in the electronic Patient Care Report (ePCR).
166
Procedures
193
Field Assessment Stroke Triage for Emergency Destination (FAST-ED)
Assessment Item Score
Facial Palsy – Weakness on one side of the face with smile
 Absent or minor paralysis
 Partial or Complete paralysis
0
1
Arm Weakness
 No drift
 Drift or some effort against gravity
0
1
 No effort against gravity OR No movement 2
Eye Deviation
 Absent
 Partial
 Forced Deviation
0
1
2
Denial / Neglect
 Absent
 Extinction to bilateral simultaneous stimulation in only one sensory modality
 Does not recognize own had or only orients to one side of the body
0
1
2
LVO is likely if FAST-ED score is > 4
193
Field Assessment Stroke Triage for Emergency Destination (FAST-ED)
Assessment Item Score
Facial Palsy – Weakness on one side of the face with smile
 Absent or minor paralysis
 Partial or Complete paralysis
0
1
Arm Weakness
 No drift
 Drift or some effort against gravity
0
1
 No effort against gravity OR No movement 2
Speech Changes
 Speech Content Normal AND Names 2-3 Items Correctly 0
 Speech Content is abnormal OR names only 0-1 Items Correctly 1
 Cannot Understand / Cannot Show Two Fingers When Asked 2
Time of Symptom Onset (not scored)
Eye Deviation
 No Deviation, Eyes Move To Both Sides Equally 0
 Gaze Preference – Clear Difficulty When Looking To One Side (Left OR Right) 1
 Forced Deviation – Eyes Deviated To One Side And Do NOT Pass Midline 2
Denial / Neglect
 Absent 0
 Extinction to bilateral simultaneous stimulation in only one sensory modality 1
 Does not recognize own hand or only orients to one side of the body 2
LVO is likely if FAST-ED score is > 4
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Intranasal - Procedures
Procedure:
q 1. Determine appropriate dose of medication per Protocol
q 2. Draw medication into syringe and dispose of the sharps, do not administer more than 1ml per nostril.
q 3. Attach intranasal device to syringe
q 4. With one hand, control the patient’s head
q 5. Gently introduce device into nare, stop when resistance is met.
q 6. Aim slightly upwards and toward the ear on the same side
q 7. Briskly compress the syringe to administer one half of the medication, repeat the procedure with the remaining medication on the 
other nares. 
 It is important for the medication to be atomized or it will not be absorbed . 
q 8. Document the results in the electronic Patient Care Report (ePCR).
~ This Space Intentionally Left Blank ~
167
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Orogastric Tube Insertion - Procedures
Prepare All Procedure Specific Materials:
q Tube
q Lubricating Gel
q Securing device/Tape
q Suction
q Syringe for injecting Air
Procedure:
q 1. Measure the length of the tube from the tip of nose to earlobe to ziphoid process, mark maximum insertion depth.
q 2. Lubricate the tube with water based lubricant prior to insertion.
q 3. Insert lubricated tube through the gastric port of the BIAD or lift tongue/jaw anteriorly while passing tip lateral to endotracheal tube.
q 4. Continue to advance the tube gently until the appropriate distance is reached .
q 5. Confirm placement by injecting 20cc of air and auscultate for the whoosh or bubbling of the air over the stomach . If any doubt about 
placement, remove and repeat the insertion.
q 6. Secure the tube.
q 7. Decompress the stomach by connecting the tube to low continuous suction (50-150mmHg).
q 8. Document the procedure, time, and result (success) on/with the electronic Patient Care Report (ePCR).
~ This Space Intentionally Left Blank ~
168
Procedures
B EMT
A A-EMT
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Restraints - Procedures
Any patient who may harm himself, herself or others may be gently restrained to prevent injury to the patient or crew. 
This restraint must be in a humane manner and used only as a last resort. Other means to prevent injury to the patient 
or crew must be attempted first. These efforts could include reality orientation, distraction techniques, or other less 
restrictive therapeutic means. Physical or chemical restraint should be a last resort technique
Procedure:
q 1. The least restrictive means of managing the patient should always be employed first.
q 2. Ensure that there are sufficient personnel available to restrain the patient safely.
q 3. Restrain the patient in a lateral or supine position. No devices such as backboards, splints or other devices will be on top of the 
patient.
q 4. The patient will never be restrained in the prone position.
q 5. The patient must be under constant observation by the EMS crew at all times. This includes direct visualization of the patient as well
as continuous cardiac, pulse oximetry and capnography monitoring as indicated.
q 6. The extremities that are restrained will have a circulation check at least every 15 minutes. The first of these checks should occur as
soon after placement of the restraints as possible. This MUST be documented in the electronic Patient Care Report (ePCR).
q 7. If the above actions are unsuccessful, or if the patient is resisting the restraints, consider chemical restraint per protocol.
q 8. IF a patient is restrained by law enforcement personnel with handcuffs or other devices EMS personnel cannot remove , a law 
enforcement officer must accompany the patient to the hospital in the transporting EMS vehicle
q 9. Consider Behavioral Emergencies Protocol.
q 10. Restraining a patient in the prone position is never authorized.
~ This Space Intentionally Left Blank ~
169
Procedures
B EMT
A A-EMT
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Prepare All Procedure Specific Materials:
q Backboard
q Straps
q C-collar appropriate for patient size
q Tape and/or Head Rolls
Procedure:
q 1. Explain the procedure to the patient.
q 2. Apply an appropriately sized c-collar while maintaining in-line stabilization of the c-spine. 
 This stabilization, to be provided by a second rescuer, should not involve traction or tension but rather simply maintaining the head in
a neutral, midline position while the first rescuer applies the collar. 
 This may be performed by any credentialed responder if indicated by protocol.
q 3. Once the collar is secure, the second rescuer should continue to maintain inline neutral position to ensure stabilization.
 The collar is helpful but will not do the job by itself.
q 4. If the patient is supine or prone, consider the log roll technique. For the patient in a vehicle or otherwise unable to be placed prone or
supine, place them on the backboard by the safest method available that maximizes maintenance of in-line spinal stability
q 5. Stabilize the patient with straps and head rolls/tape or other similar device. Once the head is secured to the backboard, the second
rescuer may release manual in-line stabilization.
q 6. NOTE: some patients , due to size or age, will not be able to be immobilized through in-line stabilization with standard
backboards and c-collars. Never force a patient into a non-neutral position to immobilize them. Such situations may require a second 
rescuer to maintain manual stabilization throughout the transport to the hospital.
q 7. Document the time of the procedure in the electronic Patient Care Report (ePCR).
~ This Space Intentionally Left Blank ~
170
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
Selective Spinal Motion Restriction - Procedures
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

EMS Providers must use extreme caution when evaluating and treating an injured player, especially when the 
extent of the injury remains unknown Suspect any unconscious football player to have an accompanying spinal 
injury until proven otherwise. If the player isn’t breathing or the possibility of respiratory arrest exists, its 
essential that certified athletic trainers and EMS providers work quickly and effectively to remove the face mask 
and administer care. In most situations, the helmet should not be removed in the field. Proper management of 
head and neck injuries includes leaving the helmet and shoulder pads in place whenever possible , removing only 
the face mask from the helmet and developing a plan to manage head-and-neck injured players using welltrained sports medicine and EMS providers.
Guidelines and Recommendations:
The following guidelines and recommendations were developed by the Inter-Association Task Force for the appropriate Care of the SpineInjured Athlete:
q 1. General Guidelines for Care Prior to Arrival of EMS
 The Emergency Medical Services system should be activated
 Any athlete suspected of having a spinal injury should not be moved and should be managed as though a spinal injury exists.
 The athlete’s airway, breathing and circulation, neurological status and level of consciousness should be assessed
 The athlete should NOT be moved unless absolutely essential to maintain airway , breathing and circulation
 If the athlete must be moved to maintain airway, breathing and circulation, the athlete should be placed in a supine position while
maintaining spinal immobilization.
 When moving a suspected spine injured athlete, the head and trunk should be moved as a unit. One accepted technique is to manually
splint the head to the trunk.
q 2. Face Mask Removal
 The face mask should be removed prior to transportation, regardless of current respiratory status (see figure 1)
 Those involved in the pre-hospital care of injured players must have the tools for face mask removal readily available .
Indications for Helmet Removal:
q 1. The athletic helmet and chin straps should only be removed if:
 The helmet and chin strap do not hold the head securely, such that immobilization of the helmet does not also immobilize the head
 The design of the helmet and chin strap is such that even after removal of the face mask the airway cannot be controlled, or ventilation
be provided.
 The face mask cannot be removed after a reasonable period of time
 The helmet prevents immobilization from transporting in an appropriate position . 
Helmet Removal:
q 1. If it becomes absolutely necessary, spinal immobilization must be maintained while removed the helmet
 Helmet removal should be frequently practiced under proper supervision by an EMS supervisor or Training Division staff
 Due to the varying types of helmets encountered, the helmet should be removed with close oversight by the team athletic trainers
and/or sports medicine staff
 In most circumstances, it may be helpful to remove cheek padding and/or deflate air padding prior to helmet removal.
Spinal Alignment:
q 1. Appropriate spinal alignment must be maintained during care and transport using backboard, straps, tape, head blocks or other
necessary equipment.
 Be aware that the helmet and shoulder pads elevate an athlete’s trunk when in the supine position
 Should either be removed, or if only one is present, appropriate spinal alignment must be maintained.
 The front of the shoulder pads can be opened to allow access for CPR and defibrillation
171
Procedures
B EMT
A A-EMT
P Paramedic 
EMR Spinal Immobilization of Athletes with Helmets -
Procedures
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Splinting - Procedures
Clinical Indications:
q Immobilization of an extremity for transport due to suspected fracture, sprain or other traumatic injury
q Immobilization of an extremity for transport to secure medically necessary devices such as IV catheter
Procedure:
q 1. Assess and document pulses, sensation and motor function prior to placement of the splint. If no pulses are present and a fracture is
suspected, consider reduction of the fracture prior to placement of the splint.
 If extended scene time, prolonged extrication and pulseless extremity, contact Medical Control for recommendations
q 2. Remove all clothing from the extremity.
q 3. Select a site to secure the splint both proximal and distal to the area of suspected injury or the area where the medical dev ice will be
placed.
q 4. Do not secure the splint directly over the injury.
q 5. Place the splint and secure with Velcro, straps, or bandage material (ie. Kling, kerlex, cloth bandage, etc.) depending on the splint
manufacturer and design.
q 6. Document pulses, sensation and motor function after placement of the splint. If there has been a deterioration in any of these 3
parameters, reposition the splint and reassess. If no improvement, remove splint.
q 7. IF a femur fracture is suspected and there is no evidence of pelvic fracture or instability, place a traction splint.
q 8. Consider pain management per Pain Management Protocol.
q 9. Document the time, type of splint, and the pre and post assessment of pulse, sensation and motor function in the electronic
Patient Care Report (ePCR).
~ This Space Intentionally Left Blank ~
172
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Pelvic Binder - Procedures
Clinical Indications:
q High Energy Mechanism such as Motor Vehicle Crash (MVC), pedestrians struck by vehicles, falls from significant height
 Suspect fracture in mechanisms with pelvic, low back or groin pain AND SBP <90mmHg or Pediatric age specific hypotension
q Pelvic stabilization is an important intervention in the management of severe pelvic trauma , and has 4 primary objectives
 Prevent re-injury from pathologic pelvic movement (most important), decrease pelvic volume, tamponade bleeding pelvic bones and
vessels, decrease pain
 Pelvic fractures have a high potential for significant intraperitoneal hemorrhage and blood
Procedure:
q Appropriately expose the patient and identify the greater trochanters bilaterally
q Assessment of the pelvis should be performed with extreme care
 Inspect for ecchymosis, deformity, asymmetry, pelvic or lower extremity wounds
 Palpate the skeletal structures – iliac crests, ischial tuberosity, lumbar spine and sacrum, greater trochanters
q Place a sheet or pelvic binder under the patient with the center at the level of the greater trochanters
q Tighten commercially available pelvic binder per manufacturer instruction
q With sheet binder, tighten by twisting and secure to maintain tension
q Assess for distal pulses before and after application
q Pelvic fractures have a high potential for significant intraperitoneal hemorrhage 
Contraindications:
q Isolated femoral neck fracture
q Suspected traumatic hip dislocation
q Pelvic binding my exacerbate injury in iliac wing fractures and injuries with an over-riding pubic symphysis
*PEARL: The greater trochanters should be the area of pressure application, and are generally lower than you think! 
173
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Principles:
q Apply Tourniquet as proximal as possible to wound, minimum of 2" above hemorrhage site. Do not cross joints or bony prominences with
the Tourniquet
q Secure Tourniquet in place and expedite transport.
q Document time and location of tourniquet deployment in electronic Patient Care Report (ePCR) and on device.
q Notify receiving center of tourniquet use, location of device and time placed.
q IF hemorrhage not controlled, a second tourniquet can be deployed, proximal to the first without overlap.
Procedure:
Tourniquet (CAT – Combat Application Tourniquet) -
Procedures
1. Route the self adhering band around the 
extremity and pass the free-running end of the 
band through the inside slit of the friction 
adapter buckle
2. Pass the band through the outside slit of the 
buckle, utilizing the friction adaptor buckle, 
which will lock the band in place.
3. Pull the self-adhering band tight and
securely fasten the band back on itself.
4. Twist the rod until bright red bleeding has
stopped.
5. Lock the rod in place with the Windlass
Clip™ 
6. Hemorrhage is now controlled. Secure the
rod with the strap: Grasp the Windlass Strap™, 
pull it tight and adhere it to the opposite hook
on the Windlass Clip™ 
174
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

SOF Tactical Tourniquet - Wide - Procedures
175
Principles:
q Apply Tourniquet as proximal as possible to wound, minimum of 2" above hemorrhage site. Do not cross joints or bony prominences with
the Tourniquet
q Secure Tourniquet in place and expedite transport.
q Document time and location of tourniquet deployment in electronic Patient Care Report (ePCR) and on device.
q Notify receiving center of tourniquet use, location of device and time placed.
q IF hemorrhage not controlled, a second tourniquet can be deployed, proximal to the first without overlap.
Procedure:
1. Release the quick disconnect buckle, then
route the constricting band around the injured
limb.
2. Reconnect the quick disconnect buckle
3. Remove slack by pulling on the loose end of
the constricting band. Removing as much slack
as possible will increased efficacy of windlass.
4. Turn windlass until bleeding stops
completely. Wound may continue to seep but 
there should be no active blood flow.
6. If possible, mark the time of tourniquet 
application so the next provider is aware.
5. Stow windlass in tri-ring once bleeding is
controlled.
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Clinical Indications:
q Inability to obtain adequate alternative peripheral access
q Access of an existing catheter for medication or fluid administration
q Central venous access in a patient in cardiac arrest
q Only appropriate for critical patients
Procedure:
q 1. Use personal protective equipment, including gloves, gown and mask as indicated.
q 2. Clean the port of the catheter with alcohol wipe
q 3. Using sterile technique, withdraw 5-10mL of blood and place syringe in sharps box.
q 4. Using 5mL normal saline, access the port with sterile technique and gently attempt to flush the saline.
 IF there is NO resistance with flush, no evidence of infiltration (i.e. No subcutaneous, collection of fluid), and no pain experienced by
the patient, then proceed to step 5
 IF there IS resistance with flush, evidence of infiltration, pain experienced by the patient, or any concern that the catheter may be
clotted or dislodged, do not use the catheter.
q 5. Begin administration of medications or IV fluids slowly. Observe for any signs of infiltration. If difficulties are encountered, stop the
infusion and reassess.
q 6. Document procedure, any complications, and fluids/medications administered in the electronic Patient Care Report (ePCR).
~ This Space Intentionally Left Blank ~
176
Procedures
P Paramedic 
Accessing Peripherally Inserted Central Catheter 
(PICC) - Procedures
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Extremity Venous Access - Procedures
Prepare All Procedure Specific Materials:
q Appropriate tubing or IV lock
q #14-#24 catheter over the needle, or butterfly needle
q Venous tourniquet
q Antiseptic swab
q Gauze pad or adhesive bandage
q Tape or commercially available securing device
Procedure:
q 1. Saline locks may be used as an alternative to IV tubing and fluid under the authorization of the Service Medical Director and at the
discretion of the provider.
q 2. Intraosseous access can be used where threat to life exists as provided for in the Venous Access – Intraosseous Procedure.
q 3. Use the largest catheter bore necessary based upon the patient’s condition and size of veins
q 4. Fluid and set up choice is preferably:
 Normal Saline with macro drip (10 drops/mL) for medical/trauma conditions.
 Normal Saline with a micro drip (60 drops/mL) for medication infusions or for patients at risk of fluid overload.
q 5. Assemble IV solution and tubing:
 Open IV bag and check for clarity, expiration date, etc.
 Verify correct solution
 Open IV tubing and assemble according to manufacturer's guidelines
q 6. Insertion:
 Explain to the patient that an IV is going to be started
 Place the tourniquet around the patient’s arm proximal to the IV site, if appropriate 
 Palpate veins for resilience
 Clean the skin with the antiseptic swab in an increasing sized concentric circle and follow it with an alcohol swab
 Stabilize the vein distally with the thumb/fingers
 Enter the skin with the bevel of the needle facing upward
 Enter the vein, obtain a flash, and advance the catheter into the vein while stabilizing the needle
 Remove the needle while compressing the proximal tip of the catheter to minimize blood loss
 Remove the tourniquet
 Connect IV tubing to the catheter, or secure the IV lock to the catheter to minimize blood loss
 Open the IV clamp to assure free flow (no infiltration, pain, etc) and set infusion rate
q 7. Secure the IV:
 Secure the IV catheter and tubing
 Recheck IV drip rate to make sure it is flowing at appropriate rate.
q 8. Trouble shoot the IV, (if the IV is not working well):
 Make sure the tourniquet is off
 Check the IV insertion site for swelling
 Check the IV tubing clamp to make sure it is open
 Check the drip chamber to make sure it is half full
 Lower the IV bag below IV site and watch for blood to return into the tubing
~ This Space Intentionally Left Blank ~
177
Procedures
A A-EMT
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

IO Intraosseous Venous Access - Procedures
Procedure:
q 1. Select the appropriate insertion site and palpate the appropriate bony landmarks to identify the site of insertion .
 The PROXIMAL HUMERUS is contraindicated in patients <18 years old, UNLESS authorized by Medical Control.
q 2. Cleanse the site with chlorhexidine, iodine or alcohol prep pad.
q 3. Device insertion
 Manual devices (Cook or Jamshidi):
q Hold the intraosseous needle at a 90odegree angle to the bony surface, aimed away from the nearby joint and epiphyseal plate. 
q Provide pressure to push the needle tip through the skin until resistance from the bone is felt. 
q Twist the needle handle with a rotating grinding motion applying controlled downward force until a “pop” or loss of resistance is
felt. 
q Do not advance more than 1cm after the loss of resistance is felt.
 Powered Intraosseous Device (EZ-IO):
q Hold the intraosseous needle at a 90odegree angle to the bony surface, aimed away from the nearby joint and epiphyseal plate. 
q Provide pressure to push the needle tip through the skin until resistance form the bone is felt. 
q Power the driver until a “pop” or loss of resistance is felt. 
q Do not advance more than 1cm after the loss or resistance is felt. 
 Automatic Intraosseous Device (NIO):
q Rotate the cap 90° in either direction to unlock
q Place dominant hand over cap, and press device against patient. While pressing down on the device with palm, pull trigger wings
upwards with fingers
q Gently pull the NIO up in a rotating motion while holding the needle stabilizer against the insertion site
q Continue holding the needle stabilizer in place and pull up the stylet to remove.
q 4. Remove the stylet and place in an approved sharps container
q 5. Attach a 10mL syringe filled with 5mL of Normal Saline; aspirate bone marrow to verify placement, then inject 5mL of Normal Saline to
clear the lumen of the needle.
q 6. Attach the IV line with fluids on a pressure bag.
q 7. Stabilize and secure the needle with dressings and tape
q 8. Document the procedure, time, and procedure success (or failure) on the PCR
Complications:
● Incorrect identification of landmarks
● A bent needle (more common with longer needles)
● Clogging of the needle with marrow, clot or bone spicules.
-Can be avoided by flushing the needle or continuous infusion
● Through and through penetration of both anterior and posterior cortices 
caused by excess force after the needle has penetrated the cortex.
● Subcutaneous or subperiosteal infiltration, caused by incomplete
placement or dislodgement of needle.
● Fractures caused by excess force or fragile bones.
● Compartment syndrome
Anterior Tibia
Proximal Humerus
(Hand Over Umbilicus 
Technique)
Proximal Humerus
(“Thumb-to-Bum” 
Technique) 
Anteromedial aspect of the proximal tibia (bony prominence below 
the kneecap). The insertion location will be 1-2cm (2 finger widths) 
below this.
Keeping the elbow flat on the floor and close to the side of the 
body, rotate the palm over the umbilicus (belly button) and palpate 
the greater tubercle of the humerus. The insertion location will be 
1-2cm (2 finger widths) above the surgical neck.
With the arm fully extended and tight to the body, rotate the hand 
medially (inward) until the palm is facing out. Palpate the greater 
tubercle of the humerus approximately 1-2cm (2 finger widths) 
above the surgical neck.
Contraindications:
 Fracture proximal to proposed intraosseous site
 History of Osteogenesis Imperfecta
 Current or prior infection at proposed
intraosseous site
 Previous intraosseous insertion or joint
replacement at the selected site
178
Procedures
A A-EMT
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

External Jugular Venous Access - Procedures
Clinical Indications: 
q Medical patients who are awake and alert, and require IV access but are peripherally exhausted
q External jugular cannulation can be attempted initially in life threatening events when no obvious peripheral site is noted .
Prepare All Procedure Specific Materials:
q Appropriate tubing or IV lock
q #14-#24 catheter over the needle or butterfly needle
q Antiseptic swab
q Gauze pad or adhesive bandage
q Tape or other securing device
Procedure: 
q 1. Position yourself at the head of the patient. 
q 2. Place the patient in a slight Trendelenburg (supine, head down) position if possible. This helps distend the vein and prevent air embolism. 
q 3. Turn the patient’s head toward the opposite side if no risk of cervical injury exists. 
q 4. Prep the site with antiseptic swab. 
q 5. Align the catheter with the vein (insertion direction is away from the patient’s head, toward the patient’s same side shoulder).
q 6. Anchoring the vein lightly with one finger above the clavicle, puncture the vein at a superficial angle midway between the angle of the
jaw and the clavicle and cannulate the vein. 
q 7. Confirm placement with saline flush. 
q 8. Attach the IV and secure the catheter (avoiding circumferential dressing or taping around the neck). 
q 9. If unsuccessful, place occlusive dressing over site and do NOT go to other side of neck
q 10. Document the procedure appropriately. 
Contraindications:
q Patient combative or uncooperative with positioning (i.e. unable to hold still while procedure is being performed)
q Anterior neck hematoma/burn/cellulitis
q Anatomic landmarks not visible
q Medical appliance in place covering anterior neck (i.e. c-collar)
q Monitor for complications
 Expanding hematoma
 Tracheal shift
 Difficulty breathing
*PEARL: Superficial insertion angle is crucial as the carotid artery is in close proximity to the EJ.
External Jugular
Vein
Internal Jugular
Carotid Artery Vein
179
Procedures
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Wound Care - Procedures
Clinical Indications:
Skin and soft tissue wounds with associated bleeding and pain.
Procedure:
q 1. Use personal protective equipment, including gloves, gown and mask as indicated.
q 2. If active bleeding, elevate the affected area if possible and hold direct pressure. Do not rely on compression bandage to control bleeding. Direct
pressure is much more effective
q 3. Consider tourniquet use early for extremity bleeding not controlled with direct pressure.
q 4. Once bleeding is controlled, irrigate contaminated wounds with saline as appropriate
 Consider Pain Management Protocol before beginning irrigation.
 Irrigation and decontamination are key to stopping ongoing tissue injury, preventing infection and promoting wound healing.
 Control bleeding and address life threats first.
 Irrigate thermal burns, chemical burns or contaminated wounds with Normal Saline, Lactated Ringer’s or sterile water.
 For chemical splashes to the eye, emergent irrigation is critical to preventing further tissue damage. If possible, have patient remove contact lenses as
early as possible. Go to Eye Pain Protocol, as appropriate.
q 5. Cover wounds with sterile gauze/dressings. Check distal pulses, sensation, and motor function to ensure the bandage is not too tight.
q 6. Monitor wounds and/or dressing throughout transport for bleeding
q 7. Bolster existing bandages as necessary if saturation or 
q 8. Consider second tourniquet use as indicated in protocol/procedure. Do not remove first tourniquet; apply the second higher on the limb.
q 9. If serious hemorrhage not controlled by other means:
 Apply approved non-heat generating hemostatic agent per manufacturer’s directions.
 Supplement hemostatic agent impregnated gauze with direct pressure and standard hemorrhage control techniques
 Apply additional hemostatic impregnated gauze and/or standard dressings as needed.
 Hemostatic impregnated gauze is contraindicated in wounds involving the thoracic cavity or violating the peritoneum of the abdominal cavity.
q 10. Document the wound assessment and care in the electronic Patient Care Report (ePCR).
Clinical Indications:
Skin and soft tissue wounds with MAJOR bleeding not controlled by direct pressure or tourniquet deployment as above .
Procedure:
q 1. Use personal protective equipment, including gloves, gown and mask as indicated.
q 2. Apply direct pressure to the wound
q 3. Insert finger(s) into the wound and apply firm pressure to visualized bleeding vessel to control bleeding .
q 4. Create a small ball at the beginning of the roll gauze (preferentially hemostatic impregnated)
q 5. Press the gauze deep into the wound, occluding the bleeding vessel against bone or firm tissue.
q 6. While maintaining pressure on the leading edge of the gauze, begin to feed more gauze into the wound, packing it tightly in place while
continuing pressure on the bleeding vessel.
q 7. Continue packing the wound until you have filled the wound space -OR- until you have a minimum 2-3" of gauze remaining
 Leave an adequate “tail” on packing to facilitate later removal at the hospital
q 8. Maintain manual direct pressure on the wound for 3-5 minutes.
q 9. Reassess and wrap the wound with a pressure dressing to maintain pressure for support.
q 10. If bleeding persists, apply more gauze but DO NOT remove the wound packing.
q 11. Continue monitoring the wound and assess for continued direct pressure as needed throughout transport.
q 12. Document the wound assessment and patient care in the electronic Patient Care Report (ePCR).
180
Procedures
Wound Packing - Procedures
B EMT
A A-EMT
P Paramedic 
EMR
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Ventricular Assist Device - Procedures
Frequently Asked Questions:
What is a Ventricular Assist Device (VAD)?
A ventricular assist device (VAD) is a mechanical pump that is used to support heart funciton and blood flow in people who have weakened hearts. 
Some common reasons for VAD implantation are MI, Heart Failure, myocarditis, cardiomyopathy and heart surgery.
How does a VAD work?
The device takes blood from a lower chamber of the heart and helps pump it to the body and vital organs, just as a healthy heart would.
What are the parts of a VAD?
The basic parts of a VAD include: a small tube that carries blood out of your heart into a pump; another tube that carries blood from the pump to your 
blood vessels, which deliver blood to your body; and a power source.
What is the power source?
The power source is either batteries or AC power. The power source is connected to a control unit that monitors the VAD functions. The batteries are 
carried in a case usually located in a holster in a vest around the patient’s shoulders.
What does the control unit (or controller) do?
The control unit gives warnings or alarms if the power is low or if it senses that the device isn’t functioning properly.
MOST patients have a tag located on the controller around their waist that lists the type of device, the institution that put it in and a number to call.
Patient Management:
q 1. Assess the patients airway and intervene per the Airway Management Protocol
q 2. Auscultate heart sounds to determine if the device is functioning and what type of device it is. If it is a continuous flow device, you should 
hear a “whirling sound”.
q 3. Assess the device for any alarms.
q 4. Look on the controller located around the patient’s waist or in the VAD PAK and see what device it is.
q 5. Assess Vital Signs – use Mean BP with Doppler, if available. The first sound you will hear is the Mean Arterial Pressure (MAP)
q 6. If no Doppler available, use the Mean on the Non-Invasive BP cuff
q 7. Intervene appropriately based on the type of alarm and patient guide.
 If patient is not responsive, has evidence of inadequate perfusion, and LVAD appears to be functioning---Perform external chest compressions
and follow ACLS protocol
 If patient is not responsive, has evidence of inadequate perfusion, and LVAD does NOT appear to be functioning---assess for a pulse
If NO pulse, perform external chest compressions and follow ACLS protocol
If pulse palpated, follow appropriate medical protocol, consider likely decompensated heart failure and proceed to chest 
compressions only if pulses are lost. 
q 8. Start one large bore IV
q 9. Transport to the closest VAD Center. Call the number listed on the device for advice.
q 10. Bring all of the patient’s equipment and paperwork to the Emergency Department.
q 11. Allow the trained caregiver to ride in the patient compartment when possible. They may be able to serve as an expert on the device if the 
patient is unconscious or unable to answer for themselves.
Quick Tips for Ventricular Assist Devices (VADs)
q Let the patient and/or caregiver take the lead; they will be your on-scene experts.
q Remember not to perform chest compressions because they could dislodge the pump, making the patient bleed to death. Use the assistance of
the VAD coordinator before starting compressions in the case of obvious arrest and pump failure.
q Defibrillate / cardiovert as normal. Do NOT place the pads over the device that is under the patient’s skin.
q Keep in mind it may be difficult to obtain an accurate SpO2 because of little or no pulse.
q BE CAREFUL WHEN REMOVING / CUTTING CLOTHING so you don’t inadvertently dislodge or cut the drive line.
q Take the patient’s emergency travel bag when leaving the scene. It should have an extra controller, batteries and the VAD Coordinator’s
emergency contact number.
http://mylvad.com/sites/mylvadrp/files/EMS%20Field%20Guides/MCSO%20EMS%20GUIDE%202015%20.pdf
http://www.jems.com/articles/print/volume-37/issue-2/patient-care/patients-ventricular-assist-device-need.html
181
Procedures
B EMT
A A-EMT
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Nitrous Oxide - Procedures
Clinical Indications: 
q Adult patients with acute pain.
q Nitrous Oxide should ONLY be used by patients who have the capacity to understand and the ability to perform self -administration of
inhaled medications.
Contraindications:
q Nitrous Oxide rapidly diffuses into air-filled spaces within the body and can significantly increase pressures exerted by gases. Therefore, it
should NOT be used in cases where there are or are suspected to be abnormal collections of air within the body . Some common examples
include but are not limited to:
 Pneumothorax
 Pulmonary Blebs (commonly seen in COPD)
 Air Embolism
 Small Bowel Obstruction
 Pneumocephalus (air within the skull)
 Eye Injury or Eye Surgery
 Recent Middle Ear Surgery
q Nitrous is known to be teratogenic and is contraindicated before the end of 3
rd trimester of pregnancy
q Altered mental status from head injury, alcohol or drugs
q Inability to follow commands and/or safely self-administer the medication
Preparation:
q Prepare all procedure specific materials:
q Set up Medical Director approved nitrous oxide system per manufacturer written procedure.
q Turn on exhaust fan in patient care area.
q Verify indications and contraindications prior to Nitrous Oxide administration
Procedure:
q 1. Instruct the patient to hold the face mask lightly on the face, covering the nose and mouth.
q 2. Instruct patient to breathe normally though the demand valve mask until pain at acceptable level or until patient no longer able to hold
the mask to their face. Personnel must not hold mask to patient’s face.
q 3. Turn off flow of nitrous oxide when patient completes self-administered dose.
q 4. Reassess patient’s pain at 3-5 minutes with pain scale. If pain not controlled, consider other pain management options.
q 5. Document start and stop times for Nitrous Oxide use. Do not exceed time permitted by NIOSH occupational exposure standards.
 In open, outside, well ventilated areas: no maximum time of administration
 Ambulance with open windows and exhaust fans running: Max of 30 minutes per 8 hour period.
q 6. Document Nitrous Oxide canister pressure at the start of administration and at the end of administration.
q 7. Record vital signs during and after treatment (Nitrous Oxide may cause BP to drop in some cases).
Special notes:
q Nitrous oxide is in liquid state in its bottle. Ensure the bottle remains in the upright position when the bottle is open and especially during
patient administration.
q Nitrous oxide can potentiate the effects of other CNS depressants such as narcotics, sedatives, hypnotics and alcohol.
q Patients on chronic opiates may be highly tolerant to the analgesic effects of nitrous.
q Nitrous oxide is minimally metabolized in humans, and therefore retains its potency when exhaled into the room by the patient; a
continuous-flow fresh-air ventilation system and/or N2O scavenger system must be used to prevent waste gas buildup in the passenger
compartment.
182
Procedures
A A-EMT
P Paramedic 
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

SALT Mass Casualty Triage - Procedures
Clinical Indications:
q It is important to use a Triage strategy any time there is a Mass Casualty Incident (MCI), or when limited resources need to be allocated to 
maximize the number of survivors
q SALT is an evidence-based, non-proprietary triage system developed in 2008. 
q SALT stands for “Sort, Assess, Lifesaving Interventions, Treatment and/or Transport” and is based on the Model Uniform Core Criteria
(MUCC) for Mass Casualty Incidents
q Only appropriate for critical patients
Procedure:
q Step 1 – Global Sorting
 Patients who can walk should be asked to move to a designated area and should be assigned LAST priority for individual assessment
 Those who remain should be asked to wave or be observed for purposeful movement, those who do not move and those with obvious
life-threatening conditions should be assessed FIRST because they are the most likely to need lifesaving interventions
q Step 2 – Assess and Lifesaving Interventions
 Control major hemorrhage through the use of tourniquets or direct pressure provided by other patients or other devices
 Open the airway through positioning or basic airway adjuncts (no advanced airway devices should be used); if the patient is a child, 
consider giving 2 rescue breaths
 Chest decompression procedure (see p163)
 Autoinjector antidote administration
 *Lifesaving interventions should be performed only within the responder’s scope of practice and only if the equipment is
immediately available
q Step 3 – Treatment and/or Transport 
 Priortize patients for treatment and/or transport based on 1 of 5 categories;
 Minimal (GREEN) – Mild injuries that are self-limited if not treated, and can tolerate a delay in care without increasing mortality
 Dead (BLACK) – Not breathing even after lifesaving interventions are attempted
 Immediate (RED) – Do not obey commands, do not have a peripheral pulse, are in respiratory distress or have uncontrolled major 
hemorrhage
 Expectant (GRAY) – Provider determines injuries are incompatible with life given the current available resources
 Delayed (YELLOW) – All patients who do not fit into one of the categories above
 The prioritization process is dynamic and may be altered by changing patient conditions, resources and scene safety
 In general, treatment and/or transport should be provided for immediate patients first, then delayed, then minimal; EXPECTANT 
patients should be provided with treatment and/or transport when resources permit
 Efficient use of transport assets may include mixing categories of patients and using alternate forms of transport
183
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Base Hospital Activation - Procedures
Clinical Indications:
q It is important to activate the Base Hospital any time there is a Mass Casualty Incident (MCI), or when limited resources need to be 
allocated to maximize the number of survivors
 An MCI (Mass Casualty Incident) is defined as any incident anticipated to result in more than five patients requiring EMS transport 
from the scene.
q Excellent communication between EMS and receiving hospitals will help coordination of care , optimize patient distribution to real time 
hospital capabilities and improve outcomes during a large scale event or MCI.
Procedure:
q Step 1 – Establish Incident Command early
 The first in unit will generally take Command of the incident, ensure that Base Hospital has been activated.
 In accordance with ICS structure, EMS can keep Command, pass Command or assimilate into the Unified Command structure.
q Step 2 – Establishment of EMS Branch
 The person in charge of EMS activities should assume the role of EMS Branch Director . This Director is tasked with assigning and
supervising the roles of: Triage Group Supervisor, Treatment Group Supervisor, Transportation Group Supervisor
 Consider assigning a record keeper to the Transportation Group Supervisor, to complete the form for after-action reporting
q Step 3 – Establish Radio Contact with Base Hospital
 Transportation Group Supervisor should be on the “Base Hospital Talk Group” to speak with Base Hospital. All hospitals are expected to
monitor this channel during a large event for information, but only Base Hospital has authority to speak
 Address the Base as “Base Hospital”; the contact person will be providing objective data regarding resource availability , regardless of
their primary hospital affiliation
 Base Hospital will provide the real time capabilities of all hospitals that have answered the EMResource alert at that time
¾ This will be listed as the number of each category of patients that the hospitals can manage at that moment
q Step 4 – Triage and Treatment
 Patients should be triaged and managed in accordance with the SALT Triage Procedure (see p183 for details)
q Step 5 – Transportation
 The Transportation Group Supervisor is responsible for assigning triaged patients to the most appropriate transportation mode based on
acuity and resource availability
 Transportation Group Supervisor should notify Base Hospital of destination, number and acuity of patients as they are assigned and leave
the scene
 Base Hospital will track the patient assignments, and will regularly update hospital capabilities as the event unfolds . Updates on
capabilities will be regularly reported, and should be available upon request by the Transportation Group Supervisor
¾ Like EMS, Hospital capabilities are NOT static; Walk-ins, security threats as well as increased staff presence can all impact the ability
of our hospitals to receive and manage patients. Frequent and clear communication about the situation and the capabilities on both
sides will be essential to successfully managing any event and optimizing patient outcomes.
 Hospital communication by transporting ambulances are conducted on the same channel as routine . Reports expected to be BRIEF and
CONCISE so as to keep radio traffic to a minimum; it is likely there will be many trying to access these channels
q Step 6 – Event Resolution
 Once all patients have cleared the scene, a final notification to Base Hospital should be made, with final tally of the number and types of
patients taken to each facility. This will be important for patient tracking, family reunification and after action reports
184
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Base Hospital Activation - Procedures
185
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Care for Law Enforcement Working Canine –
Sedation (Optional)
186
Procedures
Pertinent Positives and Negatives
 Breed, Age, Weight
 Medical History
 Allergies
CREW SAFETY IS PARAMOUNT
If a working law enforcement canine is injured or in need of medical attention, enlist the help of the canine handler. The canine patient should be secured in a muzzle. 
Remember, these animals can be dangerous to EMS providers, especially when in distress. Use extreme caution when providing care to working canines.
If at anytime the canine loses pulses, go to working 
canine CPR procedure p.187
Providers utilizing this protocol should receive additional training specific to canine care if possible. EMS agencies with law 
enforcement working canine(s) in their jurisdiction should train on this protocol regularly.
Call ALS early if canine sedation may be needed
Pearls
 Fentanyl or midazolam alone are not advised for reliable sedation. These medications MUST be used together.
 Human tourniquets (CAT, SOF-T) are not advised for canine use. May use elastic tourniquets such as the SWAT.
 IM: Quad/posterior thigh are preferred. Back muscles 3 fingerbreadths cranial to the hip, lateral to the spine second option.
 Splinting/bandaging extremity: always start at toes and wrap proximally.
 Naloxone should be available when using opioid analgesics.
Under 25kg Over 25kg
Working Canine Officer Ill or Injured
Canine Officer poses a 
safety hazard to the EMS 
crew, other responders, or 
the canine itself?
Yes No
Rapid Trauma Assessment
Hemorrhage Control, Airway Mgmt, etc.
A Consider Canine IV/IO Access p188
Transport to Emergency Vet Care Location 
p.188
Notify Receiving Facility Early
P
Fentanyl 5mcg/kg IM (max 
125mcg)
AND
Midazolam 5mg IM
Fentanyl 125mcg IM
AND
Midazolam 10mg IM
IM administration in the quads/thighs (A/B) is preferred
If signs of opioid overdose
Naloxone 2-4mg IM
Naloxone reversal can result in rapid and severe aggression. 
DO NOT remove muzzle unless for cardiac arrest care.
Rapid Trauma Assessment
Hemorrhage Control, Airway Mgmt, etc.
A Consider Canine IV/IO Access p188
P Paramedic 
Normal K9 Vital Signs
HR 60-80 bpm, resting; up to 140bpm with exertion
Rectal temp 100-102oF; up to 106oF with exertion
RR 10-40bpm
SpO2>94%
Cap Refill <2 sec
EtCO2 30-40mmHg
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Care for Law Enforcement Working Canine – Cardiac 
Arrest (Optional)
187
Procedures
Pertinent Positives and Negatives
 Breed, Age, Weight
 Medical History
 Allergies
Crew Safety is Paramount
If a working law enforcement canine is injured or in 
need of medical attention, enlist the help of the canine 
handler. 
 Canine CPR Notes
 Perform in lateral recumbency
 Rate: 100-120 compressions per minute
 Depth: ½ the width of the chest
 Allow full recoil between compressions
 Larger breeds benefit from compressions over the 
widest portion of the thorax 
 Defib pads should be placed on opposite sides of
the chest. In figure A (below), one pad would be 
under the compressor’s hands and the other in the 
same spot on the opposite side of the canine.
Unresponsive, Apneic Canine
CPR 30:2 (1 cycle = 2 minutes)
Compressions: 100-120/minute compressing ⅓ -½ the chest width
Ventilate: 10/min at appropriate tidal volume
Place Defib Pads on opposite sides of patient’s chest
Evaluate Patient & Check ECG
ROSC Transport 
p189
Vfib/pulselessVT Asystole/PEA
Defibrillate 2J/kg, Continue CPR x 2 
minutes Continue CPR x 2 minutes
A Canine IV/IO Access p188
P
Epinephrine (1:1,000) 0.01mg/kg 
IV/IO
Repeat every 3-5min
Evaluate Patient & Check ECG
Vfib/pulselessVT Asystole/PEA
ROSC Transport 
p189
Defibrillate 4J/kg, Continue CPR x 2 
minutes
P
Epinephrine (1:1,000) 0.01mg/kg 
IV/IO
Repeat every 3-5min
A Canine IV/IO Access p188
P
Amiodarone 5mg/kg IV/IO bolus if 
refractory
P
Epinephrine (1:1,000) 0.01mg/kg 
IV/IO
Repeat every 3-5min
P Consider atropine 0.05mg/kg IV/IO
RECOVER Guidelines for Veterinary Resuscitation
MEDICATION QUICK REFERENCE
Consider Naloxone 0.04mg/kg
If suspected opioid exposure
Weight (kg) 15 20 25 30 35 40 45 50
Weight (lb) 30 40 50 60 70 80 90 100
DRUG DOSE ml ml ml ml ml ml ml ml
P Epinephrine (1:1000) 0.01mg/kg 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5
O2 Tidal Volume
USE CHILD BVM 10ml/kg 150 200 250 300 350 400 450 500
Defibrillation First Shock: 2j/kg
Subsequent Shocks: 4j/kg 30/60j 40/80j 50/100j 60/120j 70/140j 80/160j 90/180j 100/200j
DRUG DOSE mg mg mg mg mg mg mg mg
P Atropine 0.05mg/kg 0.75 1 1.25 1.5 1.75 2 2.25 2.5
P Amiodarone 5mg/kg 75 100 125 150 175 200 225 250
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Care for Law Enforcement Working Canine –
Procedures (Optional)
188
Procedures
Canine Baseline Normal Vital Signs
Preferred IV Access Sites and IVF
q IV
 Primary – Cephalic Vein
 Secondary – Lateral Saphenous (hind limb)
 Tertiary – External Jugular (18g most commmon)
q IO
 Medial Tibia (easy to locate and access)
Proximal Humerus (15g, 25-45mm)
q Fluids
 Crystalloid Only – 20mL/kg bolus, 500mL max
 Hypertonic Saline – 5mL/kg bolus, 125mL max
 NO Human blood products, K9 specific only
Cephalic Vein
Lateral Saphenous Vein
 
 - 
 -
 -


 -
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Care for Law Enforcement Working Canine -
Procedures
189
Procedures
B EMT
A A-EMT
P Paramedic 
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Procedures
Mixing Push-Dose Epinephrine (1:100,000) -
Procedures
If 1:10,000 Pre-mixed Epi syringe is Available:
q 1. Waste 9mL from a pre-mixed syringe of Epinephrine 1:10,000 (leaving 1mL in the syringe)
q 2. Draw 9mL of Normal Saline back inot the ampule (1mL Epinephrine + 9mL Normal Saline)
 Resulting Solution Concentration: 10mcg Epi per mL (1:100,000 Epi)
q 5. Label the syringe to visually distinguish this syringe as the push-dose concentration
190
P Paramedic 
Equipment Needed if 1:10,000 Pre-mixed Epi syringe is NOT Available:
q 1. Expel 1mL of saline from a 0.9% Normal Saline flush, leaving 9mL remaining in the syringe
q 2. Draw up 1mL of 1:1,000 Epinephrine from vial
q 3. Expel 9mL of the solution, leaving only 1mL remaining in the syringe
q 4. Draw up 9mL of Normal Saline, filling the syringe to 10mL.
 Resulting Solution Concentration: 10mcg Epi per mL (1:100,000 Epi)
q 5. Label the syringe to visually distinguish this syringe as the push-dose concentration.
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Overview
Overview
The purpose of this section is to serve as a drug information supplement and to provide a brief description of the out -of-hospital medications that 
are authorized by International SOS EMS. This document in no way represents the comprehensive pharmaceutical knowledge required for use of
these medications by Emergency Medical Technicians providing field care . The comprehensive information about the use of these medications by 
practicing EMTs and paramedics , requires reference to other detailed sources.
Pregnancy Categories are listed for each of the medications in this book. The pregnancy category of a medication is an assessment of the risk of 
fetal injury due to the pharmaceutical, if it is used as directed by the mother during pregnancy. It does not include any risks conferred by 
pharmaceutical agents or their metabolites in breast milk.
Category A – Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is 
no evidence of risk in later trimesters).
Category B - Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well -controlled studies 
in pregnant women.
Category C - Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in 
humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks .
Category D - There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or 
studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks .
Category X - Studies in animals or humans have demonstrated fetal abnormalities and /or there is positive evidence of human fetal risk based 
on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly 
outweigh potential benefits.
Medications are listed alphabetically based on generic names.
David Angelette
Chief Medical Officer
Jonathan Campbell
Deputy Medical Director
Alexander Smith 
Clinical Operations Director
Aaron Duncan
EMS Chief
https://www.govinfo.gov/content/pkg/FR-2008-05-29/pdf/E8-11806.pdf
https://chemm.nlm.nih.gov/pregnancycategories.htm
191
Pharmaceuticals
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Acetaminophen
Acetaminophen
Mechanism of Action
Analgesic effect thought to be due to activation of descending inhibition of the serotonergic pathway in the CNS . Anti-pyretic effect thought to 
be due to inhibition of the hypothalamic heat-regulating center
Uses
Pain, Fever
Contraindications
Hypersensitivity to acetaminophen or any component of formulation 
Protocol Uses
Pain Management, Adult (p58), Pain Management, Pediatric (p107)
Side Effects
GI: Nausea, vomiting
GU: Nephrotoxicity (chronic overdose)
Heme: anemia
Skin: Hypersensitivity, skin rash 
Pharmacokinetics
Half-life ~ 2 hours; metabolized in liver; crosses the placenta 
Pregnancy Category – B
Interactions
Increase: hepatotoxic effects – alcohol, fosphenytoin
Increase: effects of warfarin 
Decrease: acetaminophen effects – barbiturates, carbamazepine
Decrease: effect of – lamotrigine 
EMT Considerations
Assess: Assess mental status and appropriateness for oral medications
Evaluate: Therapeutic response 
Treatment of Overdose
Discontinue product, activated charcoal, N-acetylcysteine, supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
192
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Adenosine
193
Adenosine
Mechanism of Action
Slows conduction through the AV node, can interrupt reentry pathways through the AV node, and can restore normal sinus rhythm in patients 
with paroxysmal supraventricular tachycardia; decreases cardiac oxygen demand, decreasing hypoxia
Uses
PSVT, as a diagnostic aid to assess myocardial perfusion defects in CAD, Wolff-Parkinson-White syndrome
Unlabeled Uses: Wide-complex tachycardia diagnosis
Contraindications
Hypersensitivity, 2
nd
- or 3
rd
-degree AV block, sick sinus syndrome
Precautions
Pregnancy (C), breast-feeding, children, geriatric patients, asthma, atrial flutter, atrial fibrillation, ventricular tachycardia, bronchospastic lung 
disease, symptomatic bradycardia, bundle branch block, heart transplant, unstable angina, COPD, hypotension, hypovolemia, vascular heart 
disease, CV disease
Protocol Uses
Tachycardia With A Pulse, Adult (p43), Tachycardia With A Pulse, Peds (p98)
Side Effects
CNS: Lightheadedness, dizziness, arm tingling, numbness, headache
CV: Chest Pain, pressure, atrial tachydysrhthmias, sweating, palpitations, hypotension, facial flushing, AV block, cardiac arrest, ventricular 
dysrhythmias, atrial fibrillation
GI: Nausea, metallic taste
Resp: Dyspnea, chest pressure, hyperventilation, bronchospasm (asthmatics)
Pharmacokinetics
Cleared from plasma in <30sec, half-life 10sec, converted to inosine/adenosine monophosphate
Pregnancy Category - C
Interactions
Increase: risk for higher degree of heart block – Carbamazepine
Increase: risk for ventricular fibrillation – digoxin, verapamil
Increase: effects of adenosine – dypridamole
Decrease: activity of adenosine – theophylline or other methylxanthines (caffeine)
EMT Considerations
Assess cardiopulmonary status – BP, pulse, respiration, rhythm, ECG intervals (PR, QRS, QT); check for transient dysrhythmias (PVCs, PACs, sinus 
tachycardia, AV block)
Assess respiratory status – rate, rhythm, lung fields for crackles; watch for respiratory depression; bilateral crackles may occur in CHF patient; 
increased respiration, increased pulse, product should be discontinued
CNS effects – dizziness, confusion, psychosis, paresthesias, seizures; product should be discontinued
Treatment of Overdose
Defibrillation, vasopressor for hypotension, theophylline
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Albuterol
194
Albuterol
Mechanism of Action
Beta2-adrenergic agonist. Activates beta2 receptors on airway smooth muscle, increasing the cyclic AMP concentration, increasing activation of 
protein kinase A and lowers intracellular ionic calcium concentrations, leading to muscle relaxation.
Uses
Bronchospasm associated with asthma, exercise induced asthma, COPD
Unlabeled Uses: Hyperkalemia
Contraindications
Hypersensitivity to sympathomimetics, tachydysrhythmias, severe cardiac disease, heart block
Precautions
Pregnancy (C), breast-feeding, cardiac/renal disease, hyperthyroidism, diabetes mellitus, hypertension, prostatic hypertrophy, angle-closure 
glaucoma, seizures, exercise-induced bronchospasm (aerosol) in children <12 y/o, hypoglycemia
Protocol Uses
Guidelines For Use of Protocols (p9), Paramedic Intercept Guidelines (p23), Radio Report Format (p28), COPD/Asthma/Stridor – Adult (p35), 
Allergic Reaction – Adult (p46), Prolonged Crush Injury – Adult, Trauma (p73), Hazmat, General – Adult, Trauma (p79);
Destination Determination – Pediatric (p88), Wheezing / Asthma – Pediatric (p93), Allergic Reaction – Pediatric (p100), Prolonged Crush Injury –
Peds, Trauma (p120)
Side Effects
CNS: Tremors, anxiety, insomnia, headache, dizziness, stimulation, restlessness, hallucinations, flushing, irritability
CV: Palpitations, tachycardia, angina, hypo/hypertension, dysrhythmias
EENT: Dry nose, irritation of nose and throat
GI: Heartburn, nausea, vomiting
MS: Muscle cramps
Resp: Cough, wheezing, dyspnea, parodoxical bronchospasm, dry throat
Misc: Flushing, sweating, anorexia, bad taste/smell changes, hypokalemia, metabolic acidosis
Pharmacokinetics
Extensively metabolized in the liver and tissues, crosses placenta, breast mild, blood-brain barrier
INH – onset 5-15min, peak 1-1.5hr, duration 3-6hr, half-life 4hr
Pregnancy Category – C
Interactions
Increase: QTc prolongation – other drugs that increase QT prolongation
Increase: ECG changes/hypokalemia – potassium wasting diuretics
Increase: action of albuterol – tricyclics, MAOIs, other adrenergics; do not use together
Decrease: effectiveness of albuterol – other β-blockers
EMT Considerations
Respiratory Function: vital capacity, forced expiratory volume, ABGs; lung sounds, hear rate and rhythm, BP, sputum (baseline and peak); 
whether patient has not received theophylline therapy before giving dose
Evaluate: therapeutic response: absence of dyspnea, wheezing after 1hr, improved airway exchange, improved ABG
Treatment of Overdose
Administer β1-adrenergic blocker, IV Fluids
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Amiodarone
195
Amiodarone
Mechanism of Action
Prolongs duration of action potential and effective refractory period, noncompetitive a- and b-adrenergic inhibition; increases PR and QT 
intervals, decreases sinus rate, decreases peripheral vascular resistance
Uses
Hemodynamically unstable ventricular tachycardia, supraventricular tachycardia, ventricular fibrillation not controlled by 1
st
-line agents
Unlabeled Uses: Atrial fibrillation treatment/prophylaxis, atrial flutter, cardiac arrest, cardiac surgery, CPR, heart failure, PSVT, Wolff-ParkinsonWhite (WPW) syndrome, supraventricular tachycardia
Contraindications
Black Box Warning – 2
nd
- and 3
rd
-degree AV block, bradycardia, severe hepatic disease, cardiac arrhythmias, pulmonary fibrosis
Pregnancy (D), breastfeeding, neonates, infants, severe sinus node dysfunction, hypersensitivity to this product/iodine/a=benzyl alcohol, 
cardiogenic shock
Precautions
Children, goiter, Hashimoto’s thyroiditis, electrolyte imbalance, CHF, respiratory disease, torsades de pointes
Protocol Uses
Cardiac Arrest – Adult (p37), Tachycardia With a Pulse – Adult (p43), Tricyclic Overdose – Adult (55);
Cardiac Arrest, General – Peds (p95), Tachycardia with a Pulse – Peds (p98), 
Double Sequential Defibrillation – Procedure (p158)
Side Effects
CNS: Headache, dizziness, involuntary movement, tremors, peripheral neuropathy, malaise, fatigue, ataxia, paresthesia, insomnia
CV: Hypotension, bradycardia, sinus arrest, CHF, dysrhythmias, SA node dysfunction, AV block, increased defibrillation energy
EENT: Blurred vision, halos, photophobia, corneal microdepositis, dry eyes
GI: Nausea, vomiting, diarrhea, abdominal pain, anorexia, constipation, hepatotoxicity
MS: weakness, pain in extremities
Resp: Pulmonary fibrosis/toxicity, pulmonary inflammation, ARDS; gasping syndrome if used with neonates
Misc: Flushing, abnormal taste or smell, edema, abnormal salivation, coagulation abnormalities
Pharmacokinetics
Metabolized by liver (CYP3A4, CYP2C8), excreted by kidneys, 99% protein binding
Pregnancy Category – D
Interactions
Increase: QT prolongation – azoles, fluoroquinolones, macrolides
Increase: amiodarone concentration, possible serious dysrhythmias – protease inhibitors, reduce dose
Increase: anticoagulation effects - warfarin
Increase: bradycardia – b-blockers calcium channel blockers
EMT Considerations
Evaluate: therapeutic response: decreased in ventricular tachycardia, supraventricular tachycardia, fibrillation
CNS Symptoms: confusion, psychosis, numbness, depression, involuntary movements; product should be discontinued
Treatment of Overdose
O2, artificial ventilation, ECG, administer dopamine for circulatory depression, administer diazepam for seizures
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Aspirin
196
Aspirin
Mechanism of Action
Blocks pain impulses in CNS, reduces inflammation by inhibition of prostaglandin synthesis; antipyretic action results from vasodilation of 
peripheral vessels; decreases platelet aggregation
Uses
Mild to moderate pain or fever including RA, osteoarthritis, thromboembolic disorders; TIAs, rheumatic fever, post-MI, prophylaxis of MI, 
ischemic stroke, angina, acute MI
Unlabeled Uses: Prevention of cataracts, Kawasaki disease, pericarditis, PCI
Contraindications
Pregnancy (D) 3
rd trimester, breastfeeding, children <12 y/o, children with flu-like symptoms, hypersensitivity to salicylates, GI bleeding, 
bleeding disorders, intracranial bleeding, nasal polyps, urticaria
Precautions
Abrupt discontinuation, acid/base imbalance, alcoholism, ascites, asthma, bone marrow suppression in elderly, G6PD deficiency, gout, heart 
failure, anemia, renal/hepatic disease, gastritis, pregnancy (C) 1
st trimester
Protocol Uses
CHF/Pulmonary Edema – Adult (p36), Chest Pain / Suspected Acute Coronary Syndrome – Adult (p41)
Side Effects
CNS: Stimulation, drowsiness, dizziness, confusion, seizures, headache, flushing, hallucinations, coma
CV: Rapid pulse, pulmonary edema
EENT: Tinnitus, hearing loss
Endocrine: Hypoglycemia, hyponatremia, hypokalemia
GI: Nausea, vomiting, GI bleeding, diarrhea, heartburn, anorexia, hepatitis, GI ulcer
Heme: Thrombocytopenia, agranulocytosis, leukopenia, neutropenia, hemolytic anemia, increased bleeding time
Resp: Wheezing, hyperpnea, bronchospasm
Skin: Rash, urticaria, bruising
Syst: Reye’s syndrome (children), anaphylaxis, laryngeal edema
Pharmacokinetics
Enteric metabolism by liver; inactive metabolites excreted by kidneys; crosses placenta; excreted in breast mild; half-life 15-20min
Pregnancy Category – D
Interactions
Increase: gastric ulcer risk – corticosteroids, anti-inflammatories, NSAIDs, alcohol
Increase: bleeding – alcohol, plicamycin, thrombolytics, anticoagulants
Increase: hypotension - nitroglycerin
Decrease: effects of aspirin – antacids (high dose), urinary alkalizers, corticosteroids
EMT Considerations
Allergic reactions: rash, urticaria; if these occur, product may have to be discontinued; patients with asthma, nasal polyps allergies: severe 
allergic reaction may occur
Ototoxicity: tinnitus, ringing, roaring in ears; audiometric testing needed before, after long-term therapy
Treatment of Overdose
Lavage, activated charcoal, monitor electrolytes, VS
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Atropine
197
Atropine
Mechanism of Action
Blocks acetylcholine at parasympathetic neuroeffector sites; increases cardiac output, heart rate by blocking vagal stimulation in heart; dries 
secretions by blocking vagus nerve stimulation
Uses
Bradycardia <40-50bpm, bradydysrhythmia, reversal of anticholinesterase agents, insecticide poisoning, blocking cardiac vagal reflexes, 
decreasing secretions before surgery, antispasmodic with GU, biliary surgery, bronchodilator, AV heart block
Unlabeled Uses: Cardiac arrest, CPR, diarrhea, pulseless electrical activity, ventricular asystole, asthma
Contraindications
Hypersensitivity to belladonna alkaloids, closed-angle glaucoma, GI obstructions, myasthenia gravis, thyrotoxicosis, ulcerative colitis, prostatic 
hypertrophy, tachycardia, asthma, acute hemorrhage, severe hepatic disease, myocardial ischemia
Precautions
Pregnancy ©, breastfeeding, children <6 y/o, geriatric patients, renal disease, CHF, hyperthyroidism, COPD, hypertension, Down Syndrome, 
spastic paralysis, gastric ulcer
Protocol Uses
Bradycardia With a Pulse – Adult (p44), Cholinergic / Organophosphate Overdose – Adult (p56), Beta Blocker Overdose – Adult (p55), Cardiac 
Arrest, General – Peds (p95), Bradycardia with a Pulse – Peds (p99)
Side Effects
CNS: Headache, dizziness, involuntary movement, confusion, psychosis, anxiety, coma, flushing, drowsiness, insomnia, delirium
CV: Hypo/hypertension, paradoxical bradycardia, angina, PVCs, tachycardia, ectopic ventricular beats, bradycardia
EENT: Blurred vision, photophobia, glaucoma, eye pain, pupil dilation, nasal congestion
GI: Dry mouth, nausea, vomiting, abdominal pain, anorexia, constipation, paralytic ileus, abdominal distention, altered taste
GU: Retention, hesitancy, impotence, dysuria
Skin: Rash, urticaria, contact dermatitis, dry skin, flushing
Misc: Suppression of lactation, decreased sweating, anaphylaxis
Pharmacokinetics
Half-life 2-3hr, terminal 12.5hr. Excreted by kidneys unchanged (70-90% in 24hr), metabolized in liver 40-50% crosses placenta
Pregnancy Category – C
Interactions
Increase: mucosal lesions – potassium chloride tab
Increase: anticholinergic effects – tricyclics, amantadine, antiparkinson agents
Decrease: effect of atropine – antacids
EMT Considerations
Assess ECG for ectopic ventricular beats, PVCs, tachycardia. Assess for increased intraocular pressure; eye pain, nausea, vomiting, blurred 
vision, increased tearing
Treatment of Overdose
O2, artificial ventilation, ECG; administer dopamine for circulatory depression; administer diazepam for seizures; assess need for 
antidysrhythmics
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Calcium
198
Calcium
Mechanism of Action
Needed for maintenance of nervous, muscular, skeletal function; enzyme reactions; normal cardiac contractility; coagulation of blood; affects 
secretory activity of endocrine, exocrine glands
Uses
Prevention and treatment of hypocalcemia, hypermagnesemia, hypoparathyroidism, neonatal tetany, cardiac toxicity caused by hyperkalemia, 
lead colic, hyperphosphatemia, Vitamin D deficiency, osteoporosis prophylaxis, calcium antagonist toxicity
Unlabeled Uses: Electrolyte abnormalities in cardiac arrest, CPR
Contraindications
Hypercalcemia, digoxin toxicity, ventricular fibrillation, renal calculi
Precautions
Pregnancy (C), breastfeeding, children, respiratory/renal disease, cor pulmonale, patient in digoxin, respiratory failure, diarrhea
Protocol Uses
Cardiac Arrest – Adult (p37), Beta Blocker Overdose – Adult (p55), Calcium Channel Blocker Overdose – Adult (p55), Prolonged Crush Injury –
Adult, Trauma (p73); Cardiac Arrest, General – Peds (p95), Overdose and Poisoning, General – Peds (p105), Prolonged Crush Injury – Peds 
(p120)
Side Effects
CV: Shortened QT, heart block, hypotension, bradycardia, dysrhythmias, cardiac arrest
GI: Vomiting, nausea, constipation
Hypercalcemia: Drowsiness, lethargy, muscle weakness, headache, constipation, coma, anorexia, nausea, vomiting, polyuria, 
Skin: Pain, burning at IV site, severe venous thrombosis, necrosis, extravasation
Pharmacokinetics
Crosses placenta, enters breast milk, excreted via urine and feces, half-life unknown, protein binding 40-50%
Pregnancy Category – C
Interactions
Increase: dysrhythmias – digoxin glycosides
Increase: toxicity - verpamil
Decrease: effects of atenolol, verapamil
EMT Considerations
Assess: ECG for decreased QT and T-wave inversion; seizure precautions with padded side rails, decreased stimuli, place airway suction 
equipment
Evaluate: therapeutic response with decreased twitching, paresthesias, muscle spasms; absence of tremor, seizure or dysrhythmia
Treatment of Overdose
Discontinue product; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Dextrose
199
Dextrose
Mechanism of Action
Needed for adequate utilization of amino acids; decreases protein, nitrogen loss; prevents ketosis
Uses
Increases intake of calories; increases fluids in patients unable to take adequate fluids, calories orally; acute hypoglycemia
Contraindications
Hyperglycemia, delirium tremens, hemorrhage (cranial/spinal), CHF, anuria, allergy to corn products
Precautions
Cardiac/renal/hepatic disease, diabetes mellitus, carbohydrate intolerance
Protocol Uses
Documentation of Vital Signs (p18), Radio Report Format (p28), Cardiac Arrest – Adult (p37), Diabetic Emergencies – Adult (p48), Beta Blocker 
Overdose – Adult (p55), Calcium Channel Blocker Overdose – Adult (p55), Opioid Overdose – Adult (p55), Cocaine and Sympathomimetic 
Overdose – Adult (p55), Neonatal Resuscitation – Peds (p94), Cardiac Arrest, General – Peds (p95), Diabetic Emergencies – Peds (p103)
Side Effects
CNS: confusion, loss of consciousness, dizziness
CV: hypertension, CHF, pulmonary edema, intracranial hemorrhage
Endo: Hyperglycemia, rebound hypoglycemia, hyperosmolar syndrome, hyperglycemic non-ketotic syndrome, aluminum toxicity, hypokalemia, 
hypomagnesium
GI: Nausea
GU: Glycosuria, osmotic diuresis
Skin: Chills, flushing, warm feeling, rash, urticarial, extravasation necrosis
Resp: Pulmonary edema
Pharmacokinetics
Metabolized at the cellular level to carbon dioxide and water.
Oral – onset 10 minutes, peak 40 minutes; IV – onset immediate, peak 30 minutes
Pregnancy Category – C
Interactions
Increase: fluid retention/electrolyte excretion—corticosteroids
EMT Considerations
Assess: Electrolytes (Potassium), blood glucose; Injection site for extravasation (redness along vein, edema at site, necrosis, pain/tenderness), 
site should be changed immediately 
Evaluate: Therapeutic response
Treatment of Overdose
Insulin; discontinue product; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Diazepam
200
Diazepam
Mechanism of Action
Potentiates the actions of GABA, especially in the limbic system, reticular formation; enhances presympathetic inhibition, inhibits spinal 
polysynaptic afferent paths
Uses
Anxiety, EtOH withdrawal, seizure disorder, muscle relaxation
Contraindications
Pregnancy (D), hypersensitivity to benzodiazepines, closed -angle glaucoma, myasthenia gravis, EtOH intoxication, liver disease
Precautions
Breastfeeding, children <6 months, geriatric patients, COPD, CNS depression, labor, Parkinson’s disease, psychosis
Protocol Uses
Seizure – Peds (p109)
Side Effects
CNS: Dizziness, drowsiness, confusion, headache, anxiety, tremors, fatigue, hallucinations, ataxia
CV: Orthostatic hypotension, tachycardia, hypotension
EENT: Blurred vision, tinnitus, mydriasis, nystagmus
GI: Constipation, dry mouth, nausea, vomiting, anorexia, diarrhea
Heme: Neutropenia
Resp: Respiratory depression
Pharmacokinetics
Metabolized by the liver via CYP2C19, CYP3A4; excreted by kidneys, crosses the placenta, excreted in breast mild; crosses the blood-brain 
barrier; half life 20-50 hours. IM: Onset 15-30min, duration 1-1½ hour; IV: Onset immediate, duration 15 min-1 hour
Pregnancy Category – Not Assigned
Interactions
Increase: Diazepam effect – amiodarone, diltiazem, disulfiram, ketoconazole, nicardipine, verapamil, valproic acid
Increase: toxicity – barbiturates, SSRIs, cimetidine, CNS depressants, valproic acid, CYP3A4 inhibitors
Increase: CNS depression – EtOH
Decrease: Diazepam metabolism – oral contraceptives, valproic acid, disulfiram, propranolol
Decrease: Diazepam effect – CYP3A4 inducers (rifampin, barbiturates, carbamazepein, phenytoin, fosphenytoin), smoking
EMT Considerations
Assess BP (lying, standing), pulse; respiratory rate,
Assess EtOH withdrawal symptoms, including hallucinations (visual, auditory), delirium, irritability, agitation, fine or coarse tremor
Assess IV site for thrombosis or phlebitis, which may occur rapidly
Evaluate therapeutic response – decreased anxiety, restlessness, muscle spasms
Treatment of Overdose
Discontinue product, supportive care, monitor VS
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Diltiazem
201
Diltiazem
Mechanism of Action
Inhibits calcium ion influx across cell membrane during cardiac depolarization; produces relaxation of coronary vascular smooth muscle, dilates 
coronary arteries, slows SA/AV node conduction times, dilates peripheral arteries
Uses
Angina pectoris due to coronary artery spasm, hypertension, atrial fibrillation, atrial flutter, paroxysmal supraventricular tachycardia
Contraindications
Sick sinus syndrome, AV heart block, hypotension <90mmHg systolic, acute MI, pulmonary congestion, cardiogenic shock
Precautions
Pregnancy (C), breastfeeding, children, geriatric patients, CHF, aortic stenosis, bradycardia, GERD, hepatic disease, hiatal hernia, ventricular 
dysfunction
Protocol Uses
Tachycardia With a Pulse – Adult (p43), Calcium Channel Blocker Overdose – Adult (p55)
Side Effects
CNS: Headache, fatigue, drowsiness, dizziness, depression, weakness, insomnia, tremor, paresthesias
CV: dysrhythmia, edema, CHF, bradycardia, hypotension, palpitations, heart block
GI: Nausea, vomiting, diarrhea, gastric upset, constipation, increased LFTs
GU: Nocturia, polyuria, acute renal failure
Skin: Rash, flushing, photosensitivity, burning or itching at injection site
Resp: Rhinitis, dyspnea, pharyngitis
Pharmacokinetics
Metabolized by the liver, excreted in the urine (96% as metabolites)
IV – onset 30-60 min; peak 2-3 hours
Pregnancy Category – D
Interactions
Increase: toxic effects – theophylline
Increase: effects of -blockers, digoxin, lithium, carbamazepine, cyclosporine, anesthetics, HMG-CoA reductase inhibitorys, benzodiazepines, 
lovastatin, methylprednisolone
Increase: effects of diltiazem – cimetidine
EMT Considerations
Assess for CHF – look for dyspnea, weight gain, edema, jugular venous distention, rales, 
Assess dysrhythmias – BP, pulse, respiratory rate, ECG and PR intervals, QRS and QT intervals
Treatment of Overdose
Discontinue product, atropine for AV block, vasopressors for hypotension
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Diphenhydramine
202
Diphenhydramine
Mechanism of Action
Acts on blood vessels, GI, respiratory system by competing with histamine for H1-receptor site; decreases allergic response by blocking 
histamine 
Uses
Allergy symptoms, rhinitis, motion sickness, antiparkinsonism, nighttime sedation, nonproductive cough
Contraindications
Hypersensitivity to H1-receptor antagonist, acute asthma attack, lower respiratory tract disease, neonates
Precautions
Pregnancy (B), breastfeeding, children <2 years old, increased intraocular pressure, cardiac/renal disease, hypertension, bronchial asthma, 
seizure disorder, stenosed peptic ulcers, hyperthyroidism, prostatic hypertrophy, bladder neck obstruction
Protocol Uses
Allergic Reaction – Adult (p46), Antipsychotic Overdose / Acute Dystonic Reaction – Adult (p55), Allergic Reaction – Peds (p100)
Side Effects
CNS: Dizziness, drowsiness, poor coordination, fatigue, anxiety, euphoria, confusion, paresthesia, neuritis, seizures
CV: hypotension, palpitations
EENT: Blurred vision, dilated pupils, tinnitus, nasal stuffiness, dry nose, throat mouth
GI: Nausea, anorexia, diarrhea
GU: Retention, dysuria, frequency
Heme: thrombocytopenia, agranulocytosis, hemolytic anemia
Misc: Anaphylaxis
Resp: Increased thick secretions, wheezing, chest tightness
Pharmacokinetics
Metabolized in liver, excreted by kidneys, crosses placenta, excreted in breast milk, half life 2-7 hours. IM – onset ½ hour, peak 1-4 hours, 
duration 4-7 hours. IV – onset immediate, duration 4-7 hours
Pregnancy Category – B
Interactions
Increase: CNS depression – barbiturates, opiates, hypnotics, tricyclics, EtOH
Increase: diphenhydramine effect – MAOIs
EMT Considerations
Assess for urinary retention, frequency, dysuria
Assess respiratory status – rate, rhythm, increase in bronchial secretions, wheezing, chest tightness
Treatment of Overdose
Discontinue product, administer diazepam for seizures, vasopressors for hypotension, phenytoin for refractory seizures
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

DuoDote Kit
203
DuoDote Kit
The DuoDote autoinjector provides a single intramuscular dose of the anti-nerve agent medications atropine and pralidoxime chloride in a self 
contained unit. The kits are only effective against the nerve agents tabun (GA), sarin (GB), soman (GD) and VX. It may also be used in cases of 
agricultural insecticide exposure, as organophosphates are a key component of the agent. Common examples of insecticides using 
organophosphates are malathion, parathion, diazinon, fenthion, dichlorvos, ethion and trichlorfon.
Mechanism of Action
Atropine counters the parasympathetic response from the muscarinic receptor overstimulation associated with organophosphate and nerve 
agent poisoning, and reverses the SLUDGEM symptoms.
Pralidoxime chloride (“2-PAM”) binds to the organophosphate or nerve agent and changes the conformation of the molecule, which causes it 
to lose its binding to the acetylcholinesterase enzyme. The joined poison / antidote then releases from the site and regenerates the enzyme, 
allowing it to function again.
Uses
Organophosphate and nerve agent poisonings.
Contraindications
None in the emergency setting.
Precautions
Known hypersensitivity to the DuoDote or Mark I Kit and Pediatric patients under the age of 3 are relatively contraindicated.
Protocol Uses
Cholinergic / Organophosphate Overdose – Adult (p55)
Each kit contains: Atropine 2.1mg and Pralidoxime chloride 600mg
Minor initial symptoms – administer ONE DuoDote Kit via autoinjector (IM)
Severe symptoms appearing within 10 minutes of first dose – administer ONE additional DuoDote Kit via autoinjector (IM)
Severe symptoms present from the beginning – administer THREE DuoDote Kits via autoinjector (IM)
Side Effects
HEENT: Dry mouth
Skin: Flushing
CNS: Dilated pupils, Headache, Drowsiness
CV: Tachycardia
Interactions
Morphine, theophylline, aminophylline and succinylcholine should be avoided in patients with organophosphate poisoning.
Barbiturates are potentiated by the anticholinesterase enzyme and should be used cautiously when treating seizures in the poisoned patient.
EMT Considerations
The use of a DuoDote Kit offers no prophylactic protection and should be administered only if symptoms are present.
There is a high potential for “off-gassing” from patients exposed to both organophosphates and nerve agents. In cases of “off-gassing”, vapors 
are given off by chemically contaminated clothing or exhaled by poisoned individuals. EMS Providers should use all appropriate PPE including 
SCBA and be vigilant when monitoring for symptoms in themselves and other responders. These patients are generally NOT safe for transport 
by Helicopter EMS (HEMS).
Pregnancy Category (Atropine) – C; Pregnancy Category (Pralidoxime) – C
Treatment of Overdose
Discontinue product; supportive care
Pharmaceuticals
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Epinephrine
204
Epinephrine (Adrenaline)
Mechanism of Action
β1- and β2-agonist causing increased levels of cAMP, thereby producing bronchodilation, cardiac and CNS stimulation; high doses cause 
vasoconstriction via alpha-receptors; low doses can cause vasodilation vai β2-vascular receptors
Uses
Acute asthma attacks, hemostasis, bronchospasm, anaphylaxis, allergic reactions, cardiac arrest, shock
Contraindications
Hypersensitivity to sympathomimetics, sulfites, closed-angle glaucoma, nonanaphylactic shock during general anesthesia
Precautions
Pregnancy (C), breastfeeding, cardiac disorders, hyperthyroidism, diabetes mellitus, prostatic hypertrophy, hypertension, organic brain 
syndrome, local anesthesia in certain areas, labor, cardiac dilation, coronary insufficiency, cerebral atherosclerosis, organic heart disease
Protocol Uses
Termination of Resuscitation (p15), COPD / Asthma / Stridor – Adult (p35), Cardiac Arrest – Adult (p37), Bradycardia With a Pulse – Adult (p44), 
Allergic Reaction – Adult (p46), Calcium Channel Blocker Overdose – Adult (p55), Hypotension / Shock (Non-Trauma) – Adult (p63), 
Hypotension / Shock (Trauma) – Adult (p85), Wheezing / Asthma – Peds (p93), Neonatal Resuscitation – Peds (p94), Cardiac Arrest, General –
Peds (p95), Post Resuscitation Care – Peds (p97), Bradycardia With a Pulse – Peds (p99). Allergic Reaction – Peds (p100), Hypotension / Shock 
(Non-Trauma) – Peds (p110)
Side Effects
CNS: Tremors, anxiety, insomnia, headache, dizziness, confusion, hallucinations, cerebral hemorrhage, weakness, drowsiness
CV: Palpitations, tachycardia, hypertension, dysrhythmias, increased T wave
GI: Anorexia, nausea, vomiting
MISC: Sweating, dry eyes
Resp: Dyspnea
Pharmacokinetics
Crosses placenta, metabolized in the liver. IM – onset variable, duration 1-4 hours; Inhaled - onset 1-5 minutes, duration 1-3 hours
Pregnancy Category – C 
Interactions
Do not use with MAOIs or tricyclics; hypertensive crisis may occur. 
Toxicity: other sympathomimetics
Decrease: hypertensive effects – β-adrenergic blockers
EMT Considerations
Assess Asthma – auscultate lungs, pulse, BP, respiratory rate and effort, sputum
ECG completed when continuous albuterol administered
Sulfite sensitivity may be life-threatening
Allergic reactions, bronchospasms
Treatment of Overdose
Discontinue product, administer α -blocker and β -blocker
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Etomidate
205
Etomidate
Mechanism of Action
Ultrashort-acting nonbarbiturate hypnotic used for rapid induction of anesthesia with minimal cardiovascular effects; modulates GABAA
receptors to induce general anesthesia. Does NOT have any analgesic properties
Uses
Conscious sedation, anesthesia for rapid-sequence intubation
Unlabeled uses: determine speech lateralization in patients prior to lobectomies to remove epileptogenic centers in the brain
Contraindications
Hypersensitivity
Precautions
Renal impairment, Elderly patients, Pregnancy category (C), unknown if excreted in breast milk 
Protocol Uses
Rapid Sequence Airway – Adult (p33); Invasive Airway – Peds (p91)
Side Effects
Suppresses corticosteroid synthesis in the adrenal cortex by inhibiting 11-beta-hydroxylase, an enzyme important in adrenal steroid production. 
CV: Arrhythmias, bradycardia, HTN, hypotension
GI: Nausea, vomiting on emergence from anesthesia
MS: Pain at injection site
Resp: Hiccups, laryngospasm, hypoventilation
Pharmacokinetics
Protein binding 76%, metabolized by hepatic and plasma esterases, excreted by kidneys, half life 1.25 hours
IV – Onset in 30-60 seconds, peak within 1 minute, duration approximately 3-5 minutes
Pregnancy Category – C 
Interactions
No interactions listed on Lexi-Comp
EMT Considerations
Administer IV push over 30-60 seconds. Solution is highly irritating to small vessels
Assess vital signs, note muscle tone prior to and after injection, drug history, hepatic or renal failure
Assess for CNS changes – dizziness, somnolence, hallucinations, euphoria, LOC
Treatment of Overdose
Discontinue product; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Famotidine
206
Famotidine
Mechanism of Action
Competitively inhibits histamine at histamine H2-receptor site, thus decreasing gastric secretion while pepsin remains at a stable level.
Uses
Short-term treatment of active duodenal ulcer, maintenance therapy for duodenal ulcer, Zollinger-Ellison syndrome, multiple endocrine 
adenomas, gastric ulcers; gastroesophageal reflux disease, heartburn
Unlabeled uses: GI disorders in those taking NSAIDs; urticaria; prevention of stress ulcers, aspiration pneumonitis, inactivation of oral 
pancreatic enzymes in pancreatic disorders
Contraindications
Hypersensitivity
Precautions
Pregnancy (B), breastfeeding, children <12 years old, geriatric patients, severe renal/hepatic disease
Protocol Uses
Allergic Reaction – Adult (p46), Allergic Reaction – Peds (p100)
Side Effects
CNS: Headache, dizziness, paresthesia, depression, anxiety, somnolence, insomnia, fever, seizures in renal disease
CV: Dysrhythmias, QT prolongation in impaired renal function
EENT: Taste change, tinnitus, orbital edema
Skin: Rash, toxic epidermal necrolysis, Stevens-Johnson syndrome
MS: Myalgias, arthralgias
Resp: Pneumonia
Pharmacokinetics
Plasma protein binding 15-20%, metabolized in liver 30% (active metabolites), 70% excreted by kidneys, half life 2½-3½ hours; 
IV – onset immediate, peak 30-60 minutes, duration 8-15 hours
Pregnancy Category – B 
Interactions
Decrease: absorption – ketoconazole, itraconazole, cefpodoxime, cefditoren
Decrease: famotidine absorption – antacids
Decrease: effect of – atazanavir, delavirdine
EMT Considerations
Assess for signs of ulcers – epigastric pain, abdominal pain, frank or occult blood in emesis
Assess for signs of allergic reaction – redness, hives, itching
Treatment of Overdose
Discontinue product; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Fentanyl
207
Fentanyl
Mechanism of Action
Inhibits ascending pain pathways in the CNS, increases pain threshold, alters pain perception by binding to opiate receptors
Uses
Controls moderate to severe pain; adjunct to general anesthetic, adjunct to regional anesthesia; conscious sedation
Contraindications
Hypersensitivity to opiates, myasthenia gravis
Precautions
Pregnancy (C), breastfeeding, geriatric patients, increased intracranial pressure, seizure disorders, severe respiratory disorders, cardiac 
dysrhythmias
Protocol Uses
Post Advanced Airway Sedation – Adult, Medical (p34), Opioid Overdose – Adult (p55), Pain Management – Adult (p58), Post Resuscitation Care 
– Peds (p97), Pain Management – Peds (p107), Sickle Cell Crisis – Peds (p111)
Side Effects
CNS: Dizziness, euphoria, sedation
CV: Bradycardia, arrest, hypo/hypertension
EENT: Blurred vision, miosis
GI: Nausea, vomiting, constipation
Skin: Rash, diaphoresis
MS: Muscle rigidity
Resp: Respiratory depression, arrest, laryngospasm
Pharmacokinetics
Metabolized by liver, excreted by kidneys, crosses placenta, excreted in breast milk. Half-life IV: 2-4 hours
IM: onset 7-8 minutes, peak 30 minutes, duration 1-2 hours. IV: Onset 1 minute, peak 3-5 minutes, duration ½ - 1 hour
Pregnancy Category – C 
Interactions
Increase: fentanyl effect (fetal respiratory depression) – cyclosporine, ketoconazole, cimetidine, fluconazole, nefazodine, zafrilukast
Increase: hypotension – droperidol
Increase: CV depression – diazepam
Increase: fentanyl effect with other CNS depressants – EtOH, opioids, sedative/hypnotics, antipsychotics, skeletal muscle relaxants, protease 
inhibitors
Decrease: fentanyl effect – CYP3A4 inducers (carbamazepine, phenytoin, phenobarbital, rifampin)
EMT Considerations
Assess vital signs, note muscle rigidity, drug history, hepatic or renal failure
Assess for CNS changes – dizziness, drowsiness, hallucinations, euphoria, LOC, pupil reaction
Treatment of Overdose
Discontinue product, naloxone
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Glucagon
208
Glucagon
Mechanism of Action
Increases in blood glucose, relaxation of smooth muscle of the GI tract, and a positive inotropic and chronotropic effect on the heart; increases 
in blood glucose are secondary to stimulation of glycogenolysis
Uses
Hypoglycemia, used to temporarily inhibit movement of GI tract as a diagnostic test
Contraindications
Hypersensitivity, pheochromocytoma, insulinoma (insulin-secreting tumor)
Protocol Uses
Cardiac Arrest – Adult (p37), Diabetic Emergencies – Adult (p48), Beta Blocker Overdose – Adult (p55), Calcium Channel Blocker Overdose –
Adult (p55), Diabetic Emergencies – Peds (p103), Overdose and Poisoning, General – Peds (p105)
Side Effects
CNS: Dizziness, headache,
CV: Hypotension
GI: Nausea, vomiting
Pharmacokinetics
IV: Onset immediate, peak 30 minutes, duration 1-1½ hours
IM: Onset 5-10 minutes, peak 13-20 minutes, duration 12-30 minutes
Pregnancy Category – B 
Interactions
Increase: Bleeding risk – anticoagulants
EMT Considerations
Assess for hypoglycemia – monitor blood glucose levels before and after use; use other products to control hypoglycemia if patient is conscious
Treatment of Overdose
Discontinue product, supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Glucose (Oral)
209
Glucose
Mechanism of Action
Needed for adequate utilization of amino acids; decreases protein, nitrogen loss; prevents ketosis
Uses
Increases intake of calories; increases fluids in patients unable to take adequate fluids, calories orally; acute hypoglycemia
Contraindications
Inability to swallow effectively, impaired airway reflexes / inability to protect airway, hyperglycemia, delirium tremens, hemorrhage (cranial/
spinal), CHF, anuria, allergy to corn products
Precautions
Cardiac/renal/hepatic disease, diabetes mellitus, carbohydrate intolerance
Protocol Uses
General Approach – Adult, Medical (p31), Airway Management – Adult (p32), Rapid Sequence Airway – Adult (p33), CHF / Pulmonary Edema –
Adult (p36), Diabetic Emergencies – Adult (p48), Refusal Protocol – Adult (p59), Refusal After EMS Treatment – Adult (p60), Seizure – Adult 
(p61), Suspected Stroke – Adult (p64), Sepsis Screening – Adult (p62), Hypotension / Shock (Non-Trauma) – Adult (p63), Environmental, 
Hypothermia – Adult, Trauma (p76), Head Injury – Adult, Trauma (p80), Lightning Strike – Adult, Trauma (p82), 
General Approach – Peds, Medical (p89), Airway management – Peds (p90), Neonatal Resuscitation – Peds (p94), Brief Resolved Unexplained 
Event (BRUE – formerly “ALTE”) – Peds (p102), Diabetic Emergencies – Peds (p103), Overdose and Poisoning, General – Peds (p105), Refusal 
Protocol – Peds (p108), Seizure – Peds (p109), Hypotension / Shock (Non-Trauma) – Peds (p110), Environmental, Hypothermia – Peds, Trauma 
(p123), Head Injury – Peds, Trauma (p126), Blood Glucose Analysis – Procedure (p152), BE-FAST Stroke Screen – Procedure (p165), FAST-ED 
Stroke Screen – Procedure (p166)
Side Effects
CNS: confusion, loss of consciousness, dizziness
CV: hypertension, CHF, pulmonary edema, intracranial hemorrhage
Endo: Hyperglycemia, rebound hypoglycemia, hyperosmolar syndrome, hyperglycemic non-ketotic syndrome, aluminum toxicity, hypokalemia, 
hypomagnesium
GI: Nausea
GU: Glycosuria, osmotic diuresis
Skin: Chills, flushing, warm feeling, rash, urticarial, extravasation necrosis
Resp: Pulmonary edema
Pharmacokinetics
Metabolized at the cellular level to carbon dioxide and water
Oral – onset 10 minutes, peak 40 minutes
Pregnancy Category – C 
Interactions
Increase: fluid retention/electrolyte excretion—corticosteroids
EMT Considerations
Assess: Mental status and appropriateness for oral medications, electrolytes (Potassium), blood glucose
Evaluate: Therapeutic response
Treatment of Overdose
Insulin, IVF, discontinue product, supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Haloperidol
210
Haloperidol
Mechanism of Action
Depresses cerebral cortex, hypothalamus, limbic system, which control activity and aggression; blocks neurotransmission produced by 
dopamine at synapse; exhibits, strong α-adrenergic, anticholinergic blocking action; mechanism for antipsychotic effects unclear
Uses
Psychotic disorders, control of tics, vocal utterances in Gilles de la Tourette’s syndrome, short-term treatment of hyperatcive children showing 
excessive motor activity, prolonged parenteral therapy in chronic schizophrenia, organic mental syndrome with psychotic features, hiccups 
(short-term), emergency sedation of severely agitated or delirious patients, ADHD
Unlabeled uses: Intraoperative nausea, vomiting; autism; migraine
Contraindications
Hypersensitivity, coma, Parkinson’s disease
Precautions 
Pregnancy (C), breastfeeding, geriatric patients, seizure disorders, hypertension, pulmonary/cardiac/hepatic disease, QT prolongation, torsades 
de pointes, prostatic hypertrophy, hyperthyroidism, thyrotoxicosis, children, blood dyscrasias, brain damage, bone marrow depression, EtOH 
and barbiturate withdrawal states, angina, epilepsy, urinary retention, closed angle glaucoma, CNS depression Black Box Warning: Increased 
mortality in elderly patients with dementia-related psychosis
Protocol Uses
Behavioral Emergencies – Adult (p47); Behavioral Emergencies – Peds (p101)
Side Effects
CNS: EPS – pseudoparkinsonism, akathisia, dystonia, tardive dyskinesia, drowsiness, headache, seizures, neuroleptic malignant syndrome, 
confusion
CV: Orthostatic hypotension, hypertension, cardiac arrest, ECG changes, tachycardia, QT prolongation, sudden death, torsades de pointes
EENT: Blurred vision, glaucoma, dry eyes
GI: Dry mouth, nausea, vomiting, anorexia, constipation, diarrhea, jaundice, weight gain, ileus, hepatitis
GU: Urinary retention, dysuria, urinary frequency, enuresis, impotence, amenorrhea, gynecomastia
Skin: Rash, photosensitivity, dermatitis
Resp: laryngospasm, dyspnea, respiratory depression
Pharmacokinetics
Metabolized by liver, excreted in urine, bile; crosses placenta; enters breast mild; protein binding 92%; terminal half-life 12-36 hours 
(metabolites) IM: Onset 15-30 minutes, peak 15-20 minutes, half life 21 hours
Pregnancy Category – C 
Interactions
Increase: serotonin syndrome, neuroleptic malignant syndrome – SSRIs, SNRIs
Increase: QT prolongation – class 1A, III antidysrhythmics, tricyclics, amoxapine, maprotiline, phenothiazines, pimozide, risperidone, 
sertindole, ziprasidone, β-blockers, chloroquine, clozapine, dasatinib, dolasetron, droperidol, dronedarone, flecainide, methadone, 
erythromycin, ondansetron, tacrolimus
Increase: oversedation – other CNS depressants, EtOH, barbiturate anesthetics
Increase: toxicity – epinephrine, lithium
Decrease: effects – lithium, levodopa
EMT Considerations
Assess patient response to medications, scene safety, evaluate for dystonic reaction
Treatment of Overdose
Discontinue product, supportive care, ECG monitoring, diphenhydramine for dystonia
Pharmaceuticals
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Hydroxocobalamin
211
Hydroxocobalamin
Mechanism of Action
Precursor to cyanocobalamin (vitamin B12). Cyanocobalamin acts as a coenzyme for various metabolic functions including fat and carbohydrate 
metabolism and protein synthesis. In the presence of cyanide, each hydroxocobalamin molecule can bind one cyanide ion and form 
cyanocobalamin, which is then excreted in the urine. 
Uses
Cyanide antidote, vitamin B12 deficiency, pernicious anemia, vitamin B12 malabsorption syndrome, increased requirements with pregnancy, 
thyrotoxicosis, hemolytic anemia, hemorrhage, renal/hepatic disease, nutritional supplementation
Contraindications
Hypersensitivity, optic nerve atrophy
Precautions
Pregnancy (A), breastfeeding, children
Protocol Uses
Cyanide Poisoning – Adult (p57)
Side Effects
CNS: Flushing, optic nerve atrophy
CV: CHF, peripheral vascular thrombosis, pulmonary edema
GI: Diarrhea
Skin: Itching, rash, pain at injection site
Endo: Hypokalemia
Systemic: Anaphylactic shock
Pharmacokinetics
Stored in liver/kidneys/stomach; 50%-90% excreted in urine; crosses placenta; excreted in breast milk
Pregnancy Category – C 
Interactions
Increase: absorption—prednisone
Decrease: absorption—aminoglycosides, anticonvulsants, colchicine, chloramphenicol, aminosalicylic acid, potassium preparations, cimetidine
EMT Considerations
Assess: For vitamin B12 deficiency (red/beefy tongue, psychosis, pallor, neuropathy); For pulmonary edema, worsening of CHF in cardiac 
patients
Perform/provide: Protection from light, heat
Evaluate: Therapeutic response:, dyspnea on exertion, palpitations, paresthesias, psychosis, visual disturbances
Treatment of Overdose
Discontinue product, IVF, supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Ibuprofen
Ibuprofen
Mechanism of Action
Reversibly inhibits cyclooxygenase-1 and 2 (COX-1 and 2) enzymes, which results in decreased formation of prostaglandin precursors, has 
antipyretic, anti-inflammatory and analgesic effects 
Uses
Pain, osteoarthritis, rheumatoid arthritis 
Off-label use: Gout (acute flares), migraines, pericarditis 
Contraindications
Hypersensitivity to ibuprofen, active gastric/duodenal/peptic ulcers, active GI bleeding 
Protocol Uses
Pain Management – Adult (p58), Pain Management – Peds (p107)
Side Effects
CNS: Headache, nervousness, dizziness 
CV: Edema 
EENT: Tinnitus 
GI: Epigastric pain, heartburn, nausea, abdominal pain, abdominal distress, flatulence, nausea and vomiting
Heme: Anemia, prolonged bleeding time 
Skin: Skin rash, maculopapular rash, pruritus 
Pharmacokinetics
Half-life 2 hours; metabolized in liver, eliminated in the urine, crosses the placenta
Pregnancy Category – D in 3
rd Trimester
Interactions
Increase: effects of anticoagulants and other blood thinners (increased bleeding) 
Decrease: effects of anti-hypertensives 
EMT Considerations
Assess: Assess mental status and appropriateness for oral medications
Evaluate: Therapeutic response 
Treatment of Overdose
Discontinue product, supportive care 
Pharmaceuticals
~ This Space Intentionally Left Blank ~
212
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Ipratropium
213
Ipratropium
Mechanism of Action
Inhibits interaction of acetylcholine at receptor sites on the bronchial smooth muscle, thereby resulting in decreased cGMP and bronchodilation
Uses
COPD, Asthma
Contraindications
Hypersensitivity to this product, atropine, bromide, soybean or peanut products
Precautions
Breastfeeding, children <12 yr, angioedema, heart failure, surgery, acute bronchospasm, bladder obstruction, closed-angle glaucoma, prostatic 
hypertrophy, urinary retention, pregnancy (B)
Protocol Uses
COPD / Asthma / Sridor – Adult (p35), Hazmat, General – Adult, Trauma (p79), Wheezing / Asthma – Peds (p93)
Side Effects
CNS: Anxiety, dizziness, headache, nervousness
CV: Palpitations
EENT: Dry mouth, blurred vision, nasal congestion
GI: Nausea, vomiting, cramps
Skin: Rash
RESP: Cough, worsening of symptoms, bronchospasms
Pharmacokinetics
15% of dose reaches lower airways. Protein binding <9%, half-life elimination 2 hours
INH – onset 15 minutes, peak 1-2 hours, duration 2-5 hours
Pregnancy Category – B 
Interactions
Increase: toxicity—other bronchodilators (INH)
Increase: anticholinergic action—phenothiazines, antihistamines, disopyramide
EMT Considerations
Assess: Palpitations; respiratory status (rate, rhythm, auscultate breath sounds prior to and after administration
Perform/provide: Storage at room temp
Evaluate: Therapeutic response: ability to breathe adequately
Treatment of Overdose
Discontinue product; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Ketamine
214
Ketamine
Mechanism of Action
Produces a cataleptic-like state in which the patient is dissociated from the surrounding environment by direct action on the cortex and limbic 
system. Noncompetitive NMDA receptor antagonist that blocks glutamate in the brain. Low doses produce analgesia and modulate central 
sensitization, hyperalgesia and opioid tolerance. Reduces polysynaptic spinal reflexes.
Uses
Induction and maintenance of general anesthesia
Unlabeled uses: Complex regional pain syndrome, analgesia, sedation
Contraindications
Hypersensitivity, conditions in which increased blood pressure would be hazardous. Additional contraindications per American College of 
Emergency Physicians (ACEP) – Infants <3 months of age, known or suspected schizophrenia (even if currently stable or controlled with 
medications)
Precautions
Increased intracranial pressure, increased ocular pressure, thyroid disorders, cardiovascular disease, respiratory depression, airway 
complications, CNS depression, emergence reaction
Ketamine crosses the placenta and can be detected in fetal tissue; it is not known if ketamine is excreted in breast milk
Protocol Uses
Rapid Sequence Airway – Adult (p33), Post Advanced Airway Sedation - Adult, Medical (p34), Behavioral Emergencies – Adult (p47), Pain 
Management – Adult (p58); Rapid Sequence Airway – Peds (p91), Post-Airway Sedation – Peds (p92), Behavioral Emergencies – Peds (p101)
Side Effects
CNS: Prolonged emergence, confusion, hallucinations, irrational behavior, increased CSF pressure, hypertonia (may resemble seizures), drug 
dependence
CV: Bradycardia, arrhythmia, hypotension, HTN, tachycardia
Derm: Erythema (transient), morbilliform rash (transient), rash at injection site
Endo: Central diabetes insipidus
GI: Anorexia, nausea, sialorrhea (drooling), vomiting
EENT: Diplopia, increased intraocular pressure, nystagmus
Resp: Airway obstruction, apnea, respiratory depression, laryngospasm
Pharmacokinetics
Metabolized in liver via hydroxylation and N-demehtylation, excreted primarily in the urine
IV – onset 30 seconds, peak 5-10 minutes; IM – onset 3-4 minutes, peak 12-25 minutes. Half life 2.5 hours
Pregnancy Category – Not Assigned
Interactions
Increase: CNS depression – alcohol, buprenorphine, cannabis, magnesium sulfate, minocycline, mirtazapine, zolpidem, hydrocodone, 
antihistamines, thalidomide
Increase: active metabolites – quazepam, stiripentol,memantine
Ketamine may increase the toxic effects of – memantine, mifepristone, thiopental, SSRI antidepressants
EMT Considerations
Assess heart rate, blood pressure, respiratory rate, SpO2
Assess for emergence reaction
Assess cardiac function continuously in patients with increased blood pressure or cardiac decompensation
Treatment of Overdose
Discontinue product; respiratory support for laryngospasm and respiratory depression, airway suctioning for increased salivation and 
secretions, supportive care for psychomotor agitation and hallucinations
Pharmaceuticals
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Ketorolac
Ketorolac
Mechanism of Action
Reversibly inhibits cyclooxygenase-1 and 2 (COX-1 and 2) enzymes, which results in decreased formation of prostaglandin precursors, has 
antipyretic, analgesic and anti-inflammatory 
Uses
Acute Pain
Contraindications
Hypersensitivity to ketorolac, aspirin and other NSAIDs, contraindicated during labor and delivery, active or history of peptic ulcer disease, 
active or recent GI bleed. Ketorolac should not be administered to females of reproductive age without a documented negative pregnancy test. 
This is due to harm that may be caused to a developing fetus, as well as potential bleeding complications in the Mother.
Elderly patients.
Patients with suspected intracranial hemorrhage, traumatic hemorrhage or anticipated emergent surgical intervention.
Protocol Uses
Pain Management – Adult (p58), Pain Management – Peds (p107)
Side Effects
CV: Edema, hypertension
EENT: Tinnitus 
GI: GI pain, dyspepsia, nausea, diarrhea 
Heme: Anemia, prolonged bleeding time, purpura 
Skin: pruritus, diaphoresis 
Pharmacokinetics
Onset IV 1 to 3 minutes, half-life elimination 5 hours, eliminated in the urine, crosses the placenta 
Pregnancy Category – D
Interactions
Increase: effects of anticoagulants and other blood thinners (increased bleeding)
Increase: effects of ketorolac 
Increase: effects of quinolones – neuroexcitatory and seizure potentiating 
Decrease: effects of anti-hypertensives 
EMT Considerations
Assess: Injection site of extravasation 
Evaluate: Therapeutic response 
Treatment of Overdose
Discontinue product, Supportive Care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
215
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Lidocaine
216
Lidocaine
Mechanism of Action
Increases electrical stimulation threshold of ventricle, His-Purkinje system, which stabilizes cardiac membrane, decreases automaticity
Uses
Ventricular tachycardia, ventricular dysrhythmias during cardiac surgery, digoxin toxicity, cardiac catheterization
Unlabeled uses: Attenuation of intracranial pressure increases during intubation/endotracheal tube suctioning
Contraindications
Hypersensitivity to amides, severe heart block, supraventricular dysrhythmias, Adams-Stokes syndrome, Wolff-Parkinson-White syndrome
Precautions: Pregnancy (B), breastfeeding, children, geriatric patients, renal/hepatic disease, CHF, respiratory depression, malignant 
hyperthermia, myasthenia gravis, weight <50 kg
Protocol Uses
Cardiac Arrest, General – Peds (p95), IO Intraosseous Venous Access – Procedure (p178)
Side Effects
CNS: Headache, dizziness, involuntary movement, confusion, tremor, drowsiness, euphoria, seizures, shivering
CV: Hypotension, bradycardia, heart block, CV collapse, arrest
EENT: Tinnitus, blurred vision
GI: Nausea, vomiting, anorexia
Hematology: Methemoglobinemia
Skin: Rash, urticaria, edema, swelling, petechiae, pruritus
Misc: Febrile response, phlebitis at injection site
Resp: Dyspnea, respiratory depression
Pharmacokinetics
Half-life 8 min, 1-2 hr (terminal); metabolized in liver; excreted in urine; crosses placenta
IV: Onset 2 minutes, duration 20 min
Pregnancy Category – B
Interactions
Increase: cardiac depression, toxicity—amiodarone, phenytoin, procainamide, propranolol
Increase: hypotensive effects—MAOIs, antihypertensives
Increase: neuromuscular blockade—neuromuscular blockers, tubocurarine
Increase: lidocaine effects—cimetidine, beta blockers, protease inhibitors, ritonavir
Decrease: lidocaine effects—barbiturates, ciprofloxacin, voriconazole
Decrease: effect of—cyclosporine
Decrease: effect—coltsfoot
EMT Considerations
Assess: ECG continuously to determine increased PR or QRS segments; if these develop, discontinue or reduce rate; watch for increased 
ventricular ectopic beats, may have to re-bolus; Blood pressure; Malignant hyperthermia (tachypnea, tachycardia, changes in BP, increased 
temp); Respiratory status (rate, rhythm, lung fields for crackles, watch for respiratory depression); CNS effects (dizziness, confusion, psychosis, 
paresthesias, convulsions-- product should be discontinued)
Evaluate: Therapeutic response: decreased dysrhythmias
Treatment of Overdose
Discontinue product, O2, artificial ventilation, ECG; administer Dopamine for circulatory depression, diazepam for seizures
Pharmaceuticals
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Lorazepam
217
Lorazepam
Mechanism of Action
Potentiates the actions of GABA, especially in the limbic system and the reticular formation
Uses
Anxiety, irritability with psychiatric or organic disorders, preoperatively; insomnia; adjunct for endoscopic procedures, status epilepticus
Unlabeled uses: Antiemetic prior to chemotherapy, rectal use, alcohol withdrawal, seizure prophylaxis, agitation, insomnia, sedation 
maintenance
Contraindications
Pregnancy (D), breastfeeding, hypersensitivity to benzodiazepines, benzyl alcohol; closed-angle glaucoma, psychosis, history of drug abuse, 
COPD, sleep apnea
Precautions: Children <12 yr, geriatric patients, debilitated, renal/hepatic disease, addiction, suicidal ideation, abrupt discontinuation
Protocol Uses
Tachycardia With a Pulse – Adult (p43), Bradycardia With a Pulse – Adult (p44), Behavioral Emergencies – Adult (p47), OB General – Adult (p50), 
Antipsychotic Overdose / Acute Dystonic Reaction – Adult (p55), Cocaine and Sympathomimetic Overdose – Adult (p55), Tricyclic Overdose –
Adult (p55), Seizure – Adult (p61), Bradycardia With a Pulse – Peds (p99), Seizure – Peds (p109)
Side Effects
CNS: Dizziness, drowsiness, confusion, headache, anxiety, tremors, stimulation, fatigue, depression, insomnia, hallucinations, weakness, 
unsteadiness
CV: Orthostatic hypotension, ECG changes, tachycardia, hypotension; apnea, cardiac arrest (IV, rapid)
EENT: Blurred vision, tinnitus, mydriasis
GI: Constipation, dry mouth, nausea, vomiting, anorexia, diarrhea
Skin: Rash, dermatitis, itching
Misc: Acidosis
Pharmacokinetics
Metabolized by liver; excreted by kidneys; crosses placenta, excreted in breast milk; half-life 14 hr
IM: Onset 15-30 min, peak 1-1.5 hours; duration 6-8 hours
IV: Onset 5-15 min, peak unknown, duration 6-8 hours
Pregnancy Category – D 
Interactions
Increase: Lorazepam effects—CNS depressants, alcohol, disulfiram, oral contraceptives
Decrease: Lorazepam effects—valproic acid
EMT Considerations
Assess: Anxiety (decrease in anxiety; mental status); Physical dependency (withdrawal symptoms: headache, nausea, vomiting, muscle pain, 
weakness, tremors, seizures)
Perform/provide: Assistance with ambulation during beginning therapy, since drowsiness, dizziness occurs; Refrigerate parenteral form
Evaluate: Therapeutic response: decreased anxiety, restlessness
Treatment of Overdose
GI lavage, VS, supportive care, flumazenil
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Magnesium
218
Magnesium
Mechanism of Action
When taken orally, promotes bowel evacuation by causing osmotic retention of fluid which distends the colon with increased peristaltic activity . 
Parenteral infusion decreases acetylcholine in motor nerve terminals and acts on myocardium by slowing rate of SA node impulse formation 
and prolonging conduction time. Magnesium is necessary for the movement of calcium, sodium and potassium into and out of the cells as well 
as stabilizing excitable membranes.
Uses
Anticonvulsant for preeclampsia/eclampsia 
Unlabeled uses: persistent pulmonary hypertension of the newborn (PPHN), cardiac arrest, CPR, digitoxin/digoxin toxicity, premature labor, 
seizure prophylaxis, status asthmaticus, torsades de pointes, ventricular fibrillation/tachycardia
Contraindications
Hypersensitivity, abdominal pain, nausea/vomiting, obstruction, acute surgical abdomen, rectal bleeding, heart block, myocardial damage
Precautions: Pregnancy (A), renal/cardiac disease
Protocol Uses
Asthma / COPD – Adult (p35), Cardiac Arrest – Adult (p37), Tachycardia With A Pulse – Adult (p43), OB General – Adult (p50), Beta Blocker 
Overdose – Adult (p55), Seizure – Adult (p61), Wheezing / Asthma – Peds (p93), Seizure – Peds (p109)
Side Effects
CNS: Muscle weakness, flushing, sweating, confusion, sedation, depressed reflexes, flaccid paralysis, hypothermia
CV: Hypotension, heart block, circulatory collapse, vasodilation
GI: Nausea, vomiting, anorexia, cramps, diarrhea
Hematology: Prolonged bleeding time
Metabolic: Electrolyte, fluid imbalances
Resp: Respiratory depression/paralysis
Pharmacokinetics
Protein binding 30% to albumin, excreted in the urine as magnesium
IM – onset 1 hour, duration 3-4 hours; IV – onset immediate, duration 30 min
Pregnancy Category – D 
Interactions
Increase: effect of neuromuscular blockers
Increase: hypotension—antihypertensives
Decrease: absorption of tetracyclines, fluoroquinolones, nitrofurantoin
Decrease: effect of digoxin
EMT Considerations
Assess: Eclampsia (seizure precautions, BP, ECG)
Evaluate: Therapeutic response (absence of seizures, stabilization of dysrhythmia, improvement in respiratory status)
Treatment of Overdose
Discontinue product; support respirations with positive pressure ventilation, supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Mark 1 Kit
219
Mark 1 Kit
Mark I NAAK (“Nerve Agent Antidote Kit”) is a dual-chamber autoinjector with two anti-nerve agent drugs. The kits are only effective against 
the nerve agents tabun (GA), sarin (GB), soman (GD) and VX. It may also be used in cases of agricultural insecticide exposure, as 
organophosphates are a key component of the agent. Common examples of insecticides using organophosphates are malathion, parathion, 
diazinon, fenthion, dichlorvos, ethion and trichlorfon.
Mechanism of Action
Atropine counters the parasympathetic response from the muscarinic receptor overstimulation associated with organophosphate and nerve 
agent poisoning, and reverses the SLUDGEM symptoms.
Pralidoxime chloride (“2-PAM”) binds to the organophosphate or nerve agent and changes the conformation of the molecule, which causes it 
to lose its binding to the acetylcholinesterase enzyme. The joined poison / antidote then releases from the site and regenerates the enzyme, 
allowing it to function again.
Uses
Organophosphate and nerve agent poisonings.
Contraindications
None in the emergency setting.
Precautions
Known hypersensitivity to the Mark I or DuoDote Kit and Pediatric patients under the age of 3 are relatively contraindicated.
Protocol Uses
Cholinergic / Organophosphate Overdose – Adult (p55)
Each kit contains: Atropine 2mg and Pralidoxime chloride 600mg
Minor initial symptoms – administer ONE Mark I Kit via autoinjector (IM)
Severe symptoms appearing within 10 minutes of first dose – administer ONE additional Mark I Kit via autoinjector (IM)
Severe symptoms present from the beginning – administer THREE Mark I Kits via autoinjector (IM)
Tube one (atropine) is always administered before tube two (2-PAM)
Side Effects
HEENT: Dry mouth
Skin: Flushing
CNS: Dilated pupils, Headache, Drowsiness
CV: Tachycardia
Interactions
Morphine, theophylline, aminophylline and succinylcholine should be avoided in patients with organophosphate poisoning.
Barbiturates are potentiated by the anticholinesterase enzyme and should be used cautiously when treating seizures in the poisoned patient.
EMT Considerations
The use of a Mark I Kit offers no prophylactic protection and should be administered only if symptoms are present.
There is a high potential for “off-gassing” from patients exposed to both organophosphates and nerve agents. In cases of “off-gassing”, vapors 
are given off by chemically contaminated clothing or exhaled by poisoned individuals. EMS Providers should use all appropriate PPE including 
SCBA and be vigilant when monitoring for symptoms in themselves and other responders. These patients are generally NOT safe for transport 
by Helicopter EMS (HEMS).
Pregnancy Category (Atropine) – C; Pregnancy Category (Pralidoxime) – C
Treatment of Overdose
Discontinue product; supportive care
Pharmaceuticals
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Methylprednisolone
220
Methylprednisolone
Mechanism of Action
In a tissue-specific manner, corticosteroids regulate gene expression subsequent to binding specific intracellular receptors and translocation 
into the nucleus. Corticosteroids exert a wide array of physiologic effects including modulation of musculoskeletal, endocrine and neurologic 
physiology are influenced by corticosteroids. Decreases inflammation by suppression of migration of polymorphonuclear leukocytes, reversal 
of increased capillary permeability, and lysosomal stabilization
Uses
Anaphylaxis, Asthma, COPD. Used primarily as an anti-inflammatory or immunosuppressant agent in the treatment of a variety of diseases.
Unlabeled uses: bronchiolitis, cadaveric organ recovery, COPD exacerbation
Contraindications
Hypersensitivity, neonates
Precautions
Pregnancy (C), breastfeeding, diabetes mellitus, glaucoma, osteoporosis, seizure disorders, ulcerative colitis, CHF, myasthenia gravis, renal 
disease, esophagitis, peptic ulcer, viral infection, TB, trauma.
Protocol Uses
COPD / Asthma / Stridor – Adult (p35), Allergic Reaction – Adult (p46), Wheezing / Asthma – Peds (p93), Allergic Reaction – Peds (p100)
Side Effects
CNS: Sedations, fatigue, restlessness, headache, sleeplessness, dystonia, dizziness, suicidal ideation, seizures, neuroleptic malignant syndrome, 
tardive dyskinesia (>3 months at high doses)
CV: hypotension, SVT
GI: Dry mouth, constipation, nausea, vomiting, diarrhea, anorexia
GU: Decrease libido, amenorrhea, galactorrhea
Hematology: Neutropenia, leukopenia, agranulocytosis
Skin: urticaria , rash
Pharmacokinetics
Metabolized by the liver, excreted in urine
Half-life 2.5-6 hours
IV: onset 1-2 minutes, duration 1-2 hours 
Pregnancy Category – C 
Interactions
Avoid use with MAOIs
Increase: sedation- alcohol, other CNS depressants
Increase: risk of EPS- haloperidol, phenothiazines
Decrease: action of metoclopramide, anticholinergics, opiates 
EMT Considerations
Assess: respiratory status (rate, rhythm, auscultate breath sounds prior to administration)
Evaluate: therapeutic response, ability to breathe adequately
Treatment of Overdose
Discontinue product; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Midazolam
221
Midazolam
Mechanism of Action
Binds to BZD receptors on the postsynaptic receptors on the postsynaptic GABA neuron at several sites within the CNS, including the limbic system, reticular 
formation. Enhancement of GABA on neuronal excitability results in hyperpolarization (less excitable state) and stabilization. BZD receptors and effects appear 
to be linked to GABAA receptors, BZDs do not bind GABAB receptors. 
Uses
Seizure, anxiolysis, pre-sedation for intubation, anesthesia
Unlabeled uses: Status epilepticus
Contraindications
Pregnancy (D), hypersensitivity to benzodiazepines, acute closed-angle glaucoma
Precautions
Breastfeeding, children, geriatric patients, COPD, CHF, chronic renal failure, chills, debilitated, hepatic disease, shock, coma, alcohol intoxication, status 
asthmaticus 
Protocol Uses
Airway Management – Adult (p32), Post Advanced Airway Sedation – Adult, Medical (p34), CHF / Pulmonary Edema – Adult (p36), Tachycardia With A Pulse –
Adult (p43), Bradycardia With A Pulse – Adult (p44), OB General – Adult (p50), Antipsychotic Overdose / Acute Dystonic Reaction – Adult (p55), Cocaine and 
Sympathomimetic Overdose – Adult (p55), Tricyclic Overdose – Adult (p55), Seizure – Adult (p61), Bites and Envenomations – Adult, Trauma (p68), 
Environmental, Hyperthermia – Adult, Trauma (p75), Airway Management – Peds (p90), Post Resuscitation Care – Peds (p97), Bradycardia with a Pulse – Peds 
(p99), Seizure – Peds (p109), Bites and Envenomations – Peds, Trauma (p117), Environmental, Hyperthermia – Peds, Trauma (p122), Head Injury – Peds, 
Trauma (p126)
Side Effects
CNS: retrograde amnesia, euphoria, confusion, headache, anxiety, insomnia slurred speech, paresthesia, tremors, weakness, chills, agitation, paradoxical 
reactions
CV: hypotension, PVCs, tachycardia, bigeminy, nodal rhythm, cardiac arrest
EENT: blurred vision, nystagmus, diplopia, loss of balance
GI: nausea, vomiting, increased salivation, hiccups
Skin: urticaria, pain/swelling/pruritus at injection site, rash
Resp: coughing, apnea, bronchospasm, laryngospasms, dyspnea, respiratory depression 
Pharmacokinetics
Protein binding 97%, half-life 1.8-6.4 hr, metabolized in liver; metabolites excreted in urine; crosses placenta and the blood brain barrier
IV – onset 3-5 minutes, duration <2 hours (6 hours in liver failure); IM – onset 15 minutes, duration 6 hours; IN – onset 4-8 minutes, duration 41 minutes
Pregnancy Category – D 
Interactions
Increase: hypotension- antihypertensives, opiates, alcohol, nitrates
Increase: extended half-life—CYP3A4 inhibitors (cimetidine, erythromycin, ranitidine)
Increase: respiratory depression—other CNS depressants, alcohol, barbiturates, opiate analgesics, verapamil, ritonavir, indinavir
Decrease: midazolam metabolism—CYP3A4 inducers (azole antifungals, theophylline) 
EMT Considerations
Assess: BP, pulse, respirations during IV; Injection site for redness, pain and swelling; Degree of amnesia in geriatric patients; may be increased; Anterograde 
amnesia; Vital signs during recovery period in obese patients, since half-life may be extended 
Preform/Provide: Assistance with ambulation until drowsy period ends; Storage at room temp, protect from light; Immediate availability of resuscitation 
equipment, O2 to support airway, do NOT give by rapid bolus 
Evaluate: Therapeutic response 
Treatment of Overdose
Discontinue product, supportive care, flumazenil (may induce seizures if used in patients with chronic benzodiazepine use), O2
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Naloxone
222
Naloxone
Mechanism of Action
Pure opioid antagonist that competes and displaces opioids at opioid receptor sites
Uses
Opiate overdose, respiratory depression induced by opioids, pentazocine, propoxyphene
Unlabeled uses: opiate-induced pruritis
Contraindications
Hypersensitivity
Precautions
Pregnancy (C), breastfeeding, children, neonates, CV disease, opioid dependency, seizure disorder, drug dependency 
Protocol Uses
Documentation of Vital Signs (p18), Cardiac Arrest – Adult (p37), Opioid Overdose – Adult (p55), Neonatal Resuscitation – Peds (p94), Overdose 
and Poisoning, General – Peds (p105)
Side Effects
CNS: Drowsiness, nervousness, seizures, tremor
CV: Rapid pulse, increase systolic BP (high doses), ventricular tachycardia/fibrillation, hypo/hypertension, cardiac arrest, sinus tachycardia
GI: Nausea, vomiting, hepatotoxicity
Resp: Tachypnea, pulmonary edema 
Pharmacokinetics
Metabolized by liver, crosses placenta; excreted in urine/breast milk
IV – onset 1 minute, duration 45 min. Half-life 30-81 minutes
Pregnancy Category – B 
Interactions
Increase: seizures - tramadol
Decrease: effect of opioid analgesics 
EMT Considerations
Assess: Withdrawal: cramping, hypertension, anxiety, vomiting; signs of withdrawal in drug-dependent individuals may occurs <2 hours after 
administration; 
Vital Signs q3-5 minutes; 
Cardiac Status: tachycardia, hypertension, monitor ECG ; 
Respiratory Function: respiratory depression, character, rate, rhythm, if respiration <10/min, administer naloxone; probably due to opioid 
overdose; monitor LOC; 
Pain: duration, intensity, location before and after administration 
Preform/Provide: Dark storage at room temp 
Evaluate: Therapeutic Response: reversal of respiratory depression; change in level of consciousness 
Treatment of Overdose
Discontinue product; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Nitroglycerin
223
Nitroglycerin
Mechanism of Action
Produces a vasodilator effect on the peripheral veins and arteries with more prominent effects on the veins. Primarily reduces cardiac oxygen 
demand by decreasing preload (left ventricular end-diastolic pressure). May modestly reduce afterload. Dilates coronary arteries and improves 
collateral flow
Uses
Unstable angina, Hypertension, Flash Pulmonary Edema
Unlabeled use: esophageal spasms, uterine relaxation, short-term management of pulmonary hypertension
Contraindications
Known hypersensitivity, increased intracranial pressure, cerebral hemorrhage
Precautions
Used with caution in postural hypotension, pregnancy, breastfeeding, children, renal disease, hepatic injury, inferior STEMI 
Protocol Uses
CHF / Pulmonary Edema – Adult (p36), Chest Pain / Suspected Acute Coronary Syndrome – Adult (p41), ST Elevation Myocardial Infarction –
Adult (p42)
Side Effects
CNS: Headache, flushing, dizziness
CV: Hypotension, tachycardia, collapse, syncope, palpitations
GI: Nausea, vomiting
Skin: Pallor, sweating, rash 
Pharmacokinetics
Metabolized by liver, excreted in urine
Half-life 1-4 min. 
Sublingual – onset 1-3 minutes, duration 30 minutes. IV – onset 1-2 minutes, duration 3-5 minutes 
Pregnancy Category – C 
Interactions
Severe hypotension, CV collapse: alcohol
Increase: effects of beta-blockers, diuretics, antihypertensives, calcium channel blockers
Increase: erectile dysfunction meds (fatal hypotension - sildenafil, tadalafil, vardenafil; do not use together)
Increase: nitrate level - aspirin
Decrease: heparin - IV nitroglycerin 
EMT Considerations
Assess: Orthostatic BP, pulse; Pain: duration time started, activity being preformed, character; Tolerance: if taking over long period of time; 
Headache, lightheadedness, decreased BP
Perform/Provide: Storage protected from light, moisture; store in cool environment 
Evaluate: Therapeutic response: decrease in anginal pain 
Treatment of Overdose
Discontinue product, IV fluids, supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Nitrous Oxide
224
Nitrous Oxide
Mechanism of Action
The mechanism of action of nitrous oxide is not completely understood . It is trifold and includes analgesia, anxiolysis and anesthesia.
Its analgesic mechanism of action is described as opioid in nature and may involve a number of spinal neuromodulators.
The anxiolytic effect is similar to that of benzodiazepines and may involve gamma aminobutyric (GABA) receptors
The anesthetic mechanism may involve GABA and possibly N-methyl-D-aspartate receptors as well. 
Uses
Nitrous is commonly used in dental surgery and as part of a procedural sedation during short, painful procedures in the Emergency Department. It acts as an analgesic 
and mild sedative when dispensed at the standard 2:1 ratio of N2O to O2. It is often used with other anesthetics.
Unlabeled use: 
Nitrous is sometimes used in auto racing. It is safe and stable at room temperature, but at ~600oC it decomposes into a gas with 33% oxygen per unit volume. 
Atmospheric air has only ~21% oxygen and thus can burn less fuel in a given volume.
Nitrous is commonly used as a short-term euphoric high which features audio and visual strobing effects. This use is generally illegal.
Contraindications
Respiratory compromise, or inability to reliably follow commands.
Nitrous rapidly diffuses into air-filled cavities, and patients in whom expansion of these air-filled cavities could compromise patient safety. This includes patients with 
pneumothorax, pulmonary blebs, air embolism, bowel obstruction, and those undergoing surgery of the eye or middle ear. 
Nitrous is known to be teratogenic and is contraindicated in pregnancy.
Precautions
Patients on chronic opiates may be highly tolerant to the analgesic effects of nitrous. When animals are given morphine chronically, they develop tolerance to its painkilling effects, and this also renders the animals tolerant to the analgesic effects of N2O.
Because nitrous oxide is minimally metabolized in humans (with a rate of 0.004%), it retains its potency when exhaled into the room by the patient, and can pose an 
intoxicating and prolonged exposure hazard to the staff if the room is poorly ventilated. Where nitrous oxide is administered, a continuous-flow fresh-air ventilation 
system or N2O scavenger system must be used to prevent a waste-gas buildup.
Protocol Uses
Pain Management – Adult (p58), Pain Management – Peds (p107), Nitrous Oxide – Procedure (p199)
Inhalational gas that MUST be self-administered by the patient.
Side Effects
CNS: Headache (especially if pt. not given inhaled O2 for 5 min after administration), Blurred Vision, Lethargy
CV: Orthostatic Hypotension, Dizziness, Faintness, or Lightheadedness
GI: Nausea, Vomiting
Heme: Methemoglobinemia
Misc: Exposure to nitrous oxide may cause vitamin B12 deficiency. It inactivates the cobalamin form of vitamin B12 by oxidation. Symptoms of vitamin B12 deficiency, 
including sensory neuropathy, myelopathy, and encephalopathy, may occur within days or weeks of exposure to nitrous oxide anesthesia in people with subclinical 
vitamin B12 deficiency.
Pharmacokinetics
Onset of action: Inhalation: 2-5 minutes
Absorption: Rapid via lungs; blood/gas partition coefficient is 0.47
Metabolism: Body: <0.004%
Excretion: Primarily exhaled gases; skin (minimal amounts)
Half-life: Approximately 5 minutes; depends on patient ventilatory volume, rate and quality. In general, the clinical effects of nitrous cease when inhalation stops, with 
minimal residual effect.
Pregnancy Category – C 
Interactions
Increase:effects of CNS depressants (EtOH, benzodiazepines, opiates, cannabis)
EMT Considerations
Assess: Vital signs for systemic hypotension 
Perform/Provide: Store at room temperature, should be stored in a cool, fire resistant area away from heat sources and combustibles 
Evaluate: Therapeutic response
Treatment of Overdose
Discontinue product; IV Fluids; 100% inhaled O2 (preferably via NRB); antiemetics; supportive care
Pharmaceuticals
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Norepinephrine
225
Norepinephrine
Mechanism of Action
β1 and α agonist causing increased contractility, increased heart rate, and vasoconstriction. Thus, increasing systemic blood pressure and coronary blood flow. 
Has greater alpha (vasoconstriction) than beta effects (contractility and heart rate).
Uses
Hypotension, shock
Contraindications
Extravasation, hypersensitivity to sympathomimetics or sulfites
Protocol Uses
Hypotension / Shock (Non-Trauma) – Adult (p63), Hypotension / Shock (Trauma) – Adult (p85), Hypotension / Shock (Non-Trauma) – Peds (p110)
Side Effects
CNS: anxiety, headache, tremor
CV: hypertension, arrhythmia 
GI : Nausea, vomiting, gut ischemia
Misc: Skin necrosis with extravasation
Pharmacokinetics
Onset of action: 1-2 minutes
Excretion: Kidney
Pregnancy Category – C 
Interactions
Concurrent use with the following may increase blood pressure further: linezolid, dihydroergotamine, TCAs 
EMT Considerations
Assess: Vital Signs: BP and pulse
Evaluate: Change in blood pressure
Treatment of Overdose
Discontinue product, administer α-blocker and/or β-blocker
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Ondansetron
226
Ondansetron
Mechanism of Action
Selective 5-HT3-receptor antagonist, blocking serotonin both peripherally on vagal nerve terminals and centrally in the chemoreceptor trigger 
zone
Uses
Chemotherapy associated nausea and vomiting, radiotherapy associated nausea and vomiting, postoperative nausea and/or vomiting
Unlabeled use: Hyperemesis gravidarum (severe or refractory), breakthrough nausea and/or vomiting associated with chemotherapy 
Contraindications
Hypersensitivity, congenital OR acquired prolonged QT, history of Torsades de Pointes
Precautions
Pregnancy (B), breastfeeding, children, geriatric patients 
Protocol Uses
Post Advanced Airway Sedation – Adult, Medical (p34), Chest Pain / Suspected Acute Coronary Syndrome – Adult (p41), ST Elevation Myocardial 
Infarction – Adult (p42), Abdominal Pain / GI Bleeding – Adult (p45), Pain Management – Adult (p58), Environmental, Hyperthermia – Adult, 
Trauma (p75), Eye Pain – Adult, Trauma (p78), Post Resuscitation Care – Peds (p97), Pain Management – Peds (p107), Sickle Cell Crisis – Peds 
(p111), Environmental, Hyperthermia – Peds, Trauma (p122), Eye Pain – Peds, Trauma (p125)
Side Effects
CNS: Headache, dizziness, drowsiness, fatigue, EPS
GI: Diarrhea, constipation, abdominal pain, dry mouth
Misc: Rash, bronchospasm (rare), musculoskeletal pain, wound problems, shivering, fever, hypoxia, urinary retention 
Pharmacokinetics
Metabolized in the liver, excreted primarily in urine
Half-life 3.5-4.7 hr 
Pregnancy Category – B 
Interactions
Decrease: ondansetron effect- rifampin, carbamazepine, phenytoin
EMT Considerations
Assess: Hypersensitivity reaction: rash, bronchospasm (rare); EPS: shuffling gait, tremors, grimacing, period rigidity
Perform/Provide: Storage at room temp 
Evaluate: Therapeutic response: absence of nausea/vomiting
Treatment of Overdose
Evaluate QT for prolongation; monitor for dysrhythmias; discontinue product; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Rocuronium
227
Rocuronium
Mechanism of Action
Blocks acetylcholine from binding to receptors on motor endplate inhibiting depolarization . Inhibits transmission of nerve impulses by binding 
with cholinergic receptor sites, antagonizing action of acetylcholine
Uses
Facilitation of endotracheal intubation; skeletal muscle relaxation during mechanical ventilation
Unlabeled use: preinduction to blunt defasciculation
Contraindications
Hypersensitivity
Precautions
Pregnancy (C), breastfeeding, children, geriatric patients, electrolyte imbalances, dehydration, respiratory/neuromuscular/cardiac/renal/
hepatic disease 
Protocol Uses
Rapid Sequence Airway – Adult (p33), Rapid Sequence Airway – Peds (p91)
Side Effects
CV: Bradycardia, tachycardia, change in BP, edema
GI: Nausea, vomiting
Skin: Rash, flushing, pruritus, urticarial
MSK: Myopathy
Resp: Prolonged apnea, bronchospasm, cyanosis, respiratory depression, dyspnea, pulmonary vascular resistance 
Pharmacokinetics
Metabolized in liver
Half-Life 30 min, duration 60-70 min 
Pregnancy Category – B 
Interactions
Theophylline increases risk of dysrhythmias
Increase: neuromuscular blockade caused by amphotericin B, verapamil, aminoglycosides, clindamycin, enflurane, isoflurane, lincomcin, 
lithium, opiates, local anesthetics, polymyxin, anti-infectives, quinidine, thiazides 
EMT Considerations
Assess: Vital Signs: BP, pulse, respirations, airway until fully recovered; Allergic reactions: rash, fever, respiratory distress, pruritus
Preform/Provide: Storage in light-resistant area, stable at room temp for 30 days 
Evaluate: Therapeutic response 
Treatment of Overdose
Discontinue product, Edrophonium or Neostigmine, Atropine, Monitor VS
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Sodium Bicarbonate
228
Sodium Bicarbonate
Mechanism of Action
Increase plasma bicarbonate which buffers hydrogen ion concentrations and reverses acidosis
Uses
Acidosis (metabolic), cardiac arrest, salicylate poisoning, tricyclic antidepressant overdose
Contraindications
Metabolic/respiratory alkalosis, hypochloremia, hypocalcemia
Precautions
Pregnancy (C), children, CHF, toxemia, renal disease, hypertension, hypokalemia, breastfeeding, hypernatremia, Cushing’s syndrome, 
hyperaldosteronism 
Protocol Uses
Cardiac Arrest – Adult (p37), Beta Blocker Overdose – Adult (p55), Tricyclic Overdose – Adult (p55), Prolonged Crush Injury – Adult, Trauma 
(p73), Cardiac Arrest, General – Peds (p95), Prolonged Crush Injury – Peds, Trauma (p120)
Side Effects
CNS: Irritability, confusion, headache, stimulation, tremors, hyperreflexia, weakness, seizures of alkalosis
CV: Irregular pulse, cardiac arrest, water retention, edema, weight gain
GI: Flatulence, belching, distension
MSK: Muscular twitching, tetany, irritability 
Pharmacokinetics
Excreted in urine
Onset 15 minutes. Duration 1-2 hours 
Pregnancy Category – C 
Interactions
Increase: effects- amphetamines, mecamylamine, quinine, quinidine, pseudophedrine, flecainide, anorexiants, sympathomimetics
Increase: sodium and decrease potassium- corticosteroids
Decrease: effects- lithium, chlorpropamide, barbiturates, salicylates, benzodiazepines, ketoconazole, corticosteroids 
EMT Considerations
Assess: Respiratory and pulse rate/rhythm; Fluid balance: edema, crackles, shortness of breath; Alkalosis: irritability, confusion, twitching, 
hyperreflexia, slow respirations, cyanosis, irregular pulse; Milk-Alkali Syndrome: confusion, headache, nausea, vomiting, anorexia, urinary 
stones, hypercalcemia 
Treatment of Overdose
Discontinue product; ventilatory support to exhale excess CO2; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Succinylcholine
229
Succinylcholine
Mechanism of Action
Acts similar to acetylcholine, producing depolarization of the motor endplate at the myoneural junction which causes sustained flaccid skeletal 
muscle paralysis.
Uses
Facilitation of endotracheal intubation
Contraindications
Hypersensitivity, malignant hyperthermia, trauma (crush injuries)
Precautions
Pregnancy (C), breastfeeding, geriatric or debilitated patients, cardiac disease, severe burns, fractures (fasciculations may increase damage), 
electrolyte imbalances (hyperkalemia), dehydration, neuromuscular disease, respiratory/cardiac/renal/hepatic disease, collagen disease, 
glaucoma, eye surgery 
Protocol Uses
Rapid Sequence Airway – Adult (p33), Rapid Sequence Airway (RSA) – Peds (p91)
Side Effects
CV: Bradycardia, tachycardia, hypo/hypertension, sinus arrest, dysrhythmias, edema
EENT: Increased secretions, Increased intraocular pressure
Heme: Myoglobinemia
Skin: Rash, flushing, pruritus, urticaria
MSK: Weakness, muscle pain, fasciculations, prolonged relaxation, myalgia, rhabdomyolysis
Resp: Prolonged apnea, bronchospasm, cyanosis, respiratory depression, wheezing, dyspnea
Systemic: anaphylaxis, angioedema, malignant hyperthermia
Pharmacokinetics
Hydrolyzed in blood, excreted in urine
IV - onset 1 min, peak 2-3 min, duration 6-10 min 
Pregnancy Category – C 
Interactions
Dysrhythmias: theophylline
Increase: neuromuscular blockade- aminoglycosides, beta-blockers, cardiac glycosides, clindamycin, lincomycin, procainamide, quinidine, local 
anesthetics, polymyxin antibiotics, lithium, opiates, thiazides, enflurane, isoflurane, magnesium salts, oxytocin 
EMT Considerations
Assess: Electrolyte imbalances (potassium, magnesium); may lead to increase action of product; Vital Signs: BP, pulse, respirations, airway; 
Recovery: decreased paralysis; Allergic Reactions: rash, fever, respiratory distress, pruritus 
Perform/Provide: Storage in refrigerator powder at room temp 
Evaluate: Therapeutic response: paralysis of jaw, eyelid, head, neck rest of body 
Treatment of Overdose
Discontinue product, supportive care, Neostigmine, Atropine
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Tranexamic Acid (TXA)
230
Tranexamic Acid (TXA)
Mechanism of Action
Displaces plasminogen from fibrin, inhibiting fibrinolysis (clot breakdown). Has inhibitory effects on plasmin, preventing further fibrinolysis.
Uses
Trauma associated hemorrhage, menorrhagia, tooth extraction in hemophiliac patients
Contraindications
IV: Hypersensitivity to tranexamic acid, active intravascular clotting, subarachnoid hemorrhage
PO: hypersensitivity to tranexamic acid, active thromboembolic disease, concurrent use with hormonal contraception
Protocol Uses
OB / Vaginal Bleeding – Adult (p51), Head Injury – Adult (p80), Hemorrhage Control – Adult (p81), Hypotension / Shock (Trauma) – Adult (p85), Head Injury –
Peds (p126), Hemorrhage Control – Peds (p127)
IV indicated for trauma associated hemorrhage
PO indicated for menorrhagia, tooth extraction in hemophiliac patients
Side Effects
CNS: Headache (PO), Dizziness (IV)
CV: Hypotension (IV)
GI: Abdominal pain (PO), Diarrhea, nausea, vomiting (IV)
Heme: thromboembolic complications (i.e. DVT), anemia (PO)
Misc: Backache (PO), blurred vision (IV and PO)
Pharmacokinetics
Onset of Action: IV: 5 minutes, PO: 2.5 hours 
Excretion: Renal
Half-life: IV: 2 hours, PO: 11 hours
Pregnancy Category – B 
Interactions
May enhance tranexamic acid: Estrogen derivatives, 
progestins
EMT Considerations
Assess: Hypersensitivity
Evaluate: Serial Blood Pressure, Mental Status, HR
Treatment of Overdose
Discontinue product, supportive care
Pharmaceuticals
B EMT
A A-EMT
P Paramedic 
M Medical Control
EMR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Key To Symbols
 – May Be Compatible
– Incompatible
▲–uncertain/variable data
- (blank) Data NA
D5W
D10NS
NS
Adenosine
Amiodarone
Atropine
Calcium chloride
Diazepam
Diltiazem
Diphenhydramine
Dopamine
Epinephrine
Etomidate
Famotidine
Fentanyl
Glucagon
Haloperidol
Hydroxocobalamin
Ketamine
Ketorolac
Lidocaine
Lorazepam
Magnesium sulfate
Methylprednisolone
Midazolam
Morphine sulfate
Naloxone
Nitroglycerin
Norepinephrine
Ondansetron
Rocuronium
Sodium Bicarb
Succinylcholine
TXA
Vasopressin
LR
Adenosine
Amiodarone
Atropine
Calcium chloride
Diazepam
Diltiazem
Diphenhydramine
Dopamine
Epinephrine
Etomidate
Famotidine
Fentanyl
Glucagon
Haloperidol
Hydroxocobalamin
KetamineKetorolac
Lidocaine
Lorazepam
Magnesium sulfate
Methylprednisolone
Midazolam
Morphine sulfate
Naloxone
Nitroglycerin
Norepinephrine
Ondansetron
Rocuronium
Sodium Bicarb
Succinylcholine
TXA
Vasopressin
C
▲
C
▲
C
C
C
C
C
C
C
C
C
C
C
▲
C
▲
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
▲
C
C
C
▲
C
C
▲
C
C
C
C
▲
C
C
C
▲
C
▲
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
▲
C
C
C
▲
C
▲
▲
C
C
▲
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
▲
▲
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
▲
▲
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
▲
C
C
C
C
C
C
▲
C
C
C
▲
C
C
▲
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
▲
▲
▲
▲
▲
C
▲
C
C
▲
▲
▲
▲
▲
C
▲
▲
C
C
C
C
C
C
▲
C
▲
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
▲
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
▲
C
▲
C
C
▲
C
▲
C
C
C
▲
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
▲
▲
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
▲
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
▲
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
▲
C
C
C
C
C
C
C
C
C
C
C
C
C
C
King Guide To Parenteral Admixtures – Adult, Medical
C
231
King Guide To Parenteral Admixtures – Adult, Medical

Medication Name
Dose
Concentration
lbs
6688
110132154176198220242264286308330
Airway Emergency Reference – Adult, Medical
Paralysis and Induction
Etomidate Ketamine Succinylcholine Rocuronium
0.3 mg/kg 2 mg/kg 2 mg/kg 1 mg/kg
2 mg/mL 100 mg/mL 20 mg/mL 10 mg/mL
kg
30 9mg / 4.5mL 60mg / 0.6mL 60mg / 3mL 30mg / 3mL40 12mg / 6mL 80mg / 0.8mL 80mg / 4mL 40mg / 4mL50 15mg / 7.5mL 100mg / 1mL 100mg / 5mL 50mg / 5mL60 18mg / 9mL 120mg / 1.2mL 120mg / 6mL 60mg / 6mL70 21mg / 10.5mL 140mg / 1.4mL 140mg / 7mL 70mg / 7mL80 24mg / 12mL 160mg / 1.6mL 160mg / 8mL 80mg / 8mL90 27mg / 13.5mL 180mg / 1.8mL 180mg / 9mL 90mg / 9mL
100 30mg / 15mL 200mg / 2mL 200mg / 10mL 100mg / 10mL110 30mg / 10mL 200mg / 2mL 200mg / 10mL 100mg / 10mL120 30mg / 10mL 200mg / 2mL 200mg / 10mL 100mg / 10mL130 30mg / 10mL 200mg / 2mL 200mg / 10mL 100mg / 10mL140 30mg / 10mL 200mg / 2mL 200mg / 10mL 100mg / 10mL150 30mg / 10mL 200mg / 2mL 200mg / 10mL 100mg / 10mL
Post Placement Management
Fentanyl
1 mcg/kg
50 mcg/mL
30mcg / 0.6mL40mcg / 0.8mL
50mcg / 1mL
60mcg / 1.2mL70mcg / 1.4mL80mcg / 1.6mL90mcg / 1.8mL
100mcg / 2mL
100mcg / 2mL100mcg / 2mL100mcg / 2mL100mcg / 2mL100mcg / 2mL
Midazolam
0.1 mg/kg
5 mg/mL
3mg / 0.6mL
4mg/0.8mL
5mg/1.0mL
5mg/1.0mL5mg/1.0mL5mg/1.0mL5mg/1.0mL5mg/1.0mL5mg/1.0mL5mg/1.0mL5mg/1.0mL5mg/1.0mL5mg/1.0mL
Ketamine
2 mg/kg
100 mg/mL
60mg / 0.6mL80mg / 0.8mL
100mg / 1mL
120mg / 1.2mL140mg / 1.4mL160mg / 1.6mL180mg / 1.8mL
200mg / 2mL
200mg / 2mL200mg / 2mL200mg / 2mL200mg / 2mL200mg / 2mL
Max Dose 30mg / 10mL 200mg / 2mL 200mg / 10mL 100mg / 10mL 100mcg / 2mL 5mg/1.0mL 200mg / 2mL
Airway Emergency Reference – Adult, Medical
232
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

PRESSOR Receptor Main Effect Main Shock Use Other
Epinephrine a1, a2, b1, b2
Vasoconstriction
Inotropy (increased squeeze)
Dromotropy (increased 
conduction through AV node)
Chronotropy (increased rate)
Anaphylaxis
Asthma
Cardiac Arrest
 Nonspecific a and b receptor activation Hard on myocardium Typically an add-on agent to norepinephrine in septic shock when an additional agent is required and
occasionally an alternative first-line agent if norepinephrine is contraindicated.
 Increases heart rate. May decrease mesenteric perfusion, may induce tachyarrhythmias and ischemia Must be diluted; eg, a usual concentration is 1 mg of 1:1,000 in 250 mL D5W (4 micrograms/mL).
Norepinephrine a1, b1 Vasoconstriction Inotropy Septic Shock Undifferentiated Shock
 First line med for most kinds of shock Initial vasopressor of choice in septic, cardiogenic and hypovolemic shock. Wide range of doses used clinically. Must be diluted; a usual concentration is 4mg in 250mL of D5W or NS (16mcg/mL)
Phenylephrine a1 Vasoconstriction Hypotension (“push dose” pressors in the ED)
 May cause reflex bradycardia Pure alpha-adrenergic vasoconstrictor. Alternative vasopressor for patients with septic shock who: (1) develop tachyarrhythmias on norepinephrine, (2) 
have persistent shock despite use of two or more vasopressor/inotropic agents including vasopressin (salvage therapy), or (3) high cardiac output with persistent hypotension.
 May decrease stroke volume and cardiac output in patients with cardiac dysfunction.  May be given as bolus dose of 50 to100 micrograms to support blood pressure during rapid sequence intubation.
Dobutamine b1, b2 Inotropy Vasodilation Cardiogenic Shock
 Minimal change in heart rate Hard on myocardium Initial agent of choice in cardiogenic shock with low cardiac output and maintained blood pressure. Add-on to norepinephrine for cardiac output augmentation in septic shock with myocardial dysfunction or 
ongoing hypoperfusion despite adequate intravascular volume and MAP.
 Increases cardiac contractility and rate; may cause hypotension and tachyarrhythmias. 
Dopamine a1, a2, b1, b2, DA
Vasoconstriction (high doses)
Inotropy
Dromotropy
Chronotropy
Septic Shock 
(2nd line behind Norepinephrine)
 More adverse effects(eg, tachycardia, arrhythmias particularly at doses ≥20 mcg/kg/minute) and failed therapy 
than norepinephrine. 
 May be useful in selected patients (eg, with compromised systolic function or bradycardia at low risk for 
tachyarrhythmias).
 Must be diluted; eg, a usual concentration is 400mg in 250mL D5W (1.6 mg/mL); use of a commercially available 
pre-diluted solution is preferred.
Vasopressin V1 Vasoconstriction Norepinephrine sparing effect at low doses
 Add-on to another vasopressor (eg, norepinephrine) to augment efficacy and decrease initial vasopressor
requirement. Not recommended as a replacement for a first-line vasopressor.
 Pure vasoconstrictor; may decrease stroke volume and cardiac output in myocardial dysfunction or precipitate 
ischemia in coronary artery disease. 
 Must be diluted; eg, a usual concentration is 25units in 250mL D5W or NS (0.1 units/mL).
Pressor FAQs – Adult, Medical
Pressor FAQs – Adult, Medical
233
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Use 60 gtt tubing based off of the following chart
mcg/min
2 mcg/min
4 mcg/min
6 mcg/min
8 mcg/min
10 mcg/min
12 mcg/min
14 mcg/min
16 mcg/min
gtt/min
30 gtt/min
60 gtt/min
90 gtt/min
120 gtt/min
150 gtt/min
180 gtt/min
210 gtt/min
240 gtt/min
gtt/sec
1 drop every 2 seconds
1 drop / second
1-2 drops / second
2 drops / second
2-3 drops / second
3 drops / second
3-4 drops / second
4 drops / second
The abbrevation gtt comes from the Latin “guttae”, meaning “drops”
All gtt/min rates on this page are based off 60 gtt tubing. 
If using 10 gtt tubing, divide the listed gtt/min rate by 6.
ALWAYS check drug concentrations BEFORE using any charts in this book
Pressor Drip Reference – Adult, Medical
Pressor Drip Reference – Adult, Medical
Mix 1mg of EPINEPHRINE (1:1,000) or NOREPINEPHRINE in 250mL NS or D5W (4mcg/ml)
Medication pump strongly recommended, when available
234

Medication Name Indication (Protocol Use) First Dose Second Dose Max 
Acetaminophen Pain Management, Adult (p. 58) 15 mg / kg PO 1000mg
Adenosine Tachycardia With A Pulse (p. 43) 6.0 mg IV/IO 12.0 mg IV/IO 6mg/12mg
Albuterol COPD / Asthma / Stridor (p. 35) 2.5 mg Neb 2.5 mg Neb 3 doses
Allergic Reaction (p. 46) 2.5 mg Neb 2.5 mg Neb 3 doses
Prolonged Crush Injury (p. 73) 2.5 mg Neb Run continuously as needed
Hazmat, General (p. 79) 2.5 mg Neb
Amiodarone Cardiac Arrest, Adult (p. 37) 300 mg IV/IO 150 mg IV/IO
Tachycardia With A Pulse (p. 43)
150 mg drip infusion over 10 minutes
(Polymorphic, Wide Complex)
Tachycardia With A Pulse (p. 43)
150 mg drip infusion over 10 minutes
(Monomorphic, Wide Complex)
Aspirin CHF / Pulmonary Edema (p. 36) 324 mg
Chest Pain / Suspected ACS (p. 41) 324 mg
ST Elevation MI (STEMI) (p. 42) 324 mg
Atropine Bradycardia With A Pulse (p. 44) 1mg IV/IO 1mg IV/IO 3 mg
Cholinergic / Organophosphate Overdose (p. 56)
Minor – 2.0 mg
Major – 6.0 mg
Calcium Chloride Cardiac Arrest, Adult (p. 37) 1.0 g IV/IO 1 dose
Calcium Channel Blocker Overdose (p. 55) 1.0 g IV/IO 1 dose
Prolonged Crush Injury (p. 73) 1.0 g IV/IO over 3 min 1 dose
Medication Quick Reference – Adult, Medical
Medication Quick Reference – Adult, Medical
235

Medication Name Indication (Protocol Use) First Dose Second Dose Max Dose
Dextrose Diabetic Emergencies (p. 48) D10W – 125mL D5W – 250mL
Diltiazem Tachycardia With A Pulse (p. 43) 0.25 mg/kg 20 mg
Diphenhydramine Allergic Reaction (p. 46) 50 mg IV/IM/IO/PO
Antipsychotic OD / Acute Dystonic Reaction (p. 55) 50 mg IV/IO/IM/PO
Epinephrine (1:1,000) Allergic Reaction (p. 46) 0.3-0.5 mg IM 0.3-0.5 mg IM 3 doses
COPD / Asthma / Stridor (p. 35) 0.3 -0.5mg IM
COPD / Asthma / Stridor (p. 35) 1 mg Neb in 2mL NS
Epinephrine (1:10,000) Cardiac Arrest (p. 37) 1 mg IV/IO
Epinephrine Infusion
(1mg of 1:1,000 in 250mL D5W)
Allergic Reaction (p. 46) 2-10 mcg/min (See Pressor Drip Sheet)
Bradycardia With A Pulse (p. 44) 2-10 mcg/min (See Pressor Drip Sheet)
Hypotension / Shock (Non-Trauma) (p. 63) 2-10 mcg/min (See Pressor Drip Sheet)
Hypotension / Shock (Trauma) (p. 85) 2-10 mcg/min (See Pressor Drip Sheet)
Etomidate Rapid Sequence Airway (p. 33) 0.3 mg/kg IV/IO 30mg
Famotidine Allergic Reaction, Adult (p. 46) 20 mg IV/IO
Fentanyl Post Advanced Airway Sedation (p. 34) 0.5-1.0 mcg/kg IV/IO 100mcg, max 3 doses
Tachycardia With A Pulse (cardioversion) (p. 43) 1 mcg/kg IV/IO 100mcg
Bradycardia With A Pulse (pacing) (p. 44) 1 mcg/kg IV/IO 100mcg
Pain Management (p. 58)
2mcg/kg IN
0.5-1.0 mcg/kg IV/IO Max 3 doses
Medication Quick Reference – Adult, Medical
Medication Quick Reference – Adult, Medical
236

Ketamine Rapid Sequence Airway (RSA) (p. 33) 2 mg/kg IV/IO 200 mg
Post Advanced Airway Sedation (p. 34) IV/IO 200mg
Behavioral Emergencies (p. 47)
2 mg/kg IV/IO
4 mg/kg IM
200mg IV/IO
400mg IM
Pain Management (p. 58) 0.25 mg/kg IV/IO 25 mg
May repeat x3
Ketorolac Pain Management (p. 58)
15 mg IV
30 mg IM
Lidocaine 2%
Intraosseous Venous Access Procedure (p. 178)
(Awake and aware of pain)
10-20 mg
½ - 1 mL of 2% at 100mg/5mL 
concentration
Medication Name Indication (Protocol Use) First Dose Second Dose Max Dose
Glucagon Cardiac Arrest (p. 37)
Ca Channel and/or Beta Blocker OD 5mg IV/IO
Diabetic Emergencies (p. 48) 1.0 mg IM
Calcium Channel Blocker Overdose (p. 55) 2mg IV/IO 2mg IV/IO
Beta Blocker Overdose (p. 55) 2mg IV/IO 2mg IV/IO
Glucose (Oral) Diabetic Emergencies (p. 48) 15 g PO (1 tube) 15 g PO (1 tube) 2 tubes
Haloperidol Behavioral Emergencies (p. 47) 5mg IM
Hydroxycobalamin 
(Cyanokit)
Cyanide Poisoning (p. 57) 70 mg/kg 5 g
Ibuprofen Pain Management, Adult (p. 58) 10mg/kg PO 400mg
Ipratroprium Bromide Asthma / COPD (p. 35) 0.5 mg Neb 2 doses
Hazmat, General (p. 79) 0.5 mg Neb
Medication Quick Reference – Adult, Medical
Medication Quick Reference – Adult, Medical
237

Medication Name Indication (Protocol Use) First Dose Second Dose Max Dose
Lorazepam Tachycardia With A Pulse (cardioversion) (p. 43) 0.1 mg/kg IV/IO/IM 2 mg
Bradycardia With A Pulse (pacing) (p. 44) 0.1 mg/kg IV/IO/IM 2 mg
Behavioral Emergencies (p. 47) 0.1 mg/kg IV/IO/IM
OB General (seizures) (p. 50) 0.1 mg/kg IV/IO/IM 2 mg
Cocaine and Sympathomimetic Overdose (p. 55) 0.1 mg/kg IV/IO/IM 2 mg
Seizure (p. 61) 0.1 mg/kg IV/IO/IM 2 mg
Magnesium Sulfate COPD / Asthma / Stridor (p. 35)
2 g in 100ml NS or D5W IV/IO 
infusion over 10 minutes
Cardiac Arrest (p. 37) 2 g IV/IO push over 1-2 minutes
Tachycardia With A Pulse (p. 43) 2 g IV/IO push over 1-2 minutes
OB General (p. 50)
4 g in 100ml NS or D5W IV/IO 
infusion over 10 minutes
MARK I Kit Cholinergic / Organophosphate Overdose (p. 56)
2 mg Atropine IM & 
600 mg 2-PAM IM
Methylprednisone Asthma / COPD (p. 35) 125 mg IV/IO
Allergic Reaction (p. 46) 125 mg IV/IO
Medication Quick Reference – Adult, Medical
Medication Quick Reference – Adult, Medical
238

ST Elevation Myocardial Infarction (STEMI) (p. 42)
0.4 mg SL if IV present 
OR 1", 1.5" or 2" Nitro Paste 0.4 mg SL if no IV present 3 doses
Nitrous Oxide Pain Management (p. 58) Nitrous Oxide – Procedure (p. 197)
Norepinephrine Hypotension / Shock (Non-Trauma) (p. 63) 4-16 mcg/min (See Pressor Drip Sheet)
Hypotension / Shock (Trauma) (p. 85) 4-16 mcg/min (See Pressor Drip Sheet)
Medication Name Indication (Protocol Use) First Dose Second Dose Max Dose
Midazolam Airway Management (p. 32) for CPAP compliance 2 mg IV/IN
Post Advanced Airway Sedation (p. 34) 0.1 mg/kg IV/IO Max 5mg
CHF / Pulmonary Edema (p. 36) 2 mg IV/IN
Tachycardia With A Pulse (cardioversion) (p. 43)
0.1 mg/kg IV/IO
0.2mg/kg IM/IN
IV/IO Max 5 mg
IM/IN Max 10mg
Bradycardia With A Pulse (pacing) (p. 44)
0.1 mg/kg IV/IO
0.2mg/kg IM/IN
IV/IO Max 5 mg
IM/IN Max 10mg
Antipsychotic Overdose / Acute Dystonic Reaction (p. 55)
0.1 mg/kg IV/IO
0.2mg/kg IM/IN
IV/IO Max 5 mg
IM/IN Max 10mg
Cocaine and Sympathomimetic Overdose (p. 55)
0.1 mg/kg IV/IO
0.2mg/kg IM/IN
IV/IO Max 5 mg
IM/IN Max 10mg
Seizure (p. 61)
0.1 mg/kg IV/IO
0.2mg/kg IM/IN
IV/IO Max 5 mg
IM/IN Max 10mg
Bites and Envenomations (p. 68)
0.1 mg/kg IV/IO
0.2mg/kg IM/IN
IV/IO Max 5 mg
IM/IN Max 10mg
Environmental – Hyperthermia (p. 75) 0.1 mg/kg IV/IO Max 5mg
Naloxone Opioid Overdose (p. 55) 0.4-2.0 mg IN/IV/IO/IM
Nitroglycerin CHF / Pulmonary Edema (p. 36)
0.4 mg SL if IV present 
OR 1", 1.5" or 2" Nitro Paste 0.4 mg SL if no IV present 3 doses
Chest Pain / Suspected ACS (p. 41)
0.4 mg SL if IV present 
OR 1", 1.5" or 2" Nitro Paste 0.4 mg SL if no IV present 3 doses
Medication Quick Reference – Adult, Medical
Medication Quick Reference – Adult, Medical
239

Medication Name Indication (Protocol Use) First Dose Second Dose Max Dose
Ondansetron Post Advanced Airway Sedation (p. 34) 0.15mg/kg IV/IO/ODT/IM 4.0 mg
Chest Pain / Suspected ACS (p. 41) 0.15mg/kg IV/IO/ODT/IM 4.0 mg
ST Elevation MI (nausea) (p. 42) 0.15mg/kg IV/IO/ODT/IM 4.0 mg
Pain Management (p. 58) 0.15mg/kg IV/IO/ODT/IM 4.0 mg
Environmental – Hyperthermia (p. 75)
(ODT for cramps/exhaustion only)
0.15mg/kg IV/IO/ODT/IM 4.0 mg
Rocuronium Rapid Sequence Airway (RSA) (p. 33) 1.0 mg/kg 100 mg
Post Advanced Airway Sedation (p. 34) 1.0 mg/kg 100 mg
Sodium Bicarb Cardiac Arrest (hyperkalemia) (p. 37) 50 mEq IV/IO
Tricyclic Overdose (p. 55) 1 mEq/kg IV/IO over 5 minutes 100 mEq
Prolonged Crush Injury (p. 73) 50 mEq IV/IO
Hazmat General (p. 79) 2.5mL in 5mL NS, neb
Succinylcholine Rapid Sequence Airway (RSA) (p. 33) 2 mg/kg IV/IO 200 mg
2 mg/kg IV/IO 200 mg
Tranexamic Acid (TXA) Hemorrhage Control – Trauma (p. 81) 2 gm IV/IO over 1 minute 2 gm
Head Injury (p. 80) 2 gm IV/IO over 1 minute 2 gm
Medication Quick Reference – Adult, Medical
Medication Quick Reference – Adult, Medical
240

Airway Emergency Reference – Peds, Medical
Medication Name
Dose
Concentration
lbs
2-4
6-7
13-14
17-18
21-23
kg
1
3
6
8
10
Etomidate
0.3 mg/kg
2 mg/mL
Paralysis and Inducction
0.3mg / 0.2mL
0.9mg / 0.5mL
1.8mg / 0.9mL
2.4mg / 1.2mL
3mg / 1.5mL
Ketamine
2 mg/kg
100 mg/mL
2mg / 0.1mL
6mg / 0.1mL
12mg / 0.1mL
16mg / 0.2mL
20mg / 0.2mL
Succinylcholine
2 mg/kg
20 mg/mL
Rocuronium
1 mg/kg
10 mg/mL
Fentanyl
1 mcg/kg
50 mcg/mL
2mg / 0.1mL
6mg / 0.3mL
12mg / 0.6mL
16mg / 0.8mL
20mg / 1mL
1mg / 0.1mL
3mg / 0.3mL
6mg / 0.6mL
8mg / 0.8mL
10mg / 1mL
1mcg / 0.1mL
3mcg / 0.1mL
6mcg / 0.1mL
8mcg / 0.2mL
10mcg / 0.2mL
Midazolam Ketamine
0.05 mg/kg 2 mg/kg
5 mg/mL 100 mg/mL
Post Placement Management
0.05mg / 0.1mL 2mg / 0.1mL
0.15 / 0.1mL 6mg / 0.1mL
0.3mg / 0.1mL 10mg / 0.1mL
0.4mg / 0.1mL 16mg / 0.2mL
0.5mg / 0.1mL 20mg / 0.2mL
26-27 12 3.6mg / 1.8mL 24mg / 0.2mL 24mg / 1.2mL 12mg / 1.2mL 12mcg / 0.2mL 0.6mg / 0.1mL 24mg / 0.2mL
32-34
43-45
55-56
76-78
132-133
165-166
220-221
15
20
25
4.5mg / 2.3mL
6mg / 3mL
7.5mg / 3.8mL
30mg / 0.3mL
40mg / 0.4mL
50mg / 0.5mL
35
60
75
100
Max Dose
10.5mg / 5.3mL
18mg / 9mL
22.5mg / 11.3mL
30mg / 15mL
30mg / 15mL
70mg / 0.7mL
120mg / 1.2mL
150mg / 1.5mL
200mg / 2mL
200mg / 2mL
30mg / 1.5mL
40mg / 2mL
50mg / 2.5mL
70mg / 3.5mL
120mg / 6mL
150mg / 7.5mL
200mg / 10mL
200mg / 10mL
15mg / 1.5mL
20mg / 2mL
25mg / 2.5mL
35mg / 3.5mL
60mg / 6mL
75mg / 7.5mL
100mg / 10mL
100mg / 10mL
15mcg / 0.3mL
20mcg / 0.4mL
25mcg / 0.5mL
35mcg / 0.7mL
60mcg / 1.2mL
75mcg / 1.4mL
100mcg / 2mL
100mcg / 2mL
0.75mg / 0.15mL 30mg / 0.3mL
1mg / 0.2mL 40mg / 0.4mL
1.25mg / 0.25mL 50mg / 0.5mL
1.75mg / 0.35mL 70mg / 0.7mL
3mg / 0.6mL 120mg / 1.2mL
3.75mg / 0.75mL 150mg / 1.5mL
4mg / 0.8mL 200mg / 2mL
4mg / 0.8mL 200mg / 2mL
Airway Emergency Reference – Peds, Medical
241

Medication Name
Dose
Concentration
lbs
2-4
6-7
17-18
21-23
1
st Shock Epinephrine
(1:10,000)
2
nd Shock Amiodarone
Biphasic 0.01 mg/kg Biphasic 5 mg/kg
2 J/kg 0.1 mg/mL 4 J/kg 50 mg/mL
kg May repeat x 2
OR switch to Lidocaine
1 2 J 0.01mg / 0.1mL 4 J 5mg / 0.1mL
3 6 J 0.03mg / 0.3mL 12 J 15mg / 0.3mL
8 16 J 0.08mg / 0.8mL 32 J 40mg / 0.8mL
10 20 J 0.1mg / 1mL 40 J 50mg / 1mL
Atropine
0.02 mg/kg
0.1 mg/mL
0.1mg / 1mL
(minimum)
0.1mg / 1mL
(minimum)
0.16mg / 1.6mL
0.2mg / 2mL
Calcium
Gluconate
100 mg/kg
100 mg/mL
100mg / 1mL
300mg / 3mL
800mg / 8mL
1gm / 10mL
Sodium Bicarb
1 mEq/kg
1 mEq/mL
1mEq / 1mL
3mEq / 3mL
8mEq / 8mL
10mEq / 10mL
3
rd Shock
Biphasic
4-10 J/kg
4-10 J
12-30 J
32-80 J
40-100 J
Lidocaine
1 mg/kg
20 mg/mL
May repeat at 5-10 
minutes, ½ dose
1mg / 0.1mL
3mg / 0.2mL
8mg / 0.4mL
10mg / 0.5mL
26-27 12 24 J 0.12mg / 1.2mL 48 J 60mg / 61.2mL 0.24mg / 2.4mL 1gm / 10mL 12mEq / 12mL 48-120 J 12mg / 0.6mL
32-34
43-45
55-56
76-78
132-133
165-166
220-221
15 30 J 0.15mg / 1.5mL 60 J 75mg / 1.5mL
20 40 J 0.2mg / 2mL 80 J 100mg / 2mL
25 50 J 0.25mg / 2.5mL 100 J 125mg / 2.5mL
0.3mg / 3mL
0.4mg / 4mL
0.5mg / 5mL
1gm / 10mL
1gm / 10mL
1gm / 10mL
15mEq / 15mL
20mEq / 20mL
25mEq / 25mL
60-150 J
80-200 J
100-200 J
35 70 J 0.35mg / 3.5mL 140 J 175mg / 3.5mL
60 120 J 0.6mg / 6mL 200 J 300mg / 6mL
75 150 J 0.75mg / 7.5mL 200 J 300mg / 6mL
100 200 J 1mg / 10mL 200 J 300mg / 6mL
Max Dose 200 J 1mg / 10mL 200 J 300mg / 6mL
0.7mg / 7mL
1mg / 10mL
1mg / 10mL
1mg / 10mL
1mg / 10mL
1gm / 10mL
1gm / 10mL
1gm / 10mL
1gm / 10mL
1gm / 10mL
35mEq / 35mL
50mEq / 50mL
50mEq / 50mL
50mEq / 50mL
50mEq
140-200 J
200 J
200 J
200 J
200 J
15mg / 0.8mL
20mg / 1mL
25mg / 1.3mL
35mg / 1.8mL
60mg / 3mL
75mg / 3.8mL
100mg / 5mL
3 mg/kg
Medication Quick Reference – Peds Cardiac Arrest 
(General) p. 95
Medication Quick Reference – Peds Cardiac Arrest (General) p. 95
13-14 6 12 J 0.06mg / 0.6mL 24 J 30mg / 0.6mL 0.12mg / 1.2mL 600mg / 6mL 6mEq / 6mL 24-60 J 6mg / 0.3mL
242

Medication Name
Dose
Concentration
lbs
2-4
6-7
13-14
17-18
21-23
kg
1
3
6
8
10
Epinephrine
(1:10,000)
0.01 mg/kg
0.1 mg/mL
Every 3-5 min while 
setting up to pace
0.01mg / 0.1mL
0.03mg / 0.3mL
0.06mg / 0.6mL
0.08mg / 0.8mL
0.1mg / 1mL
Atropine
0.02 mg/kg
0.1 mg/mL
If Brady due to 
vagal tone
0.1mg / 1mL
(minimum)
0.1mg / 1mL
(minimum)
0.12 mg / 1.2mL
0.16mg / 1.6mL
0.2mg / 2mL
Midazolam 
INTRANASAL
0.2 mg/kg
5 mg/mL
Lorazepam IV
0.05 mg/kg
2 mg/mL
Midazolam IV
0.05 mg/kg
5 mg/mL
Sedation for Pacing
0.2mg / 0.1mL
0.6mg / 0.1mL
1.2mg / 0.2mL
1.6mg / 0.3mL
2mg / 0.4mL
0.05mg / 0.1mL
0.15mg / 0.1mL
0.3mg / 0.2mL
0.4mg / 0.2mL
0.5mg / 0.3mL
0.05mg / 0.1mL
0.15mg / 0.1mL
0.3mg / 0.1mL
0.4mg / 0.1mL
0.5mg / 0.1mL
Adenosine Adenosine
0.1 mg/kg 0.2 mg/kg
3 mg/mL 3mg / mL
First Dose Second Dose
0.1mg / 0.1mL 0.2mg / 0.1mL
0.3mg / 0.1mL 0.6mg / 0.2mL
0.6mg / 0.2mL 1.2mg / 0.4mL
0.8mg / 0.3mL 1.6mg / 0.5mL
1mg / 0.3mL 2mg / 0.7mL
Amiodarone
5 mg/kg
50 mg/mL
Infuse over 20-60 
minutes
5mg / 0.1mL
15mg / 0.3mL
30mg / 0.6mL
40mg / 0.8mL
50mg / 1mL
26-27 12 0.12mg / 1.2mL 0.24mg / 2.4mL 2.4mg / 0.5mL 0.6mg / 0.3mL 0.6mg / 0.1mL 1.2mg / 0.4mL 2.4mg / 0.8mL 60mg / 1.2mL
32-34
43-45
55-56
76-78
132-133
165-166
220-221
15
20
25
0.15mg / 1.5mL
0.2mg / 2mL
0.25mg / 2.5mL
0.3mg / 3mL
0.4mg / 4mL
0.5mg / 5mL
35
60
75
100
Max Dose
0.35mg / 3.5mL
0.6mg / 6mL
0.75mg / 7.5mL
1mg / 10mL
1mg / 10mL
0.5mg / 5mL
0.5mg / 5mL
0.5mg / 5mL
0.5mg / 5mL
0.5mg / 5mL
3mg / 0.6mL
4mg / 0.8mL
5mg / 1mL
7mg / 1.4mL
10mg / 2mL
10mg / 2mL
10mg / 2mL
10mg / 2mL
0.75mg / 0.4mL
1mg / 0.5mL
1.25mg / 0.6mL
1.75mg / 0.9mL
2mg / 1mL
2mg / 1mL
2mg / 1mL
2mg / 1mL
0.75mg / 0.2mL
1mg / 0.2mL
1.25mg / 0.3mL
1.75mg / 0.4mL
2mg / 0.4mL
2mg / 0.4mL
2mg / 0.4mL
2mg / 0.4mL
1.5mg / 0.5mL 3mg / 1mL
2mg / 0.7mL 4mg / 1.3mL
2.5mg / 0.8mL 5mg / 1.7mL
75mg / 1.5mL
100mg / 2mL
125mg / 2.5mL
3.5mg / 1.2mL 7mg / 2.3mL
6mg / 2mL 12mg / 4mL
6mg / 2mL 12mg / 4mL
6mg / 2mL 12mg / 4mL
6mg / 2mL 12mg / 4mL
175mg / 3.5mL
300mg / 6mL
300mg / 6mL
300mg / 6mL
300mg / 6mL
Tachycardia With A Pulse 
(
p. 98
)
Bradycardia With A Pulse 
(
p. 99
)
Medication Quick Reference – Peds Perfusing 
Arrhythmias, p. 98-99
Medication Quick Reference – Peds Perfusing Arrhythmias, p. 98-99
243

Medication Name
Dose
Concentration
lbs
2-4
6-7
13-14
17-18
21-23
Epinephrine IM
(1:1,000)
Epinephrine IV
(1:10,000)
0.01 mg/kg 0.005 mg/kg
1 mg/mL 0.1 mg/mL
kg
1 0.01mg / 0.1mL 0.005mg / 0.1mL
3 0.03mg / 0.1mL 0.03mg / 0.3mL
6 0.06mg / 0.1mL 0.06mg / 0.6mL
8 0.08mg / 0.1mL 0.08mg / 0.8mL
10 0.1mg / 0.1mL 0.1mg / 1mL
Albuterol
2.5 mg / 3mL
Diphenhydramine
1 mg/kg
50 mg/mL
1mg / 0.1mL
3mg / 0.1mL
6mg / 0.1mL
8mg / 0.2mL
10mg / 0.2mL
Famotidine
0.5 mg/kg
10 mg/mL
0.5mg / 0.1mL
1.5mg / 0.2mL
3mg / 0.3mL
4mg / 0.4mL
5mg / 0.5mL
Epinephrine gtt
0.1-1 mcg/kg/min
1mg of 1:1,000 in 250mL D5W
1mcg/min / 15gtt/min
3mcg/min / 45gtt/min
6mcg/min / 90gtt/min
8mcg/min / 120gtt/min
10mcg/min / 150gtt/min
Methylprednisolone
2 mg/kg
62.5 mg/mL
2mg / 0.1mL
6mg / 0.1mL
12mg / 0.2mL
16mg / 0.3mL
20mg / 0.3mL
26-27 12 0.12mg / 0.1mL 0.1mg / 1mL 12mg / 0.2mL 6mg / 0.6mL 10mcg/min / 150gtt/min 24mg / 0.4mL
32-34
43-45
55-56
76-78
132-133
165-166
220-221
15 0.15mg / 0.2mL 0.1mg / 1mL
20 0.2mg / 0.2mL 0.1mg / 1mL
25 0.25mg / 0.3mL 0.1mg / 1mL
15mg / 0.3mL
20mg / 0.4mL
25mg / 0.5mL
7.5mg / 0.8mL
10mg / 1mL
12.5mg / 1.3mL
10mcg/min / 150gtt/min
10mcg/min / 150gtt/min
10mcg/min / 150gtt/min
35 0.3mg / 0.3mL 0.1mg / 1mL
60 0.3mg / 0.3mL 0.1mg / 1mL
75 0.3mg / 0.3mL 0.1mg / 1mL
100 0.3mg / 0.3mL 0.1mg / 1mL
Max Dose 0.3mg / 0.3mL 0.1mg / 1mL
35mg / 0.7mL
50mg / 1mL
50mg / 1mL
50mg / 1mL
50mg / 1mL
17.5mg / 1.8mL
20mg / 2mL
20mg / 2mL
20mg / 2mL
20mg / 2mL
10mcg/min / 150gtt/min
10mcg/min / 150gtt/min
10mcg/min / 150gtt/min
10mcg/min / 150gtt/min
10mcg/min / 150gtt/min
30mg / 0.5mL
40mg / 0.6mL
50mg / 0.8mL
70mg / 1.1mL
120mg / 1.9mL
125mg / 2mL
125mg / 2mL
125mg / 2mL
Medication Quick Reference – Peds Allergic Reaction, p. 100
244
Medication Quick Reference – Peds Allergic Reaction, 
p. 100

Disposable Diaper ROUGH Weight Estimate Chart
Diaper Size
P
N
1
2
3
4
5
6
7
Medication Name
Dose
Concentration
lbs
2-4
6-7
13-14
17-18
21-23
kg
1
3
6
8
10
Midazolam 
INTRANASAL
0.2 mg/kg
5 mg/mL
Lorazepam IV
0.1 mg/kg
2 mg/mL
Midazolam IV
0.1 mg/kg
5 mg/mL
0.2mg / 0.1mL
0.6mg / 0.1mL
1.2mg / 0.2mL
1.6mg / 0.3mL
2mg / 0.4mL
Glucagon IM D10
3 mL/kg
0.1mg / 0.1mL
0.3mg / 0.2mL
0.6mg / 0.3mL
0.8mg / 0.4mL
1mg / 0.5mL
0.1mg / 0.1mL
0.3mg / 0.1mL
0.6mg / 0.1mL
0.8mg / 0.2ml
1mg / 0.2mL
0.5mg
0.5mg
0.5mg
0.5mg
0.5mg
3mL
9mL
18mL
24mL
30mL
26-27 12 2.4mg / 0.5mL 1.2mg / 0.6mL 1.2mg / 0.2mL 0.5mg 36mL
lbs
<6
<10
8-14
12-18
16-28
22-37
27+
35+
41+
kg
<2.7
<4
3-6
5-8
7-13
9-17
12+
16+
18+
32-34
43-45
55-56
76-78
132-133
165-166
220-221
15
20
25
35
60
75
100
Max Dose
3mg / 0.6mL
4mg / 0.8mL
5mg / 1mL
7mg / 1.4mL
10mg / 2mL
10mg / 2mL
10mg / 2mL
10mg / 2mL
1.5mg / 0.8mL
2mg / 1mL
2mg / 1mL
2mg / 1mL
2mg / 1mL
2mg / 1mL
2mg / 1mL
2mg / 1mL
1.5mg / 0.3mL
2mg / 0.4mL
2.5mg / 0.5mL
3.5mg / 0.7mL
6mg / 1.2mL
7.5mg / 1.5mL
10mg / 2mL
10mg / 2mL
0.5mg
0.5mg
1mg
45mL
60mL
75mL
1mg
1mg
1mg
1mg
1mg
105mL
125mL
125mL
125mL
125mL
Medication Quick Reference – Peds Seizure, p. 109
Medication Quick Reference – Peds Seizure, p. 109
245

Approved Abbreviations
A&O x 3
Alert and Oriented to Person, Place and 
Time C/O Complains Of
A&O x 4
Alert and Oriented to Person, Place, 
Time and Events
A-Fib Atrial Fibrillation
AAA Abdominal Aortic Aneurysm
ABC’s Airway, Breathing and Circulation
ABD Abdomen
ACLS Advanced Cardiac Life Support
AKA Above The Knee Amputation
ALS Advanced Life Support
AMA Against Medical Advice
AMS Altered Mental Status
AMT Amount
APPROX Approximately
ASA Aspirin
ASSOC Associated
BG Blood Glucose
BILAT BIlateral
BKA Below The Knee Amputation
BLS Basic Life Support
BM Bowel Movement
BP Blood Pressure
BS Breath Sounds
BVM Bag-Valve Mask Ventilations
C-SECTION Caesarean Section
C-SPINE Cervical Spine
CA Cancer
CABG Coronary Artery Bypass Graft
CAD Coronary Artery Disease
CATH Coronary Catheter
CC Chief Complaint
CCR Cardiocerebral Resuscitation
CT Computed Tomography (CAT Scan)
CVA Cerebrovascular Accident (Stroke)
D5W 5% Dextrose in Water
DKA Diabetic Ketoacidosis
DNR Do Not Resuscitate
DOA Dead on Arrival
DOB Date of Birth
DOE Dyspnea on Exertion
DT Delirium Tremens
CHF Congestive Heart Failure
CMS Circulation, Motor, Sensation
CNS Central Nervous System
COPD Chronic Obstructive Pulmonary Disease
CP Chest Pain
CPAP Continuous Positive Airway Pressure
CPR Cardiopulmonary Resuscitation
CSF Cerebrospinal Fluid
DVT Deep Vein Thrombosis
HOME TABLE OF CONTENTS 246 PHARMACEUTICALS BACK

Approved Abbreviations
Dx Diagnosis
ECG Electrocardiogram HTN Hypertension
ED Emergency Department
EEG Electroencephelogram
EMT-B EMT Basic
EMT- A Advanced EMT
EMT-P Paramedic
ET Endotracheal
EtOH Ethanol (alcohol)
ETT Endotracheal Tube
EXT External (extension)
°F Farenheit
FB Foreign Body
FLEX Flexion
Fx Fracture
g gram(s) 
GERD Gastroesophageal Reflux Disease
GI Gastrointestinal
GSW Gunshot Wound
gtts “Guttae” (Latin for drops)
GU Genitourinary
GYN Gynecology (gynecological)
H/A Headache
HEENT Head, Eyes, Ears, Nose, Throat
HR Heart Rate
Hx History
ICP Intracranial Pressure
ICU Intensive Care Unit
IDDM Insulin-Dependent Diabetes Mellitus
IM Intramuscular
IN Intranasal
LAT Lateral
lb pound 
LLQ Left Lower Quadrant
LMP Last Menstrual Period
LOC Level of Consciousness /
Loss of Consciousness
LR Lactated Ringers
LUQ Left Upper Quadrant
MAST Military Anti-Shock Trousers
mcg microgram(s)
IO Intraosseous
IV Intravenous
JVD Jugular Vein Distention
kg kilogram 
KVO Keep Vein Open
L-SPINE Lumbar Spine
L/S-SPINE Lumbarsacral Spine
L&D Labor and Delivery
247
ERG Emergency Response Guide
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Approved Abbreviations
MED Medicine Peds Pediatric
mg miligram(s)
MI Myocardial Infarction (heart attack)
min minimum/minute
MRI Magnetic Resonance Imaging
MS Mental Status
MVA Motor Vehicle Accident
MVC Motor Vehicle Crash
N/V Nausea/Vomiting
N/V/D Nausea/Vomiting/Diarrhea
NAD No Apparent Distress
NG Nasogastric Tube
NC Nasal Cannula
NEB Nebulizer
NIDDM Non Insulin-Dependent Diabetes 
Mellitus
NKDA No Known Drug Allergies
NRB Non-Rebreather
NS Normal Saline
NSR Normal Sinus Rhythm
O2 Oxygen
OB/GYN Obstectrics/Gynecology
PA Physician Assistant
PALP Palpation
PAC Premature Atrial Contraction
PE Pulmonary Embolus
PERRL Pupils Equal, Round, Reactive to Light
PMHx Past Medical History
PO Per Os (By Mouth)
PRN Pro Re Nata (As Needed)
PT Patient
PVC Premature Ventricular Contraction
SVT Supraventricular Tachycardia
Sx Symptom
SZ Seizure
T-SPINE Thoracic Spine
TB Tuberculosis
Temp Temperature
TIA Transient Ischemic Attack
TKO To Keep Open
Tx Treatment
RLQ Right Lower Quadrant
RN Registered Nurse
RUQ Right Upper Quadrant
S/P Status Post
SOB Shortness of Breath
SQ Subcutaneous
ST Sinus Tachycardia
Rx Medicine
248
MD Medical Doctor
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

Approved Abbreviations
URI Upper Respiratory Infection
UTI Urinary Tract Infection
VF Ventricular Fibrillation
VS Vital Signs
VT Ventricular Tachycardia
WAP Wandering Atrial Pacemaker
WNL Within Normal Limits
YO (YOA) Years Old (Years of Age)
+ Positive
- Negative
? Questionable
~ Approximately
> Greater Than
< Less Than
= Equal
ACS-COT American College of Surgeons 
Committee on Trauma
ACEP American College of Emergency 
Physicians
SAEM Society of Academic Emergency 
Medicine
NAEMSP National Association of EMS Physicians
NREMT National Registry of EMTs
AAP American Academy of Pediatrics
AHA American Heart Association
ILCOR International Liaison Committee on 
Resuscitation
249
UOA Upon Our Arrival
TXA Tranexamic Acid
ECPR Extracorporeal Cardiopulmonary CPR
TEMS Tactical EMS
HPCPR High Performance CPR
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

INDEX
12-Lead ECG Capnography
Abdominal Pain
Acute Coronary Syndrome (ACS)
Airway Management, Adult
Airway Obstruction
Airway Endotracheal Intubation, Adult
Airway Suctioning
Airway Video Laryngoscopy
Allergic Reaction, Adult
Altered Mental Status, Adult
Anticholinergic
Antidepressants
Antipsychotics
Asthma, Adult
Asystole, Adult
Atrial Fibrillation/Flutter, Adult
BE-FAST Stroke Screen
Behavioral
Beta Blocker
Bites, Adult
Blood Glucose Analysis
Bradycardia, Adults
Bougie
Burns, Adult
Calcium Channel Blockers
Carbon Monoxide
Cardiac Arrest, Adult
Cardiac Arrest – Traumatic, Adult
Cardioversion
Chemical Burns
Chest Decompression
CPAP
CPR – Cardiopulmonary Resuscitation
Cricothyrotomy
Cricothyrotomy – Control Cric
Cricothyrotomy – Open (Surgical)
Criteria for Death
Crush Injury, Adult
Cyanide Poisoning
Defibrillation (Manual and AED)
Chest Injury, Adult
Chest Pain
CHF – Congestive Heart Failure
Child Abuse
Child Birth
Cocaine
Conducted Electrical Device (TASER)
COPD – Chronic Obstructive Pulmonary Disease
Destination
129
45
41
32
132
134
142-143
135
46
55
55
35
37
43
165
47
55
68
152
44
69
55
147
57
37
70
154
71
164
146
155
148
150
149
15
73
157
72
41
36
16
52
55
83
35
11
HOME TABLE OF CONTENTS 250 PHARMACEUTICALS BACK

INDEX
Diabetic Emergencies, Adult
DNR – Do Not Resuscitate Hypothermia, Adult
Documentation
Domestic Violence
Double Sequential Defibrillation
ECG
Elder Abuse
Electrical Burns
Envenomations, Adult
Excited Delirium 
External Cardiac Pacing
Extracorporeal Cardiopulmonary Resuscitation 
(ECPR) 
Extremity Injury, Adult
Eye Pain, Adult
Failed Airway, Adult
GI Bleeding
Hazardous Materials
Head Injury, Adult
Hemorrhage Control, Adult
HEMS – Helicopter EMS
High Performance CPR (HPCPR)
Hypertension
Hyperthermia, Adult
Hypotension, Non-Trauma, Adult
Intercept Guidelines
Interhospital
Intranasal
Intravenous Access – Extremity IV
Intubation
King Airway
Norepinephrine
OB General
Opioid OD
Organophosphates
Orogastric Tube Insertion
Pain Management, Adult
Paramedic / Non-Paramedic
Labor (Imminent Delivery)
Lightning Strike
Lights/Sirens During Patient Transport
LMA – Laryngeal Mask Airway
Long Board Selective Spinal Immobilization
Tachycardia With A Pulse, Adult
Newly Born
Nitrous Oxide
48
14
18
19
158
129
16
71
68
159
39
77
78
45
79
80
81
12
156
75
63
76
23
20
167
177
134
138
225
50
55
56
168
58
22
52
82
21
84
43
53
182
251
Needle Jet Insufflation
Nerve Agent
151
Drowning (Near), Adult 74
Hypotension, Trauma, Adult 85
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

INDEX
Pediatric – Airway Management Pediatric – Neonatal Resuscitation
Pediatric – Allergic Reactions
Pediatric – Altered Mental Status
Pediatric – Brief Resolved Unexplained Event (BRUE)
Pediatric – Asthma 
Pediatric – Asystole
Pediatric – Bradycardia With A Pulse
Pediatric – Bites/Envenomations 
Pediatric – Burns
Pediatric – Cardiac Arrest
Pediatric – Cardiac Arrest (Traumatic)
Pediatric – Chest Injury
Pediatric – Crush Prolonged
Pediatric - Destination
Pediatric – Diabetic Emergencies
Pediatric – Drowning (Near)
Pediatric – Endotracheal Intubation
Pediatric – Eye Pain
Pediatric – Failed Airway
Pediatric – Head Injury
Pediatric – Hemorrhage Control
Pediatric – Hypotension / Shock (Non-Trauma)
Pediatric – Pain Management
Pediatric – Post Resuscitation
Pediatric – Pulseless Electrical Activity PEA
Pediatric – Refusal 
Pediatric – Seizure 
Pediatric – Sexual Assault
Police Custody
Posterior ECG
Post-Resuscitation, Adult
Post Advanced Airway Sedation, Adult
Pulmonary Edema
Pulse Oximetry
Pulseless Electrical Activity PEA, Adult
Pediatric – Sickle Cell Crisis
Pediatric – Spinal Immobilization
Pediatric – Tachycardia With A Pulse
Pediatric – Vfib/Pulseless Vtach Arrest
Pediatric – Wheezing 
Pharmaceuticals 
Medical Provider Bystander On Scene
Poison Control
90
100
102
93
95
99
117
118
93
116
119
120
88 / 114
103
121
136
125
126
127
110
94
107
97
95
108
109
27
131
40
34
36
133
95
111
128
98
95
93
191
25
26
252
Patient Care During Transport
Pediatrics
24
87
Pediatric – IV Access
Pediatric – Overdose and Poisoning
104
105
Patient Without A Protocol Pediatric - HyperthermiaPHARMACEUTICALS 122
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

INDEX
Rapid Sequence Airway RSA
Venous Access - Extremity
Rehab – Public Safety Personnel
Refusal, Adult
Restraints
Right Sided ECG
Seizure, Adult
Sexual Assault, Adult
Shock (Non-Trauma), Adult
Spinal Immobilization
Spinal Immobilization - Athletes
Splinting 
STEMI – ST Elevation Myocardial Infarction
Stroke
Suctioning
Sympathomimetic
TASER
Termination of Resuscitation
Thrombolytic Screening
Tourniquet (Combat Application Tourniquet)
Venous Access – Intraosseous (IO)
V Fib / Pulseless V Tach, Adult
WMD (Weapons of Mass Destruction)
Wound Care
33
86
59-60
169
130
61
63
170
171
172
42
64
142
55
83
15
174
177
178
37
180
253
Wound Packing 180
Radio Report 28
Sepsis Screening, Adult 62
Tracheostomy Care 144
Tranexamic Acid 230
Tricyclic Antidepressant
Vaginal Bleeding
Venous Access – EJ (External Jugular)
55
51
179
Venous Access – Existing PICC, etc. 176
Tourniquet (SOF-T Wide Tourniquet) 175
Transfer Of Care
Trauma General, Adult
29
66
HOME TABLE OF CONTENTS PHARMACEUTICALS BACK

HOME TABLE OF CONTENTS PHARMACEUTICALS BACK
International SOS Responder Resources
“In case you haven’t felt it today… You are appreciated.
In case you wanted to quit today… Don’t. You are needed.
In case you need to talk but feel no one will listen… There are many who will. In 
case you haven’t heard it today… THANK YOU”
Employee Assistance Program (EAP)
TOLL FREE: +1 888 851 7032
DIRECT LINE: +1 919 706 4551
EMAIL: support@resourcesforyourlife.com
WEBSITE: http://global.resourcesforyourlife.com
COMPANY CODE: CMAHI
iConnectYou (iOS & Android)
COMPANY PASSCODE: 224710
International SOS Medical Direction
Chief Medical Officer
Dr. David Angelette
david.angelette@internationalsosgs.us
Deputy Medical Director
Dr. Jonathan Campbell 
jonathan.campbell@internationalsosgs.us
International SOS Clinical Operations
Clinical Operations Director
Tom Nagle 
tom.nagle@internationalsosgs.us
Clinical Operations Director
Alexander Smith 
alexander.smith@internationalsosgs.us
International SOS Emergency Medical Services
EMS Chief
Aaron Duncan 
aaron.duncan@internationalsosgs.us
EMS Deputy Chief
Justin McGowan
justin.mcgowan@internationalsosgs.us